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Abstract 
Where is the Person in Symptom Cluster Research? The Experience of 
Symptom Clusters in Patients with Advanced Lung Cancer 
 
This thesis describes a three-year qualitative study which aimed to 
explore the experience of symptom clusters in patients with advanced 
lung cancer.  The study employed a patient-focused approach 
utilising Interpretative Phenomenological Analysis (IPA) (Smith et al. 
2009a).  This methodology (IPA), informed by a contextual 
constructionist stance, was selected to explore the experience of 
symptom clusters, for its focus on the lived experience, the context 
and meanings which surround such experiences and its idiographic 
approach.   
 
Ten patients (a sample size which is the upper limit of the number of 
participants advocated for studies employing IPA (Smith et al. 
2009b;Reid et al. 2005;Smith and Osborn 2004)) with advanced lung 
cancer took part in the study and data were collected using 
unstructured, in-depth interviews at two time points: on recruitment 
and three to five weeks later.  Data were analysed using 
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Interpretative Phenomenological Analysis, within the framework 
advocated by Smith and Osborn (2003).   
 
The study generated interesting and significant findings.  The 
experience of symptom clusters in patients with advanced lung 
cancer was characterised by two super-ordinate themes: „The lived 
experience of symptom clusters and the role of context and meaning‟ 
and „Symptom clusters and loss of sense of self‟.    
 
The super-ordinate theme of „The lived experience of symptom 
clusters and the role of context and meaning‟ in the first instance, 
illustrates that the participants in this study were experiencing 
symptom clusters and providing detail on the components, nature 
and patterning of the symptom clusters reported, particularly the way 
that one or two salient symptoms were commonly highlighted from 
all the other symptoms experienced.  This super-ordinate theme also 
demonstrates the core role that context and meaning play in the 
lived experience of symptom clusters, with many of the participants 
in this study framing their experiences of symptom clusters within a 
fear of death, stigma and loss of sense of self.   
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The second super-ordinate theme informing this thesis is „Symptom 
clusters and loss of sense of self‟.  This super-ordinate theme 
illustrates the impact of symptom clusters on the participants‟ lives, 
and how this, in turn, impacted on their sense of self in a number of 
different ways.  For some, their sense of self was compromised by 
the concurrent symptoms that they were experiencing, as they 
prevented them from undertaking roles and activities that they were 
accustomed to in the past.  This super-ordinate theme also highlights 
the role of the body relative to the self, and describes how the 
participants‟ sense of self was transiently lost during periods when 
they experienced symptom clusters of high severity.  The findings 
presented also demonstrate the knock-on effect of loss of sense of 
self experienced, with the participants feeling like they were a burden 
due to their incapacitation, and at times hiding the multiple 
symptoms that they were experiencing, in a bid to protect their loved 
ones from their illness.  In light of the loss of sense of self 
experienced, this super-ordinate theme also demonstrates how the 
participants employed various strategies in a bid to try and maintain 
a coherent and valued sense of self.   
 
The findings presented illustrate how the use of IPA facilitated the 
collection of data that provided an in-depth understanding of the 
complexity of the experience of symptom clusters in patients with 
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advanced lung cancer, adding a unique contribution to this body of 
knowledge.  
 
The results of this study highlight the limitations of definitions that 
currently underpin the study of symptom clusters in patients with 
cancer and the current empirical base to date, particularly the way 
that they do not acknowledge the core role that context and meaning 
play in the lived experience of this phenomenon.  This lack of 
recognition of these core elements of the patient experience of 
symptom clusters poses the risk of this body of research producing 
data that have limited relevance to the patient and therefore clinical 
practice.   
 
It is therefore proposed that the study of symptom clusters in 
patients with cancer needs to move away from the reductionist 
approach which currently dominates and to broaden its scope, to one 
that acknowledges the complexity of the experience of symptom 
clusters, the core role that context and meaning play in such 
experiences, and contributions that patient experience can make in 
advancing this important and emerging body of research.   
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Chapter 1:  Introduction 
 
1.1 Rationale for thesis 
My interest in the concept of symptom clusters and rationale for this 
thesis started when I was contemplating undertaking a PhD and 
looking at potential topics in which to base my thesis on.  I knew that 
I wanted to carry out my research in the area of cancer symptom 
management based on my clinical background and research interests 
at that time, however, I also wanted to research into an area that 
was relatively novel but at the same time had the potential to make a 
positive impact within clinical practice. 
 
I had read an editorial which discussed a relatively new concept of a 
symptom cluster in patients with cancer.  Immediately on reading 
this editorial, this topic captured my attention, particularly as it was 
introducing a different approach to symptom management that had 
not previously been explored and had real potential to make a 
dramatic change within clinical practice.  My enthusiasm was 
heightened by my previous extensive clinical experience in caring for 
people with lung cancer.    
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From my experiences of working with this patient population and with 
wider reference to the literature, I was aware that lung cancer was 
one of the commonest forms of cancer (International Agency for 
Research on Cancer 2000) and that its incidence was increasing in 
many countries (Ferlay et al. 2007).  I was also cognisant of the fact 
that it was the leading cause of cancer-related deaths in men and 
women in Europe (International Agency for Research on Cancer 
2000), with only 12% of people living 5 years or more, and with this 
figure being significantly less for people residing in the UK (Sant et 
al. 2009).  Linked to such poor survival figures was also an 
awareness that most people with lung cancer died within an 8-12 
month period of diagnosis (Sola et al. 2004), and that this factor was 
significantly influenced by the fact that they often presented with 
advanced disease (Corner et al. 2005).  Therefore, based on my 
clinical practice, I was aware that for most patients, within this short 
space of time, had to undergo a range of invasive procedures and 
toxic treatments such as chemotherapy and radiotherapy, whilst at 
the same time having to deal with supportive and palliative care 
issues due to both the trajectory of the disease and the side-effects 
of treatment.   
 
Therefore, it was not surprising that this group of patients commonly 
experience multiple symptoms (Cleeland 2007; Cooley et al. 
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2003b;Cooley et al. 2002; Cooley 2000; Sarna and Brecht 1997; 
Sarna 1993), experience significant distress due to their symptoms 
(Molassiotis et al. 2010; Cooley et al. 2003b; Cooley et al. 2002; 
Cooley 2000;Tishelman et al. 2000; Degner and Sloan 1995) and are 
reported to have a significant number of concerns regarding 
existential issues (Coyle 2006; Coyle 2004; Weisman and Worden 
1977).  Therefore, I felt that to conduct research in the area of 
symptom clusters would be of considerable benefit to patients with 
lung cancer and had the potential to make a significant contribution 
to clinical practice in the future.   
 
However, whilst I found the concept of symptom clusters in patients 
with cancer of significant interest, on reading the literature pertaining 
to this area of research I was surprised at the lack of scientific 
evidence informing this concept and the way that symptom clusters 
were portrayed using statistical associations, which I felt represented 
little of the underlying reality of the symptom experience which I had 
witnessed in practice for a number of years.  For months I kept 
thinking that I must be missing some seminal papers, that surely this 
concept had not been developed and explored without an 
appreciation of the experiential expert - the patient.  However, my 
endless searches remained futile, leading me to the conclusion that 
this really was the case, and that to date, no study had formally 
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explored the patient‟s perspective of this concept of symptom 
clusters in the context of their lives.  I therefore decided that, in light 
of the significant limitations identified, I would make a novel 
contribution of knowledge and conduct a study formally exploring the 
experience of symptom clusters in patients with cancer from their 
perspective.   
 
For the purpose of this study, a symptom cluster is defined as being 
the experience of three or more concurrent symptoms.  This 
definition of symptom clusters used in this thesis is based on existing 
definitions of symptom clusters in patients with cancer which purport 
that „concurrence‟ is a core characteristic of this phenomenon (Kim et 
al. 2005; Dodd et al. 2001b) and where the number of symptoms 
thought to constitute a symptom cluster is three or more (Dodd et al. 
2001a; Dodd et al. 2001b).  Furthermore, the characteristic of 
concurrence has been used as evidence of symptom clustering in 
previously published qualitative studies of symptom clusters in 
patients with cancer (Lopez et al. 2011; Molassiotis et al. 2010; 
Molassiotis et al. 2008).  In addition, the term symptom cluster used 
in this thesis includes symptoms which are derived from the toxicities 
of cancer related treatments.  This characteristic of symptom 
clustering is recognised in existing definitions of symptom clusters, 
where it is stated that symptoms within a cluster may originate from 
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different aetiologies (Kim et al. 2005; Dodd et al. 2001b).  
Furthermore, several papers have been published in the literature 
which report on treatment related symptom clusters in patients with 
cancer (Kim et al. 2009; Maliski et al. 2008; Hadi et al. 2008b; Given 
et al. 2007; Kim et al. 2007; Nail et al. 2006; Francoeur 2005).   
 
I decided that the best way to explore the patient experience of this 
concept was to use a qualitative approach as discussed in chapter 4 
which, instead of trying to reduce the experience to statistical 
associations, would embrace the experience of symptom clusters in 
patients with cancer in all its complexity and reality.  This choice was 
based on my epistemological stance and belief that knowledge is 
influenced by the perceptions of the person in the context of their 
lives, and that there is not one but many knowledges about any one 
phenomenon.   
 
Having decided on a qualitative approach I then had to decide on 
what methodology would be most appropriate to address the aim of 
my study and the research questions posed.  IPA was selected for its 
affinity with my epistemological stance and its focus on the lived 
experience and the role of cognitions, which I felt were central to 
explore and understand the experience of this phenomenon from the 
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perspective of the patient.  Furthermore, in comparison to the other 
methodological approaches which I considered, IPA paid particular 
homage to the idiographic experience at the level of the individual, 
which I felt was extremely important and strengthened the patient-
centred approach that I intended to adopt. 
 
Patients with advanced lung cancer were selected for the study 
sample primarily as they are known to commonly experience multiple 
concurrent symptoms and have been reported to experience higher 
levels of symptom severity and distress compared to patients with 
other cancer types (Cooley 2000).  Furthermore, a number of various 
symptom clusters had already been reported in this patient group in 
the literature (Wang et al. 2008; Brown et al. 2007; Fox and Lyon 
2006; Wang et al. 2006; Gift et al. 2004; Gift et al. 2003).  As stated 
earlier, although secondary to the selection of the study sample, this 
choice appeared to be fitting in light of this group of patients giving 
me the original impetus to explore this concept further in patients 
with advanced lung cancer, and my significant clinical experience of 
caring for them.   
 
The method of data collection was once again informed by my 
epistemological stance (contextual constructionist) and a drive to 
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maintain a patient focus, and to explore the concept as far as 
possible from the perspective of the patient within the context of 
their lives.  Consistent with IPA, I therefore chose unstructured 
interviews, as I felt that this approach facilitated the inductive 
bottom-up generation of data, allowing the participants to talk about 
issues of importance to them in their lives in the first instance, before 
focussing upon their experience of symptom clusters.  Such an 
approach facilitated the collection of data which allowed me to 
elucidate the participants‟ experiences of symptom clusters within the 
context of their lives, which I felt was fundamental to me 
understanding such experiences and therefore addressing the aims 
and research questions posed in this study. 
 
As will be evident in the following chapters of this thesis, the 
approach used in this study provides a detailed and realistic 
understanding of the experience of symptom clusters in patients with 
advanced lung cancer, making an important contribution to this body 
of knowledge.  Having outlined the rationale and approach used in 
this thesis, I will now provide a brief summary of the structure of this 
thesis.   
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1.2 Structure of thesis  
The following two chapters of this thesis (chapters 2 and 3) begin 
with a review of the literature. The literature in these chapters was 
identified from various sources, including database searches, PhD 
theses, conference proceedings and reference lists from key research 
papers.  Key words for literature searching were identified from the 
study aims and from articles accessed in the early stages of the 
review and these are displayed in table 1 below.  However, whilst 
using such keywords proved to be successful in identifying the 
literature pertaining to symptom clusters in patients with cancer, 
they were of less benefit in identifying seminal works relating to 
medical anthropology or the sociological study of illness and disease, 
aspects of which I was aware would form a significant part of review 
and critique of the literature.  Therefore, to substantiate the search of 
databases detailed in table 1, I also had to identify some seminal 
works pertaining to such areas (Kleinman 1988b; Cassell 1982; Good 
and Good 1980; Kleinman 1980; Cassell 1978) and use them as a 
source of identifying more and recent perspectives on the study of 
health and illness. 
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Table 1:  Databases used for literature search according to topic and keywords (no 
date range applied) 
Database Keywords Hand-searched journals 
CINAHL 
Medline 
PsychInfo 
ASSIA 
Lived Experience 
Experience 
Symptom/s 
Side Effect/s 
Toxicity/Toxicities 
Symptom Cluster/s 
Lung Cancer 
Cancer 
Cancer Nursing 
Oncology Nursing Forum 
Journal of Pain and 
Symptom Management 
 
 
The second chapter of this thesis, „The Illness Experience‟, starts by 
discussing different conceptualisations of the illness experience, 
highlighting the contrasting assumptions made within each approach.  
It then highlights how, to date, the biomedical model, with its focus 
on disease and the physical domains of the illness experience, 
continues to dominate current health care.  Using a critique of the 
literature, whilst recognising the substantial benefits of the 
biomedical model to date, I review the multiple challenges made to it 
over the past four decades.  I discuss how many of the challenges 
made some years ago remain valid today, particularly the limitation 
of the biomedical model to fully include lay perspectives of illness, its 
affinity with reductionist methods of measurement and its neglect of 
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context.  This discussion is then followed by an exploration of the 
alternative models which have been developed in direct response to 
many of the identified criticisms of the biomedical model.  It is 
argued that these models offer a more humanistic approach to the 
experience of illness, which go far beyond the physical confines of the 
biomedical model and therefore may be argued to be more fitting to 
deal with the complexities of the illness experience. 
 
The third chapter of the thesis continues the critique of a reductionist 
approach and discusses its dominance in the study of symptom 
clusters in patients with cancer.  It debates how current definitions 
have employed a biomedical stance, defining symptom clusters in 
terms of relationships between symptoms, the aetiology of symptoms 
and the impact of symptoms on patient outcomes.  It is argued that 
the biomedical perspective employed in current definitions has 
influenced the way that researchers have approached the study of 
symptom clusters in patients with cancer, with most studies 
employing quantitative approaches and reductionist methods of 
measurement.  It is argued that whilst such approaches have 
contributed to the knowledge base of symptom clusters in patients 
with cancer, the predominant use of quantitative methodology has 
resulted in a body of evidence which explains the concept of 
symptom clusters primarily using statistical associations which, it is 
11 
 
contended, reflect a narrow view of the underlying reality of the 
experience of symptom clusters in the patients‟ lives.  It is therefore 
postulated that in order to develop and strengthen the concept of 
symptom clusters in patients with cancer, it is imperative that the 
patient‟s perspective of this phenomenon is explored.   
 
The discussion in Chapter 4 follows the arguments made in the 
literature review chapters and explores the need to understand the 
patient experience of symptom clusters using an individualised 
approach and highlights the rationale for adopting a qualitative 
approach utilising IPA in the current study.  Chapter 5 describes in 
detail the aims, study design, sample recruited to the study, and the 
rationales for the choice of the particular methods that were 
employed.  The chapter also considers how these data were 
analysed.   
 
In Chapter 6, the conduct and the findings from the pilot study and 
the modifications that were made in preparation for the main study 
are presented.  In Chapter 7, the findings of this study are introduced 
as well as the patient sample, and details of the interviews conducted 
in this study.  In chapters 8 and 9, the study findings are presented, 
describing the two super-ordinate themes („The lived experience of 
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symptom clusters and the role of context and meaning‟ and 
„Symptom clusters and loss of sense of self‟) identified in this study 
and the themes that inform these.  In Chapter 10, the strengths and 
limitations of the study are considered and the findings discussed in 
relation to the wider literature and existing research.  The 
implications of the study findings for future research and clinical 
practice are also considered in this chapter.  
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Chapter 2: The illness experience 
 
2.1 Introduction 
This chapter sets the scene for this study and discusses different 
perspectives and approaches to the experience of illness.  It starts by 
discussing the work of seminal authors, such as Kleinman (1988b) 
and Cassel (1982) who argue that disease and illness are two 
fundamentally different concepts.  It then goes on to discuss how 
within current healthcare the concept of „disease‟, with its close 
affinity to the biomedical model of care, continues to dominate, 
despite significant limitations being identified, particularly the passive 
role that it affords the patient and its oversimplification of the illness 
experience.  This discussion then extends and encompasses 
alternative models which have been developed in direct response to 
the criticism of the biomedical model, where it is argued that these 
models offer a more humanistic perspective of the experience of 
illness, placing the patient at the fore and addressing the complexity 
and subjectivity of the illness experience.    
 
2.2 Illness or disease? 
The terms „disease‟ and „illness‟ have been discussed by medical 
anthropologists for decades to describe the different approaches to 
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health (Kleinman 1988a; Kleinman 1988b; Cassell 1982; Kleinman 
1980).  For example, Kleinman (1988a) argues that the two concepts 
(illness and disease) are fundamentally different from each other.  He 
states that: 
 
Disease is a problem from the practitioner‟s perspective.  In the 
narrow biological terms of the biomedical model, this means 
that disease is reconfigured only as an alteration in biological 
structure functioning (Kleinman 1988a:5-6).   
 
In contrast, he describes illness as being: 
 
[T]he innately human experience of symptoms and suffering.  
Illness refers to how the sick person and the members of the 
family or wider social network perceive, live with, and respond 
to symptoms and disability (Kleinman 1988a:3).   
 
The disparities between the two phenomena are evident in 
Kleinman‟s (1988a) descriptions of the two states, with „disease‟ 
using the „lens‟ of the biomedical model to focus on the underlying 
pathology of the condition and appearing to neglect the perspective 
of the patient.  „Illness‟, in comparison, appears to be an inherently 
human experience that recognises the impact of a condition on the 
wider realms of a patient‟s life.  This interpretation supports that of 
Cassel (1978) who states that „illness‟ means what the patient feels 
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when he goes to the doctor and „disease‟ to mean what he has on the 
way home from the doctor‟s office. 
 
This humanistic perspective afforded by the model of illness is 
supported by Thorne who states: 
 
 …illness is experienced not as a factual clinical event, but 
rather as a lived, cognitive, emotive, social and even political 
event that is entered into by thinking, feeling and interpreting 
beings individually and collectively (Thorne 1999:398).   
 
Furthermore, according to Robertson and Boyle, health and illness 
are as much social and cultural phenomena as they are biological 
(Robertson and Boyle 1984).   
 
Whilst the works of the authors cited above (Kleinman 1988a; 
Kleinman 1988b; Cassell 1982; Kleinman 1980) portray illness and 
disease as two distinctly different concepts, there is debate within the 
literature regarding their conceptual boundaries.  For example, it has 
been argued that the two concepts overlap, with the occurrence of 
disease often resulting in the experience of illness (Kleinman, 1980).  
However, in contrast, it has also been purported that the two states 
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can occur distinct from one another (Helman 1981).  For example, 
Hypochondria has been used as an exemplar to demonstrate how 
illness can occur without the presence of disease (Cassell 1978).  The 
same arguments have been made relative to the experience of 
disease, with conditions such as severe trauma and sepsis being used 
to describe the occurrence of disease that manifests itself so rapidly 
that illness does not have any time to follow.   
 
The argument that disease and illness are distinct from one another 
is further supported by a recent study by Wikman, Marklund and 
Alexanderson (2005).  Using cross-sectional data from 
comprehensive interview surveys with 3500 people on the concepts 
of illness, disease and sickness absence, they reported that there was 
little overlap between these different concepts of ill health and 
concluded that further research was required to explore why such 
disparities exist.   
 
Such debate continues in current day literature, where it is contended 
that conditions such as Chronic Fatigue Syndrome do not „fit‟ within 
the spectrum of disease, as they are poorly defined, have multiple 
potential aetiologies, and therefore do not confer within the discrete 
categories of the biomedical paradigm (Lloyd et al. 2000).  However, 
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despite such debate being presented in the literature, the biomedical 
model of care, with its focus on disease, continues to dominate 
current health care today.   
 
2.3 The biomedical model 
The biomedical model, stemming from Virchow‟s conclusion that all 
disease results from cellular abnormalities (Porter 1997), has within it 
a number of key assumptions (Giddens 2009; Nettleton 2006; Wade 
and Halligan 2004) as detailed in table 2 below. 
 
Table 2:  Assumptions of the biomedical model 
Disease is the deviation from normal biological functioning (Wade and Halligan 
2004; Cassell 1982; Cassell 1978; Engel 1977). 
Disease occurs naturally independent of social behaviour or influences (Nettleton 
2006). 
Health is the absence of disease and can only be restored using medical 
intervention.  From this perspective, „the human body is a machine and the doctor 
or surgeon is the mechanic who fixes it when something goes wrong‟ (Crossley 
2000:2). 
Each disease is caused by a specific, potentially identifiable source (Wade and 
Halligan 2004).   
All diseases have distinguishable characteristics such as symptoms, and that these 
remain the same irrespective of the historical or cultural context in which they are 
situated (Giddens 2009).   
Mind/body dualism: physical and mental health problems are separate entities 
(Wade and Halligan 2004). 
Only medically trained health professionals have the expertise to diagnose health 
problems. 
The patient is a passive recipient of health care (Bury 2001).  
Ignores lay account of illness (Bury 2001).  
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2.3.1 Benefits of the biomedical model 
The contributions of the biomedical model to healthcare cannot be 
ignored, with advances in the diagnosis and treatment of numerous 
conditions resulting in reduced rates of mortality and increased 
longevity in distinct patient populations worldwide (Gaede et al. 
2008; Wade and Halligan 2004; Misselbrook 2001; Bunker 2001; 
Bunker 1995; Bunker et al. 1994).  Examples of such improvements 
include advances in cardiac care where the use of thrombolysis, 
aspirin, angiotensin-converting enzyme inhibitors, statins and 
coronary artery bypass surgery have result in significant reductions in 
patient mortality compared to twenty years ago (Unal et al. 2005).   
 
For other common conditions such as cancer, such improvements are 
also evident, with significant reductions in cancer incidence and 
mortality rates reported in the Western World (Jemal et al. 2011; 
Jemal et al. 2010; Ferlay et al. 2007a; Ferlay et al. 2007b).  Such 
findings have been attributed to the advent of screening programmes 
(Sarkeala et al. 2008; Hakama et al. 2008), public health campaigns 
and advances in many treatment modalities such as chemotherapy 
and radiotherapy, which has resulted in people with cancer being 
diagnosed earlier and living with the disease for longer (McArdle et 
al. 2010; Westlake and Cooper 2008; Nilsson et al. 2004; Jonker et 
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al. 2000).  Based on such developments, there is ongoing debate that 
cancer should be viewed as being a chronic illness (Cayless et al. 
2010; Hubbard et al. 2010; McCann et al. 2010; Hubbard et al. 
2006), as opposed to one which has historically been associated with 
significant suffering and poor survival rates. 
 
However, in contrast, for developing countries, such improvements 
have not been observed, with cancer incidence and mortality rates 
reported to be rising (Jemal et al. 2011; Jemal et al. 2010) and this 
has been attributed to the combination of late stage diagnosis and 
poor access to timely and standard treatment.  Based on the success 
of biomedical interventions in the Western World, such as 
programmes for tobacco control, vaccination, screening and public 
health campaigns, it has been advocated that such trends can be 
reversed in developing countries if similar interventions were to be 
delivered on a global basis (Jemal et al. 2011; Jemal et al. 2010).  As 
such, there have been calls for health professionals, public health 
professionals and policy-makers to play an active role in accelerating 
the application of such interventions worldwide. 
 
The significant benefits of the biomedical model on the health of the 
Western world have been demonstrated not only on a disease-
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specific basis, but also generally.  The seminal work of Bunker (2001; 
1995; 1994) is one example, whereby via a meta-analyses of the 
literature, he attempted to quantify the benefits in morbidity and 
mortality from current Western medical practice and claimed from his 
findings that three of the seven years of increase in life expectancy 
since the 1950s could be attributed to medical intervention.  
Furthermore, he also estimated that medical intervention provided on 
average 5 years‟ partial relief from the deterioration in quality of life 
associated with chronic disease.  Whilst Bunker‟s (2001; 1995; 1994) 
work can be critiqued on the grounds that it did not provide 
information on the criteria used for the selection of studies and that it 
focused on the results of only RCTs, the findings of his study do 
provide a crude measure of the benefits of the medical model in the 
Western world, and may therefore provide evidence to substantiate 
why this model of care remains prevalent in contemporary 
healthcare.   
 
The above findings purporting the benefits of the biomedical model 
are further supported by studies which have demonstrated that 
reductions in mortality are greater for those conditions that are 
amenable to medical intervention compared to those that are not 
(Charlton and Velez 1986).  Furthermore, it has been claimed that 
patients who have conditions that are „receptive‟ to treatment have 
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on average an increased life expectancy of between 5-18 years 
compared to conditions where treatment regimes are not as 
responsive (Mackenbach 1996). 
 
However, despite the evident success of the biomedical model in the 
field of medical science and its dominance within current healthcare 
systems, many of its assumptions and its utility and effectiveness 
within healthcare are being increasingly questioned (Giddens 2009; 
Nettleton 2006; Wade and Halligan 2004).  Such challenges to the 
biomedical model have occurred over the past four decades and 
continue to attract much debate within the literature today.  These 
challenges are discussed in the following sections.   
 
2.3.2 Critique of the biomedical model 
As previously stated, the critique of the biomedical model extends 
over a significant period of time.  Most of this critique focuses on 
three main areas:  refuting the anticipated benefits, the passive role 
of the patient, and the affinity of the model with reductionist methods 
of measurement.  Each will be discussed in turn below. 
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2.3.2.1 Refute of the anticipated benefits of the biomedical 
model 
Historically, challenges made towards the biomedical model of care 
were made by refuting some of its anticipated benefits.  An example 
of this is the seminal work of McKeown (1976) who, by using 
historical analysis, claimed that improvements in health and 
decreases in mortality in the 1970s were not due to advances in 
science as assumed by many, but were due to the implementation of 
broad scale economic and social interventions that had taken place.  
His results therefore indicated that social conditions were a 
fundamental cause of human disease which was contradictory to the 
scientific assumptions of the biomedical model, that is, that disease 
occurs independently of social behaviour or social influence (Giddens 
2009; Bynum 2008; Szreter 2002).  The findings of McKeown (1976), 
whilst radical at that time and contested by others on the grounds of 
their lack of recognition of the significant contributions that medicine 
had made to the health and reductions in mortality of the population 
at that time (Bynum 2008), have nevertheless been highly influential 
in the recognition of the sociological perspective of disease and the 
acceptance of the role that culture and context play in the causation 
and experience of illness (World Health Organisation 2008; Bynum 
2008; Szreter 2002).   
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This notion of the offered benefits of the biomedical model and the 
sociological perspective of disease was also the focus of Illich‟s 
(1975) seminal work on the iatrogenic consequences of medicine.  He 
contends that biomedicine did more harm than good.  As opposed to 
curing and healing, Illich (1975) argued that modern medicine did 
the opposite and contributes to illness through its iatrogenic effects 
(clinical iatrogenesis).  He also argued that the increase in use of 
medical interventions created a „morbid‟ society, as people focused 
on the domains of health and disease, which, in turn, created an 
artificial demand for medicine (social iatrogenesis).  Furthermore, 
Illich (1975) claimed that this increase in demand for medical 
expertise resulted in a de-skilling of the patient, as people became 
more dependent on the medical system and unable to deal with their 
conditions themselves (cultural iatrogenesis). 
 
Whilst Illich‟s (1975) critique of the biomedical model was made over 
three decades ago, many of the points he raised are however 
supported in modern-day literature where the iatrogenic 
consequences of medicines are increasingly being reported (Glover-
Thomas and Fanning 2010; Dunne and Quayle 2001).  Moreover, 
Ilich‟s (1975) statements pertaining to the social and cultural 
iatrogenic consequences of the biomedical model appear to be 
warranted, with growing recognition by politicians and clinicians alike, 
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as healthcare systems cannot meet the current and future demands 
of its consumers.  In response, many directives have been launched 
at policy level to encourage patients to undertake their own self-care 
and take responsibility for the management of their own conditions 
(Scottish Government 2007; Department of Health 2007).   
 
The above response has highlighted how the biomedical model has 
been challenged by a number of scholars contesting its anticipated 
benefits and its ignorance of the sociological perspectives of disease.  
Whilst many of the challenges to this model were made over 30 years 
ago, many of the arguments made remain relevant and valid today, 
such as McKeown‟s (1976) contention of the influence of social 
conditions on the occurrence and experience of disease and Illich‟s 
(1975) claims that the benefits of the biomedical are outweighed by 
the associated harm.  Another main critique of the biomedical model 
within the literature is based on the limited role that it affords to the 
patient and limited acknowledgement of lay accounts of illness.  This 
observation will be discussed in the following section.   
 
2.3.2.2 The biomedical model and the patient 
The critique of the biomedical model extends to the role that the 
model affords to the recipient of healthcare – the patient.  It is 
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argued that the biomedical model confers a paternalistic model of 
care where the doctor commands the medical knowledge and the 
patient is in a position of dependence (Kaba and Sooriakumaran 
2007; Lupton 1997; Foucault 1980).  Such views purport that the 
medical professionals enhance their position of power by assuming 
that it is their privileged right to define and treat illness, thereby 
subordinating the opinions and knowledge of lay people.  It has been 
argued that this power relationship is more apparent in socio-
economically disadvantaged groups „whose lack of power is further 
entrenched through their social interactions with powerful doctors 
who seek to maintain the social status quo‟ (Lupton 1997:100).  This 
type of clinician-patient relationship is therefore said to deny 
individuals the right of self-determination and autonomy (Ho and 
Byluna 2008).  However, it has been argued that this perspective of 
the medical encounter offers an exaggerated example of the doctor-
patient relationship and, as stated by Atkinson (1995:33) „..is 
exaggerated to the point that the lay client becomes not the 
beneficiary but the victim of the consultation‟. 
 
With relevance to current-day medicine, the advent of models of 
„patient-centred care‟ (Mead and Bower 2000) appear to be rebuffing 
the portrayal of the physician-patient encounter depicted in the 
biomedical model (Kaba and Sooriakumaran 2007; Lupton 1997; 
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Foucault 1980).  There is a growing body of evidence to suggest that 
this culture of care is starting to change and patients are now 
encouraged to take a more active and autonomous role in their care 
(Hack et al. 2005).  The once one-sided doctor-dominated 
relationship is beginning to be replaced by a patient-centred model of 
care where mutual participation and shared decision-making are 
central processes (Donaldson 2008; Kaba and Sooriakumaran 2007).  
Nurses have also made significant contributions to the development 
and delivery of patient-centred care, where the advent of nurse-led 
interventions has been reported to result in improvements in patient 
satisfaction, quality of care and result in cost reductions (Olsson et al. 
2009; Wolf et al. 2008). 
 
However, the passive role the biomedical model affords to the patient 
has been challenged on the grounds that it ignores the validity of lay 
accounts of illness (Kleinman 1988b; Engel 1977).  Such a stance 
stems from the positivistic paradigms which govern this model of 
care.  The biomedical model assumes that the scientific method is the 
best approach by which to study the body, with its belief that the 
„truth‟ of the knowledge produced can only be verified through 
measurement and observation.  Its links to positivism take on the 
assumption that the human body can be analysed independently of 
the mind and that reality exits outside the realms of subjective 
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human perceptions (Lincoln and Guba 1985).  However, according to 
Bury (2001), lay accounts of illness are being increasingly accepted 
as valid sources of information.  He asserts that the rise of the 
patient narrative can be attributed to a number of related factors, for 
example, the decline in the importance of biologically-driven 
phenomena such as infections, with a growing awareness of the 
impact of degenerative and chronic conditions (Bury 1997; Charmaz 
1991; Bury 1991; Charmaz 1983; Bury 1982).  Such awareness, 
Bury (2001) argues, has resulted in healthcare focusing more on the 
management and care of conditions rather than on their treatment 
and cure.  Furthermore, he states that the wide availability of 
information available to patients via mediums such as the internet 
and media has resulted in a reduction in medical authority, as 
patients now have the information to challenge healthcare 
professionals and make their views count (Bury 2001). 
 
The above literature, whilst recognising the significant contributions 
that the biomedical model has made to healthcare worldwide, also 
discusses how this model has been challenged on the grounds of its 
assumed benefits and its neglect of the sociological perspective of 
illness.  It has also discussed how the biomedical model has been 
criticised for the passive role that it affords to the patient and its lack 
of recognition of lay accounts of illness.  The next section will discuss 
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the most widely critiqued attribute of the biomedical model: its 
affinity with reductionist methods of measurement 
 
2.3.2.3 Reductionism 
A widely accepted critique of the biomedical model is the seminal 
work of Engel (1977), who, in the 1970s, forewarned of a crisis in the 
biomedical model of care due to its sole focus on the biological 
manifestation of disease.  He argues that this focus on the physical 
dimensions of illness excludes the patient narrative and the social, 
psychological and behavioural dimensions of illness.  He contends 
that this stance results in an oversimplification of the illness 
experience which, in reality, is much more complex than the 
biomedical model leads us to believe.  According to Engel (1977), this 
oversimplification is partly attributable to the „embrace‟ of the 
biomedical model with reductionist models of measurement.  As 
Engel states: 
 
Thus the biomedical model embraces both reductionism, the 
philosophic view that complex phenomena are ultimately 
derived from a single primary principle, and mind–body 
dualism, the doctrine that separates the mental from the 
somatic.  Here the reductionist primary principle is 
physicalistic; that is, it assumes that the language of chemistry 
and physics will ultimately suffice to explain biological 
phenomena (Engel 1977:130).  
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As with Engel (1977), many of the existing critiques of the biomedical 
model within the literature are based on its reliance on reductionist 
methods of measurement and the way that they aim to reduce 
complex phenomena to their core physical elements; into units that 
can be measured and quantified (Wade and Halligan 2004; Willig 
2001; Thorne 1999; Cassell 1982; Mishler 1979).  It is argued that 
this focus on the physical dimensions of illness results in the 
exclusion of the „human aspects‟ of illness (Thorne 1999; Cassell 
1982; Engel 1977) which does not help us to „comprehend the whole 
person‟ (Cassell 1982:643).  Furthermore, according to Willig (2001), 
this exclusion of the human facets of the illness experience results in 
data being collected which have little resemblance to the actual 
experience in the context of a person‟s life and does not recognise 
the role of social, historical and cultural factors in the formation of 
knowledge.  
 
This critique of the „oversimplification‟ of the biomedical model is 
strongly supported by the vast body of empirical evidence which 
highlights the complexity of the illness experience.  The experience of 
chronic illness is one area where this critique is best exemplified, 
particularly in the works of scholars such as Bury (2001; 1997; 1982) 
and Charmaz (1991; 1983).  Their research has highlighted the ways 
in which chronic illness impacts on daily living, social relationships 
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and people‟s sense of self and identity.  Their research also focuses 
on the ways that individuals cope with the demands placed on them 
by their illness and its associated treatments and how they try to 
maintain a coherent valued sense of self throughout.   
 
The focus of such studies has therefore been on the meaning of the 
experience of chronic illness and how people adapt and cope with 
their illness, highlighting the importance of understanding the 
contextual dimension of the experience of illness.  Of particular 
relevance to this thesis is that it is argued that the experience of 
cancer has much in common with the experience of chronic illness, 
with many of the characteristics described above being exhibited by 
both of these patient populations (Cayless et al. 2010; Hubbard et al. 
2010; McCann et al. 2010).  This is of particular pertinence to the 
experience of lung cancer where many of the manifestations of the 
experience of chronic illness have been reported in this patient 
population.  This includes a loss of personal and social identity 
(Chapple et al. 2004; Mathieson and Stam 1995), the inability to 
undertake previous activities of daily living (Quast and Williams 
2009; Kiteley and Fitch 2006) and social isolation (Ekfors and 
Petersson 2004).  It may be argued that such experiences are more 
profound in patients with lung cancer due to their poor survival rates, 
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and them having to deal with multiple distressing issues in a 
relatively short period of time. 
 
Reductionist methods of measurement have also been criticised on 
the grounds that they aim to make generalisations about populations 
at the expense of an appreciation of the idiographic experience of 
illness.  Furthermore, concern has been raised at the use of such 
generalisations in informing political and health reforms with the 
neglect of the perspectives of the individual (Thorne and Jillings 
1996).   
 
Carr and Higginson (2001) add to this critique of the use of 
reductionist methods and discuss how many of the quantitative 
measures used are derived from the perspective of „experts‟ (health 
professionals/academics) which have „limited relevance‟ to the world 
of the patient.  This „limited relevance‟ is partly explained by health 
professionals‟ traditional focus on medical aspects of care which do 
not capture the „far-reaching‟ effects of illness on a person‟s life 
(Carter et al. 2004:612).  This critique is also supported by published 
evidence which demonstrates the difference of patients, carers and 
health professionals‟ perceptions of illness; often what is deemed to 
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be important by the patient is not recognised by people caring for 
them (Kuther et al. 2006; Hill 2002; Nekolaichuk et al. 1999).   
 
Related to the above critique and the argument that reductionist 
methods of measurement have „limited relevance‟ to the individual, is 
a study conducted by Krishnasamy (2000) on the experience of 
fatigue in patients with advanced cancer.  Using a case study 
methodology, she reported inconsistencies between quantitative 
fatigue measurements and the patients‟ narratives.  She stated that 
quantitative measures oversimplified the experience of fatigue and 
did not capture the distress and meaning of the symptom in the 
individual‟s life and therefore conveyed „little of the underlying reality‟ 
(Krishnasamy 2000:412).  She concluded that by continuing to 
measure complex phenomena using reductionist methods of 
measurement, „many distressing facets of experience are likely to 
remain hidden form the clinical and research agenda‟ (Krishnasamy 
2000:411).   
 
The above literature has provided a critique of the limitations of the 
biomedical model made over the past four decades and provides a 
current-day context to many of the challenges posed many years 
ago.  Therefore, it is not surprising that, in light of such consistent 
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critique, a number of scholars have proposed alternatives to the 
biomedical model and these are discussed below. 
 
2.3.2.4 Alternatives to the biomedical model 
In light of the limitations of the biomedical model demonstrated 
above, a number models have been developed which provide an 
alternative view of the domains of health and illness (Crossley 2000; 
Good and Good 1980; Engel 1977).  Of note, is that the alternative 
models discussed below are those which have been identified in the 
literature as being developed in direct critique of the biomedical 
model.   
 
One of the most influential of those models is Engel‟s biopsychosocial 
model of care (Engel 1977).  This model of care hypothesises that 
biological, psychological and social factors all contribute in a 
combined manner to the experience of illness (Engel 1977).  It has 
been described both as a „philosophy of clinical care‟ and „a practical 
clinical guide‟ (Alonso 2004; Suls and Rothman 2004; Borrell-Carrio 
et al. 2004; Engel 1977).  On a philosophical level, it is a means of 
understanding how the experience of illness is affected by multiple 
factors from the molecular to societal influences (Borrell-Carrio et al. 
2004).  On a practical level, it has been described as an approach 
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which allows health professionals to recognise the importance of 
subjective experience in determining health (Borrell-Carrio et al. 
2004).  
 
Since its introduction, the biopsychosocial model of care has been 
widely adopted by a number of health-related disciplines such as 
medicine, nursing, and health psychology.  However, despite its 
popularity and recognition, there is evidence within the literature to 
suggest that the biomedical model of care still dominates current 
healthcare today (Fava and Sonino 2008; Alonso 2004; Suls and 
Rothman 2004).  Cited reasons for this continued dominance include 
the difficulty experienced by health professionals in competing with 
traditional biomedical models of care and that clinicians are still 
reluctant to integrate an alternative model into their treatment plans 
(Alonso 2004).  Reasons for such reluctance include the increased 
demands that the delivery of the biopsychosocial model places on the 
health professional (Alonso 2004).  It has been argued that the use 
of this model of care in practice brings to the fore a wider spectrum 
of patient need which requires a greater investment of time on behalf 
of the health professional, not only to deal with such needs but also 
to acquire knowledge to be able to address these needs (Alonso 
2004).  It has also been argued that the perpetual dominance of the 
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biomedical model is partly attributable to the way that health 
professionals, in their training and clinical practice, have been: 
 
[E]ducated and socialized in a worldview that affords illness a 
concrete, objective meaning.  This perspective privileges such 
factors as functional limitations, degree of pain, and certainty 
of prognosis , rendering them prominent and visible within 
health care discourse (Thorne 1999:398). 
 
Since the introduction of Engel‟s biopsychosocial model (1977), a 
number of other models of health have been developed, which, like 
the biopsychosocial model, directly challenge the biomedical 
paradigm.   
 
The work of Crossley (2000) in the area of health psychology is one 
example.  She challenged traditional health psychology‟s attempt at 
delivering a biopsychosocial model of care on the grounds of its 
overuse of reductionist methods of measurement and analysis, which 
she claimed resulted in a failure to comprehend the crucial elements 
of human experience.  As an alternative, she proposed a critical 
hermeneutic approach to health psychology, which she argued would 
facilitate „a deeper understanding of both the psychological 
dimensions of human experience and also, relatedly, of the 
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sociocultural dimensions of such experiences‟, appreciating the role of 
human agency and meaning in the illness experience (Crossley 
2000:6).  Within the hermeneutic approach, Crossley (2000) 
advocated the use of qualitative research methods which, as opposed 
to the reductionist methods employed in the mainstream branch, 
„create a detailed and profound insight into a particular, perhaps 
unique, account or experience, rather than a set of broad 
generalisations about commonalities between different people‟ 
(Crossley 2000:7-8).   
 
Whilst the above challenges posed by Crossley (2000), with their 
particular relevance to the limitations of the use of reductionist 
methods in the measurement of subjective human experience, are 
supported widely in the literature, her work, nevertheless, was 
viewed as being radical by some of her contemporaries (Nicolson 
2001; Owens 2001).  Two direct critiques made in response to her 
paper have presented different viewpoints (Nicolson 2001; Owens 
2001).  For example, Nicolson (2001) agrees with much of Crossley‟s 
(2001; 2000) argument on the grounds of the limitations of the 
biomedical approach and adds to it by contending that health 
psychology‟s affinity with the biomedical model is preventing it from 
being recognised as a discipline in its own right.  In comparison, 
Owens‟s (2001) response to the paper argues that the biomedical 
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model has not neglected the social and psychological factors of 
disease, and she states that she is not yet convinced „that we should 
give up the undoubted power of scientific approaches in our pursuit 
of the understanding of how psychology relates to health‟ (Owens 
2001:263).  However, irrespective of differing viewpoints, both 
scholars (Nicolson 2001; Owens 2001) agree that Crossley‟s (2001; 
2000) vision for an alternative approach to health psychology did 
open up new avenues of exploration and contemplation of the future 
direction of the discipline as a whole. 
 
As with Engel (1977) and Crossley (2000), Good and Good (1980) 
also proposed an alternative to the biomedical model of care: „A 
Cultural Hermeneutic Model of Clinical Practice‟.  This model views 
the patient‟s illness as a „syndrome of meaning‟ (Good and Good 
1980:180) with its purpose being to enable the clinician to 
understand the meaning of an illness in a person‟s life and to 
translate this information into clinical practice.  Good and Good 
(1980) state that clinicians achieve this by decoding the patient‟s 
semantic network, which entails (as with classical hermeneutics) 
„moving dialectically from the part (the “text”, the symptom) to the 
whole (the “context”, the illness network) and back again, to bring 
understanding of the illness from the sufferer‟s perspective‟ (Good 
and Good 1980:180).  As they state: 
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Symptoms do not reflect somatic abnormalities in any simple 
way, and the relationship among symptoms does not mirror a 
set of mechanistic or functional physiological relationships.  
Symptoms are irreducingly meaningful.  Illness and symptoms 
are experienced as realities and thus are integrated logically 
and meaningfully (Good and Good 1980:191). 
 
This focus on the semantics of the illness experience as afforded by 
Good and Good (1980), whilst in stark contrast to the biomedical 
model of care, does appear to be warranted based on the large body 
of evidence which demonstrates the central role that meaning plays 
in the experience of illness.   
 
Seminal works from authors such as Frankl (1959), Cassel (1982) 
and Kleinman (1988b) argue that meaning is a fundamental 
dimension of being human and that illness and suffering cannot be 
comprehended without contemplating the concept of meaning 
(Cassell 1982; Frankl 1959).  Such arguments are supported by a 
variety of other seminal authors on the role of meaning in the 
experience of illness, such as Sontag (1988; 1977), Frank (1991), 
and Zaner (2004).  All have, in some way, described what the 
experience of illness is like for the ill, what it means to be ill and how 
individuals make sense of illness in their lives.  For example, the 
work of Sontag (1988; 1977) has highlighted the negative cultural 
meanings that society appends to illnesses such as cancer and AIDS, 
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assuming that such diseases occur as the fault of „someone who has 
indulged in unsafe behaviour‟ (Sontag 1988:25).  She describes how 
this assumption leads to a culture where the person is blamed rather 
than comforted about their disease, causing significant distress to the 
individual.  Personal narratives such as those by Frank (1991) on the 
experience of serious illnesses such as cardiac disease and cancer, 
also highlight how „illness leaves no aspect of life untouched‟ (Frank 
1991:6) and how „when the body breaks down, so does life‟ (Frank 
1991:8). 
 
This focus and importance on meaning also extends to the symptom 
experience.  Using cancer as an exemplar, numerous studies have 
demonstrated how patients do not view symptoms through the 
narrow lens of the biomedical model, but view them as being 
meaningful experiences.  For example, Ferrel and Dean‟s seminal 
paper on the meaning of pain (1995) reported how the participants in 
their study viewed pain as being a punishment, a sign of illness 
progression and of impending death, and such findings have been 
reported elsewhere in the literature (Lindqvist et al. 2006; Lindqvist 
et al. 2004).  The symptoms of fatigue, breathlessness and weight 
loss have also been reported by patients with cancer to be symbolic 
of nearing death, feelings of being trapped inside a failing body and 
of being a burden to others (Wu and McSweeney 2007; Lindqvist et 
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al. 2006; Hopkinson et al. 2006; Gibson et al. 2005; O'Driscoll et al. 
1999).  The experience of the symptoms of weight loss and alopecia 
have been associated with feelings of stigma in patients with 
advanced cancer, often due to the overt visibility of these symptoms 
to others and their societal status as being „cancer symbols‟ (Plough-
Hansen 2007; Hopkinson et al. 2006; Wilson and Luker 2006; 
Chapple et al. 2004; Rosman 2004; Scambler 1988; Sontag 1988; 
Sontag 1977; Goffman 1963).     
 
Therefore, as previously stated, the Cultural Hermeneutic Model of 
Clinical Practice advocated by Good and Good (1980) does appear to 
have a significant scientific basis to warrant its semantic approach.  
This model, as with the others described above, is in contrast to the 
biomedical model, and, to an extent, this is not surprising as they 
were all developed in direct response to the critique of the biomedical 
model and identified limitations of this model of care.  Instead of 
focusing on the biological manifestation of disease, all of these 
alternative models advocate a wider appreciation of the context and 
impact of illness within a person‟s life.  These models also highlight 
the importance of addressing the subjectivity of the illness 
experience, focusing on the idiographic and capturing experience in 
all its complexity, rather than trying to reduce and objectify it.  These 
alternative approaches also pay homage to the patient narrative and 
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instead of excluding it, welcome its use in determining the meaning 
and the reality of the experience of the illness in a person‟s life.   
 
It may, therefore, be argued that these alternative models afford a 
more humanistic approach to the experience of illness, which goes far 
beyond the confines of the biomedical model.  It could be contended 
that such alternative models are more fitting to understand the 
complexities of the illness experience and in addressing the needs of 
patients.  Having provided a critique of the biomedical model, and the 
alternative models of care offered in direct response to such 
challenges, the following chapter continues this discussion relative to 
the study of symptom clusters in patients with cancer.    
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Chapter 3: The study of symptom clusters in 
patients with cancer 
 
3.1 Introduction 
This chapter begins by defining what a symptom is, the different 
interpretations of the symptom experience, and the importance of 
symptoms in the experience of illness, particularly the experience of 
cancer.  This discussion is then followed by an overview of research 
in the area of cancer symptom management, describing its journey 
from 2001, when the concept of symptom clusters was formally 
introduced within the cancer symptom management arena, to the 
present.  Of note, is that since the formal introduction of symptom 
clusters into the cancer nursing literature, it has been described as a 
„concept‟ (Barsevick 2007a; Barsevick 2007b; Dodd et al. 2001a; 
Dodd et al. 2001b), therefore, in order to maintain consistency, the 
term „concept‟ is used throughout this thesis. 
 
The sections that follow then focus the discussion on the concept of 
symptom clusters in patients with cancer, discussing the current 
scientific base which underpins the concept and the empirical 
evidence gleaned since the introduction of the concept almost 10 
years ago.  It concludes by highlighting the limitations of this body of 
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research, particularly its affinity to the biomedical model of care and 
its neglect of the perspective of the patient.   
 
3.2 The definition of a symptom 
A number of definitions of the term „symptom‟ have been offered in 
the literature (Lenz and Pugh 2008; Armstrong 2003; Dodd et al. 
2001a; Lenz et al. 1997; Teel et al. 1997; Lenz et al. 1995; McDaniel 
and Rhodes 1995; Rhodes and Watson 1987).  For example, Lenz 
and Pugh (2008) define symptoms as being „perceived indicators of 
change in normal functioning‟ and as „...red flags to the threat of 
health‟ (Lenz and Pugh 2008:164).  Rhodes and Watson (1987), in 
their discussion of the concept of symptom distress, define symptoms 
as being subjective phenomena which symbolise to the individual a 
departure from normal function, sensation or appearance or as 
perceived indicators of change in normal functioning.  Dodd et al 
(2001a) define a symptom as being „a subjective experience 
reflecting changes in the biopsychosocial functioning, sensations, or 
cognition of an individual‟ (Dodd et al. 2001a:669).  There are other 
definitions offered in the literature (Fu et al. 2004; Armstrong 2003; 
Teel et al. 1997; McDaniel and Rhodes 1995; Larson et al. 1994) 
however, common to all is the subjective nature of symptoms, that 
they denote a departure from normal functioning and that they are of 
particular relevance to the individual experiencing them. 
44 
 
As discussed in the previous chapter and highlighted by Tishelman 
(1991), the term „symptom‟ can be construed in a number of ways, 
depending on the standpoint of the persons involved.  Using the 
biomedical perspective, a symptom is viewed as being representative 
of a pathological pathway for diagnosis and cure.  From a medical 
anthropological perspective, symptoms are viewed in a different way: 
not as being a „reflection of the disease‟, but representing the 
meaning that the illness holds for the individual.  Whilst this topic has 
attracted much debate in the literature (Krishnasamy et al. 2001; 
Corner and Bailey 2001; Tishelman et al. 1991), irrespective of the 
approach employed, all recognise the central role that symptoms play 
in the identification and management of disease and the negative 
impact that poorly controlled symptoms have on patient outcomes 
(Mansson et al. 2007; Trotti et al. 2007; Cleeland 2007; Lipscomb et 
al. 2007; Hegyvary 1993).  Such findings are of particular pertinence 
to patients with cancer as they commonly experience multiple 
symptoms which are often severe, resulting in a high symptom 
burden (Breivik et al. 2009; Yamagishi et al. 2009; Cleeland 
2007;Donovan et al. 2005; Miaskowski 2002; Vainio et al. 1996).  
Therefore, it is not surprising that a large body of evidence exists 
which has explored the experience of symptoms in patients with 
cancer.  This is discussed below. 
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Historically, past research in the area of cancer symptom 
management has focused on the incidence and severity of individual 
symptoms such as pain, fatigue and depression (Richardson and 
Ream 1996; Ream and Richardson 1996; Sheehan et al. 1995; 
Ferrell and Dean 1995; Bendelow and Williams 1995; Winningham et 
al. 1994; Given et al. 1993; Blesch et al. 1991; Grossman et al. 
1991; Padilla et al. 1990; Ferrell et al. 1989; Cleeland et al. 1986; 
Zigmond and Snaith 1983).  However, this individual focus of study 
has been criticised on the grounds that it does not address the fact 
that people with cancer tend to experience multiple concurrent 
symptoms and that they rarely experience symptoms in isolation 
(Miaskowski et al. 2004b; Dodd et al. 2001a; Dodd et al. 2001b).  
Therefore, it has been argued that this approach does not reflect the 
„real life‟ experiences of the patient (Barsevick et al. 2006b).  
Furthermore, the effectiveness of symptom management 
interventions developed in response to the findings of such studies 
have been questioned on the grounds of the high levels of morbidity 
which continue to be reported in patients with cancer (Breivik et al. 
2009; van den Beuken-van Everdingen et al. 2007; Miaskowski et al. 
2004b; National Institute of Health 2002).  These findings may 
suggest that such interventions have not been as effective as 
previously assumed.   
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In response to some of the criticisms cited above relative to the 
study of individual symptoms in patients with cancer, Dodd and 
colleagues (Dodd et al. 2001a; 2001b) called for the consideration of 
the concept of „symptom clusters‟ in oncology research (Barsevick 
2007a).  Such a concept, they argued, would address the fact that 
people with cancer rarely experience symptoms in isolation and 
would open up new avenues of exploration regarding ways in which 
the management of multiple symptoms in patients with cancer could 
be addressed.   
 
However, it should be highlighted that symptom clustering is not 
unique to the area of oncology symptom management but has been 
used in other disciplines, such as psychiatry, psychology and general 
medicine, since the 20th century (Barsevick 2007a; Zimmerman et al. 
2006; Shelby et al. 2005; Asmundson et al. 2000) where specific 
patterns of symptoms were thought to constitute a „syndrome‟ or 
„disease process‟ (Miaskowski et al. 2004a).  Today, with advances in 
medicine and laboratory/radiological data assisting in the diagnosis of 
various conditions, the use of symptom clusters is less evident 
(Barsevick 2007a).  However, within some disciplines, where the 
aetiology and underlying mechanism of certain conditions remains 
relatively unknown, symptom clusters are still used to assist in their 
diagnosis (Barsevick 2007a).  Examples of conditions which still use 
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the concept of clustering to aid diagnosis include pre-menstrual 
conditions (Fugate Woods et al. 1999), chronic pain (Geisser et al. 
1998), depression (Benazzi 2003) and gastrointestinal conditions 
(Vaira et al. 2001).  However, as will be evident in the forthcoming 
sections, the concept of symptom clusters in patients with cancer has 
been applied in a different way from the disciplines described above.  
Instead of aiding in the classification of disease taxonomies, this 
concept has been used as a means of identifying relationships 
between symptoms with the aim of developing symptom 
management interventions targeted at treating clusters of symptoms.    
 
As has been previously stated, the concept of symptom clusters in 
patients with cancer was first formally introduced into the area of 
cancer symptom management by Dodd et al (2001a) who highlighted 
the limitations of current symptom management approaches.  They 
criticised past and current approaches on the grounds that they 
focused on the assessment and management of individual symptoms 
and questioned their effectiveness in dealing with the „real life‟ 
symptom experiences of people with cancer who rarely experienced 
symptoms in isolation but who experience several symptoms at the 
same time (Dodd et al. 2001a).  They introduced the concept of a 
symptom cluster as a potential solution to the management of 
symptoms in patients with cancer, claiming that it could lead to the 
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development of effective symptom management interventions which 
could target groups (clusters) of symptoms as opposed to individual 
symptoms and, thereby, offer a comprehensive approach to 
assessment and intervention.  Since the formal introduction of the 
concept by Dodd and her team (2001a) there has been an upsurge of 
studies exploring the concept of symptom clusters in patients with 
cancer.  However, on review of the literature it may be argued that 
this body of evidence has within it a number of significant limitations.  
These limitations will be discussed in the following sections relative to 
the scientific basis which informs the study of symptom clusters in 
patients with cancer and the empirical studies which have explored 
this concept to date.  
 
3.3 Conceptual frameworks of symptom clusters 
Whilst there are a number of theories, concepts and models which 
have been developed to conceptualise the symptom experience (Lenz 
and Pugh 2008; Humphreys et al. 2008; Kim et al. 2005; Goodell and 
Nail 2005; Parker et al. 2005; Armstrong 2003; Haworth and Dluhy 
2001; Dodd et al. 2001a; Lenz et al. 1997; McClement et al. 1997; 
Teel et al. 1997; Lenz et al. 1995; McDaniel and Rhodes 1995; 
Larson et al. 1994; Rhodes and Watson 1987), none have been 
developed specifically to conceptualise the experience of symptom 
clusters in patients with cancer, but a few do claim to accommodate 
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the concept of symptom clustering within their conceptualisations.  
These include the Theory of Unpleasant Symptoms (Lenz and Pugh 
2008), The Theory of Symptom Management (Humphreys et al. 
2008) and the Symptoms Experience Model (Armstrong 2003).   The 
core components of these theories and this model are detailed in 
table 3 below. 
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Table 3:  Theories and model underpinning the study of symptom clusters in patients with cancer 
Theory/Model Domains Components of domains 
Theory of 
Unpleasant 
Symptoms (Lenz 
and Pugh 2008) 
Influencing Factors Physiologic 
Psychologic 
Situational 
 Symptoms Intensity 
Distress 
Timing 
Quality (cognitions – what it feels like to have the symptom) 
 Performance Outcomes* Functional Status 
Cognitive Functioning 
Physical Performance 
Theory of 
Symptom 
Management 
(Humphreys et al. 
2008) 
Symptom Experience* Perception of Symptoms 
Response to Symptoms 
Evaluation of Symptoms 
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 Components of Symptom 
Management Strategies* 
Who (delivers?) What? When? Where? Why? How much? To whom? How? 
 Outcomes* Symptom Status 
Functional Status 
Emotional Status 
Mortality  
Morbidity and co-morbidity 
Self-care 
Quality of Life 
 *All of the above influenced by 
person, environment, 
health/illness 
Person (demographic, psychological, sociological, developmental) 
Environment (physical, social, cultural) 
Health/Illness (risk factors, health status, disease and injury) 
Symptoms 
Experience Model 
(Armstrong 2003) 
Antecedents Demographic (age, gender, marital status, race, culture, role, education, 
socioeconomic status 
Disease Characteristics (type and stage, type of treatment, co morbidities, 
and medical factors 
Individual Characteristics (health knowledge, values, past experiences, 
sense of coherence) 
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 Symptom Experience Frequency 
Intensity 
Distress 
Meaning 
 Consequences Adjustment to illness 
Quality of Life 
Mood 
Functional Status 
Disease Progression 
Survival 
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As can be seen in table 3, these theories and this model provide an 
abstract conceptualisation of the symptom experience.  All focus in 
some way on factors that influence the symptom experience: the 
symptom experience itself and the outcome of symptoms.  They all 
highlight the complexity of the symptom experience; how this 
experience manifests itself at many different levels from the cellular 
to the societal level but ultimately occurs at the level of the 
individual. 
 
However, whilst these conceptualisations of the symptom experience 
informing the study of symptom clusters paint a very complex 
picture, we will see in section 3.4 (which discusses studies of 
symptom clusters in patients with cancer to date) that this 
complexity has not been addressed and how most researchers to 
date have adopted a biomedical approach, using reductionist 
methods of measurement which aim to reduce rather than embrace 
the complexity of this phenomenon.  These studies therefore present 
the experience of symptom clusters in the form of statistical 
associations which, it may be argued, provides a narrow view of the 
experience of symptom clusters in patients with cancer and does not 
portray the full reality of the experience of this phenomenon in the 
person‟s life.    
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In addition to the theoretical and conceptual models above informing 
the study of symptom clusters in patients with cancer, definitions of 
symptom clusters available in the literature have also been used to 
guide research in this area.  These are detailed in table 4 below.    
 
Table 4:  Definitions of symptom clusters in patients with cancer 
Authors Definition 
Dodd et al ( 2001b) 
 
 
 
Dodd et al (2004) 
*Added to existing definition later in the 
literature 
„when three or more concurrent 
symptoms are related to each other they 
are called a symptom cluster.  The 
symptoms within a cluster are not 
required to share the same etiology‟. 
*‟Symptom clusters may have an 
adverse effect on patient outcomes and 
may have a synergistic effect as a 
predictor of patient morbidity‟. 
Kim et al ( 2005) ‟when 2 or more symptoms that are 
related to each other and that occur 
together.  Symptoms clusters as 
composed of stable groups of 
symptoms, are relatively independent of 
other clusters, and may reveal specific 
underlying dimensions of symptoms.  
Relationships among symptoms within a 
cluster should be stronger than the 
relationship among symptoms across 
different clusters.  Symptoms in a 
cluster may or may not share the same 
etiology‟.  
 
On observing the previous definitions of symptom clusters offered in 
the literature, it is evident that there are number of shared 
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characteristics, for example, the concurrence of symptoms, the 
requirement that symptoms within a cluster are related to each other 
and that they do not need to share the same aetiology.  However, 
both definitions contrast with respect to the number of symptoms 
within a cluster and whether symptom clusters impact on patient 
outcomes.   
 
Relative to the number of symptoms in a cluster, we can ask which 
definition is correct.  Is it defined as two or more symptoms as 
advocated by Kim et al (2005) or three or more symptoms as 
advocated by Dodd et al (2001b)?  Such differences in definitions of 
the same phenomenon leave researchers conducting research in this 
area being faced with the dilemma of which definition to use.  As we 
can see in appendix 5, this contradiction has led to different research 
teams using different definitions (Glaus et al. 2006; Bender et al. 
2005).  There are also some examples of studies where clusters have 
been identified using the two-symptom criterion that would not have 
met cluster status if the three-symptom criterion had been applied 
(Maliski et al. 2008).  Therefore, such lack of consensus in definitions 
undermines the findings of such studies and questions what findings 
are valid.  To answer this question regarding the validity of the 
results gleaned from studies of symptom clusters in patients with 
cancer, some scholars may explore the scientific base informing such 
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definitions.  However, it may be argued that the scientific base 
underpinning both definitions of symptom clusters in patients with 
cancer is weak.  For example, Dodd and her team (Dodd et al. 
2001b) have not offered any rationale in the literature for their 
definition of a symptom cluster.  In comparison, whilst Kim and her 
team (2005) did derive their definition using concept analysis, they 
used literature predominantly from the disciplines of psychology, 
psychiatry and general medicine, which is not the context in which 
the intended definition was proposed to be used.  This neglect of 
context in the process of concept development has been criticised by 
a number of scholars (Hupcey and Penrod 2005; Paley 1996) and has 
been argued to result in a concept being developed which has little 
relevance to the field in which it was originally intended to be used, 
being described by Paley (1996) as an „arbitrary and vacuous 
exercise‟ (Paley 1996:578).   
 
In addition to difference in characteristics of symptom clustering 
offered in the two definitions, they can also be critiqued on the 
grounds that they afford little detail on the attributes that they do 
define.  Both definitions state that symptoms within a cluster should 
be related, however, they offer no detail on the nature or the 
magnitude of the relationship.  Once again this leads to researchers 
having to make their own interpretation regarding the relationships 
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within a cluster.  As we can see in appendix 5, this ambiguity results 
in a variety of different approaches being used to provide evidence to 
substantiate the formation of a cluster, with this eclectic mix of 
approaches preventing any meta-analysis of the data being 
conducted.   
 
Current definitions of symptom clusters in patients with cancer can 
also be criticised on the grounds that they focus solely on the 
objective characteristic of clustering, paying no homage to the 
subjectivity of the symptom experience at the level of the individual.  
As discussed in the previous chapter, this focus on objectifying and 
defining has close affinity with the biomedical model which has 
received criticism for the narrow lens that it affords to the experience 
of illness.  It may be argued that by framing current definitions of 
symptom clusters in this manner we are perpetuating this biomedical 
focus on the study of symptom clusters and forgetting the „person‟ in 
symptom clusters research.  Such observations call for the subjective 
exploration of this concept from the perspective of the patient in 
order to bring their perspective into this important and emerging 
area of cancer symptom research.    
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From the above literature, it is evident that the current scientific base 
underpinning the study of symptom clusters in weak.  Such claims 
can be made when taking into consideration the lack of any dedicated 
theoretical framework developed intentionally to accommodate the 
concept of symptom clusters in patients with cancer, lack of evidence 
substantiating current definitions, lack of consensus between existing 
definitions, lack of detail regarding identified attributes of symptom 
clustering and their biomedical focus which ignores the perspective of 
the patient.  However, despite such limitations in the definitions of 
symptom clusters available in the literature, they have been 
extensively used to guide research into this area of cancer symptom 
management.  This observation will be discussed in the section that 
follows.   
 
3.4 Empirical studies of symptom clusters in patients with 
cancer 
Since the formal introduction of the concept of symptom clusters in 
patients with cancer in 2001, there has been a dramatic increase in 
the number of empirical studies conducted in patients with cancer 
exploring this concept and these are detailed in appendix 5.    
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On review of these studies of symptom clusters in patients with 
cancer since the formal introduction of the concept in 2001 to the 
present, it is apparent that there are a number of limitations, with 
the most significant limitation being that, as a body of research, it 
has neglected the perspective of the patient.  This major limitation is 
discussed in the following literature relative to the samples of 
patients recruited to studies, the methods of data collection 
employed in studies, and the methods of analysis used. 
 
Relative to the samples of patients recruited to studies of symptom 
clusters in patients with cancer, a significant criticism of the sampling 
approaches adopted to date is the way that most studies have 
employed heterogeneous patient samples (Molassiotis et al. 2010; 
Cheung et al. 2009; Yamagishi et al. 2009; Yeh et al. 2008; Olson et 
al. 2008) consisting of patients with various cancers, at various 
stages of disease and receiving an array of different treatments.  It 
may be argued that this eclectic mix of patients neglects the needs of 
patients both at a group level and also at the level of the individual. 
 
At a group level, there are numerous studies which detail how people 
with different cancer types experience a different profile of symptoms 
and have different needs (Sanders et al. 2009; Gwede et al. 2008; 
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Jiong and Girgis 2006; Glaus et al. 2006; Cooley 2000; Arbuckle et 
al. 2000).  At an individual level, the theories of the symptom 
experience already mentioned in chapter 3 (Lenz and Pugh 2008; 
Humphreys et al. 2008; Armstrong 2003; Larson et al. 1994) and 
also empirical studies exploring the experience of symptoms in 
patients with cancer (Miaskowski et al. 2006; Kiteley and Fitch 2006; 
Knobf 2001; O'Driscoll et al. 1999; Wells 1998; Richardson and Ream 
1996), all agree on the importance of understanding the experience 
of symptoms at the level of the individual within the context of his or 
her life.   
 
This lack of focus on the experience of symptom clusters within 
specific cancer types, and at the level of the individual is of particular 
concern to the study of symptom clusters in patients with cancer 
where repeated calls for the clarification of the concept have been 
made in order to determine the critical elements that need to be met 
to constitute a symptom cluster (Hadi et al. 2008b; Miaskowski and 
Aouizerat 2007; Barsevick 2007b; Kim et al. 2005; Dodd et al. 
2004).  According to Dodd (2004) the study of symptom clusters in 
patients with cancer is in the phases of concept exploration and 
clarification, where the concept has been introduced in the literature 
but „it is too early to articulate its definite properties and potential 
explanatory power‟ and where refining of the concept is required to 
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„resolve the conflicts about meaning and definitions‟ (Dodd et al. 
2004: 77).  It may be argued that clarification and identification of 
the core characteristics of symptom clusters can only occur if we 
move away from this heterogeneous approach and pay closer 
attention to the experience of these symptom clusters within defined 
patient groups and at the level of the person.  If we do not do this, 
then we run the risk of the concept remaining poorly defined and its 
critical elements remaining unrecognised.   
 
This critique of lack of patient focus in the study of symptom clusters 
in patients with cancer continues into the methods of data collection 
employed and the analysis strategies adopted.  From appendix 5, it is 
evident that all of the studies listed (apart from three) have used 
quantitative methods of data collection.  The limitations of the use of 
reductionist methods of measurement have been discussed in greater 
depth in the previous chapter, however, overall it has been argued 
that such approaches oversimplify and decontextualise the illness 
experience, bypassing the patient‟s verbal account and conveying 
little of the underlying reality or meaning of the experience to the 
patient.  As highlighted on a number of occasions throughout this 
thesis, such neglect of the perspectives of the patient are of great 
concern, and may be viewed as a considerable limitation in the 
evidence underpinning the study of this phenomenon to date.   
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Linked to this critique of the use of quantitative methodology is the 
large variety of data collection tools used, some of which were not 
developed specifically to assess symptoms in patients with cancer 
(Yeh et al. 2008; Maliski et al. 2008; Bender et al. 2008a; Fox and 
Lyon 2006).  Such observations have a number of implications.  
Firstly, it has been recognised that the types of questionnaires used 
in a study will, in part, determine the cluster of symptoms identified 
(Lopez et al. 2011; Molassiotis et al. 2010), and this is evidenced in 
appendix 5, where there is an extensive list of different symptom 
clusters being identified in different patient populations.  However, on 
a practical level, how can researchers and clinicians deal with such 
variety, and how do they decide which findings are the most relevant 
to practice?  It may be argued that the only way that such decisions 
can be made is to complement such findings with patient-centred 
inductive approaches which can offer clarification from the 
perspective of the patient as to which clusters appear to be most 
meaningful and relevant in the context of their lives.  Secondly, for 
the studies that used tools which were not designed purposively to 
measure symptom in patients with cancer (Yeh et al. 2008; Maliski et 
al. 2008; Bender et al. 2008a; Fox and Lyon 2006), at the most 
fundamental level, how can we be sure that their measurements are 
valid and are therefore meaningful?   
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Linked to the predominant use of quantitative methods of data 
collection is the use of statistical analyses to provide evidence of 
symptom clusters in patients with cancer.  A wide array of statistical 
approaches have been employed in studies to date, including simple 
correlations (Maliski et al. 2008), factor analysis (Bender et al. 
2008a; Chen and Lin 2007), cluster analysis (Yeh et al. 2008; Glaus 
et al. 2006; Miaskowski et al. 2006), principal component analysis 
(Chow et al. 2007), hierarchical multiple regression analysis 
(Barsevick et al. 2006a), and mixed effect growth curve models 
(Wang et al. 2006).  Linked to each statistical approach is a different 
set of assumptions regarding the nature and magnitude of 
relationships between symptoms in a cluster.  Therefore, this leads to 
different clusters of symptoms being identified based on sets of 
different criteria and statistical assumptions.  Once again (as with the 
variety of data collection tools used), this variability in approaches 
used poses problems for the interpretation of findings of such studies 
and their practical application in clinical practice.   
 
Another significant limitation relative to the methods of data 
collection used in the study of symptom clusters in patients with 
cancer is the significant use of secondary data analysis in the current 
body of evidence.  The results of such studies can be questioned on a 
number of grounds, for example, the samples and methods of data 
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collection used were not selected purposively to explore symptom 
clusters in patients with cancer.  It has also been argued that the use 
of such approaches results in the formulation of research questions 
that are data driven rather than driven by the need for new or further 
knowledge about a phenomenon (Hofferton 2005).  Therefore, both 
of these points raised pose a significant concern and questions the 
validity of the results of such studies, and their appropriateness in 
determining symptom clusters in patients with cancer.  
 
As intimated on a number of occasions in this thesis, this 
inconsistency in approaches to the study of symptom clusters in 
patients with cancer may, in part, stem from the lack of conceptual 
clarity and the abstractness of current definitions, which leaves 
researchers having to decide for themselves characteristics which 
constitute evidence of symptom clustering.  It may be argued that 
the only way that such limitations can be overcome is to explore the 
concept of symptom clusters from the perspective of the person 
experiencing it; only then will the „essences‟ of the phenomenon 
come to light, providing a framework to direct further research in this 
area.    
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Supporting this patient-centred approach are the findings of the only 
three studies published in the literature to date which have utilised a 
qualitative approach relative to the study of symptom clusters in 
patients with cancer (Lopez et al. 2011; Molassiotis et al. 2010; 
Molassiotis et al. 2008).  However, it should be noted that two of the 
studies cited above (Molassiotis et al. 2010; Molassiotis et al. 2008) 
were not intended primarily to explore the concept of symptom 
clusters in patients with cancer, but engaged in the concept in the 
presentation and discussion of their findings.   
 
One of the studies (Molassiotis et al. 2008) explored the experience 
of chemotherapy related nausea in patients with cancer and, using 
content analysis, reported that participants‟ narratives of the 
symptom often concurred with other symptoms, suggesting that such 
findings provide preliminary evidence to support a cluster of 
symptoms consisting of nausea, loss of appetite, taste disturbance, 
vomiting and „possibly‟ intolerance of smells.   
 
The second study by the same authors (Molassiotis et al. 2010) 
reported respiratory clusters of symptoms (cough, breathlessness, 
and fatigue) which played a central role in the participants‟ symptom 
experiences a year after diagnosis and that these symptoms were 
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often the ones that patients felt were of greatest prominence in their 
lives.  Of note is that this study was a secondary analysis of an 
existing data set and therefore had inherent limitations, as discussed 
previously.  Furthermore, whilst the authors claimed to use IPA as a 
method of data analysis, the descriptive level of the findings 
presented in this paper suggests otherwise, as they do not confer 
with the deep level of analysis associated with this methodology and, 
therefore, the depth of findings expected in such studies.   
 
The most recent study published (Lopez et al. 2011), unlike the two 
previous studies (Molassiotis et al. 2010; Molassiotis et al. 2008), did 
aim to explore patient narratives regarding the development and 
coexistence of symptoms in patients with gynaecological cancer, 
using data from qualitative longitudinal interviews over a 12-month 
period.  Using content analysis, four symptom clusters were identified 
from the participants‟ narratives (Lopez et al. 2011), which included: 
 
 Tiredness, sleeplessness, pain, depression  
 Hair loss, ocular changes, body image, identity experience and 
anxiety 
 Nausea, loss of appetite, taste changes, bowel function, weight 
changes, distress 
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 Numbness and tingling sensations in the hands and feet, 
restlessness, sleeplessness, and depression 
 
Whilst the findings of the study do contribute to the body of research 
pertaining to the study of symptom clusters in patients with cancer 
on the grounds of its qualitative approach, it may also be argued that 
that the use of content analysis provides only a descriptive account of 
the experience of symptom clusters in patients with cancer.  
Furthermore, it has been contended that this approach has an affinity 
with reductionist methods of measurement, and often results in the 
oversimplification of phenomenon which are by their very nature 
complex (Weber 1990). 
 
Outcomes of the studies by Lopez et al (2011), Molassiotis et al 
(2010) and Molassiotis et al (2008), highlight that the patient 
narrative is one way to elicit the occurrence of symptom clusters, 
suggesting that the statistical analysis approaches more widely 
utilised in the past, may not be the only way to identify and 
comprehend the existence and experience of symptom clusters in 
patients with cancer.  Such an assertion has been previously posed 
by Kim et al (2005) who ask „Are symptom clusters that are identified 
by statistical methods theoretically or clinically useful?  Or are there 
better methods to identify symptom clusters and what are they?‟.  
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Unless we explore symptom clusters from a patient perspective, this 
question will never be answered.   
 
Therefore, in conclusion, whilst the study of symptom clusters in 
patients with cancer has opened up new avenues for research into 
cancer symptom management identifying symptom clusters in 
various patient populations, it can be argued that the theoretical 
basis underpinning this body of research is weak and that this lack of 
conceptual clarity has resulted in the production of a disparate body 
of research which is limiting the transference of this knowledge into 
clinical practice.   
 
It may be postulated that in order to address such limitations, the 
core „essences‟ of the phenomenon need to be identified 
(Krishnasamy et al, 2001), to provide researchers conducting studies 
in this area, clarification of the defining attributes of the phenomenon 
in which to guide future research.  It may argued that in order to 
identify the core „essences‟ of this phenomenon, then we need to 
explore the phenomenon from the perspective of the patient 
(Krishnasamy 2000) as they are the experiential expert.    
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Of relevance to the study of symptom clusters is that to date, no 
study has explored the lived experience of symptom clusters in 
patients with cancer and this itself may be viewed as being a 
significant limitation in this body of research.  It may therefore be 
argued that in order to strengthen the scientific base and advance 
the concept of symptom clusters in patients with cancer, we need to 
explore the experience of symptom clusters from the perspective of 
the patient; we need to bring the „person‟ in.   
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Chapter 4 Methodology 
 
This chapter of my thesis discusses my methodological approach and 
describes the methods that I selected to explore the lived experience 
of symptom clusters in patients with advanced lung cancer.  Firstly, I 
discuss the limitations of the predominantly quantitative approach to 
the study of symptom clusters and why a qualitative approach was 
selected.  I then discuss epistemologies which underpin qualitative 
research methods and set out my philosophical position.  This is then 
followed by a discussion of qualitative research methodologies 
providing a rationale for why Interpretative Phenomenological 
Analysis (IPA) was selected to explore the experience of symptom 
clusters in people with advanced lung cancer.   
 
Chapter 3 of this thesis discussed the concept of symptom clusters in 
patients with cancer and highlighted a number of theoretical and 
methodological limitations in symptom clusters research to date (Kim 
et al. 2005).  One area which was highlighted was the predominantly 
quantitative approach which has been used by researchers to identify 
and measure symptom clusters and the utility of such an approach 
has been questioned on the grounds that they reflect little of the 
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underlying reality of the experience of symptom clusters within a 
person‟s life (Willig 2001).   
 
However, whilst recognising the contributions that such approaches 
have made to the study of symptom clusters in patients with cancer 
to date (see chapter 3), for subjective „lived‟ manifestations, such as 
symptoms, which „represent expressions of the reality of the patient‟s 
world‟ and are „linked to the stresses and experiences of that person, 
composed of both cultural and personal meaning‟ (Tishelman et al. 
1991:1230), it may be argued that they neglect the context and 
meaning associated with the symptom experience and convey little of 
the underlying reality (Krishnasmamy, 2000: 41).  Furthermore, it 
has been advocated that before measurement can take place, we 
need to explore the meanings those particular phenomena have to 
the person experiencing them.  As Krishnasamy (2000) states: 
 
Without securing meaning before measurement, it is unlikely 
that an instrument will provide data which can contribute to an 
understanding of how the phenomena under investigation 
impact on the lives of the participants and what factors 
exacerbate or relieve it (Krishnasamy 2000:411).   
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To date, no studies of symptom clusters in patients with cancer have 
explored the lived experience, meanings and context which shape 
this phenomenon from the patient‟s perspective.  Therefore, the 
current evidence base, which has predominantly used quantitative 
approaches, may be said to be fundamentally lacking.  Furthermore, 
it could be argued that without the exploration of the experiences, 
context and meaning of poorly understood phenomena, such as 
symptom clusters, „future research of poorly understood phenomena 
cannot be generated with any degree of certainty‟ (Krishnasamy et 
al. 2001:412).  Therefore, it appears that in order to develop and 
build upon the current evidence and theoretical basis of the concept 
of symptom clusters in patients with cancer, it is imperative that we 
explore and understand the experiences, context and meanings 
which surround this phenomenon.   
 
4.1 More than a method 
In contrast to quantitative methodologies which have predominantly 
been used in the study of symptom clusters to date (which, in turn, 
focus on causal relationships explicated in terms of observational 
statements, verifications and predictions), qualitative methodologies 
offer alternate ways of exploring human behaviour.  They express a 
preference for contextual understanding and are interested in the 
meanings that an individual attributes to events (Willig 2001; 
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Barbour 2000).  Qualitative approaches aim to understand experience 
from the perspective of those who live with it (Schwandt 1994) and 
all have a concern with the richness of the human experience 
(Ashworth 2003).   
 
Such an approach appears to be a suitable approach to explore the 
experiences, context and meanings of symptoms clusters in patients 
with cancer.  However, there is not one but many qualitative research 
methodologies which have a shared concern with context and 
meaning; many of them are deeply rooted in various theories of 
knowledge (epistemology) which make assumptions about „how, 
what and can we know about the world‟ (Willig 2001:2) and the 
claims that such knowledge can make on the subject being studied 
(Green and Thorgood 2005).    
 
Therefore, it is important that when selecting a qualitative 
methodology, the researcher adopts an epistemological position in 
order to be clear about the objectives of their research and to know 
what kinds of things it is possible for them to find out about the 
phenomenon under investigation (Reicher 2000).  As stated by 
Reicher (2000), qualitative research methodologies „have different 
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philosophical roots, different theoretical assumptions and they ask 
different types of questions‟ (Reicher 2000:4).   
 
Qualitative researchers can adopt a variety of epistemological 
positions and there are different ways of conceptualising these 
epistemological positions assumed by the different approaches to 
qualitative research (Reicher, 2000; Madill, 2000).  However, at the 
most fundamental level, most methods share an assumption that 
there is no objective reality and that knowledge and its production 
are context-specific (Lyons and Coyle 2007).  Madill (2000) 
conceptualised the differences in epistemological positions of 
qualitative research in terms of a continuum where on one end 
stands realist epistemologies (naïve, scientific, critical)  and at the 
other end, constructionist (contextual and radical).   
 
Realist epistemologies include naïve, scientific and critical 
approaches.  Naïve realism is linked to the correspondence of the 
theory of truth which assumes reality can be discovered with the 
appropriate methods and that it exists independent to our 
perceptions of it, that is, that there are phenomena out there waiting 
to be discovered (Madill et al. 2000).  Scientific realism views the 
scientific method as being the best mode of inquiry and that the 
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world described by science is the real world.  In comparison to naïve 
and scientific realism, critical realism demonstrates a subtler form of 
epistemological realism in that it recognises that knowledge is not 
objective and therefore assumes that all knowledge is context-
specific and influenced by the perspective of the perceiver and 
therefore admits a degree of subjectivity (Madill, 2000).   
 
A constructionist epistemology advocates that „human experience 
including perception is mediated historically, culturally and 
linguistically‟ (Willig, 2001:7).  Therefore, a constructionist approach, 
in contrast to a naïve or scientific realist approach, believes that 
there is not an objective reality or truth waiting to be discovered.  
Rather, the constructionist believes that we construct reality in our 
given situations and therefore it follows that knowledge and 
understanding are highly contextual and situation-dependent; 
therefore, there is not one but many insights into the same 
phenomenon (Willig, 2001; Madill, 2000).  Constructionism is 
therefore relative in that it does not privilege any picture of reality 
but views all to be equally acceptable and valid.  In the research 
process, it emphasises the constructive nature of the participant-
researcher interaction and their co-construction of meaning and 
therefore views researchers not as observers (as in many 
quantitative approaches) but as being an integral part of the research 
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process (Pidgeon and Henwood 1997).  Constructionism emphasises 
the role of language and sees it much more than a medium to 
transport an accurate and straightforward description of a given 
reality.  With this approach, language is seen as a set of social 
practices that perform part of the process of constructing reality 
(Willig 2001).  
 
There are many constructionist epistemologies and how far along the 
continuum the researcher stands is a matter of their epistemological 
position.  For example, the contextual constructionist expands one of 
the main tenets of constructionism in relation to the belief that all 
knowledge is context-sensitive and that it is integral to human 
experience (Jaeger and Rosnow 1988).  According to Jaeger and 
Rosnow (1988), „contextualism highlights that human activity does 
not develop in a social vacuum but is vigorously situated within a 
socio-historical and cultural milieu of meanings and relationships‟ 
(1988:65).  At the end of the constructionist continuum is the radical 
constructionist, who challenges the „notion that there can be any 
absolute foundations for knowledge‟, and who „is characterised by a 
profound distrust of the idea that language can represent reality‟ 
(Madill et al. 2000:12)   
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4.2 My epistemological position 
As has been previously stated, it is important that when selecting a 
qualitative methodology the researcher adopts an epistemological 
position in order to be clear about the objectives of their research 
and to know what kinds of things it is possible for them to find out 
about the phenomenon under investigation (Reicher 2000).   
 
As a researcher, I reject the notions of naïve and scientific realist 
stance in that I do not believe that there is one single objective 
reality, independent of our perceptions of it, or that the scientific 
method is the only true way to access the real world.  I do have an 
affinity to the critical realist approach in that I do believe that there is 
a real world, but that knowledge of it is influenced by the perceptions 
of the person in the context of their lives.  I identify with many of the 
assumptions made by constructionist theories in recognising the 
centrality of historical, social and cultural processes on how we 
experience and understand our lives, resulting in not one but many 
knowledges about a phenomenon.  I have a particular affinity to the 
focus of the contextual constructionist and the importance of context 
in knowledge production.  However, I do challenge radical 
constructionist approaches and how they contest the notion of there 
being any foundation for knowledge.  I am also critical of  
constructionist approaches and how they do not take into account the 
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extra discursive dimensions such as the body which „obscures and 
downplays the significance of its functional, physiological, hormonal, 
anatomical and phenomenological aspects‟ (Cromby and Nightingale 
1999:11).  This point is supported by Broom and Willis (2007) in 
their critique of constructionist approaches, who ask: „What can be 
more real than cancer, pain or diabetes?‟ (Broom and Willis 
2007:27).   For the study of „lived‟ phenomena such as symptoms, 
which have physical dimensions, it is imperative that the body is not 
„treated as a mere metaphor‟ (Cromby and Nightingale 1999:11).   
 
Therefore, in conclusion, I am advocating a qualitative approach to 
the study of symptom clusters in patients with cancer which is 
informed by a contextual constructionist approach but which criticises 
such approaches for their ignorance of extra-discursive dimensions 
such as the body.  As has been previously stated, there are many 
qualitative research methodologies however it is beyond the scope of 
this thesis to discuss them all.  In light of the researcher‟s 
epistemological position, this thesis will discuss qualitative research 
methodologies which are informed by constructionist epistemologies, 
such as social constructionist versions of Grounded Theory, Discourse 
Analysis and Interpretative Phenomenological Analysis (Willig, 2001), 
and, in doing so, will provide the justification of why the 
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Interpretative Phenomenological Analysis (IPA) method was selected 
for this study. 
 
4.3 Qualitative research methodologies 
As has been previously stated, this section of the thesis will discuss 
qualitative research methodologies which have been linked to 
constructionist theories and will provide a rationale for the selected 
method of IPA to explore the lived experience of symptom clusters in 
patients with advanced lung cancer. 
 
Social constructionist versions of Grounded Theory have been linked 
to a contextual constructionist epistemology.  This methodology was 
originally developed by Glaser and Strauss (1967) in response to 
their disdain at the way existing theories dominated research.  Their 
aim was to develop new „contextualised‟ theories which were 
grounded in the data from which they emerged.   
 
Since its introduction, a number of versions of Grounded Theory have 
evolved from the literature including the contextual constructionist 
versions (Mills et al. 2006) which have been developed in response to 
criticism of the ontological and epistemological origins of the earlier 
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versions.  Much of this debate has stemmed from the inductive 
nature of Grounded Theory and the terms such as „emergence‟ and 
„discovery‟ of categories from the data, suggesting that the 
researcher uncovered something that was already there and 
therefore had no constructive role in this process.  Such assumptions 
were therefore thought to ascribe to positivistic positions which hold 
that there is a direct correspondence of things in the world and our 
perception of them; thus, it is possible to obtain accurate knowledge 
of things in the world, provided we can adopt (Charmaz 2000) an 
impartial, unbiased and objective viewpoint.  The social 
constructionist versions, such as the ones developed by Strauss and 
Corbin (1994) and  Charmaz (2000), contested this viewpoint and 
argue that categories and theories do not simply emerge from the 
data but are constructed by the researcher through their interaction 
with the data.  With this constructionist version of Grounded Theory, 
the role of the researcher is acknowledged as is what he or she 
brings to the research process (Charmaz 2000; Strauss and Corbin 
1994).  Therefore, in this instance, the theory reflects only one 
version of the data and subscribes to relativist positions on the 
nature of knowledge.    
 
Whilst social constructionist versions of Grounded Theory have an 
affinity with the epistemological stance of the researcher and 
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therefore appeared be an „attractive‟ methodology for researchers 
wanting to explore the experience, meaning and context of symptom 
clusters in patients with cancer, such an approach was not thought to 
be suitable for the following reasons outlined below.  Grounded 
theory was originally developed to theorize social processes and 
aimed to answer sociologically derived questions (Charmaz 2000).  
Its suitability to answer research questions regarding the meaning 
and nature of experience have been questioned (Willig, 2001) with 
some advocating the use of phenomenological types of inquiry for 
this.  Therefore, as the research questions asked in this study are 
exploring the experience of people with advanced lung cancer who 
are experiencing symptom clusters, Grounded Theory was felt to be 
an unsuitable research methodology to answer such questions.  
Furthermore, one of the main tenets of Grounded Theory is theory 
generation and this is not one of the aims of this study.   
 
Another qualitative research methodology which has been linked to 
constructionist theories is Discourse Analysis.  This term is used to 
describe a number of qualitative approaches which focus on how 
people construct meaning through the use of language (Lyons and 
Coyle 2007).  Therefore, such approaches are critical of cognitivism 
(Willig, 2001) and do not view the role of language as reflecting 
reality by describing experiences or revealing underlying 
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psychological process.  Rather, they view language as a tool which 
constructs reality; „it examines how people use language to construct 
versions of their worlds and what is gained from these constructions‟ 
and therefore adopts a social constructionist position (Lyons and 
Coyle, 2007; 100).    
 
There are two main approaches used in the study of discourse; 
Discursive Psychology and Foucauldian Discourse Analysis (Willig, 
2001).  Whilst both approaches agree on the discursive construction 
of reality and are therefore critical of cognitivism (that is to say that 
language provides a way for individuals to express what is in their 
minds), they, however, differ by the types of questions that they aim 
to answer and in the intellectual traditions which inform these 
questions.   
 
Discursive Psychology stems from ethnomethodology and 
conversational analysis and is concerned with discourse in relation to 
how participants use language to negotiate and manage social 
interactions, and how they use language to achieve objectives (Potter 
and Wetherell 1987).  Issues such as „stake‟ and „interest‟ are 
therefore interesting concepts to the Discursive Psychologist.  
Foucauldian Discourse Analysis, in contrast to viewing how people 
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use language to achieve objectives, is interested in how people use 
the discursive resources available to them („discursive economy‟) 
within a context and how this constructs power relations and a sense 
of self (Willig, 2001).  In this sense, discourse is viewed as having 
the ability to facilitate and control what can be said by an individual 
and the setting it is said in.  Whilst both approaches agree on the 
linguistic construction of social reality, they diverge on the existence 
of reality, independent of language.  Discursive psychology focuses 
exclusively on language and therefore ascribes to the radical 
constructionist position that there can never be any truth about a 
phenomenon as this is socially constructed.  Foucauldian Discourse 
Analysis, however, holds on to the tenet that there is some reality 
which is independent of language (Willig 2001). 
 
Whilst these approaches offer a sophisticated understanding of the 
use of language which is an attractive feature to some, their 
dismissal of the role of cognitions and their sole focus on language 
mean that they are not interested in mental processes and how they 
influence an individual‟s behaviour.  Therefore, as this study is aiming 
to explore the experience, context and meanings of symptom clusters 
in patients with advanced lung cancer, it is important not only to 
focus on how people talk about a phenomenon but also to understand 
what they think about it.  Therefore, it is important that that these 
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cognitions are addressed in order to answer the research questions 
posed.  Therefore, on these grounds, Discourse Analysis was not 
selected for this study.    
 
Having presented and discussed qualitative methodologies linked to 
the epistemological stance of the researcher and providing 
justification for their rejection in the current study, the methodology 
employed in this current study (Interpretative Phenomenological 
Analysis) will be discussed and contrasted to the previous approaches 
in order to provide justification for its selection.   
 
Interpretative Phenomenological Analysis (IPA), as with the previous 
methodologies discussed, is linked to a contextual constructionist 
stance (Willig, 2001).  It is ontologically rooted in critical realism 
believing that there are stable and enduring features of reality that 
exist outwith human conceptualisation and that different accounts of 
phenomena are possible because people experience different 
components of reality (Smith et al. 2009a).  
 
IPA has been linked to the social cognition paradigm in that it 
assumes a connection between what people say and what they think 
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about phenomena.  However, it does not believe this link to be direct 
in that it recognises the various linguistic abilities that people have in 
expressing themselves and also that they may not wish to disclose 
certain information (Smith and Eatough 2006).  IPA also recognises 
the role that language plays in how individuals make sense of their 
lived experience and, in turn, how researchers make sense of the 
way individuals related these experiences.  Therefore, IPA is said to 
have some similarities with discursive approaches in their focus on 
the use of language.  However, IPA differs from discursive psychology 
(which is radically critical of cognition) on the view that reality is only 
constructed through language and that we can only refer to the world 
that we construct in this way (Smith, 2007).  As stated by Smith and 
Eatough, „IPA would disagree with a claim that language is the sole or 
primary constructor of reality‟ (Smith and Eatough 2006:326). 
 
One of the main theoretical touchstones of IPA is phenomenology, 
which is concerned with human understanding.  It originated from 
the works of Edmund Husserl (1962) who has commonly been 
deemed to be the „father of phenomenology‟.  His philosophical 
ideologies gave rise to the descriptive phenomenological approach 
(Cohen 1987; Husserl 1962).  He argued that consciousness is the 
medium with which all human phenomena are experienced (Giorgi 
2005) and believed that it was imperative that fundamental 
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structures of consciousness, that is to say the „essences‟, were 
revealed (Lopez and Willis 2004; Koch 1995; Husserl 1962).  Husserl 
(1962) believed that „the essences‟ were universal to any lived 
experience and that they represented the true nature of the 
phenomenon under investigation, resulting in one correct explanation 
of the phenomena under investigation.  Husserl thought that it was 
necessary to develop a rigorous, scientific foundation for the natural 
and human sciences and, as a result, introduced the concept of 
„transcendental objectivity‟ (Lopez and Willis 2004).  In order to 
achieve this, he proposed that individuals had to „bracket‟ the outer 
world by continually assessing and „neutralising‟ any biases and 
preconceptions that may be present (Lopez and Willis, 2004), only 
then could contact with the „essences‟ be achieved.   
 
IPA‟s claims of being a phenomenological approach have been 
criticised on the grounds that true phenomenological approaches 
should aim to bracket out preconceptions in order to view the world 
in a pre-cognitive state (Moustakas 1994) and that interpretation and 
phenomenology are not compatible.  However, IPA ascribes more to 
the latter phenomenological works of Heidegger (1962) and Gadamer 
(1989). 
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Heidegger, a student of Husserl, revisited many of his 
phenomenological assumptions and based himself in the interpretive 
or hermeneutic research tradition (Lopez and Willis 2004).  His 
approach, rather than focusing on the description of core essences, 
looked for the meanings embedded in everyday life.  The aim of his 
form of enquiry was on experience rather than what was consciously 
known; it focused on the „person and the context of their existence‟ 
(Mackey 2005).  In contrast to the epistemological stance of Husserl 
(1962), Heidegger came from a more ontological perspective; his 
objective was to understand the nature of being itself and used the 
term „being-in-the-world‟ to denote this concept (Heidegger 1962).  
He believed that phenomenological enquiry should focus on the 
relationship of the individual to his/her life „world‟ and used the term 
„indissolute unity‟ to emphasise this concept (Heidegger 1962).  
Heidegger (1962) advocated that that there are many ways of „being 
in the world‟ but most important was in being aware of one‟s own 
being, that is to say, Dasein.  To exist in this way, he believed, was 
to exist „authentically‟ and he proposed that access to the „lived 
experience‟ can only be achieved through exploration of this entity.  
He contested Husserl‟s phenomenology and believed that description 
devoid of interpretation was impossible and pioneered interpretation 
as both a concept and method of phenomenology (Heidegger 1962).  
He believed that understanding through interpretation was 
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meaningful and resulted in the true revelation of the phenomena 
(Heidegger 1962). Furthermore, in contrast to the works of Husserl 
(1962) and his views on „bracketing‟, Heidegger (1962) believed the 
presence of fore-structures (for example, existing knowledge and 
experience) to be both useful and valuable.  He used the term „the 
hermeneutic circle‟ to illustrate the continual relationship between 
pre-existing knowledge and experience in understanding. 
 
Following on from the work of Heidegger, Gadamer (1989) 
questioned how understanding was possible (Laverty 2003).  As with 
his predecessor, he believed that language and understanding were 
inseparable features of „being in the world‟ (Laverty 2003).  He 
viewed humans as being intrinsically historical individuals and 
believed that all interpretations of existence needed to be framed in 
terms of historical consciousness.  He rejected Husserl‟s notion of 
bracketing, describing it as being „absurd‟ (Gadamer 1989:398).  
According to Gadamer (1989), being aware of one‟s own 
history/experiences (which he termed „prejudices‟) enables 
individuals to transcend to a „fusion of horizons‟ (Gadamer 
1989:305).  Gadamer (1989) defined the „horizon‟ as „the range of 
vision that includes everything that can be seen from a particular 
vantage point‟, and utilised the term „fusion of horizons‟ to denote 
the dialectical interaction between the expectation of the interpreter 
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and the meaning of the text (Laverty 2003:10).  According to Koch 
(1999), research grounded in the works of Gadamer aims to 
understand the fusion of horizons between the researcher and the 
participant or between the text and the person interpreting it.   
 
Therefore, Heidegger‟s (1962) stance on the individual „being in the 
world‟ and Gadamer‟s (1989) view on the importance of historical 
and socio-cultural background in shaping our perceptions of the 
world, support IPA‟s notion of seeking an „insider‟s‟ perspective and 
interpretation in that it acknowledges the researcher‟s past and 
personal beliefs in the construction of knowledge (Fade 2004).  IPA 
has also been linked to the theory of hermeneutics (interpretation) 
and, as has been previously inferred, plays homage to the role of the 
researcher in the research process (Smith et al. 2009a).  It 
acknowledges how access to the participants‟ „lived experience‟ is 
influenced by their role in the research process in that they are 
required to make sense of participants‟ accounts through a process of 
interpretation.  IPA is said to involve a double hermeneutic in that as 
well as the individual attempting to make sense of their world, the 
researcher is, in turn, trying to make sense and interpret the 
accounts of the participant (Smith and Eatough 2007). 
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IPA has also been linked to Symbolic Interactionism (Mead 1934) 
which focuses on the meanings that individuals ascribe to events and 
how these meanings are obtained through the process of 
interpretation.  It is interested in how meanings occur and, in turn, 
are made sense of, with particular interest in social interactions 
(Smith 1996).  
 
IPA has been described as an idiographic mode of inquiry (Smith and 
Eatough 2007).  In contrast to nomothetic approaches where analysis 
is conducted only at a group level, IPA advocates the examination of 
the individual case in the first instance and therefore can make 
claims on an individual basis.  It also facilitates the analysis of 
individuals at a group level in order to identify shared themes that 
participants may have (Smith and Eatough 2007).  This approach, 
therefore, has much affinity with Grounded Theory in that it focuses 
on individual cases in the first instance before integrating cases to 
present findings at a group level (Willig, 2001).  However, both 
approaches, whilst having many similarities, differ in one main area: 
the role they give to cognitions.  Whilst Grounded Theory is 
concerned with explicating the verbal statements of participants it 
does not link this to underlying cognitions and, unlike IPA, is not 
interested in what a participant thinks about a particular 
phenomenon.   
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4.4 Rationale for using IPA  
Therefore, following a discussion on various qualitative research 
methodologies (Grounded Theory, Discourse Analysis), including IPA, 
a rationale for why IPA was selected to study the lived experience of 
symptom clusters in patients with cancer will be provided in the 
following text.    
 
One of the main differences between the three approaches discussed 
is the role of cognitions.  IPAs focus on the role of cognitions and how 
these can be inferred through the analysis of language, which allows 
the researcher to explore how individuals make sense of their 
experiences and what they think about phenomena (Smith et al. 
2009a; Smith and Eatough 2007; Smith and Eatough 2006).  In 
order to explore and understand the lived experience of symptom 
clusters in patients with cancer it is important that we get some 
insight on how people feel and think about this phenomenon and the 
meanings that they ascribe to it;  we need to get „an insider‟s 
perspective‟.  As advocated by Krishnasamy (2000), we need to 
explore the meanings that particular phenomenon have to the person 
experiencing it.  Grounded Theory and Discourse Analysis do not 
facilitate such an exploration (Smith et al. 2009a).   
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As has been previously stated, some qualitative research 
methodologies, such as Discourse Analysis, have been criticised for 
their omission of extra discursive factors such as the body.  IPA is a 
methodology which acknowledges the body and therefore can 
contribute to the biopsychosocial perspectives of health (Reid et al. 
2005).  It recognises the importance of understanding a patient‟s 
perception of, and interpretation of, their bodily experiences and the 
meanings which they assign them, an approach which has been 
neglected in the study of symptom clusters in patients with cancer to 
date.  
 
The phenomenological origins of IPA and its focus on the lived 
experience of the person in the context of their own life (Smith et al. 
2009a) has an affinity with the constructionist standpoint of the 
researcher and the importance of gaining knowledge in the context of 
the person being in the world.  The hermeneutic component of IPA 
(Smith et al. 2009a; Smith and Eatough 2007; Smith and Eatough 
2006) also identifies with this constructionist stance in viewing 
knowledge as a co-construction with the researcher and the 
participant.  This is in contrast to other methodologies (for example, 
the non-constructionist version of Grounded Theory) which aim to 
minimise the role of the researcher in the process.  
93 
 
Finally, the idiographic focus of IPA (Smith et al. 2009a) is in contrast 
to the predominate nomothetic approach to the study of symptom 
clusters in people with cancer to date, which will facilitate an in-depth 
exploration of this phenomenon from the perspective of the 
individual.  With the advocacy of patient-centred and individualised 
care (Olsson et al. 2009; Wolf et al. 2008) it is imperative that the 
experience of the phenomenon at an individual level is explored.  This 
idiographic focus is not evident in the other approaches discussed 
earlier in the text. 
 
Therefore, in conclusion, having provided justification for the 
qualitative exploration of symptom clusters in patients with cancer 
and why IPA was considered an appropriate methodology for the 
study of this phenomenon, the methods used in this study will now 
be presented. 
94 
 
Chapter 5 Study methods 
 
5.1 Introduction 
The previous chapter provided the justification for the qualitative 
exploration of symptom clusters in patients with cancer and why IPA 
was considered an appropriate methodology for the study of this 
phenomenon.  This chapter of the thesis details the methods used in 
this study.  This will include a discussion of the aims and research 
questions which governed this study, the sample of patients recruited 
to the study, the study design, methods, and data analysis strategies 
used to ensure that the aims of the study were met.   
 
5.2 Aim of the study 
As previously stated, the aim of this study was to explore and 
understand the experience of symptom clusters in patients with 
advanced lung cancer.  In order for me to address the study aims, 
the following research questions were developed:   
 
 What is the „lived experience‟ of symptom clusters in patients 
with advanced lung cancer? 
 How do people with advanced lung cancer understand and 
make sense of the symptom clusters that they are 
experiencing? 
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I anticipated that the first research question would allow me to 
address my study aims by determining the lived experience of 
symptom clusters in patients with advanced lung cancer.  The second 
question would facilitate an understanding of the experience of 
symptom clusters in the context of the patient‟s life.  Throughout this 
study, these questions were referred to frequently to ensure that the 
aim of this research study was being addressed.  As indicated in 
chapter 1, for the purposes of this study a symptom cluster was 
defined as being the experience of three or more concurrent 
symptoms.   
 
5.3 Study design 
As discussed in the previous chapter pertaining to the methodology 
selected for this study, a qualitative, prospective study design was 
used.  In order to test the proposed study procedures I conducted a 
pilot study and results of this are presented in chapter 6 of this 
thesis. 
 
5.4 Patient population 
5.4.1 Clinical site 
The study was conducted in one clinical site in Scotland.  This site 
was selected since it offers both inpatient and outpatient oncology 
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services to patients within the defined locality with over 500 patients 
from this site being diagnosed with lung cancer each year.  This site 
was also selected for pragmatic reasons, as I already had an 
established network of health professionals to assist me in the 
recruitment process.   
 
5.4.2 Sampling strategy and sample size 
Criterion sampling was used to recruit patients to this study.  This 
type of sampling is commonly used in qualitative research studies 
and „fits well‟ with the methodological principles of an IPA study 
which is to explore the meaning of phenomena within the experience 
of the individual (Smith et al. 2009a).  This type of sampling allows 
the researcher to „review and study all cases that meet some pre-
determined criterion‟ and therefore ensure that the participants 
recruited to the study are „rich‟ with information which can be used to 
answer the research questions posed and address by the study aims 
(Patton 2002). 
 
I planned to recruit 10 patients in total to this study.  This sample 
size is the upper limit of the number of participants advocated for 
studies employing IPA (Smith et al. 2009b; Reid et al. 2005; Smith 
and Osborn 2004).  I felt that this size of sample would allow me to 
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pay homage to the idiographic focus of IPA whilst allowing me to 
develop meaningful points of similarity and difference between the 
participants.   
 
5.4.3 Selection of the sample 
Studies utilising IPA typically try to find a homogenous sample for 
whom the research question will be meaningful (Smith et al. 2009a).  
Therefore, patients with advanced lung cancer experiencing multiple 
concurrent symptoms were selected for the study sample.  This 
sample was selected as they are known to commonly experience 
multiple concurrent symptoms and have been reported to experience 
higher levels of symptom severity and distress compared to patients 
with other cancer types (Cooley 2000).  Furthermore, a number of 
various symptom clusters had already been reported in this patient 
group in the literature (Wang et al. 2008; Brown et al. 2007; Fox and 
Lyon 2006; Wang et al. 2006; Gift et al. 2003).  Details of the 
participants recruited to this study are presented in table 13 (chapter 
7).  
 
I did face the dilemma of deciding what criteria I could apply to 
ensure that the patients that I intended to recruit to the study were 
experiencing the phenomenon that I wanted to explore.  On reading 
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the literature, and as highlighted in chapter 3, it had come to light 
that the strength of the scientific base underpinning current 
definitions of symptoms clusters had been criticised widely in the 
literature, and at the most fundamental level it had been questioned 
„whether the characteristics defined in conceptual definitions‟ could 
be observed in patients with cancer (Barsevick et al. 2005).  
However, whilst taking the above into consideration, I also felt that I 
needed to have some criteria which were indicative of symptom 
clustering in this patient group.  Therefore, I decided to use the only 
information which was available to me at that time, and define a 
symptom cluster for the purpose of this thesis as being the 
experience of three or more concurrent symptoms.  This definition is 
based on existing definitions of symptom clusters in patients with 
cancer which purport that „concurrence‟ is a core characteristic of this 
phenomenon (Kim et al. 2005; Dodd et al. 2001b) and where the 
number of symptoms thought to constitute a symptom cluster is 
three or more (Dodd et al. 2001a; Dodd et al. 2001b).  Furthermore, 
the characteristic of concurrence has been used as evidence of 
symptom clustering in previously published qualitative studies of 
symptom clusters in patients with cancer (Lopez et al. 2011; 
Molassiotis et al. 2010; Molassiotis et al. 2008).  The requirement for 
participants to be able to communicate in English was a pragmatic 
decision based on the method of data collection employed in the 
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study (unstructured interviews).  In the likelihood of the participants 
being recruited to the study presenting with advanced disease, the 
necessity to have a life expectancy of greater than two months was 
selected to facilitate the objectives of the study and minimise attrition 
rates which are known to be high in this patient group (McMillan and 
Weitzner 2003).  The decision not to allow participants with a 
diagnosis of any other type of cancer was made in order to maintain 
the homogeneity of the study sample.  A table of the inclusion and 
exclusion criteria for this study are detailed in table 5 below. 
 
Table 5: Details of inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
Aware of a diagnosis of lung cancer 
 
A diagnosis of any other type of cancer 
Experiencing multiple concurrent 
symptoms (three or more) 
Unable to meet any of the inclusion 
criteria 
Able to communicate in English verbally  
Life expectancy of greater than two 
months 
 
Deemed physically and psychologically 
fit to participate by any member of the 
healthcare team 
 
Able to give written, informed consent  
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5.4.4 Process of recruitment 
The process of recruitment was guided by discussions with clinical 
collaborators at the clinical site and in line with ethical 
recommendations (see section 5.4.5).  Eligible participants were 
identified by the Lead Nurse for Lung Cancer based at the 
participating hospital, who provided them with both verbal and 
written information about the study (see appendix 1).  If the patient 
was interested in participating in the study, the Lead Nurse for Lung 
Cancer asked them to sign a form, authorising him to pass on their 
personal contact details to the researcher (see appendix 2).    
 
Following a period of no less than 72 hours, the researcher then 
contacted the patients, explained the study, answered any questions 
and asked them if they would like to take part in the study.  If the 
participant did wish to take part in the study, a mutually suitable 
date, time and place was organised for the patient and the 
researcher to meet in order to obtain written informed consent and to 
conduct the first interview (see appendix 3).  All patients who were 
contacted by the researcher agreed to take part in the study.  
Patients were also reminded that they could withdraw from the study 
at any time without their treatment and care being affected in any 
way. 
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5.4.5 Ethical considerations 
Ethical approval was granted by the Local Ethics Committee in 
December 2006.  There were a number of ethical considerations that 
I had to address prior to and throughout this research study.  These 
issues were addressed using Beauchamp and Childress‟s (2001) 
principles of biomedical ethics as a framework.  This included respect 
for autonomy, beneficence and non-malfeasance, and justice.  Each 
of these considerations will be discussed in turn below. 
 
5.4.5.1 Respect for autonomy 
Respect for autonomy acknowledges a person‟s right to make 
decisions and take actions based on their own values and beliefs.  It 
means not interfering with other people‟s choices and ensuring they 
are free from coercion regarding any decision that they make 
(Beauchamp and Childress 2001).   
 
In this study, I ensured that the participants‟ autonomy was 
protected by gaining written, informed consent.  This included 
ensuring that the participants knew that it was their decision on 
whether or not they participated in the study and that if they decided 
not to take part, their care and treatment would not be affected in 
any way.  I also ensured that they were provided with adequate 
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information, both verbally and in writing, to make certain that their 
decision on whether or not to participate in the study was based on 
an appropriate understanding of the study and the expected benefits, 
burdens, risks and reasonable alternatives.   
 
Autonomy was also protected in the interview process telling the 
participants at the start of the interviews that they did not have to 
answer a question if they did not want to, that they could stop the 
interview at any time and that they were free to withdraw from the 
study at any point if they wished.  Participant autonomy was also 
preserved by the use of unstructured interviews which allowed the 
participants to set their own agenda and determine what issues they 
wanted to talk about in their interviews.  Furthermore, prior to the 
second interview, the participants were once again asked if they were 
happy to be interviewed, reminded that their participation was 
entirely voluntary, and that they could withdraw at any time.  
 
5.4.5.2 Beneficence and non-malfeasance 
These terms denote balancing the benefits of participating in the 
study to the potential harm (Beauchamp and Childress 2001).  As 
with respect for autonomy, adherence to this issue was ensured by 
providing patients with both verbal and written information of the 
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benefits and risks pertaining to their involvement in the study.  
Issues regarding the beneficence and non-malfeasance of the study 
were also apparent in relation to the interview process.  When 
planning my study, I was concerned that the participants would 
become upset and distressed during their interviews when talking 
about sensitive topics, particularly in light of the unstructured 
approach that I proposed to use.  Whilst it was not my intention to 
cause any level of distress to the participants, I felt that I had to 
make sure that my research plan had addressed these issues to 
ensure patient wellbeing throughout their participation in the study.   
 
Therefore, I employed a number of measures to ensure that issues 
such as beneficence and non-malfeasance were being addressed.  At 
the start of the study, I reinforced the information already provided 
in the patient information sheet regarding the risk of them becoming 
upset during their interviews when discussing topics of a sensitive 
nature.  I told them that in such circumstances they could suspend or 
terminate the interview if they wished, and that if they decided to 
undertake any of the above, then their care and treatment would not 
be affected in any way.  In addition, throughout the interviews, 
particularly at times when the participants talked about sensitive 
topics, I frequently asked them if they were happy to talk more on 
the subject, asking them to give me reaffirmation that they 
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consented to the interview process throughout and that they were 
happy to talk about the topics at hand.  Whilst being offered this 
option on several occasions throughout both interviews, no 
participant declined to talk about a topic when further questioned.  At 
the end of each interview, I also asked each of the participants what 
they felt about their experience of being interviewed, and all stated 
that they viewed it as being a positive experience and found it 
beneficial to talk to someone about their illness who was not 
immediately involved in their family/social circle or medical care.  I 
also gave them a card for a recognised cancer charity confidential 
helpline with a contact number on it to use if they became upset 
about any of the issues that they had discussed.   
 
In ensuring no harm to the participants involved in this study, I also 
had to ensure that all documentation, reports and publications 
relating to the study were in accordance with the regulations set out 
in the Data Protection Act (1989).  It was essential to ensure that no 
patient identifiers were detailed on any of the study documentation.  
This was achieved by giving all patients who consented to the study a 
unique study number from which patients could not be identified by 
anyone other than the researcher.  Anonymity in the participants‟ 
transcripts was ensured by eradicating any names and identifiable 
data, and replacing all names with pseudonyms.  Furthermore, it was 
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important to ensure that personal details were stored securely in a 
locked filing cabinet which could not be accessed by anyone other 
than the researcher.  Throughout the research process the 
participants were assured that their responses were confidential and 
that their anonymity would be protected.  According to University of 
Stirling regulations, data collected during the study will be archived 
for ten years.  
 
5.4.5.3 Justice   
The term „justice‟ refers to the human regard for fairness, and for 
everyone to be given the same chance to take part in research 
studies (Beauchamp and Childress 2001).  Adherence to this principle 
was maintained by ensuring that all eligible patients were invited to 
participate in the study.  Issues such as „gatekeeping‟ by health 
professionals could have potentially impacted on the adherence to 
this ethical principle, however in this study gatekeeping was not an 
issue.  This may have been due to the close collaboration between 
myself and the clinical team and the mutual belief in the potential 
benefit of the study in patients with lung cancer.  Having discussed 
the ethical issues pertaining to this study, the following section will 
detail the data collection methods employed in this study. 
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5.5 Data Collection 
The aim of this study was to explore and understand the experience 
of symptom clusters in patients with advanced lung cancer.  In order 
to meet this aim, the methods that I adopted had to facilitate the 
collection of data which would provide an „insider‟s‟ perspective of 
this phenomenon and give experience a central position whilst 
recognising the multiple factors that can influence such experience.  
The use of in-depth interviews appeared to be a method which would 
allow me to collect such data and address the aims of the research 
posed.  A key feature of this type of method of data collection is its 
in-depth of focus on the individual (Ritchie and Lewis 2006).  It has 
been described by Ritchie and Lewis (2006) as being: 
 
The only way to collect data where it is important to set the 
perspectives heard within the context of personal history or 
experience; where delicate or complex issues need to be 
explored at a detailed level, or where it is important to relate 
different issues to individual personal circumstances‟ (Ritchie 
and Lewis 2006:58)   
 
Other methods of data collection have been used in IPA studies such 
as focus groups (Dunne and Quayle 2001; Flowers et al. 2001),  
observational notes (Larkin and Griffiths 2002), diaries (Smith 1999), 
and e-mail (Murray and Harrison 2004). However, these methods of 
data collection were not selected as I felt they did not pay homage to 
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the idiographic focus of IPA methodology (focus groups), would not 
facilitate the collection of in-depth data that I required to answer my 
research questions (observational notes), and were not appropriate 
for use in the patient population that I intended to recruit, who were 
patients with advanced lung cancer, many of whom would be frail 
and nearing the end of life (e-mail).   
 
5.5.1 Semi-structured or unstructured interviews? 
Having decided to use in-depth interviews as my method of data 
collection, I then had to determine what type of in-depth interview 
technique to use.  Within qualitative research there are 
predominantly two types of interviews which are used: the semi-
structured interview, and the unstructured interview.  Each type of 
interview produces different data and should be selected based on 
the aim of the study and the research questions posed.   
 
In the semi-structured interview, the questions asked by the 
researcher function as prompts that encourage the participant to talk 
and it is these questions which direct the interview and type of data 
collected, in order to answer the research questions posed (Willig 
2001).  In comparison, in the unstructured interview, only one 
question is asked at the beginning of the interview and the way that 
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the interview transpires is entirely dependent on how the participants 
reply to the first question (Smith et al. 2009a).  This type of 
interview is commonly used when there is not a lot known about the 
topic under study and is central to specific methodologies, such as 
IPA, where the researcher aims to explore the meaning or essence of 
the phenomenon being investigated (Smith et al. 2009a; Smith 
1996).  According to Smith et al (2009a), this method of interviewing 
attempts to „implement IPA‟s inductive epistemology to the fullest 
extent‟ and „facilitates an appreciation of the participants‟ priorities‟ 
(2009a:70).   
 
In relation to the current study, I was aware that most IPA studies 
published in the literature had used semi-structured interviews 
(Smith and Eatough 2007) and that this type of interview was viewed 
as being an exemplary method of data collection for this selected 
methodology (Smith 2004).  However, as the aim of my study was to 
explore the experience of symptom clusters in patients with advanced 
lung cancer, I felt that it was imperative that I captured the patient‟s 
(not my) perspective of this phenomenon.  I wanted to acknowledge 
the patient as being the „experiential expert‟ to bring to the fore 
issues which were important to them relative to the experience of 
symptom clusters in the context of their lives (Smith et al. 2009a; 
Corbin and Morse 2003).  Furthermore, in line with my 
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epistemological stance, being a contextual constructionist, I also 
wanted to ensure that I captured the context of the experience of 
symptom clusters, as I viewed this as being a crucial element to my 
understanding of this phenomenon in patients with advanced lung 
cancer.   
 
Therefore I chose to use unstructured interviews which I felt would 
allow the participants the space and the opportunity to spontaneously 
talk about issues which they deemed to important and meaningful 
within their lives, before probing and focusing the discussion on the 
experience of symptom clusters.  I felt that this approach would 
facilitate an inductive bottom-up generation of data relating to 
symptom clusters (as the principle means to understand how they 
are experienced within the context of peoples‟ lives) and prevent me 
from prematurely/forcefully go in fishing for the concepts 
immediately.  Therefore the unstructured interview appeared to be 
the most suitable method in which to achieve these objectives.   
 
5.5.2 Details of interviews 
5.5.2.1 Number and timing of interviews 
Having decided on an unstructured interview approach for the study, 
I then had to consider the number and timing of the interviews that I 
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proposed to conduct.  When addressing these issues I had to take 
into consideration not only the study aims and research questions 
that I had to answer, but also the patient sample that I intended to 
recruit.  I had decided to conduct the study in patients with advanced 
lung cancer.  Taking into consideration that the majority of patients 
with lung cancer present with advanced disease (Corner et al. 2005), 
and from previous clinical experience working with this patient group, 
I knew that many of the participants recruited to the study would be 
frail, experiencing a high symptom burden and nearing the end of 
life.  Therefore, I felt that asking them to participate in one in-depth 
interview that could potentially last for two hours may be too onerous 
for them and therefore ran the risk of the interview being terminated 
early.  I therefore decided that in order for me answer my research 
questions and gain an in-depth exploration of the participants‟ 
experiences, whilst at the same time addressing issues such as 
participant burden, that I would conduct two interviews with the 
participants, 3-5 weeks apart.  As stated by Flowers (2008:25), the 
use of multiple interviews „may relate to “pragmatic” concerns. These 
may include, for example, participant characteristics such as their 
availability, health (e.g. people with respiratory conditions), or 
“attentional capacity” (e.g. children)‟.  This approach to interviewing 
has also been advocated for use in patients with progressive diseases 
and, as stated by Murray and Sheik ( 2006): 
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A single interview or focus group, especially with ill people, 
might be inadequate to fully explore issues, especially if 
addressing a sensitive or complex area.  Returning for further 
rounds of data collections, not only allows participants to 
disclose information at their own pace, but also permits trust, 
empathy and a deeper understanding to emerge (Murray and 
Sheikh 2006:901).   
 
Furthermore, this approach to interviewing had previously been used 
in studies utilising IPA (Flowers 2008; Dickson et al. 2008; Smith 
1999).  
 
The timing between interviews was selected to facilitate an iterative 
approach between the first and second interview (detailed in the 
following section) without unduly burdening the patient and in light of 
the high levels of attrition commonly reported in this patient group 
(Sherman et al. 2005; Murray et al. 2004).    
 
5.5.2.2 Setting of interviews 
The setting for the interviews was determined jointly by myself and 
the participants.  I provided them with the option of being 
interviewed at home or in a quiet room in the hospital.   
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5.5.2.3 Interview schedule 
As stated above, unstructured interviews were selected as the 
method of data collection for this study.  In this type of interview, the 
researcher traditionally starts with a single core question which then 
directs the rest of the interview (Smith et al. 2009a).  According to 
Smith et al. (2009a), IPA studies „attempt at the research question 
“sideways”‟.  This occurs because most research questions are 
situated at an abstract level, which are not suitable to be posed 
directly to the patient.  Instead, interview questions are developed to 
facilitate the discussion of relevant topics which will allow the 
research question to be answered.   
 
I therefore decided to start the first interview with each of the 
participants by asking „What does cancer mean to you?‟  This 
question was selected in light of the core role that meaning plays in 
the illness experience (Thorne 1999; Johnson Taylor 1995; O'Connor 
et al. 1990; Kleinman 1988a; Good and Good 1980; Mishler 1979; 
Frankl 1959), with particular relevance to the symptom experience 
(Krishnasamy 2000; Ferrell and Dean 1995; Kleinman 1988a; Good 
and Good 1980).  It was anticipated that asking this question would 
facilitate the open the discussion of relevant topics with an 
appreciation of the participants‟ priorities, to allow the aims and 
objectives of the study to be met.   
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The participants‟ response to this initial question posed in the first 
interview was viewed as reflecting an overall summary of what they 
wished to talk about and was used to set a participant-led agenda.  I 
therefore returned to each issue in turn, probing downwards from the 
general to the specific.  The interview was facilitated by me reflecting 
and probing, asking questions such as „Can you tell me more about 
that?‟, „What were you thinking at the time?‟, and „How did you feel 
about that?‟.  My main role in the interview process was to stimulate 
discussion and allow the participant to talk freely and comfortably 
about their experiences. 
 
Taking into consideration the iterative approach adopted by the 
study, the aim of the second interview was to explore in more detail 
some of the issues that were not probed in the first interview, in 
order to clarify details and to ask new questions based on close 
reading of the first interview transcript.  I therefore started the 
second interview by asking „Is there anything from our last interview 
that you would like to talk about?‟  Once again I used the same 
probing techniques.  I used verbatim quotes from the first interview 
when asking participants to elaborate on a topic previously discussed.  
Using this format, the aims of the second interview did appear to be 
met allowing more in-depth exploration of points that had been 
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previously raised and the uncovering of „new‟ issues which were not 
discussed in the first interview. 
 
All interviews were recorded following consent being provided by the 
participants at the start of each interview.  Following each interview, 
field notes and reflexive accounts were maintained to assist in any 
subsequent interviews and data analysis.  The interviews were 
transcribed verbatim by one of the members of the study support 
team.  I checked each transcript with the digital recordings to ensure 
that all the information had been recorded correctly and made some 
minor modifications to them where required.  I securely stored all 
recordings and transcripts in a locked filing cabinet.   
 
5.6 Data Analysis 
„The essence of IPA lies in its analytic focus‟ which is to direct „our 
analytic attention towards our participants‟ attempt to make sense of 
their experiences‟ (Smith et al. 2009a:77).  According to Smith and 
Osborn (2003:66), „meaning is central to that experience and the aim 
of the analysis is to try to understand the content and complexity of 
those meanings‟.  They also point out that such meanings are not 
„transparently available‟ but must be reached through sustained 
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engagement with the text and the process of interpretation (Smith 
and Osborn 2003:66).  
 
The step-by-step approach to analysis advocated by Smith and 
Osborn (2003) was used to analyse the data.  The procedure which I 
adopted in this study involved treating the two interviews for each 
participant (where available) as one set of data.  In brief, the 
analytical stages included: reading and re-reading of the interview 
transcripts; initial noting; development of emerging themes; 
searching for connections amongst emergent themes; moving to the 
next case; and looking for patterns across cases.  This procedure was 
not designed to be used in a linear manner, but to be applied flexibly 
according to the analytic task at hand.  Each point in the process of 
analysis is detailed below with exemplars from Dan‟s transcripts to 
illustrate each process and to illustrate the procedures followed.   
 
5.6.1 Reading and re-reading of the interview transcripts 
This is the first step in the process of data analysis and is used to 
immerse the researcher in the data so that the participant becomes 
the focus of the analysis (Smith et al. 2009a; Smith and Osborn 
2003).  I therefore read each transcript several times, aware that 
each reading had the potential to offer me new insights into the data.  
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On two occasions whilst reading the transcripts I also listened to the 
audio recording at the same time, as this allowed me to re-familiarise 
myself with the participants and their accounts.  With each reading, I 
became more immersed in the data, uncovering new issues and 
becoming more receptive to what was said by the participants.  
During this time I made some notes I thought may be useful to 
return to at a later date, to check against any interpretations that I 
had made. 
 
5.6.2 Initial noting 
This part of the analytical process assists the researcher in becoming 
familiar with the text and to start to identify the ways in which the 
participants talk about, understand and think about issues they have 
raised (Smith et al. 2009a; Smith and Osborn 2003).  Therefore, 
having read the transcripts on several occasions, I started to record 
anything that I thought was interesting and/or significant in the left-
hand margin.  This process is illustrated in the following excerpt from 
Dan (see Table 6 below). 
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Table 6:  Initial noting 
Exploratory comments Original Transcript (Dan, page 12-13, interview 2) 
Breathing again – blames this solely on his 
condition worsening – scared that he was 
going to die – once again link with 
breathlessness and death.  Very important as 
he spontaneously talks about this symptom  
 
Positive thinking – feels that this has some 
therapeutic benefit – see previous quote in 
interview 
Breathing getting to him – sense he feels that 
he cannot tolerate it anymore 
Links breathlessness with feeling low 
Breathing affecting him – scared that it will 
come to a point when they can no longer 
treat his breathlessness – feels at this point 
death will be very near – afraid of this 
Comes to this point – jokes he would commit 
suicide – but then states that he is jesting – 
shows how significant this symptom is to him 
Uses humour a lot when talking about issues 
which he finds upsetting –coping with fear of 
death  
Changes subject – talks about how he needs 
DAN: …  you get into it, y., y., y., as I said I was going doon, the breathing was 
getting to me and I was gradually sliding the wrong way, I'm usually sliding – 
“uphill” but wi' the breathing getting tae me I was sliding doon hill, but I was feart I 
was going to slide too far doonhill, you know what I mean 
 
 
 
 
 
ROMA Can you tell me a wee bit more …about… 
 
DAN: Well eh, during the xx [name of nurse] and ?????? and aw that says it was 
your attitude, your approach that‟s kept you up you know eh, and with this 
breathing getting to me and so…[makes gasping sound] it does get you down, you 
say to yoursel, and what and, and they‟ll say to you, we‟ll maybe no can dae much 
fur yae em, its just through the illness and your saying to yourself, Jesus Christ if 
that‟s the case I‟ll jump oaf … I know that I'm telling it to you, but I don‟t really 
mean it, I‟ll jump oaf a brig and dae away wi' masel then you know, rather than this 
hinging our yae and, and I said the other day…and I got for my last chemo this 
week, next week, I says to her what happens efter that wi' the breathing, I says do 
I get a Calor Gas can tied tae my back, ken [cracks joke], I'm still joking about it 
like, you know but, seriously deep down it is very serious like you know em, but 
you‟ve goat tae keep your pecker up by joking aboot things like, you know because 
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humour to cope with what his happening to 
him 
 
Social comparison – coping – others who are 
worse than him  
 
All that matters to him is that he is still 
breathing – still alive – is this at whatever 
cost? 
 
Value of life – just being alive is good enough 
for him – does quality matter to him? 
 
Comfort that the consultant told him that his 
is like everyone else – no one really knows 
what the future holds…. 
Body – he will know when he is at that stage- 
his body will tell him – once again uses the 
body as a gauge in determining how he is 
 
 
if everybody was dull in doldrum, the world would be a hellish place, you‟ve goat to 
have a bit of laughter in life and your actually make, your basically keeping your ain 
perk up by making a joke by saying, well I don‟t want a hose stuck up my nose, 
kind of thing like you know … [laughs], you know he was like that [demonstrates], 
??????????????????????? [29.09] because actually your making a joke regarding 
yourself, I've, I've seen other folk oh my god… you feel very sorry for people….it‟s a 
way oh life … em, if you have to get it, you‟ve to get it … it‟s the only way to walk 
one fit in front oh the other then you dae it … and folk‟s say to me, how are you this 
morning, I‟ll say fine .. eh, aye no bad I says, how are you, ah nae use oh 
complaining, naebody listens like you know or eh, och I walk along the road and 
I'm still breathing, so I take it I'm still here like, you know, just … you know 
somebody said to me, I says well I walk some other ??????? how are you this 
morning?  I says I woke up this morning and I'm still here, so … another day … and 
that‟s the way I've looked at it, throughout.  Its no until I wake up in the morning 
and I'm still breathing, I'm still here, the mans daing his joab, he's keeping me 
alive [laughs] and hopefully he‟ll keep me alive a long while.  Because as I said to 
you the last time, I asked him one day outright, I says how long has I got to go?, 
he says how long have I got, he says eh, I could jump in front of a bus the morn 
and be deed, I says well that is very true, but the ????????????????????? I could 
jump in front oh a bus the morn tae mate, the man cannae answer the question.  
OK when you, possibly when you get further doon the line and your really in a state 
they can say well you‟ve got X amount of months, years, days, weeks, but your 
really doon, by that time you know yoursel, cause its you should know yerself 
[laughs] eh, and naw they don‟t, they're doing their job, like everybody else… to 
the best of their ability, you know I admire them for it 
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5.6.3 Looking for themes in the first case 
This stage of the analysis involves looking for emergent themes from 
the data by observing the relationships, connections and patterns 
between the exploratory codes.  This process involves a shift in the 
researcher‟s focus from the original transcripts to the exploratory 
coding, in an attempt to reduce the volume of data whilst at the 
same time maintaining the essence of what the participant has said 
(Smith et al. 2009a; Smith and Osborn 2003).    
 
I therefore viewed the exploratory codes that I made in the left hand 
margins of the transcripts, and attempted to capture what was 
represented in the text through the use of thematic labels.  These 
labels were inserted in the right-hand margin of the text.  I was 
thorough in this process to ensure the thematic labels developed 
were grounded in the data.  This process is illustrated in the same 
quote by Dan used above.  It demonstrates how I moved from the 
initial codes to the development of thematic labels (see Table 7 
below).   
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Table 7:  Looking for themes in the first case 
Exploratory comments Original Transcript (Dan, page 12-13, interview 2) Emergent Themes 
Breathing again – blames this 
solely on his condition 
worsening – scared that he 
was going to die – once again 
link with breathlessness and 
death.  Very important as he 
spontaneously talks about this 
symptom  
 
Positive thinking – feels that 
this has some therapeutic 
benefit – see previous quote 
in interview 
Breathing getting to him – 
sense he feels that he cannot 
tolerate it anymore 
Links breathlessness with 
feeling low 
Breathing affecting him – 
scared that it will come to a 
point when they can no longer 
treat his breathlessness – 
feels at this point death will 
DAN: …  you get into it, y., y., y., as I said I was going 
doon, the breathing was getting to me and I was 
gradually sliding the wrong way, I'm usually sliding – 
“uphill” but wi' the breathing getting tae me I was 
sliding doon hill, but I was feart I was going to slide too 
far doonhill, you know what I mean 
 
 
ROMA Can you tell me a wee bit more …about… 
 
DAN: Well eh, during the xx [name of nurse] and ……. 
and aw that says it was your attitude, your approach 
that‟s kept you up you know eh, and with this breathing 
getting to me and so…[makes gasping sound] it does 
get you down, you say to yoursel, and what and, and 
they‟ll say to you, we‟ll maybe no can dae much fur yae 
em, its just through the illness and your saying to 
yourself, Jesus Christ if that‟s the case I‟ll jump oaf … I 
know that I'm telling it to you, but I don‟t really mean 
it, I‟ll jump oaf a brig and dae away wi' masel then you 
know, rather than this hinging our yae and, and I said 
the other day…and I got for my last chemo this week, 
next week, I says to her what happens efter that wi' the 
breathing, I says do I get a Calor Gas can tied tae my 
Breathlessness- salient symptom – links 
to prognosis 
 
 
 
 
 
 
 
Coping –positive attitude 
Breathlessness – salient – fear of death 
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be very near – afraid of this 
Comes to this point – jokes he 
would commit suicide – but 
then states that he is jesting – 
shows how significant this 
symptom is to him 
Uses humour a lot when 
talking about issues which he 
finds upsetting –coping with 
fear of death  
Changes subject – talks about 
how he needs humour to cope 
with what his happening to 
him 
 
Social comparison – coping – 
others who are worse than 
him  
 
All that matters to him is that 
he is still breathing – still alive 
– is this at whatever cost? 
 
Value of life – just being alive 
is good enough for him – does 
quality matter to him? 
back, ken [cracks joke], I'm still joking about it like, you 
know but, seriously deep down it is very serious like you 
know em, but you‟ve goat tae keep your pecker up by 
joking aboot things like, you know because if everybody 
was dull in doldrum, the world would be a hellish place, 
you‟ve goat to have a bit of laughter in life and your 
actually make, your basically keeping your ain perk up 
by making a joke by saying, well I don‟t want a hose 
stuck up my nose, kind of thing like you know … 
[laughs], you know he was like that [demonstrates], 
??????????????????????? [29.09] because actually your 
making a joke regarding yourself, ... 
 
 
 
 
I've, I've seen other folk oh my god… you feel very 
sorry for people….it‟s a way oh life … em, if you have to 
get it, you‟ve to get it … it‟s the only way to walk one fit 
in front oh the other then you dae it … and folk‟s say to 
me, how are you this morning, I‟ll say fine .. eh, aye no 
bad I says, how are you, ah nae use oh complaining, 
naebody listens like you know or eh, och I walk along 
the road and I'm still breathing, so I take it I'm still here 
like, you know, just … you know somebody said to me, I 
says well I walk some other ??????? how are you this 
morning?  I says I woke up this morning and I'm still 
here, so … another day … and that‟s the way I've looked 
at it, throughout.  Its no until I wake up in the morning 
and I'm still breathing, I'm still here, the mans daing his 
Humour - coping 
 
 
 
 
 
 
 
 
 
 
Social comparison - coping 
 
Breathlessness – salient – need to 
breathe to live 
 
Social comparison - coping 
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Comfort that the consultant 
told him that his is like 
everyone else – no one really 
knows what the future 
holds…. 
Body – he will know when he 
is at that stage- his body will 
tell him – once again uses the 
body as a gauge in 
determining how he is 
 
 
 
 
joab, he's keeping me alive [laughs] and hopefully he‟ll 
keep me alive a long while.  Because as I said to you 
the last time, I asked him one day outright, I says how 
long has I got to go?, he says how long have I got, he 
says eh, I could jump in front of a bus the morn and be 
deed, I says well that is very true, but the 
????????????????????? I could jump in front oh a bus 
the morn tae mate, the man cannae answer the 
question.  OK when you, possibly when you get further 
doon the line and your really in a state they can say well 
you‟ve got X amount of months, years, days, weeks, but 
your really doon, by that time you know yoursel, cause 
its you should know yerself [laughs] eh, and naw they 
don‟t, they're doing their job, like everybody else… to 
the best of their ability, you know I admire them for it 
 
Reliance on health professionals to live 
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Once I had identified the thematic labels I then looked for 
connections between the emergent themes.  I did this by typing all 
the themes in chronological order into a list and then tried to identify 
patterns between them which would lead to the development of a 
super-ordinate theme.  Smith (2004:71) has described this process 
like being a magnet „with some of the themes pulling others in and 
helping make sense of them‟.  He also points out that in this stage of 
the analysis some of the themes may not be used because they do 
not fit with the emerging structure or because they have a weak 
evidential base.  At the end of this process a table is produced which 
illustrates each super-ordinate theme and the themes which comprise 
it.  Smith and Eatough (2007) state that if the researcher has been 
successful in this process „it should be possible for someone else to 
track the analytic journey from the raw data through to the end of 
the table‟ (Smith and Eatough 2007:48).  Therefore, in order to allow 
reader to track this process, a super-ordinate theme („Fear of Death‟) 
and related sub-themes are illustrated in table 8.   
 
Table 8:  Super-ordinate Theme of „Fear of death‟ and related sub-themes 
FEAR OF DEATH 
Symptom Clusters- threat of death nearing 
Coping with fear of death  
Reliance of health professionals and treatment to live 
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This process continued until a full table detailing each super-ordinate 
theme and emergent themes informing them had been made.  An 
example of the super-ordinate themes derived for Dan is provided in 
table 9. 
 
Table 9:  Super-ordinate themes for Dan 
Super-ordinate themes Sub-themes 
Symptom Clusters Linking up symptoms  
Finding out the cause of symptoms 
Salient symptom  
Meaning of cancer  Bad Disease 
Fear of Death Symptom Clusters- threat of death nearing 
Coping with fear of death  
Reliance of health professionals and treatment to live 
Loss of sense of self Symptoms and being unable to do everyday things 
Being a burden 
Stigma  Childhood experiences of cancer 
Symptoms and stigma 
Coping Minimising symptoms 
Normality 
Positive attitude 
Humour 
Work 
Social Comparison 
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Only after gestalt (Smith et al. 2009a) was reached for each 
individual case was a cross-case analysis conducted.  I did this by 
laying out each table of super-ordinate themes for each participant 
side by side and looked across them for the recurrence of themes.  
Following guidance by Smith et al (2009a), if a recurrent theme was 
present in over half the sample then it was deemed to be a super-
ordinate theme for the entire data set.  This process is exemplified in 
table 10 below.   
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Table 10:  Identifying recurrent themes  (Y=Yes, N=No) 
Super-ordinate themes/ 
sub-themes 
Emily Veronica Flora Dan Paul Thomas Jessie Suzie Richard Ruby Present ≥50% 
of sample?  
The lived experience of symptom 
clusters and the role of context and 
meaning 
Y Y Y Y Y Y Y Y Y Y Y 
The experience of symptom clusters Y Y Y Y Y Y Y Y Y Y Y 
Death Y Y Y Y Y Y Y N Y Y Y 
Stigma Y Y N Y N Y Y Y N N Y 
Symptom clusters and loss of sense 
of self 
Y Y Y Y Y Y Y Y Y N Y 
The impact of symptom clusters on the 
self 
Y Y Y Y N Y Y Y Y N Y 
Being a burden Y Y N Y N Y Y Y Y N Y 
Trying to maintain a coherent and 
valued self 
Y Y Y Y Y N Y Y Y N Y 
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5.7 Reflexivity 
Interpretive phenomenological analysis „emphasizes that the research 
exercise is a dynamic process with an active role for the researcher in 
that process‟ (Smith and Eatough 2006).  It aims to see things from 
an „insider‟s perspective‟, with the role of the researcher on this 
process being emphasised  by using their own conceptions to 
understand/make sense of the participants‟ experiences through the 
process of interpretation (Smith and Eatough 2006).  Furthermore, 
within qualitative research there has been a call for researchers to be 
more reflexive about their impact on the research process in order to 
„enhance the credibility of their findings by accounting for the 
researcher‟s values, beliefs, knowledge and biases‟ (Cutcliffe 
2003:137) .   
 
Therefore, throughout the study I maintained a reflexive journal (see 
appendix 4) which included personal reflections and a log for 
methodological decisions and accompanying rationales as advocated 
by Lincoln and Guba (1985).  Findings pertaining to my personal 
reflections on my experience of conducting the study interviews and 
study methods are detailed in Chapter 6 (section 6.2.3.6) where I 
discuss the conduct and findings of the pilot study.  This section 
details how I struggled with the duality of the nurse researcher role, 
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particularly at times when the participants became upset during their 
interviews.  It also details my thoughts regarding methods used and 
their suitability in addressing the research questions posed.   
 
5.8 Assessing validity 
The validity and quality of the study was evaluated using the criteria 
developed by Yardley (2000) which have been advocated for use in 
studies employing IPA (Smith et al. 2009a).  These criteria are 
described under four broad headings: sensitivity to context; 
commitment and rigour; transparency and coherence; and impact 
and importance.  Each of these criteria will be presented below with 
details on how they were met in this study.   
 
5.8.1 Sensitivity to context 
Yardley argues that a good qualitative study will have demonstrated 
sensitivity to context.  This principle was demonstrated in this study 
in a number of ways.  The selection of IPA in itself was a way of 
demonstrating sensitivity to context as this methodology is influenced 
by a contextual constructionist stance (Willig 2001) and pays homage 
to context throughout all stages of the research process.  Sensitivity 
to context was also demonstrated by the literature review conducted 
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for this study, which assisted in the orientation of the study and, as 
will be demonstrated, related to the discussion of the findings.   
 
5.8.2 Commitment and rigour 
Yardley‟s (2000) second criterion is „commitment and rigour‟.  
Commitment, both personally and professionally, was demonstrated 
throughout the entire research process from the inception of the topic 
to the writing up of the findings.  This principle was of particular 
relevance during the data collection phase and the analysis of the 
data, where attentiveness to the participant was paramount.  Rigour, 
which refers to the thoroughness of the study, was demonstrated by 
ensuring that the study sample was appropriate to answer the 
research questions posed and address the aim of this study.  Rigour 
was also demonstrated in the quality of the interviews conducted and 
the completeness of the analysis undertaken. 
 
5.8.3 Transparency and coherence 
The third criterion offered by Yardley (2000) is „transparency and 
coherence‟.  Transparency was demonstrated by clearly detailing 
each stage of the research process including a description of how the 
participants were selected, how the interview was constructed and 
conducted, and what procedures were followed to analyse the data.  
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Coherence was verified by providing a coherent argument throughout 
this thesis.  It was also demonstrated by ensuring that each stage of 
the study was consistent with the methodology selected (IPA). 
 
5.8.4 Impact and importance 
The final criterion set by Yardley (2000) is „impact and importance‟.  
She states that no matter how well a research study is carried out, 
the main test of its validity is whether the findings report something 
that is interesting, important or useful.  This principle is 
demonstrated in the findings of this study, which open up novel 
avenues for the study of symptom clusters in patients with cancer.   
 
This chapter has detailed the methods selected for this study, 
including a discussion on the aims of the study, the design of the 
study, the study sample, methods of data collection and analytic 
strategies used to ensure that research questions were answered and 
the aims met.  The following chapter will discuss the conduct and 
findings from the pilot study and the subsequent modifications made 
in preparation for the main study.   
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Chapter 6 Pilot Study 
 
6.1 Introduction 
A pilot study was conducted before the main study as it is an 
important stage of the research process (van Teijlingen and Hundley 
2002).  It allows the researcher to test the proposed study design 
and procedures, identifying areas where the main research project 
may require modification.  A pilot study was therefore undertaken to 
allow the researcher to reflect on multiple aspects of the research 
process.  The aims of this pilot study were to: 
 
 Assess the likely success of the proposed recruitment 
approaches 
 Assess the proposed data collection techniques 
 Assess the proposed data analysis techniques 
 Train the researcher in as many aspects of the research 
process as possible 
 
This chapter discusses the pilot phase and issues raised in relation to 
its aims. 
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6.2 Conduct of the pilot study 
The pilot study was conducted at one clinical site in Scotland over a 
three-month period between January and March 2007.  Ethical 
approval was granted from the local ethics committee for both 
phases of this study (pilot and main).  A total of three participants 
were recruited to the pilot study and all the participants were subject 
to the study procedures outlined in chapter 5 of this thesis.  
 
6.2.1 Population 
Three participants were recruited to the pilot study.  Table 11 below 
highlights the demographic characteristics of this group.  Data on the 
occupation, educational level and ethnicity of the participants were 
not formally collected in this study and therefore are not detailed in 
table 11.   
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Table 11:  Demographic characteristics of the pilot phase sample 
Patients in sample (n=3)  
Age (mean) 
30-39 years 
40-49 years 
50-59 years 
60-69 years 
70-79 years 
63 years 
0 
0 
0 
1 
2 
Gender 
Male 
Female 
 
0 
3 
Stage of disease (TNM) 
IIIa 
IIIb 
IV 
0 
0 
3 
 
All participants in the study sample were female and of similar age 
and all had advanced disease.  This pilot sample was atypical of the 
characteristics expected to be observed in this patient group on the 
grounds of gender.  Lung cancer commonly affects more men than 
women, with the most current reported ratio being 4:3 (Office for 
National Statistics 2010; ISD 2010; Welsh Cancer Intelligence and 
Surveillance Unit 2010; Northern Ireland Cancer Registry 2010).  
Therefore, the absence of males within the pilot study sample was 
unusual and precluded the identification of the perceptions of both 
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men and women on the feasibility and acceptability of the methods 
used.  This observation is discussed further in section 6.2.2, which 
discusses issues regarding recruitment.   
 
6.2.2 Recruitment process and study sample 
The importance of pilot testing approaches to recruitment has been 
advocated by van Teijleingen and Hundley (2002).  As outlined in 
chapter 5, eligible participants were identified by the Lead Nurse for 
Lung Cancer at the participating site, who provided them with both 
verbal and written information about the study.  If the patient was 
interested in participating in the study, the Lead Nurse for Lung 
Cancer asked them to sign a form, authorising him to pass on their 
personal contact details to the researcher.  Following a period of no 
less than 72 hours, I then contacted the patients, explained the 
study, answered any questions and asked them if they would like to 
take part in the study.  If the participant did wish to take part in the 
study, I arranged a mutually suitable date, time and place to meet 
with the patient in order to obtain written informed consent and to 
conduct the first interview. 
 
Discussions with collaborators at the clinical site indicated that on 
average 500 new patients were diagnosed with lung cancer each year 
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and therefore, based on these figures, I did not anticipate any 
problems regarding recruitment.  Throughout the pilot study all three 
participants were recruited over a 6-week period, indicating that the 
availability of eligible participants to take part in the study would not 
be an issue in the main study.  However, as presented in section 
6.2.1, the sample that I recruited to the study in the pilot phase were 
all female, and I therefore had to find out why this happened and if 
there was any valid reason for me to change my recruitment criteria 
and/or procedures.   
 
I therefore discussed the recruitment procedures with the Lead Nurse 
for Lung Cancer to further examine who had been approached, and 
reasons, if any, for their refusal to participate.  I was informed that of 
the two men who were approached and asked if they would like to 
participate in the study, one felt that he was not well enough to 
participate and the other did not want to talk about his experiences 
since diagnosis.  Such findings have been reported elsewhere in the 
literature pertaining to the recruitment of patients with advanced 
cancer to research trials (Sherman et al. 2005; Cooley et al. 2003a).  
However, whilst recognising the added value in exploring the 
experiences of both male and female participants with advanced lung 
cancer, I felt that to try and stratify the study sample was not 
appropriate in light of the qualitative paradigm informing the study 
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and the selected methodology (IPA).  As Smith and colleagues 
(2009a) state, „sampling must be consistent with the qualitative 
paradigm‟ and the „participants grant us access to a particular 
perspective on the phenomenon under study‟, that is, they „represent 
a perspective rather than a population‟ (Smith et al. 2009a).  
Therefore, whilst acknowledging that the results of this pilot study did 
not represent the perceptions and views of any male participants, it 
was decided that the criteria for sampling adopted in the pilot study 
would be maintained throughout the main study. 
 
6.2.3 Interviews 
 
6.2.3.1 Timing of interviews 
As described in chapter 5, interviews were conducted with the 
participants at two time points: on recruitment to the study, and 
three to five weeks later.  This timing of interviews was selected in 
order to meet the aim of this study but without unduly burdening the 
patient.  All participants were interviewed three weeks apart, with the 
exception of the first participant who died before the subsequent 
interview could be conducted.  
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Following the conducting of the interviews I then reflected on the 
process to determine whether any changes should be made to the 
ensuing main study.  The timing of the interviews did appear to 
facilitate the iterative approach intended with all of the participants 
taking part in the second interview being able to clearly recall what 
they had discussed in the previous interview and being able to 
elaborate on any points that were raised.  However, one issue that 
came to light in relation to the timing of the interviews was the time 
taken for the transcriptions to be typed with some being transcribed 
only a few days before the second interview.  This left the researcher 
with little time to prepare for the second interview and identify areas 
from the first interview which warranted further exploration.  
However, as the timing of the interviews did facilitate and meet the 
study objectives, it was felt that this aspect of the interview process 
should remain unchanged and that added administrative support 
would be accessed where possible to facilitate the typing of the 
transcripts throughout the main study. 
 
The issue of attrition was also highlighted in the pilot study with the 
first participant dying before the second interview could be 
conducted.  This issue is not new to research in people with advanced 
cancer and has been widely reported in the literature (Harris et al. 
2008).  Changing the timing of the interviews to minimise levels of 
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attrition throughout the study was therefore declined as this is a 
recognised factor when conducting research in people with advanced 
cancer.  Furthermore, in light of the study sample, it was thought 
that reducing the time period between interviews may have resulted 
in high levels of participant burden.   
 
6.2.3.2 Setting of interviews 
The setting for the interviews was jointly determined by the 
researcher and participants.  The majority of participants were 
interviewed in their own homes, with the exception of one lady where 
her first interview was conducted within a quiet room in the hospital 
due to a previous in-patient admission.   
 
The interview setting did appear to meet the study requirements by 
providing participants with a place where they felt free to express 
and share their experiences with the researcher.  However, within the 
hospital environment there were numerous interruptions, with staff 
accessing the room for equipment, which did interrupt the flow of the 
interview on a few occasions.  Therefore, following the pilot phase, 
this issue was discussed with the local collaborator, and it was agreed 
that for any subsequent interviews conducted in the hospital setting, 
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a room outside of the ward setting would be selected, if appropriate, 
to minimise the chance of any disruption.   
 
6.2.3.3 Interview schedule 
As discussed in chapter 5, unstructured interviews were selected as 
the method of data collection employed in the pilot study.  This 
therefore determined the type and number of questions asked in the 
interview.  The opening question in the first interview was „What does 
cancer mean to you?‟  This question was well received by the 
participants; they appeared to understand what I was asking them 
and they could easily reply.  In each case, this question evoked a 
number of replies which were then noted and use to set the 
participant-led agenda.  The second interview started with the 
question „Is there anything from our last interview that you would 
like to talk about?‟  Using this question, the aims of the second 
interview did appear to be met allowing more in-depth exploration of 
points that had been previously raised and the uncovering of „new‟ 
issues which were not discussed in the first interview.     
 
6.2.3.4 Interview technique 
My interview technique was reviewed by my supervisory team once I 
had conducted the first two interviews.  This entailed them reading 
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the transcripts and making a number of suggestions on how the 
interviews could be improved.  Suggestions included:  
 
 The use of more probing questions to encourage 
discussion and gain greater depth and understanding of 
the participants‟ experiences (Why? How? Can you tell 
me more about that? Tell me what you were thinking? 
How did you feel?) 
 Reflecting, summarising and stating that I would like to 
go back and talk about issues raised in turn 
 Using and feeling comfortable with silences 
 Not being afraid to „unpack the obvious‟ 
 
These techniques were used in subsequent interviews in the pilot 
study and assisted in the in-depth exploration of pertinent issues 
related to the topic under investigation.  By using such probes, 
participants engaged in conversation about the meaning of their 
experiences and how they made sense of what was happening to 
them, fitting within the realms of the selected methodology and the 
aim of the study.   
 
6.2.3.5 Confirming the perspectives of the patient 
When planning my study, I wanted my interpretations of what had 
been said in the interviews to be confirmed by the participants as I 
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felt that this would act as measures of rigour (Yardley 2000) in the 
study.  Therefore, in the pilot phase I provided the participants with 
an overview of what had been said in the previous interviews.  Whilst 
the two participants who were interviewed twice did agree with the 
summaries I offered to them regarding what they had said, one of 
the interviewees did comment that she felt embarrassed when being 
informed about what she had talked about previously and felt that 
she was „moaning about their illness‟.   
 
Forbat and Henderson (2005) have reported similar accounts in their 
paper on the „theoretical and practical reflections on sharing 
transcripts with participants.  They report that „one sees not only 
empowerment and ownership but also surprise and embarrassment‟ 
and they call for a „more considered and reflexive approach to 
understanding the process of sharing transcripts with participants‟.  
However, they also state that this process may also be „extremely 
fruitful in achieving the desired research objectives, such as engaging 
participants to reflect further on their first interview and to check 
details or add to their initial conversation‟ (Forbat and Henderson 
2005).  On reflection, as the aim of the second interview was to 
explore in more detail some of the issues that were not probed in the 
first interview, to clarify details and to ask new questions based on 
close reading of the first interview transcript, I felt that this already 
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acted as a measure of the participants‟ agreements with what had 
been said previously.  Providing participants with an additional 
summary of the previous interview was not thought to offer any 
additional benefit and had the potential to unduly embarrass or upset 
the participants.  It was therefore decided that this process would be 
omitted in the main study.  
 
6.2.3.6 My reflexive thoughts on the interviews 
As stated in chapter 5, a reflexive journal was maintained by myself 
throughout the entire study.  This included details on the daily 
schedule of the study, personal reflections, and a log for 
methodological decisions and accompanying rationales as advocated 
by Lincoln and Guba (1985).  Throughout the pilot phase, the 
maintenance of a reflexive journal allowed me to explore my role in 
the research process.  I found myself having to deal with the duality 
of the nurse researcher role; I identified myself with the work of 
Borbasi (2005), who reported that as a nurse she did not want to 
burden sick people with lots of questions but as a researcher wanted 
to extract as much information as possible (Borbasi 1996; Borbasi 
1994).  Furthermore, she noted that a number of patients wept 
during their conversations and she felt responsible for their anguish.  
Such feelings have also been reported by other nurse researchers 
conducting qualitative studies (Pellat 2003).  With particular 
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reference to interviews in the pilot study, I did feel that these issues 
did prevent me from probing and further exploring pertinent issues 
raised.  Through personal supervision and liaising with study 
supervisors/senior colleagues, these issues were discussed and a 
formal debriefing mechanism with senior colleagues was incorporated 
into the main study after each interview.  I also ensured that the 
timings of the interviews were spaced out in the main study in order 
for me to have enough time to reflect on the previous interview.   
 
Relative to the methods adopted in the study the reflexive journal 
allowed me to reflect on the unstructured approach which I had 
selected, the timing of the interviews and the questions that I had 
developed in order for me to address the aims of the study and the 
research questions posed.  On reflection, no significant changes were 
made as I felt that the approach used facilitated the inductive 
bottom-up generation of data which I hoped to achieve.  I felt that 
this approach provided the participants with the space and 
opportunity to talk about issues which were important to them in 
their lives, before talking in more depth about their experiences of 
symptom clusters.  I felt that this approach allowed me to 
understand the context of the experiences of symptom clusters within 
the participants‟ lives, which, as a contextual constructionist (see 
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Chapter 4), I felt was crucial to me understanding the experience of 
symptom clusters in patients with advanced lung cancer. 
 
6.2.4 Data analysis 
All interviews were digitally recorded and transcribed verbatim by a 
member of the research support team.  IPA was used to organise and 
manage the data in the pilot phase.  The stages outlined in chapter 5 
were used to analyse the data.  Conducting this analysis in the pilot 
phase of the study served a number of purposes.  It gave me the 
opportunity to engage in the practical application of IPA on my own 
data, and this was a good way for me to learn the core components 
of this analysis strategy.  At the same time, it allowed me to critically 
review my interview technique and think about ways in which it could 
be improved.  This process was pivotal in informing the iterative 
changes made in the main study.   
 
In order to test the proposed data analysis framework, the interviews 
conducted with participant 2 were analysed.  Given that the objective 
of the second interview was to clarify, explore in more detail and 
reflect on events in the first interview, it was felt that it was 
appropriate to analyse the two interviews together as a set.   
145 
 
Data analysis throughout the pilot study was assessed by one of the 
study supervisors.  Feedback from the first attempt of analysis 
highlighted the lack of use of descriptive thematic analysis with the 
researcher moving on to a higher level of interpretation before this 
was completed.  Such recommendations are reflected in the views of 
Smith and Eatough (2006) who state that the writing up of an IPA 
study should aim to „to provide a close textual reading of the 
participants‟ account moving between description and different levels 
of interpretation of the data to a more highly, nuanced, interpretive 
and theoretical level‟ (Smith and Eatough, 2006:338).  
 
Other suggestions made by the study supervisor included noting the 
participants‟ use of language (me, you, I), the use of similarities and 
differences, the use of particular words, the use of laughter, 
repetition, and changes in tone, such as moving from being hesitant 
to being articulate.  Overall, the step-by-step framework advocated 
by Smith and Osborn (2003) was straightforward to use and 
therefore this method of data analysis was used throughout the main 
study.  
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6.2.5 Conclusions drawn from the conduct of the pilot study 
In conclusion, the pilot phase of the study was particularly useful in 
identifying issues relevant to the conducting of the main study.  In 
relation to the recruitment and consent of participants, it indicated 
the appropriateness of the procedures that were in place but 
highlighted the issue of an all female sample.  Whilst the relevance of 
a male perspective in relation to the area under investigation was 
highlighted, in light of the selected methodology it was thought 
inappropriate to modify the sampling frame.    
 
The timing of the interviews appeared to fit well with the study aims 
by facilitating an iterative process without unduly burdening the 
participants.  The issue of attrition was raised as the first participant 
died shortly after the first interview, however, similar reports have 
been cited in the literature pertaining to research in people affected 
by cancer at the end of life and it was therefore decided that the 
scheduling of the interviews would remain unchanged.  The setting of 
the interviews in the participants‟ homes or within the hospital 
environment did appear to facilitate the aims of the study by 
providing a relaxed and quiet atmosphere for the interview to take 
place, however, the limitations of conducting an interview within the 
hospital environment were noted.  The pilot study raised some 
important issues related to the conduct of the interviews with 
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particular reference to the role of the researcher throughout this 
time.  In particular, it highlighted the key role that the researcher 
played in this process, emphasising the importance of maintaining a 
close and reflexive record throughout the study.   
 
Procedures to ensure rigour were assessed and re-evaluated, 
resulting in the decision not to feed back to participants an account of 
their previous interviews as the iterative approach adopted in the 
second interview appeared to address this issue.  The analysis 
framework was tested and no significant problems noted in relation 
to its use in the subsequent main study.  Overall, the pilot study was 
of extreme benefit in testing the proposed study design and 
procedures, allowing some minor modifications to be made prior to 
progressing onto the main study.    
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Chapter 7 Introduction to the results chapters 
 
7.1 Summary of study results 
The following two chapters present the results of this thesis.  They 
detail the findings of two super-ordinate themes derived from this 
study: „The lived experience of symptom clusters and the role of 
context and meaning‟, and „Symptom clusters and loss of sense of 
self‟. 
 
The findings provide a rich portrayal of the lived experience of the 
symptom clusters in patients with advanced lung cancer.  As stated 
in chapter 1, for the purpose of this thesis, a symptom cluster is 
defined as being the experience of three or more concurrent 
symptoms.  This definition of symptom clusters is based on existing 
definitions of symptom clusters in patients with cancer which purport 
that „concurrence‟ is a core characteristic of this phenomenon (Kim et 
al. 2005; Dodd et al. 2001b) and where the number of symptoms 
thought to constitute a symptom cluster is three or more (Dodd et al. 
2001a; Dodd et al. 2001b).  Furthermore, the characteristic of 
concurrence has been used as evidence of symptom clustering in 
previously published qualitative studies of symptom clusters in 
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patients with cancer (Lopez et al. 2011; Molassiotis et al. 2010; 
Molassiotis et al. 2008). 
 
The findings correspond to the two research questions posed in this 
thesis by providing in-depth and detailed interpretation of the lived 
experience of symptom clusters in patients with advanced lung 
cancer and provide an insight into how people with advanced lung 
cancer understand and make sense of their experiences of this 
phenomenon.  A brief overview of the findings is outlined below prior 
to their detailed presentation in Chapters 8 and 9 of this thesis.  
Table 12 details the super-ordinate themes, sub-themes and themes 
derived from this study. 
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Table 12:  Super-ordinate themes, Sub-themes and themes derived from this study 
Super-ordinate 
theme 
 Sub-themes 
o themes 
The lived 
experience of 
symptom clusters 
and the role of 
context and 
meaning 
 The experience of symptom clusters 
o Identifying „salient‟ symptoms 
 Death 
o The meaning of lung cancer – death 
o Fear of death and the lived experience of symptom 
clusters 
o Fear of death and coping with symptom clusters 
 Stigma 
o Childhood recollections of stigma 
o Lung cancer – a self inflicted illness? 
o Stigma and the lived experience of symptom clusters 
Symptom clusters 
and loss of sense of 
self 
 
 The impact of symptom clusters on the self 
 Being a burden 
 Trying to maintain a coherent and valued self:  
o Comparing themselves to other people with cancer 
o Normality 
 
Chapter 8 presents the first super-ordinate theme which is titled „The 
lived experience of symptom clusters and the role of context and 
meaning‟.  The first sub-theme presented in this chapter, „The 
experience of symptom clusters‟, illustrates how the participants in 
this study were experiencing symptom clusters, and how they linked 
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together several of the concurrent symptoms that they were 
experiencing, implying that they associated the occurrence of certain 
symptoms with others.  The findings presented also illustrate the 
components of the symptom clusters experienced by the participants 
in this study, with four core symptoms (fatigue, pain, cough and 
breathlessness) identified as commonly occurring in the narrative 
symptom clusters reported.   
 
This sub-theme also details how the narrative symptom clusters 
reported by the participants were most prevalent during times when 
they were receiving cancer related treatments such as radiotherapy 
and chemotherapy.  During these periods, the participants commonly 
experienced several concurrent symptoms that were often transient 
in nature and diminished with time.  However, of interest, and in 
contrast to these findings, was the observation that some symptom 
clusters did not diminish but appeared to remain constant over the 
patient trajectory.  Furthermore, this sub-theme also details how 
some of the participants in this study used symptom clustering as a 
means of trying to deduce a cause for the symptoms that they were 
experiencing, with them often attributing the presence of one or two 
symptoms on the formation of another. 
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Further findings presented in this sub-theme also illustrate how the 
participants‟ narratives surrounding their experiences of symptom 
clusters often entailed them highlighting one „salient‟ symptom from 
all the rest that they were experiencing, thus demonstrating that the 
participants did not appear to view all of their symptoms as having 
equal weighting, but did appear to give some symptoms greater 
credence over others.  As will be evident in chapters 8 and 9 of this 
thesis, the significance of these specific symptoms to the individual 
from all the rest that they were experiencing, appeared to be strongly 
influenced by the context of a lung cancer diagnosis and the 
meanings that they ascribed to this symptom.  In this study those 
meanings were commonly a fear of death, stigma and loss of sense 
of self.   
 
This chapter then details the remaining two sub-themes informing 
the super-ordinate theme of „The lived experience of symptom 
clusters and the role of context and meaning‟ which are entitled 
„Death‟ and „Stigma‟.  The findings presented within each of these 
sub-themes, demonstrate how the context of being diagnosed with a 
terminal illness such as lung cancer and its association with self-
infliction, resulted in many of the participants ascribing negative 
meaning to their illness (which in this study was fear of death and 
stigma) and how this negative meaning in turn influenced their 
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experiences of symptom clusters and how they made sense of and 
understood such experiences.    
 
The sub-theme „Death‟ starts by describing in detail the wider context 
of the participants‟ experiences of being diagnosed with a life-limiting 
illness such as lung cancer, and how this manifests in an inherent 
fear of death which appeared to be far reaching and ever present.  
The section that follows detailing the theme „Fear of death and the 
lived experience of symptom clusters‟ then describes how this 
context of being diagnosed with a life-threatening illness appeared to 
significantly influence the participants‟ experiences of symptom 
clusters, with many of them ascribing this negative meaning (fear of 
death) to their experience of this phenomenon.   
 
Such findings, relative to the experience of symptom clusters, were 
most apparent at times when the participants experienced concurrent 
symptoms of high severity where their synergistic effect and the 
significant debilitation they caused appeared to signify to the 
participants that the threat of death was nearing.   
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This fear of death associated with the wider context of a lung cancer 
diagnosis also appeared to influence the participants‟ interpretation of 
symptom clusters in the way that they appeared to pick out salient 
symptoms from all the rest that they were experiencing and this 
appeared to be due to these symptoms in particular being symbolic 
of their mortality.  Such findings therefore provide insight on how 
people with advanced lung cancer understand and make sense of 
their experience of symptom clusters by picking out salient 
symptoms from all the others that they are experiencing, based on 
the meanings that they ascribe to them.    
 
The theme „Fear of death and coping with symptom clusters‟ further 
illustrates the core role of context and meaning in the experience of 
symptom clusters and how the fear of death associated with a lung 
cancer diagnosis, not only directly influenced the participants‟ 
experiences of symptom clusters, but also affected the way that they 
coped with them.  The participants‟ fear of death, coupled with a 
desire to live, resulted in them often tolerating multiple symptoms of 
high severity due to their cancer treatments in order to live another 
day.  Such findings therefore highlight how the meanings that the 
participants ascribed to their experience of symptom clusters, in turn, 
influenced how they coped with them, often resulting in significant 
distress within the individual. 
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The third sub-theme supporting the super-ordinate theme of „The 
lived experience of symptom clusters and the role of context and 
meaning‟ is „Stigma‟.  This sub-theme is supported by three themes 
which are: „Childhood recollections of stigma‟, „Lung cancer – a self 
inflicted illness?‟ and „Stigma and the lived experience of symptom 
clusters‟.   
 
The first two themes presented in this section, „Childhood 
recollections of stigma‟ and „Lung cancer – a self inflicted illness?‟ 
illustrate, in the first instance, how the context of being diagnosed 
with lung cancer and its association with self-infliction resulted in 
many of the participants associating an element of stigma to their 
disease.  Such feelings of stigma were not only influenced by the 
participants‟ current experiences of lung cancer, but also by their 
past experiences of cancer as a child where the disease was often 
stigmatised and excluded by society.   
 
The third theme, „Stigma and the lived experience of symptom 
clusters‟, follows on from these two themes, and illustrates how these 
contextual factors described above significantly influenced the 
participants‟ experience of symptom clusters.  As with the previous 
section detailing the theme of „Fear of death and the lived experience 
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of symptom clusters‟, what was apparent and of significance to this 
thesis, was the way that despite experiencing symptom clusters, the 
participants would often focus many of their dialogues on individual 
symptoms.  In this study, this focus on specific symptoms, within the 
experience of symptom clusters, was often due to the associated 
feelings of „felt‟ stigma that the participants ascribed to a particular 
symptom.  This symptom appeared to be selected from the other 
concurrent symptoms experienced, based on the participants‟ 
perceptions of its potential to attract the attention of others, 
particularly in public places, and therefore pose the risk of potential 
discrediting if strangers were to find out that their symptom was due 
to a lung cancer diagnosis.  
 
The second super-ordinate theme informing this thesis is „Symptom 
clusters and loss of sense of self‟.  This super-ordinate theme 
illustrates the impact of symptom clusters on the participants‟ lives, 
and how this, in turn, impacted on their sense of self in a number of 
different ways.  The first sub-theme informing this super-ordinate 
theme, „The impact of symptom clusters on the self‟, describes how 
the symptom clusters that the participants were experiencing 
resulted in them no longer being able to undertake many of the 
activities and roles that they had become accustomed to in the past 
and upon which they had built positive self-images.  This in turn 
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imposed significant restrictions on their life which impacted on their 
sense of self, as they could no longer claim identities based on prior 
activities, interests or pursuits.   
 
Of particular relevance to this thesis and the concept of symptom 
clusters in patients with cancer was the way that the participants‟ 
narratives surrounding this „loss of sense of self‟ focused commonly 
only on one or two symptoms, despite them reporting to be 
experiencing several concurrent symptoms at this time.  Symptoms 
such as fatigue and breathlessness appeared to be of particular 
importance to the participants and their sense of self, due to their 
link with impaired physical functioning, and therefore their 
importance in determining which activities/roles that the participants 
could or could not undertake.  Such findings therefore highlight how, 
within the experience of symptom clusters, the participants did not 
appear to view all of the symptoms that they were experiencing in 
the same way, as the current evidence base would suggest, but 
appeared to give particular symptoms greater priority over others 
based on the perceived impact of these symptoms on their sense of 
self and their life.   
 
158 
 
The sub-theme of „The impact of symptom clusters on the self‟ also 
highlights the central role of the body in the experience of symptom 
clusters, and how, at times, when the participants experienced 
symptom clusters of high severity, the body which they had become 
accustomed to became „alien‟ to them, resulting in a transient loss of 
sense of self, causing considerable distress to them. 
 
The sub-theme that follows, „Being a burden‟, demonstrates the 
„knock-on effect‟ of the experience of symptom clusters on the self.  
This sub-theme describes how the participants‟ sense of self was 
further fractured by the dependence that their multiple, concurrent 
symptoms created on others, resulting in the participants feeling they 
were a burden, which further resulted in increased suffering and 
emotional upset.   
 
The third sub-theme informing this super-ordinate theme, „Trying to 
maintain a coherent and valued self‟, further illustrates the far 
reaching effect of the experience of symptom clusters on the 
participants‟ lives.  It describes how the participants, in light of the 
loss of sense of self experienced as a result of the symptom clusters 
that they were experiencing, employed strategies such as social 
comparison and accessing „normality‟ to try and maintain a sense of 
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the person they were before their lung cancer diagnosis.  Therefore, 
having presented a summary of the results of this study, the 
following section will detail the study population recruited to this 
study. 
 
7.2 Study Population 
A total of 10 participants took part in this study between May 2007 
and February 2008.  This sample size is the upper limit of the number 
of participants advocated for studies employing IPA (Smith et al. 
2009b; Reid et al. 2005; Smith and Osborn 2004).  The mean age of 
the participants recruited to the study was 63 years; most of the 
participants were female and all had advanced lung cancer. 
 
Data on occupation, educational level, deprivation index and ethnicity 
of the participants were not formally collected in this study and 
therefore are not detailed in table 13 below.  Participants were 
recruited from a district which is in one of the most deprived areas of 
Scotland, with high levels of unemployment and people living on a 
low income (http://www.scotland.gov.uk/Topics/Statistics/SIMD).  In 
line with the selected methodology (IPA), all the participants were 
given pseudonyms.
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Table 13:  Characteristics of participants recruited 
Pseudonym Gender 
(Male/Fe
male) 
Age 
(years) 
Stage Treatment Additional Information Concurrent symptoms 
experienced on recruitment to the 
study 
Flora   Female 80  IV Chemotherapy 
Radiotherapy  
Flora has several children.  
Matriarch of the family.  
Independence of prime concern to 
her – does not want the family to 
take over.  A few family members 
living with her but she continues to 
cook for them and look after 
grandchildren. 
Lack of appetite, hair loss, 
fatigue, dizziness, rash, pain 
Veronica Female 58  
  
IV Chemotherapy 
Radiotherapy 
Lives with husband who now 
undertakes all household chores.  
Does very little now except go to 
and from hospital.  Very 
despondent and angry about lung 
cancer diagnosis.  Scared to leave 
loved ones behind, feels like her 
life has been taken away from her.   
Nausea, vomiting, dry mouth, 
swollen legs, lack of appetite, 
fatigue, breathlessness 
 161 
 
Emily Female 64  
 
IV Chemotherapy Lives with husband who is the main 
carer and now undertakes most 
household chores.  Cannot go 
anywhere on her own anymore – 
always needs to be supervised.  
This makes her angry.  Angry at 
illness – prevents her from 
accessing normality.  Views herself 
as being different from other 
people who do not have cancer - 
„insider looking at the outside 
world‟ 
Cough, fatigue, nausea, vomiting, 
feeling low, dizziness, pain, 
hoarse voice, breathlessness 
Dan Male 
  
63 IV Chemotherapy Lives with wife, son and daughter.  
Views himself as being the main 
provider for the family.  Has 
continued to work since being 
diagnosed with lung cancer – this is 
a central coping mechanism for 
him.  Scared of what the future will 
hold.   
Cough, breathlessness, lack of 
appetite, weight loss, fatigue, 
gastritis 
Paul Male 63  
 
IIIb Chemotherapy Lives alone.  Divorced from wife, 
only recently revived relationship 
with children.  Has had lots of 
turmoil in life – regrets the past, 
now has a renewed sense of the 
value and simple things in life. 
Breathlessness, lack of appetite, 
weight loss, nausea, vomiting, 
pain, burning on the sole of his 
feet 
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Thomas Male 58 IIIb Chemotherapy Lives with family.  Has now 
stopped work.  One of his main 
frustrations is that he cannot help 
people anymore.  Viewed by 
friends and family as the 
„handyman‟ – he can no longer 
maintain this role and this causes 
considerable distress to him 
Cough, lack of appetite, fatigue, 
nocturia, breathlessness 
Jessie Female 73  
 
IV Chemotherapy Lives with husband who now does 
all of the household chores.  Has 
two sons, one has a chronic illness 
which causes her much concern.  
Feels guilty that she cannot fulfil 
role of „wife‟ and „mother‟ – this 
makes her upset.  Previously had a 
very active social life – much of 
this has now stopped due to her 
condition. 
Breathlessness, lack of appetite, 
hair loss, fatigue, nocturia, 
headache, pain, constipation, 
„feels cold all of the time‟, 
insomnia, swollen legs 
Suzie Female 68  
 
IIIb Surgery  
Chemotherapy 
 
Lives with husband.  Still shocked 
that she developed lung cancer as 
she was not a smoker and led a 
healthy lifestyle.  Appears to be 
embarrassed that she has this 
disease.  Appears to try and 
conceal it from others. 
Breathlessness, weight loss, hair 
loss, vomiting, fatigue, pain, 
mouth ulcers 
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Richard Male 
 
58 IIIb Surgery 
Chemotherapy 
Radiotherapy 
 
Lives with wife.  Children now 
married but visit regularly.  Feels 
that he is the main provider of the 
family, wants to protect them from 
his illness.  Lives in a constant fear 
of death – now appreciates the 
simple things in life.  His father 
died of lung cancer and this 
appears to have been a significant 
factor in his experience of his 
illness. 
Weight loss, fatigue, nausea, 
vomiting, dysphagia, pain, hair 
loss 
Ruby Female 47 IV Chemotherapy Lives with husband who now 
undertakes most of the household 
chores.  Daughter lives in England 
and has recently had a baby 
daughter.  Visits her mother on a 
regular basis with the baby.  Ruby 
is distraught by her illness, and 
fears what will happen to her 
family when she is no longer there. 
Cough, hair loss, nausea, 
dizziness 
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7.3 Details of interviews 
All interviews lasted between 45 and 70 minutes.  Most of the participants 
opted to be interviewed at home (n=6), however, some preferred a quiet 
room in the hospital, which often coincided with days/times that they had 
appointments at the hospital.  Three patients died during the period 
between the first and second interview (Paul, Veronica and Ruby) and 
therefore only participated in one interview.   
 
Having provided a summary of the results, provided details of the study 
sample recruited to the study and details regarding the interviews that 
were conducted in this chapter, the following chapter of this thesis will 
present the results of the first super-ordinate theme of „The lived 
experience of symptom clusters and the role of context and meaning‟. 
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Chapter 8 The lived experience of symptom 
clusters and the role of context and meaning 
 
This is the first of the two results chapters of this thesis, and details 
the super-ordinate theme „The lived experience of symptom clusters 
and the role of context and meaning‟.  
 
This chapter illustrates in the first instance that the participants in 
this study talked about their experiences of symptom clusters, 
associating at times the occurrence of certain symptoms with others.  
The findings also illustrate the constituents and patterning of 
symptom clusters reported by the participants, highlighting common 
cluster symptoms that were experienced (fatigue, cough, pain and 
breathlessness), symptoms that tended to co-occur together and the 
timing, duration and nature of the symptom clusters reported.  This 
chapter also provides insight into how people with advanced lung 
cancer understand and make sense of the symptom clusters that 
they are experiencing, using concurrence as a means of trying to find 
a cause for the symptoms that they were experiencing. 
 
The findings described in this chapter also highlight that within the 
experience of symptom clusters, the participants in this study did not 
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appear to view all of the symptoms that they experienced as being of 
equal importance, but instead singled out specific symptoms which 
were of particular salience to them.  As described in this chapter and 
the one that follows, this „singling out‟ of symptoms within the 
context of symptom clusters appeared to be related to the meanings 
that the participants associated with these symptoms, which, in this 
study, were commonly a fear of death, stigma and loss of sense of 
self.   
 
8.1 The experience of symptom clusters 
As stated above, the participants in this study did talk about their 
experiences of symptom clusters.  Many of the participants‟ 
narratives surrounding their symptom experiences depicted 
symptoms as co-occurring in groups, providing evidence of symptom 
clustering.  Such findings are exemplified by the following quote by 
Richard, who experienced multiple symptoms such as pain, fatigue, 
nausea and vomiting, and hair loss during his radiotherapy 
treatment.  His dialogue suggests that this experience was one of his 
worst to date, due to the profound debilitation that his symptoms 
caused.  Within his quote, there is also a sense that Richard 
perceived the multiple symptoms that he experienced as having a 
cumulative effect, all contributing to the high symptom burden that 
he experienced during this time: 
 167 
 
Richard: …for aboot two weeks – awful ... absolutely awful, 
the worst feeling ever ... you know, you were just ... your arms 
were sore ... your legs were just ... just totally knackered, 
that‟s the best way I can describe it ... and you, you had the 
sick feeling, you know ... and a couple oh times I was 
physically sick eh ... the hair was getting thin, no that I've got 
a lot of hair anyway, but ... it was getting thinner, you just 
did'nae feel right at all ... I don't know if I've described it 
properly, but that was how I felt – awful; absolutely… (Richard, 
interview 1, page 43). 
 
Within the participants‟ dialogues surrounding their experiences of 
symptom clusters, what was also apparent was the way that they did 
appear to associate the occurrence of certain symptoms closely with 
others.  This perceived association between symptoms is illustrated in 
the following brief quote by Jessie.  In this quote, we can see how 
Jessie talks about the multiple symptoms that she is experiencing at 
this time, such as fatigue, insomnia, nocturia and swollen legs.  In 
her description, it is apparent that she links her fatigue to her 
insomnia, which is in turn attributed to the Frusemide she takes to 
treat her oedematous legs.  The way that she describes such 
experiences as being a „vicious circle‟, suggests that this pattern of 
events is never ending, and constantly repeats itself.   
 
Jessie: I could sleep, I mean even if I get up, have my 
breakfast, get washed and dressed and sit down I fall asleep 
again, fall asleep in the car, I think I've got sleepy sickness ... 
[laughter] ... but having said that you see I can be up quite a 
few times during the night, so I'm no really getting a proper 
 168 
 
sleep through the night, you know wi' the, eh .. up to go to the 
toilet, through the night.  You take your Frusemide, you don't 
take the Frusemide your legs aw swell up, it‟s a vicious circle 
aint it, but eh ...‟ (Jessie, interview 1, pages 45-46). 
 
Within the participants‟ narratives surrounding their experiences of 
symptom clusters, four core symptoms (fatigue, pain, cough and 
breathlessness) were commonly cited as being associated with the 
occurrence of several other co-occurring symptoms.  Only one 
symptom cluster depicted in the participants‟ narratives did not 
consist of one of these core symptoms.   
 
Fatigue was the most common symptom cited by the participants as 
co-occurring with other symptoms, followed by pain, cough and 
breathlessness, respectively.  Other symptoms that were identified as 
co-occurring with these core cluster symptoms included insomnia, 
headache, nausea, vomiting, nocturia, feeling low/depression, 
myalgia, hair thinning, diarrhoea, and burning on the soles of the feet 
(see table 14 below).   
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Table 14:  Symptom clusters identified from participants‟ narratives during 
interviews 
Symptom clusters associated with fatigue 
Fatigue, feeling low, pain 
Fatigue, cough and pain 
Fatigue, cough, breathlessness, depression 
Fatigue, nocturia, constipation, headache 
Fatigue, nausea and lack of appetite 
Fatigue, weakness, lack of appetite 
Fatigue, insomnia, cough 
Fatigue, feeling low, pain 
Fatigue, pain, asthenia, nausea, hair thinning 
Fatigue, breathlessness, anxiety, pain  
Symptom clusters associated with cough 
Cough, fatigue, pain 
Cough, fatigue, breathlessness, depression 
Cough, fatigue, insomnia 
Cough, breathlessness, pain 
Cough, gastritis, breathlessness 
Cough, nausea, vomiting 
Cough, breathlessness, nausea, vomiting 
Symptom clusters associated with pain 
Pain, fatigue, feeling low 
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Pain, fatigue, cough  
Pain, cough, breathlessness 
Pain, breathlessness, anxiety 
Pain, nausea, breathlessness 
Pain, fatigue, asthenia, nausea, hair thinning 
Pain, insomnia, burning of the soles of the feet 
Pain, breathlessness, anxiety, fatigue 
Symptom clusters associated with breathlessness 
Breathlessness, fatigue, cough, depression 
Breathlessness, cough, pain 
Breathlessness, cough, gastritis 
Breathlessness, cough, nausea, vomiting 
Breathlessness, pain, anxiety 
Breathlessness, nausea, pain  
Breathlessness, anxiety, pain, fatigue 
Clusters without core symptoms (fatigue, cough, pain, breathlessness) 
Shivering, sweating, feeling cold 
 
Within the participants‟ narratives, symptoms that frequently co-
occurred with the symptom of fatigue were feeling low/depressed and 
pain.   The following excerpt from Emily highlights such associations 
when she talks about the symptoms that she experienced due to her 
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chemotherapy treatment.  In her account, she describes the knock-
on effect of her fatigue on the occurrence of other symptoms such as 
pain and feeling low: 
 
Emily: …but eh, I still feel quite tired right enough, no 
sleepy tired just tired, like I can't be bothered, I feel as if I 
start to do things and then … my body gets sore, my legs get 
sore, and maybe that‟s an excuse for me to go and sit down, I 
don‟t know but eh, that can get you a wee bit down at times as 
well.. (Emily, interview 1, page 25).  
 
For other prevalent cluster symptoms such as cough, this symptom 
was observed to commonly co-occur with breathlessness.  Such 
findings are exemplified in the brief quote by Dan, who talks about 
how his cough leads to the occurrence of his breathlessness: 
 
Dan:  [coughs] well it‟s, I would say in the last couple oh 
months eh, it‟s just, it started oaf wi' a tickly cough and when 
you‟ve goat the cough you get breathless, eh (Dan, interview 1, 
page 40). 
 
Symptoms that were noted to commonly co-occur with pain within 
the participants‟ narratives were fatigue and breathlessness. This 
clustering of symptoms is best illustrated in the following quote by 
Jessie who talks about how she feels when she is breathless.  Her 
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narrative describes the symptoms which co-occur with her 
breathlessness, such as pain and fatigue.  She appears to be shocked 
at the significant impact that her symptoms have upon her, 
particularly their rapidity.  Although she uses humour, there is an 
underlying sense that she is embarrassed at the way that she falls 
asleep during such episodes, however, her dialogue also suggests 
that she has little control of her actions at this time: 
 
Roma: And how do you feel when your breathless, can you 
tell me a wee bit more about how you‟re feeling? 
Jessie: Aye, panicky, panicky and, and sore across my 
chest and you‟re sitting [makes panting sounds] ... I mean I 
have actually, haven‟t I, I cannae get away wi' it myself, I have 
to come up the stairs, plank masel doon here [makes a puffing 
sound] still got my jacket on and fell asleep.  I mean I used to 
[.............] sitting there wi' yer jacket on and I'd just go ... 
Carer: But eh…it‟s sitting down, just ... 
Jessie: … and that‟s me away to sleep [laughs] oh I could 
sleep at the drop oh a hat – anytime (Jessie, interview 1, pages 
44-45). 
 
For many of the participants, symptom clustering appeared to be 
most prevalent at times when they were receiving cancer related 
treatments such as chemotherapy and radiotherapy.  At such times 
the participants would describe the multiple symptoms that they 
experienced and their cumulative impact upon them.  However, what 
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was also noticeable was the way that these clusters of symptoms did 
appear to diminish over time.  The following quote, also from Jessie, 
best demonstrates this point, when she talks about the multiple 
symptoms that she experiences for two or three days following her 
chemotherapy treatment:   
 
Jessie: You‟re just so, so tired, really I've been just, so 
tired that I, I could sleep at the drop oh a hat.  But I mean I'm 
prepared for that, it tells you in the literature eh, wi' your 
different chemos that you will be tired and you‟ve got tae gie 
yerself time for rest, I just did'nae realise how tired ... [laughs] 
... I'm definitely like Rip Van Winkle, I mean as I say I can get 
up, get washed, dressed, get my breakfast, sit doon here and 
go [makes snoring sound] ... faw „sleep.  Now you should‟nae 
really be tired after you‟ve been in bed aw night but as I say, 
it‟s broken sleep through the night, you know, you‟re getting up 
to, to go the toilet quite a few times and there's a, a stage isn't 
there when the, wi' the chemo, but I don't know how to explain 
it ... it‟s like ... there's a stage where, you know, you‟re no too 
bad and then you get, suddenly you‟re up and doon and up and 
doon and up and doon at that toilet ... 
Carer: Oh, aye, aye   
Jessie: ... I don't know why it goes like that and then that 
disappears and you have a ... a bout oh constipation so you 
take they thingies, whatever they're called ... or ... 
Carer: Senna   
Jessie: Senna, aye, I take a Senna and I'm ok and next 
day, eh, I don't take diarrhoea wi' that  right enough, but eh, 
and I always seem to get a headache at some point during the 
..  
Carer: It‟s when, it‟s when yae get the build-up of fluid, 
after the chemo she seems to gets a wee build oh fluid for a 
couple oh days and then, one ... it usually happens one, it‟s 
probably because she's lying down, she eh, the fluid starts to 
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come off again and she […] down all night and that‟s when you 
get up in the morning you‟ve usually got a sore head, but I 
think it‟s to do wi' the amount of fluid going, coming off…mm 
mmm, bit oh a, bit oh a headache ... but it goes away, you 
know, the headache goes away, mmm mmm   
Carer: I think that‟s tied up wi' that   
Jessie: Aye, it could be […]   
Carer: But it, it seems to happen every time she takes this 
chemo, you know, two or three days after it she gets this wee 
bout, but we know it‟s only going to last a day and then ... 
Jessie: Aye and it goes away again, you know ..(Jessie, 
interview 1, pages 51-53).   
 
From the quote above, the ephemeral nature of the cluster of 
symptoms that Jessie experiences is apparent.  Her dialogue details 
the patterns of her multiple symptoms at this time with some co-
occurring and some diminishing as a new symptom arises.  There is a 
sense that this patterning of symptoms repeats itself, as both Jessie 
and her husband appear to be familiar with the sequence of the 
occurrence of these symptoms and know when they will diminish.   
 
However, on further exploration of the data, what was also of note 
was that for some of the participants, certain clusters of symptoms 
did not diminish, but were ever present.  For example, for Emily, the 
cluster of cough, pain and fatigue did not diminish, but had been 
present since the pre-diagnosis stages of her illness.  As will be 
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illustrated in the section and chapters that follow, Emily often 
highlighted her cough as being the most problematic symptom of all, 
and the chronic association of her cough with pain and fatigue may 
have attributed to her perceiving this symptom in such a negative 
manner.   
 
For some of the participants, their linking up of co-occurring 
symptoms appeared to act as a way of them trying to make sense of 
the impact of the multiple symptoms upon themselves.  The following 
quote, also from Emily, best exemplifies this point.  In her previous 
interview she talked about how she associated her pain with fatigue, 
and is asked by the researcher in the second interview to elaborate 
on this statement.  From the dialogue below, it appears that Emily 
tries to understand and make sense of the fatigue that she is 
experiencing by partly attributing this to her cough and insomnia.  It 
may be inferred that by sourcing the cause of her fatigue, Emily feels 
more in control of her symptom and can therefore deal with the 
consequences of it within her life:  
 
Roma: OK.  Em, moving … we talked a wee bit about your 
pain as well last time em, and you were talking about your pain 
and it says, you know, it drains your energy away, can you tell 
me a wee bit more about that, why you described it like that, in 
that way?   
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Emily: Well, I just assume that‟s part oh why I feel at 
times really, no energy, you know and you just think well, 
between not sleeping very good and the cough and whatever, 
just an accumulation of things eh, that‟s probably what I mean 
it‟s, kind of draining, just a lot of different wee things that, all 
goes into one big thing and, you just don‟t feel very good when 
it‟s happening.. (Emily, interview 2, page 49).  
 
In addition to the characteristics of the experience of symptom 
clusters previously detailed, and, as briefly discussed above, what 
was also apparent in the participants‟ dialogues surrounding their 
experiences of symptom clusters, was the way that they would often 
highlight one symptom above the rest that they were experiencing.  
This point is exemplified in the following quote by Dan: 
 
Dan:  I've lost a wee bit oh weight in the last month, I‟ll be 
perfectly honest wi' yae, I have lost, maybe about 6 pund, the 
last month, but that‟s through the breathing and God knows 
what, like, you know, cause your werenae feeling like eating.  
… Well, I wisnae eating, that‟s why I … that‟s the only reason 
I've lost weight, because I wisnae eating, you know, eh, loss oh 
appetite if you like through – possibility chemo. … I was going 
doon, the breathing was getting to me and I was gradually 
sliding the wrong way, I'm usually sliding – “uphill” but wi' the 
breathing getting tae me I was sliding doon hill, but I was feart 
I was going to slide too far doonhill, you know what I mean … 
Well eh, …. [name of nurse] and … and aw that says it was 
your attitude, your approach that‟s kept you up you know eh, 
and with this breathing getting to me and so…[makes gasping 
sound] it does get you down (Dan, interview 2, pages 12-13). 
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As detailed in greater depth in this chapter and the one that follows, 
often this individual symptom was selected based on its symbolic 
connotations, which, in this study, were commonly a fear of death, 
„felt stigma‟ and loss of sense of self.  These findings are discussed in 
the first instance in the following section which details the theme of 
„Identifying „salient‟ symptoms‟, and then in greater depth in sections 
8.2, 8.3 and in chapter 9 that follow. 
 
8.1.1  Identifying „salient‟ symptoms 
As indicated above, what was noticeable in the participants‟ 
narratives surrounding their experiences of symptom clusters was the 
way that they tended to highlight one specific symptom from all the 
rest that they were experiencing, and, as illustrated in the results 
chapters that follow, this appeared to be primarily attributed to 
meanings that the participants associated with this symptom. 
 
From all of the participants, the narratives from Emily best exemplify 
this point.  Emily talked about her experiences of symptom clusters 
on several occasions throughout both of her interviews, often 
describing the significant debilitation and distress that they caused.  
However, within many of her dialogues surrounding her experiences 
of symptom clusters, she commonly highlighted her cough as being 
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the most problematic symptom of them all.  Of significance, and as 
discussed in greater depth in section 8.3 of this chapter, is the way 
that Emily associated her cough with feelings of „felt stigma‟, and this 
in turn may explain why she perceived her cough in such a negative 
way. 
 
In the extract that follows we see how Emily talks about her 
experiences of multiple symptoms such as cough, breathlessness, 
and pain.  However, in her dialogue it is also apparent that she views 
her cough as having a negative influence over all the other symptoms 
that she experiences and this is implied by the way she states that 
the „coughing generally makes things worse‟.   
 
Emily: Eh, I've no really, I mean, the coughing generally 
makes things worse and that‟s generally at night eh, or that, 
but if I'm getting short of breath sometimes I get a bit of pain… 
(Emily, interview 2, pages 58-59).  
 
This highlighting of her cough from all of the other symptoms that 
she experienced occurred on a number of other occasions throughout 
Emily‟s interviews.  In the following excerpt we also see how she 
highlights her cough as being the main contributor to the pain that 
she experiences. 
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Emily: Well eh … the coughing, as I said, sometimes 
you‟ve got no pain but, till you start coughing and eh, it‟s just 
that it catches you in between your shoulders eh, and I think 
because you‟re coughing so hard you feel as if it‟s, the pain‟s 
going right down to the bottom of your back, round your waist, 
but eh, when the coughing subsides, that seems to get a bit 
better as well, it disnae go away, these things never do but, 
the coughing definitely aggravates it I think, and that‟s when 
you feel the pain more.. (Emily, interview 1, page 51).   
 
This highlighting of a particular symptom was also apparent in 
Jessie‟s narratives surrounding her experiences of multiple 
symptoms.  In the previous extracts we see how Jessie experienced 
several concurrent symptoms such as breathlessness, lack of 
appetite, hair loss, fatigue, nocturia, headache, pain, constipation 
and insomnia.  However, in the short quote that follows, we can see 
how Jessie highlights her breathlessness as being the most 
frightening symptom of all.  Such findings can be further explained 
with reference to section 8.2 that follows, detailing the theme of „Fear 
of death and the lived experience of symptom clusters‟, which 
illustrates how the participants‟ experiences of symptom clusters 
were frequently situated within a fear of death. 
 
Jessie: I think that‟s the most frightening of the lot is the 
breathing, you know when you ... you cannae breathe properly 
you, you kinda panic… (Jessie, interview 1, page 43). 
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This highlighting of individual symptoms within the experience of 
symptom clusters is further exemplified in the following brief quote 
from Dan.  Despite experiencing several concurrent symptoms, such 
as cough, breathlessness, lack of appetite, weight loss, fatigue and 
gastritis (see table 13), we see how sentinel the symptom of 
breathlessness is to him.  His use of the word „perfect‟ to describe a 
state where he is not breathless, highlights the central significance of 
this symptom to him and suggests that he gives this symptom 
superiority above all the rest that he is experiencing at this time:   
 
Dan:  See, if I could breathe, I'd be perfect within myself 
– perfect (Dan, interview 2, page 52).   
 
The first sub-theme presented in this chapter, „The experience of 
symptom clusters‟, has illustrated how the participants in this study 
did talk about their experiences of symptom clusters, and appeared 
to associate the occurrence of certain symptoms with others.  It also 
highlights that within the experience of symptom clusters in patients 
with advanced lung cancer, four core symptoms exist (fatigue, cough, 
pain and breathlessness) which commonly feature in the narrative 
symptom clusters depicted by the participants.   
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The results presented in this sub-theme also demonstrate that 
occurrence of symptom clusters in patients with advanced lung 
cancer is most prevalent during periods of treatment.  The 
participants‟ descriptions of symptom clusters at such times often 
depicted the transient nature of symptoms, with many occurring and 
then diminishing with time.  However, in contrast, some of the 
clusters described by the participants did not appear to follow this 
trend, but appeared to remain constant throughout the patient 
trajectory. 
 
The findings illustrated in this sub-theme also provide insight into 
how the participants in this study made sense of the symptom 
clusters that they were experiencing, often using the co-occurrence 
of symptoms as a means of sourcing the cause of another symptom.   
 
However, of particular significance is the way that the participants, 
within the experience of symptom clusters, commonly chose to 
emphasise and highlight individual symptoms that they were 
experiencing.   This is characterised in the following quotes by 
Richard when he talks about his experiences of radiotherapy:  
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Richard:  … for aboot two weeks – awful ... absolutely awful, 
the worst feeling ever ... you know you were just ... your arms 
were sore ... your legs were just ... just totally knackered, 
that‟s the best way I can describe it ... and you, you had the 
sick feeling you know ... and a couple oh times I was physically 
sick eh ... the hair was getting thin, no that I've got a lot of 
hair anyway but ... it was getting thinner, you just didnae feel 
right at all ... I don't know if I've described it properly, but that 
was how I felt – awful; absolutely awful,  (Richard, interview 2, 
page 12). 
Richard:… but I lost a lot of weight I lost nearly 2 stone during 
that period, I couldn‟t swallow e-r-r but they told me this was 
[coughs] part of the treatment where they were aiming the 
radiotherapy it will affect me ... You know, the … what have 
you, so I was ... I couldnae swallow so I wasn‟t eating I was 
drinking a lot of fluid, e-r-r, and I felt bad at losing the weight, 
I started to worry about that, e-r-r and again my own GP, he 
was brilliant, don‟t worry about it, it‟s normal, it‟ll come back on 
to you, your weight will come back and it has, you know 
everybody has told me this and it‟s came that way (Richard, 
interview 1, page 29).  
 
As will be further illustrated in the sections and chapter that follow, 
the prominence of these individual symptoms within the experience 
of symptom clusters was commonly mediated by the meanings that 
individuals ascribed to these symptoms.  In this study, these 
meanings were commonly a fear of death, stigma, and loss of sense 
of self.  This is discussed in greater depth in the sections that follow. 
 
8.2  Death 
This section of this thesis details the second sub-theme „Death‟, 
which informs the super-ordinate theme of „The lived experience of 
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symptom clusters and the role of context and meaning‟ derived from 
this thesis.  This sub-theme and the one that follows („Stigma‟) 
illustrates how the context of being diagnosed with a life-limiting 
illness such as lung cancer and its association with self infliction, 
resulted in many of the participants ascribing negative meaning to 
their illness.  This chapter also highlights how this context and the 
negative meaning the participants associated with their illness in turn 
influenced their experiences of symptom clusters, with them often 
attributing these negative meanings to their experiences of this 
phenomenon.  Such findings therefore highlight the core role that 
context and meaning play in the experience of symptom clusters in 
patients with advanced lung cancer.   
 
The section that follows provides data in the first instance to illustrate 
the context of a lung cancer diagnosis and how the participants in 
this study associated their illness with an overwhelming fear of death.  
The sections that follow then demonstrate how this context of fear of 
death significantly influenced the participants‟ experiences of 
symptom clusters by the way they used these negative meanings to 
understand and make sense of their experiences of this phenomenon. 
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8.2.1  The meaning of lung cancer - death 
When asked at the start of the first interview „What does cancer 
mean to you?‟, many of the participants replied to this question by 
talking about their fear of death.  This is not surprising in light of the 
terminal nature of their disease and the limited survival rate (Sola et 
al. 2004; International Agency for Research on Cancer 2000).  This 
fear of death provided a context for many of the participants‟ 
experiences of symptom clusters (see section 8.2.2). 
 
Perhaps the most extreme example of this fear of death associated 
with the context of lung cancer diagnosis was provided by Ruby, a 58 
year old woman who had recently been diagnosed with lung cancer 
and was told that she only had months to live.  Here she talked about 
her „fear of the unknown‟: 
 
Roma: … when I said to you, “What does cancer mean to 
you?” and you said “devastation”, can you explain a wee bit 
more what you mean by that? 
Ruby: Your life‟s in turmoil.  Em … I'm frightened oh the 
unknown … eh … the treatments … the treatment makes you 
feel terrible, em … your immune system‟s always down, well, 
not always down, but you‟ve tae watch.  You cannae go oot, 
you know, mixing … even in shops, things like that, you know … 
you‟ve to watch what you're doing, eating … well I eat well 
anyway … it‟s just frightened oh the unknown, the unknown. 
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Roma: If you can, can you tell me a wee bit more about 
that...? 
Ruby: The unknown? 
Roma: Being frightened of the unknown... 
Ruby: Well, that Dr [name] … he told me I‟d a year to live 
and it‟s my daughter and my … my grandchildren and my 
husband, you know … it‟s, you're frightened oh leaving them, 
you're no wanting tae leave them, you know … so … [sounds 
emotional] (Ruby, interview 1, page 2). 
 
Ruby‟s words cut straight to the core, like most of the participants 
she explains several key aspects of the experiences of living with 
cancer: the impact of treatment and the limitations that brings.  
However, the extract brings with it a sense of fear and this is implied 
in the difficulty she has when talking about the likelihood of her 
death.  The way that she does not openly use the word „death‟ and 
talks about the „unknown‟ and uses euphemisms when talking of 
„leaving‟ her grandchildren and husband suggests some sense of 
avoidance; she knows she is going to die but appears to find talking 
about it too distressing.  
 
The innate fear of death expressed by Ruby was also reflected in the 
accounts of many of the other participants.  What was apparent was 
that this fear of death was not something that came and went but 
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was omnipresent.  In their narratives, their fear of death was 
perceptible throughout many of their interviews. 
 
The following quote from Richard highlights this when he talks about 
his fear of death, which he describes as being the „fear factor‟.  Of all 
the participants, Richard‟s fear of death appeared to be most 
prominent and this may have been due to his past experiences of his 
father dying of lung cancer.  The use of the term „fear factor‟ to label 
his fear of death suggests that it is something that is highly 
important to him and prominent in his life.  It may be also be inferred 
that by giving his fear a label, Richard can contain it and make it 
easier to control: 
 
Richard: … but the fear is always there, you are, you're 
frightened, aye ... that‟s the best way to describe it, fear, the 
fear factor, you know ... you deal wi' that as well ... you try and 
put it in the back oh your mind, but it always surfaces ... fear 
always surfaces ... (Richard, interview 2, page 7).  
 
8.2.2  Fear of death and the experience of symptom 
clusters 
This fear of death, stemming from the wider context of being 
diagnosed with a life-limiting illness such as lung cancer, in turn, 
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significantly influenced the participants‟ experiences of symptom 
clusters.   
 
For some of the participants, this context of a fear of death, 
manifests itself at times when the participants experienced 
concurrent symptoms of high severity due to the treatments that 
they were receiving.  There was a sense that at such times, in light of 
their failing bodies, they felt that the threat of death was nearing, as 
they were afraid that they would not recover from such episodes and 
would die.  The following two excerpts from Flora exemplify this fear 
of death when she talks about how she felt „terrible‟ after her 
radiotherapy treatment.  Such experiences were profoundly 
distressing for Flora as they threatened her independence, something 
which she greatly valued and strived to maintain in her life.   
 
In the first quote presented below, Flora talks about the significant 
debilitation that she encountered due to the concurrent symptoms 
that she experienced following her radiotherapy treatment.  The 
incapacitation that she experiences due to her symptoms is apparent, 
with her only managing to perform the most basic activities of daily 
living:   
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Roma: And when you were feeling weak after the 
radiotherapy can you explain a wee bit more about that?  
Flora: Weak, I could hardly do anything, it took me all my 
time, it gave you a very tired feeling, it took you all your time 
to get out of bed and put your clothes on, sometimes I just put 
my dressing gown on, and come down, I still had my nightie 
on, you know, that‟s how weak it felt, you know.   But after a 
week I started to get better again, mmm mmm.  But I really 
felt ill for a week, I did … 
Roma: …And when you were feeling tired and weak … 
Flora : …Tired, tired, as if I'd been ill, you know, say you 
had a bad illness, say like a chest infection or anything like that 
and you feel weak, I had one not so long ago didn‟t I, I had a 
chest infection and pleurisy, mmm mmm… 
Roma: Can you explain a wee bit more about that, that 
feeling that …? 
Flora : Oh, the tired feeling after … 
Roma: Uh huh … 
Flora : Well, I was just dragging my feet behind me, I was 
… that‟s when I let [daughter] make my dinner and that, you 
know, make my food and I was kinda off my food as well, 
mmm mmm, … (Flora, interview 1, page 24). 
 
Such experiences are further elaborated in the quote that follows, 
when Flora talks about her thoughts during this time:  
 
Roma: And, and what were you thinking at the time, do 
you know, when you were, that week when you were feeling 
like that [week after radiotherapy]?     
Flora:  All I could think was “My gosh, I hope I get better, 
uh huh, this is a terrible feeling, uh huh”.  But I think someone 
told me, they must have in the hospital, that you don‟t feel 
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very well after radiotherapy, I had heard someone saying it and 
it was true, so I‟ll see when I, if I get this shoulder done in 
radiotherapy, I‟ll see if it was the same, you know, once I get 
this done, uh huh...  
Roma: And when you say it was terrible, you might think 
these are silly questions, but it‟s to try and understand why 
you, you describe feeling that way, … did you feel it was 
terrible the way you were feeling? 
Flora: Well, why did I feel it was like that?  Well, I'd never 
ever felt like that before, you know, I'd never felt like that 
before because I was always fairly healthy and got around, but 
it was horrible, mmm mmm.  But I used to say to myself “I 
must get better, I will get better”, and I did get better ... 
Roma: Could, if, you know, if you want, can you tell me a 
wee bit more about that, about why you were thinking that at 
the time – “I must get better, I will” … ? 
Flora: Well, I had lots of things I wanted to do, you know 
… yes, that‟s how I felt, there was lots of things I wanted to do, 
mmm mmm.  I can't go just now, there's tons of things I want 
to do, mmm mmm … [slight pause] … (Flora, interview 1, 
pages 25-26). 
 
In the second quote presented above, it is evident that Flora 
associates the severity of the concurrent symptoms that she is 
experiencing as being symbolic to her that the threat of death is 
near.  She appears to be scared as she has never experienced this 
level of symptomatology before and therefore does not know what to 
expect.  This uncertainty appears to „fuel‟ the fear that she is 
experiencing.  Her fear of death also appears to be magnified by her 
strong will to live and, for Flora, this may in part stem from the 
central role that she plays within her large family and their reliance 
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on her.  She appears to try and cope with this threat of death by 
convincing herself that the high severity of her symptoms that she is 
experiencing is just to be expected as she has been told this in the 
past.  She also appears to believe in the healing power of the mind, 
and uses this strategy to try and help herself recover from this 
episode in her illness.   
 
This context of being diagnosed with a life-limiting illness such as 
lung cancer and the fear of death which ensued also influenced the 
participants‟ experiences of symptom clusters in another way.  
Despite all of the participants reporting to be experiencing several 
concurrent symptoms, of particular relevance to this thesis was the 
way that they dedicated much time and detail in talking about certain 
symptoms such as breathlessness, lack of appetite and weight loss.  
The significance of these specific symptoms to the participants, from 
all the rest that they were experiencing, appeared to stem from the 
way that they associated these symptoms with death.  Such findings 
may be partly explained by the way that all of these symptoms 
(breathlessness, lack of appetite and weight loss) are reflective of the 
basic physiological requirements to maintain life.   
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This is best illustrated in the following quote by Dan.  Despite 
reporting to be experiencing several concurrent symptoms at this 
time, here we see how he dedicates much time and detail when 
talking about his breathlessness.  This focus on his breathlessness 
and the detail that he affords in describing it was not only apparent 
on this occasion but on numerous occasions throughout both of his 
interviews.  The inherent fear of death which pervades his thoughts 
when he is breathless is evident.  It appears that the longer his 
breathlessness lasts and the more severe it becomes, the more it 
turns into a „real‟ experience to him.  The use of this term by Dan 
suggests that when his breathlessness gets to the point of being 
„real‟, the threat of death is no longer a possible or potential 
occurrence, but becomes a fact.   
 
Roma: What were you thinking when you were feeling this 
breathlessness? 
Dan:  Oh Christ, you were thinking, “Is it your last 
minute?”  Naw, no really like, you know, but, you‟re saying to 
yourself, “Christ I hope this disnae last too bloody long or if this 
gets worse they‟ll need tae dae something real,” you know?  Oh 
aye it‟s, it‟s just, that‟s the kind of stage you‟re at like, you 
know, what do we do next like, you know … but what dae you 
dae next if you cannae get a … if you cannae get a breath, 
Christ you might as well no be here … you‟ll no be here, cause 
it‟s the breathing that keeps you going! (Dan, interview 2, page 
14). 
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Such feelings may in part stem from Dan being told by the health 
professionals caring for him that his breathlessness may be a „sign of 
the future‟ and that there may come a point when they can no longer 
treat his breathlessness.  The thought of his breathlessness 
progressing to a level where there is no intervention appears to scare 
Dan.  Although he denies it, there is a sense that such an existence 
would be so intolerable to him that he would contemplate ending his 
own life.  Such thoughts of suicidal ideation were apparent on 
another two occasions during Dan‟s interviews when he talked about 
his breathlessness.  Common to all was the feeling of hopelessness 
evoked in Dan when contemplating there being a time in the future 
when his breathlessness could no longer be treated and the 
consequences of this in his life:  
 
Roma: OK.  So, you know, we, we were talking about 
breathlessness before as well and you said it could be a sign of 
the future, when you were talking about your breathlessness …   
Dan:  Well that‟s what I was getting to last week … it was a 
sign oh the future, because they were telling me that eh, and 
there might no be nothing you can dae aboot it, well, I says, I 
wouldnae like to go a bit breathless like that.  What I would 
dae, I don‟t think I would dae away wi' masel … don‟t … I'm no 
that bloody stupid ... (Dan, interview 2, page 16).  
 
The fear of death derived from the context of a lung cancer 
diagnosis, not only permeated the participants‟ experiences of 
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breathlessness, but also other symptoms, such as lack of appetite 
and weight loss.  As with the above, in relation to the experience of 
breathlessness, despite experiencing multiple, concurrent symptoms 
at this time, the participants appeared to focus much of their 
dialogue on these individual symptoms and this appeared to be due 
to the symbolic connotations of these symptoms with a fear of death.  
This focus on individual symptoms within the experience of symptom 
clusters implies that patients with lung cancer experiencing this 
phenomenon do not view all the symptoms that they are 
experiencing as being of equal priority, but tend to stratify them 
based on the meanings that they ascribe to them.  This is exemplified 
in the following quotes by Paul when he talks about his chemotherapy 
treatment: 
 
Paul:  … this time it‟s like a stronger dose and I was feeling a 
wee bit nausea and, I wisnae feeling too good about myself, 
right … and eh, aye, I was just, I was getting the pains again ... 
I've no been eating ... (Paul, interview 1, page 12). 
 
He then goes on to talk of his fear of being discharged home 
following his chemotherapy treatment, highlighting that his fear of 
going home stems from his inability to eat: 
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Paul:  … and again, it‟s going tae ma heed, he's wanting tae 
throw me oot and oh, that just get some of the nervous system 
going again, you know, that disnae help yae.  They start tae 
calm yae doon and get food intae you, and he's upsetting yae 
and, a-a-w God, I begin tae sae tae masel, do they no read 
your case notes afore they come up, cause this is a doctor I've 
no seen, I've seen I don't know how many doctors have been 
up at me, but anyway, [name of nurse]‟s like that, naw that‟ll 
no happen like that, don't you worry about that, see, but I just 
worry, I can'nae eat, [name of nurse] the noo as it is, I want 
tae eat and I cannae eat, och I don't know, but probably a lot 
oh it‟s ma head as well, you know what I mean, my thinking, I 
don't know … (Paul, interview 1, pages 14-15).  
 
The anger and frustration that he experiences relative to this 
symptom is evident in his account.  When prompted to talk more and 
describe why he is frustrated, it is apparent that he links eating as 
having some therapeutic benefit and therefore this may be a way of 
him striving for health and therefore distancing himself from the 
threat of death.  By being unable to eat, there is a sense that he feels 
that the threat of death is nearing, that time is running out and if he 
does not start to eat soon it will be too late and he will not „recover‟ - 
he will die.  Such findings may therefore explain why Paul, within the 
experience of symptom clusters, chooses to talk about this individual 
symptom in so much detail due to the significance that it holds for 
him and its association with a fear of death: 
 
Paul:  I want tae eat some days but I cannae, I get a wee 
bit frustrated wi' that, you know, but it‟s going to take time I 
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suppose, you know it‟s like everything else aint it, it‟s aw doon 
tae time … 
Roma: Why do you feel frustrated that you can't eat? 
Paul:  Aye.  „Cause I know once I start to eat, I‟ll 
recuperate, I‟ll recover, I know that.  I cannae eat.  I want tae 
eat, I've tried aw the fishes that they had and chicken, in fact 
they had chicken the other day there, roast chicken and I seen 
the boys wiring intae it and I was like that, you know that looks 
no bad that, I don't like the meals in here anyway, they come 
fae [distant city], right, and they're no very good, right, is that 
no crazy bringing meals fae [distant city]?  Freeze them and 
then bring them up here and re-heat them, so anyway, the 
chicken looked no bad, I says “Go and gie us a bit oh chicken 
wi' a wee drop gravy, that‟s fine,” … I couldnae get it ower, I 
says “Ach, I‟ll need tae leave that,” you know that was me 
finished wi' that, so aye, so it‟s a wee bit frustrating, you 
cannae eat, cause I know once I start to eat I‟ll recover, I know 
that, actually I weighed masel the day, I've loast a stone in 
weight fae I come in here a fortnight ago, I've no had a meal 
yet, so that‟s no good either, because if you‟re no eating you 
cannae fight nothing, so … [sighs] …[pause] (Paul, interview 1, 
page 16). 
 
8.2.3  Fear of death and coping with symptom clusters 
The context of a lung cancer diagnosis and the fear of death which 
manifests as a result of this also appeared to influence the way that 
the participants coped with the symptom clusters which they 
experienced as a results of their cancer treatments.  The participants‟ 
dependence on such treatments to live combined with their fear of 
death, at times resulted in them enduring several concurrent 
symptoms of high severity in order to stay alive.  In such instances, 
the toxic side effects of their treatment, resulting in the occurrence of 
symptom clusters of high severity, causing much distress and 
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suffering, were outweighed by the participants‟ strong desire just to 
live another day.  
 
The following straightforward quote by Veronica exemplifies this point 
and demonstrates how after being diagnosed with a terminal illness 
such as lung cancer, she is only concerned with the bare 
fundamentals in life.  She states that in her situation you only have 
two choices: you either take the treatment and live, or you don‟t take 
the treatment and die.  When faced with such decisions Veronica 
appears to have no concern over the effects of her treatment or what 
her quality of life will be; the primacy of living appears to surpass 
this: 
 
Veronica: You either take the chemotherapy and you‟ve a 
chance o‟ life or don‟t take it and you‟ll die, that‟s it…  
(Veronica, interview 1, page 3).  
 
Integral to the some of the participants‟ accounts was also a sense 
that despite experiencing symptom clusters of high severity due to 
their cancer treatments, they appeared to have no limit to what they 
would tolerate in order to prolong their life.  For example, in the 
extract below, Jessie describes how her treatment was discontinued 
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by her oncologist due to toxicities that she was experiencing at the 
time.  However, despite this, at her next visit she points out to the 
doctor that she is „willing to try anything‟.  The use of the term 
„anything‟ suggests that she has no limits to what she would try and 
is not bothered with effects of it.  As with some of the other 
participants, in light of being diagnosed with a terminal illness and 
resultant dependence on treatments, Jessie‟s main concern is to live 
and this appears to outweigh the distress associated with the toxic 
effects of the treatment upon her:    
 
Jessie: He [consultant] says it‟s making you ill, he said, I 
think we‟ll give you a, a couple oh months complete rest fae it, 
you know ... he says there's no point in making you ill.  
However, after the first month I got word to come back and see 
him and I said to the other young doctor that I saw, I said you 
know I, I'm willing to try anything, so whether he has 
mentioned that to him, I don't know but I got called in after the 
one month and he put me onto treatment ... (Jessie, interview 
1, page 5).   
 
However, in contrast to some of the other participants and with 
reference to the above, Dan did appear to have some limits to what 
he would accept as being worthy of life.  His desire to live also 
appeared to be influenced by his wish to have some quality to his life.  
The following extract illustrates this point, when Dan talks about his 
breathlessness:    
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Dan:   Oh aye it‟s, it‟s just, that‟s the kind of stage you‟re 
at like you know, what do we do next like, you know … but 
what dae you dae next – if you cannae get a … if you cannae 
get a breath, Christ you might as well no be here … you‟ll no be 
here, cause it‟s the breathing that keeps you going, and if you 
get to the stage that you have to crawl literally?  It‟s nae life … 
(Dan, interview 2, page 14).   
 
In summary, this sub-theme has illustrated how, for the participants 
in this study, being diagnosed with a life-limiting illness such as lung 
cancer with a high symptom burden, resulted in an inherent fear of 
death.  It also illustrates how this fear of death derived from the 
context of a lung cancer diagnosis significantly influenced the 
participants‟ experiences of symptom clusters.  This was most 
apparent at times when they experienced concurrent symptoms of 
high severity, which denoted to the participants that the threat of 
death was nearing.  This fear of death within the experience of 
symptom clusters also appeared to influence the way that the 
participants understood and made sense of this phenomenon, not 
choosing to focus on all their symptoms, but tending to pick out 
salient symptoms based on their symbolic connotations with death.  
Such findings therefore imply that the participants in this study did 
not view all of their concurrent symptoms as being of equal weighting 
but appeared to give those symptoms which they viewed as being 
symbolic of death greater credence over the others.  This fear of 
death also appeared to influence the way that the participants coped 
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with the symptom clusters that they experienced as a consequence of 
their treatment, with them often tolerating severe and debilitating 
toxicities in order to live another day.    
 
An inherent fear of death was not the only meaning the participants 
derived from the wider context of a lung cancer diagnosis.  The 
association of lung cancer with self-infliction also resulted in the 
participants associating an element of stigma with their illness and 
this, in turn (as with fear of death), also influenced their experiences 
of symptom clusters.  These findings are presented in the section 
that follows. 
 
8.3  Stigma  
The previous section has described how the fear of death experienced 
by the participants within the context of being diagnosed with a life-
limiting illness such as lung cancer, significantly influenced their 
experiences of symptom clusters.   
 
As stated above, this fear of death was not the only meaning that the 
participants associated with their lung cancer diagnosis.  The 
association between lung cancer and potential self-infliction also 
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resulted in many of the participants associating an element of stigma 
with their illness.  As with fear of death, this stigma derived from the 
context of a lung cancer diagnosis, also influenced the participants‟ 
experiences of symptom clusters.  In the section that follows, the 
participants‟ experiences of stigma are presented in the first instance, 
prior to the discussion of these findings relative to the participants‟ 
experiences of symptom clusters.   
 
8.3.1  Childhood recollections of stigma  
The majority of the participants spontaneously discussed issues 
related to stigma in their interviews and their narratives commonly 
surrounded their childhood experiences of cancer or the cause of 
their disease.  For some of the participants, feelings of stigma 
following a lung cancer diagnosis appeared to be influenced by their 
childhood experiences of cancer where it was stigmatised by society.   
 
In the following example, we see how one of the participants, Dan, 
recalls a time in his childhood when stigma presented a key lens 
through which people understood cancer.  Here he describes how 
people would try to avoid having to socially engage with others who 
had cancer, perhaps in the context of a lack of effective treatments 
and their probable impending death.  There is a sense that people 
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were angry at others who developed this disease and this may have 
been related to their fear of the disease and resultant feelings of 
vulnerability created within them as a consequence of this.   
 
Dan:  I mean, at one time if you mentioned you had 
cancer – Jesus Christ it was like a red rag to a bull ... I, I mean 
everybody gies you a wide berth, you know that yoursel I 
mean, lets be honest about it like, I mean, eh, you walk doon 
the street and somebody‟ll say, “Oh, he's got cancer,” Christ 
you were nearly across the road at one time and I'm talking in 
older day, I'm not talking, I'm talking when I was a wee boy 
like, so I'm going really back … (Dan, interview 2, page 5). 
 
Inherent in his narrative is also a sense that Dan, in light of being 
diagnosed with a terminal illness, has reflected on his life, and feels 
embarrassed by his past behaviour towards people with cancer.  He 
tried to distance himself from such actions by pointing out that this 
happened when he was a boy – a long time ago – at an age when he 
was not fully responsible for his conduct.  He appears to be trying to 
point out that he is a better person now. 
 
Feelings of stigma were not only evident in the participants‟ childhood 
recollections of cancer, but also when they talked about the cause of 
their disease.  Many of them stated that they were or had been 
smokers, however, evident in their accounts was the way that they 
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would try and distance themselves from being blamed for their 
disease, due to fear of potential discrediting.  As previously stated, 
such findings may provide the context to explain why feelings of 
stigma significantly influenced their experiences of symptom clusters. 
 
8.3.2  Lung cancer: A self-inflicted illness? 
The proven causal link between health behaviours such as smoking 
and the development of lung cancer has been widely reported in the 
literature and therefore may explain why many of the participants 
chose to talk about the cause of their disease.  A few, like Thomas, 
openly acknowledged the role that smoking played in the 
development of their lung cancer. 
 
Roma: Could you explain a bit more about what you mean 
by that when you say it‟s an illness? 
Thomas: Well, it‟s a self-inflicted one, I don‟t know.  Lung 
cancer is a self-inflicted illness, no two ways about that, errr, 
I‟ve self-inflicted it on me „cause I‟ve smoked for about 25-30 
years and then stopped (Thomas, interview 1, page 1). 
Later in the quote he whispers: 
Thomas: Err, [whispers the following] I didnae help myself 
any, as I‟ve smoked for 25 years and I‟m what, 50 blah, blah, 
58, I didnae help myself any (Thomas, interview 1, page 2).  
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In the extract above, we also see how Thomas is adamant that he 
has self-inflicted his lung cancer upon himself and this is implied by 
the way that he repeats this statement on more than one occasion.  
However, there is also a sense that he is ashamed that he has caused 
his illness and this is implied by him whispering the latter quote – as 
if he does not want anyone else to hear what he is saying.  Of 
significance is that when Thomas said this he was in a private room 
in the hospital with only himself and the researcher present.  This 
whispering suggests an element of paranoia in Thomas‟s behaviour at 
this time and that he fears being discredited if someone else was to 
hear him admit that he inflicted his lung cancer upon himself. 
 
In contrast to Thomas, even though some of the participants were 
also smokers, they minimised the role that smoking played in their 
development of their disease and appeared to dismiss it as a 
potential cause.  This response has been reported elsewhere in the 
literature and appears similar to the process of „unrealistic optimism‟ 
described by Weinstein (2005), who reported that smokers 
underestimate their risk of lung cancer relative to both their smoking 
and non-smoking counterparts. 
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The most extreme example of this tendency to avoid blame was 
provided by Veronica, who, despite overtly stating that she smoked, 
quickly dismissed it as potential cause of her lung cancer and said 
that it was just down to luck:   
 
Veronica I‟ve never once said “Why me?”  Why not me?  It‟s 
just your Donald Duck, that‟s it.  „Cause apart frae smoking, I 
stopped the smoking [...] my cousin [name] he‟s never smoked 
a cigarette in his life, I doubt very much whether he‟s had a 
pint, very clean living person, you know.  His idea of a good 
night is a fish supper and a bottle of Irn Bru or something like 
that.  Nothing wrong with that, that‟s his choice, but he‟s going 
through hell tae, you know… (Veronica, interview 1, page 11).   
 
In the quote above, we see how Veronica tries to reinforce her belief 
that her lung cancer was not self-inflicted by comparing herself to a 
person she knows who never smoked, yet still developed the disease.  
However, of particular significance is the start of the quote, when 
Veronica states „I‟ve never once said “Why me?”  Why not me?‟  This 
suggests that Veronica does not want people to view her as being a 
victim of her disease and feel sorry for her.  It may be cautiously 
inferred that she feels this way as she thinks she does not deserve 
this concerned reaction from others, as deep down she feels that she 
has inflicted her cancer upon herself.  Therefore, her outwardly 
denying the potential role of smoking in the development of her lung 
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cancer may be a way of her coping with this and trying to distance 
herself from any culpability and potential discrediting.    
 
From the above findings, it is apparent that many of the participants 
chose to talk about the cause of their lung cancer.  What is common 
to all is the way that they would try and distance themselves from 
the role that health behaviours within their own control, such as 
smoking, may have played in the development of their disease.  Such 
findings suggest that the participants acted in this way as they 
perceived an element of stigma related to their lung cancer and 
feared potential discrediting if they were linked in any way to the 
development of their disease themselves.  Such feelings of perceived 
stigma were not only expressed by people who were or had been 
smokers, but also by one of the participants who did not smoke.  
 
Such findings are reflected in the literature where people with 
advanced lung cancer perceive themselves to be stigmatised more 
than other cancer groups due to the strong association with the 
disease and smoking, irrespective of whether they are smokers or not 
(LoConte et al. 2008; Chapple et al. 2004).  This is exemplified in the 
following quote from Suzie when she talked about how shocked she 
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was when she was diagnosed with lung cancer and how she thought 
it would happen to other people but never happen to her: 
 
Roma: „Cause you were, you were saying there, you know, 
you thought it‟d be other people ...  
Suzie: Mm hmm, mmm mmm ...  
Roma   ... and not me ... 
Suzie   Mm hmm ...   
Roma   Why, why do you think that? 
Suzie: I don't, I don't, I really don't know.  I'd always 
eaten well and looked after myself and you think sometimes it 
happens to people that don't look after themselves and maybe 
don't eat well and abuse their bodies – smoke; I've never done 
any oh these things and yet it, it .. I think it was more a shock 
then (Suzie, interview 1, page 2).   
 
In the above quote, in addition to the feelings of shock overtly stated 
by Suzie, there is also a sense that she feels that her cancer 
diagnosis was unjust.  Such findings may be referenced to the „just 
world hypothesis‟, which states that people believe that they live in a 
world where people generally get what they deserve (van den Bos 
and Maas 2009).  There is a sense that Suzie feels that her lung 
cancer was not deserved, as she has „looked after herself‟ as opposed 
to most people who develop this disease, who, in her opinion, have 
„abused‟ their bodies.  The use of the word „abuse‟ suggests that 
Suzie associates such people as having maltreated and neglected 
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their bodies.  When referenced to the literature on stigma in patients 
with lung cancer (LoConte et al. 2008; Chapple et al. 2004), her 
account suggests that she  associates an element of stigma herself 
related to the role of smoking in the development of lung cancer. 
There is also a sense that Suzie would have preferred to have 
developed another type of cancer, one that is not associated with 
self-neglect. Overall, in her account, it is apparent that she wants to 
distance herself from the „stereotypical‟ person with lung cancer and 
throughout tries to prove how different she is.  
 
Taking into consideration the perceived stigma experienced by the 
participants related to the causation of their disease and their 
childhood experiences of cancer-related stigma, it is understandable 
that feelings of stigma derived from their lung cancer diagnosis, 
influenced their experiences of symptom clusters.   These findings 
are presented in the following section of this chapter. 
 
8.3.3  Stigma and the lived experience of symptom 
clusters 
The previous section has provided evidence to substantiate the 
feelings of stigma that the participants in this study experienced as a 
result of being diagnosed with lung cancer.  Such findings may 
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therefore explain why such feelings in turn, influenced the 
participants‟ experiences of symptom clusters.   
 
As discussed previously, what was noticeable from the study findings 
was that despite reporting to be experiencing symptom clusters, the 
participants‟ narratives would commonly focus on individual 
symptoms.  In this study, this focus on individual symptoms within 
the experience of symptom clusters appeared to be influenced by the 
meanings that the person ascribed to a particular symptom.  This 
point is exemplified in the following quotes by Thomas: 
 
Thomas:  I must admit I was feeling … tired … I started to 
cough and I was just about sick, I wasnae sick! I wasnae sick, 
but oh, I wasnae far away fae it and I thought I‟d not be able 
to stop, but no, it cleared up … but oh, this cough is doing me 
in … (Thomas, interview 1, page 15). 
Thomas:  I‟m … am always wary about this cough (Thomas, 
interview 1, page 11).   
Thomas:  ... embarrassing, that I was sitting there spluttering 
away ... albeit it .. whatever and I've got all these folk round 
about me and such like ...... wi' this cough, even though you‟re 
doing that [indicates covering mouth and nose with hand] ... I 
think that‟s more what I was thinking, kinda, that was ... I 
wisnae wanting tae be ... and everybody felt, I felt as though 
maybe everybody was looking at me and saying ... look at ... 
what's he doing in here? ... coughing away like that ... 
(Thomas, interview 2, page 37). 
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This singling out of symptoms, within the experience of symptom 
clusters, was also apparent for those symptoms which the 
participants associated with feelings of stigma.  Individual symptoms 
such as cough and breathlessness were of particular salience to the 
participants, as these symptoms were commonly ones that they 
perceived as being difficult to control and that they could not 
anticipate.  Therefore, such symptoms were viewed as having the 
potential to attract the attention of others in public places and 
therefore pose the risk of them being discredited on the grounds of 
their lung cancer diagnosis.  Scambler and Hopkins (1990:1193) 
describe this type of stigma as „felt stigma‟, which is „a fear of 
encountering stigmatisation‟ without any actual experience of 
stigmatisation.  „Felt stigma‟ is distinct from „enacted stigma‟ where 
there is actual discrimination against the individual on the „grounds of 
social unacceptability or inferiority‟.   
 
The participants‟ narratives focusing on individual symptoms (within 
the experience of symptom clusters) commonly occurred at times 
when they were out in public places and their symptom attracted the 
attention of strangers, resulting in them asking questions about the 
cause of their symptom.  During such episodes, the participants 
described how they were faced with the dilemma of whether to tell 
the person that they had cancer or not.  The role of control of 
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information is central to the theory of stigma and social identity 
(Goffman 1963) as in such instances the stigma is often not 
immediately apparent and is not known beforehand.  Therefore, the 
person is faced with the dilemma of „to display or not to display; to 
tell or not to tell; to let on or not to let on; to lie or not to lie; and in 
each case, to whom, how, when and where‟ (Goffman 1963). 
 
The following extract from Emily exemplifies this finding and traces 
the links between the context of a lung cancer diagnosis, the 
resultant stigma and the focus on individual symptoms within the 
experience of symptom clusters.  Of salience is that despite Emily 
reporting the experience of several symptoms, such as cough, 
nausea, vomiting, fatigue, dizziness and pain, here we see how her 
dialogue centres solely on her cough.  When referred back to section 
8.1.1 detailing the theme of „Identifying Salient Symptoms‟, many of 
Emily‟s narratives surrounding her experiences of multiple symptoms 
highlighted her cough as being the most problematic symptom of 
them all.  The significance of Emily‟s cough to her may therefore be, 
in part, due to the „felt stigma‟ that she associated with this 
symptom.   
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In the following excerpt Emily recollects a time when she was in the 
supermarket and she started to cough, which attracted the attention 
of strangers around her:  
 
Emily: … sometimes if I'm in company I get very 
embarrassed eh, because sometimes there's people there I 
don‟t know and they don‟t know me, I think they think I've got 
a terrible cold and I shouldn‟t be out and I'm out causing, 
spreading germs, just an instance I was in [supermarket] 
yesterday and eh, I took a coughing fit, standing at the check-
out and the woman turned round and looked at me and she 
just said, “That sounds awful,” but I couldn‟t turn round and 
say “I know, but it‟s no the cold, I've got cancer,” you know, I 
says “Och, never mind,” and she says “What's wrong wi' you 
voice?” 
Roma: Right ... 
Emily: I says “I've got a sore throat,” 'cause I wisnae 
going to stand and say to a stranger, so naturally she would 
assume, I thought that I had a bad cold ... 
Roma: Uh huh ... 
Emily: ... and I was maybe there spreading it to other 
people, so these kind of things, that worries me quite a lot, 
maybe that‟s where the nuisance comes in, because depending 
on how I'm feeling sometimes I don‟t want to do things where 
there is company, because of the cough‟ (Emily, interview 1, 
pages 8-9).  
 
The above quote is complex and illustrates how Emily‟s experience of 
„felt‟ stigma in public places focuses solely on her cough, despite her 
experiencing several other symptoms at this time.  What is apparent 
is that Emily is concerned first and foremost about what people are 
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thinking of her during such episodes.  With reference to feelings of 
stigma described in the previous sections, it may be inferred that 
Emily is so preoccupied with the reactions of others because she is 
scared that people will find out that her cough is not due to a 
common ailment but that it is due to her lung cancer.  She appears 
to be afraid that she will be discredited if other people find out that 
she has this disease and this may be due to its self-inflicted nature 
and its associated poor survival rate.  Of relevance is the way that 
Emily talked about how she re-lived such events for days after they 
happened, and how such flashbacks would evoke considerable 
anxiety within her.  Such findings highlight how traumatic these 
experiences were to Emily and the significant distress that they 
caused. 
 
Complementing such findings is also the way that Emily talked about 
what her life would be like without her cough, suggesting that if it 
were socially invisible then her life would be much easier.  The way 
that Emily described her cough as being „special‟ suggests that she 
viewed her cough as being distinct from all the other symptoms 
which she experienced at that time.  Such findings therefore suggest 
that Emily did not view all her symptoms as being of equal 
importance, but gave certain symptoms precedence over others, 
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based on the meaning and perceived impact of the symptom within 
her life.    
 
Emily: ... if there was no, nobody could see it, nobody 
could tell me it, this cough is special, nobody can tell otherwise, 
so if I didn‟t have the cough … well, everything else you just 
need to, like a bad cold, get on with it ... (Emily, interview 1, 
page 9). 
 
Feeling of „felt‟ stigma also resulted in the participants trying to hide 
their symptoms from others, particularly in public places, in an 
attempt to conceal their lung cancer diagnosis.  As with many of the 
participant narratives described earlier in this chapter, of interest was 
the way that they did not try to hide all of the concurrent symptoms 
that they were experiencing at that time, but tended to only focus on 
one symptom.   
 
The following quote by Suzie highlights this point.  In the following 
excerpt she talks about how she tried to hide her breathlessness from 
others when walking up a hill, to avoid people approaching her and 
asking what is wrong with her.  Of interest, is that Suzie also 
reported to be experiencing several other symptoms at this time such 
as weight loss, hair loss, vomiting, fatigue and pain. 
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Roma: ... and you know, what was interesting was when 
you said, the nurse said to you, stop in the middle and have a 
rest, and you were saying ... 
Suzie: No ... [laughs] 
Roma: Can you tell me a bit more about that?  
Suzie: No, I just ... [laughs] ... people look at yae and 
think “What's wrong wi' her?” ... [laughs]  I never ... you know, 
I just carry on, just take my time.   
Roma: If you don't mind can you tell me a wee bit more 
about why, why you feel that, if you were to stop, people would 
look at you? 
Suzie: I know, I know it‟s daft, no, probably nobody would 
look at you, but I just feel ... they'd be, maybe looking at you 
and saying, “I wonder what's wrong wi' her?” [laughs]  I know 
it‟s daft ... (Suzie, interview 1, page 11).  
 
Such feelings of stigma may stem from a quote made by Suzie, 
detailed earlier in this thesis, where she talked about how she had 
led a healthy life, never smoked, and was shocked that she 
developed lung cancer as it usually happens to people who „abuse‟ 
their bodies, which suggests that she associates an element of stigma 
related to her disease.  Taking this into account, the above quote 
implies that one reason Suzie does not want to stop is that she does 
not want to take the risk of people questioning her and finding out 
about her diagnosis.  Instead she adopts other strategies where her 
breathlessness can remain concealed, such as „taking her time‟.  Like 
many of the other participants, when walking up the hill she appears 
to be preoccupied with thoughts of what other people will think of her 
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which is a well known characteristic of the stigmatised person 
(Goffman, 1963).   
 
Of note and of bearing to these findings, is a point later in her 
interview, when Suzie described how her breathlessness evoked 
feelings of anxiety and fear, as she was scared of what would happen 
to her when she experienced this symptom due to its unpredictable 
nature and her lack of control over this symptom.  Such findings may 
therefore partly explain why Suzie chose to hide this symptom in 
particular from all the others that she was experiencing at this time, 
due to its labile and capricious behaviour, and therefore its significant 
potential to attract the attention of others in public.   
 
The above section has illustrated how the „felt stigma‟ that the 
participants associated with their lung cancer diagnosis, in turn, 
influenced their experiences of symptom clusters.  This meaning 
derived from the wider context of a lung cancer diagnosis, appeared 
to influence the way that the participants understood and made 
sense of their experiences of symptom clusters, resulting in them 
picking out individual symptoms (from several that they were 
experiencing at this time), based on the feelings of „felt‟ stigma that 
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this particular symptom created.  Such findings are exemplified in the 
followings quotes by Jessie: 
 
Jessie:  But eh, that‟s my main reason I think, I feel if I'm 
eating I'm no going to lose too much weight and I'm no going 
to get “thin, thin” and ... but my sister will say that to me, 
she‟ll say, “I mean anybody looking at you would never know 
there was anything wrong wi' yae like that” and I ... I mean I 
see people that have it, that look really bad, you know, and I 
think oh, I don't want to get like that ... I‟ll just ... I‟ll eat my 
food just as much as I can, as well as I can .. you know 
[laughs] … But as I say, it might no be solely the, the food, I 
don't know ... that makes them thinner, I think it is ... I think 
it‟s 'cause you don't eat you get thinner, you know ... but eh ... 
I just assume it‟s that, but em, otherwise we‟re awright.  I 
mean you, you can go up to the clinic and ... sometimes see 
them, they're like that [indicates a thin person] ... you know, 
they're really just so thin and fragile-looking (Jessie, interview 
2, page 27). 
Jessie:  I, I just have this feeling that em ... well, you, you 
most folk that have cancer go thinner and thinner and thinner 
don't they?  So I just feel if I eat, its going to prevent that 
[starts to laugh] ... well maybe no prevent it, but it‟ll help it, if 
it ... I mean if you don't eat you're going to get thinner, 
anyway I don't know if its that on its own or if it‟s the cancer as 
well that makes you thinner or its just the no eating that makes 
you thinner, but I just feel as long as I, as my appetites no too 
bad, I'm quite happy, you know ... I'm quite happy about that.  
(Jessie, page 26, interview 2) 
Jessie:... I'm hardly skinny so, I'm doing awright, I'm no losing 
much weight (Jessie, interview 1, page 16). 
 
Such findings (as with the previous sections presented) therefore 
highlight the core role that context and meaning play in the 
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experience of symptom clusters in patients with advanced lung 
cancer. 
 
8.4  Conclusion 
This chapter of this thesis has presented the super-ordinate theme of 
„The role of context and meaning in the lived experience of symptom 
clusters‟.  
 
In the first instance, this chapter illustrates that the participants in 
this study did experience symptom clusters and that they did 
perceive there to be associations between the symptoms that they 
experienced.  Furthermore, the findings presented also denote the 
occurrence of core symptoms which commonly feature in the 
experience of symptom clusters in patients with advanced lung 
cancer (fatigue, cough, pain and breathlessness) and, in turn, 
describes the symptoms that these core cluster symptoms commonly 
concurred with.   
 
In addition, the findings also illustrate time points where the 
occurrence of symptom clusters in patients with advanced lung 
cancer are most prevalent, which in this study was throughout 
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treatment phases.  Complementing such results is also the 
information detailed in this chapter regarding the nature and pattern 
of symptom clusters experienced by the participants in this study, 
with clusters experienced during treatments often being transient in 
nature, and others remaining constant throughout the patient 
pathway.  However, of particular significance to this thesis is the way 
that the participants in this study did not appear to view all the 
symptoms that they experienced in the same way, but did appear to 
highlight salient symptoms based on the meanings that they ascribed 
to them.    
 
Relative to the fear of death, the influence of this context on the 
participants‟ experiences of symptom clusters manifests itself in a 
number of ways.  For some, this fear of death was most prominent at 
times when they experienced concurrent symptoms of high severity, 
which denoted to the participants that death was nearing.  This fear 
of death also influenced how the participants coped with the 
symptom clusters that they experienced as a result of their cancer 
treatments, with them often tolerating distressing and disabling 
symptoms in order to live another day.  This fear of death, within the 
backdrop of the experience of symptom clusters, also appeared to 
influence the way that the participants understood and made sense of 
the multiple symptoms that they were experiencing.  Many of their 
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dialogues would focus on individual symptoms despite them 
experiencing several at this time, and this focus on individual 
symptoms appeared to be related to the meaning that they ascribed 
to these symptoms, which, in this study, was commonly a fear of 
death.  Symptoms such as breathlessness, lack of appetite and 
weight loss were commonly highlighted by the participants from all 
the rest that they were experiencing and this may be due to the fact 
that all of these symptoms reflect the basic physiological functions 
required to maintain life. 
 
As well as fear of death, the participants in this study also associated 
an element of stigma related to their lung cancer diagnosis, and, as 
presented above, this may have been due to the perceived self-
inflicted nature of their disease.  This context of lung cancer related 
stigma, as with fear of death, also appeared to permeate the 
participants‟ experiences of symptom clusters.  As was apparent, 
relative to the context of fear of death, was that amidst the 
experience of symptom clusters, the participants would commonly 
choose to focus their narratives on only one symptom.  This symptom 
was often selected based on its potential to attract the attention of 
others in public places and therefore pose the risk of the individual 
being potentially discredited based on the grounds of their lung 
cancer diagnosis. 
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Therefore, the findings presented in this chapter highlight that the 
experience of symptom clusters in patients with advanced lung 
cancer is a highly contextualised experience which is deeply 
embedded in meaning.  The results suggest that people with 
advanced lung cancer use the context of their illness and the 
meanings derived as a means of understanding and making sense of 
their experiences of symptom clusters, by creating an hierarchy of 
symptoms, choosing to focus on individual symptoms that are most 
meaningful to them in their lives.  Therefore, having presented the 
super-ordinate theme of „The role of context and meaning in the lived 
experience of symptom clusters‟, the following chapter will present 
the second super-ordinate theme of this thesis which is entitled 
„Symptom clusters and loss of sense of self‟. 
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Chapter 9 Symptom clusters and loss of sense of 
self 
 
9.1 Introduction 
The previous chapter has detailed the super-ordinate theme of „The 
lived experience of symptom clusters and the role of context and 
meaning‟.  This chapter follows on and presents the findings of the 
second super-ordinate theme derived from this study which is 
„Symptom clusters and loss of sense of self‟.  This super-ordinate 
theme is informed by three sub-themes: „The impact of symptom 
clusters on the self‟, „Being a burden‟, „and „Trying to maintain a 
coherent and valued self‟.   
 
This super-ordinate theme is used to illustrate the „knock-on‟ effect of 
the experience of symptom clusters on the participants‟ lives, and 
how this often manifested itself in a loss of sense of self.  It 
highlights how this loss of sense of self was closely followed by 
feelings of being a burden at the dependency on others created by 
the many symptoms that the participants were experiencing.  
However, it also demonstrates how the participants, in light of this 
assault on their sense of self due to the symptoms that they were 
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experiencing, employed various strategies in a bid to try and 
maintain a coherent and valued sense of self. 
 
9.2 The Impact of Symptom Clusters on the Self 
In the interviews several of the participants talked about the 
limitations placed on their lives due to the symptom clusters that 
they were experiencing and how this impacted on their sense of self.  
On analysis of the data, what became apparent was the different 
ways in which the experience of symptom clusters contributed to the 
loss of sense of self that they experienced.   
 
For most of the participants, their loss of sense of self relative to the 
experience of symptom clusters was related to their inability to 
undertake many of the taken for granted roles and activities that 
they occupied in the past.  This in turn impacted on their sense of 
self, as they observed „their former self-images crumbling away 
without the simultaneous development of equally valued new ones‟ 
(Charmaz, 1983: 168).   
 
Of particular significance to the study of symptom clusters in patients 
with advanced lung cancer, was how the participants‟ dialogues 
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surrounding their loss of sense of self would often focus on one 
symptom, despite them reporting to be experiencing several 
concurrent symptoms at this time.  This symptom was often the one 
which significantly impacted on their level of physical functioning.  
This focus on individual symptoms in the presence of symptom 
clusters is a common theme derived throughout all the super-
ordinate themes presented in this thesis, and the implications of such 
findings are discussed in greater depth in this chapter and the 
discussion that follows. 
 
For many of the participants, their dialogues surrounding their loss of 
sense of self commonly focused on the symptom of fatigue.  This 
symptom appeared to be selected from all the other concurrent 
symptoms that they were experiencing as it prevented them from 
carrying out many of the roles and activities which they undertook 
prior to their cancer diagnosis.  The impact of this symptom relative 
to the loss of sense of self experienced by the participants is probably 
best exemplified in the following quote by Thomas.  It conveys the 
significant impact that his fatigue had on his life.  
 
Thomas:... just I feel I'm always, I feel tired aw the time.  
Now, I was never ever like that, I could go on for hours and 
hours and hours, but now I feel as though if I do something ... 
 224 
 
I want to sit down and close my eyes ... (Thomas, interview 2, 
page 12). 
 
In the above quote, it is evident that Thomas‟s fatigue was ever 
present and did not diminish.  It resulted in considerable restrictions 
being placed on his life and resulted in him being unable to function 
at the level that he had become accustomed to prior to the onset of 
his illness.  This, in turn, appeared to impact on his sense of self, as 
he felt that he was a different person to the one that he was in the 
past.  Such findings were of particular significance to Thomas, as in 
his interviews he described how within his family and social circle he 
was viewed as being the „handyman‟.  He was the person they would 
go to if they needed help to fix appliances or do various DIY jobs 
around the house.  However, in light of the symptoms that he 
experienced and the resultant physical limitations, he also spoke 
about how he could no longer maintain this role in his life.  This, in 
turn, manifested itself in feelings of anger and frustration, as he 
wanted to help his friends and family but couldn‟t.     
 
This point is further exemplified by comparing the way that Thomas 
spoke about some of the other concurrent symptoms that he was 
experiencing.  In the quote below, we see how when he talks about 
the symptom of nausea, there is no mention of the impact of this 
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symptom on his sense of self.   He describes his nausea in a matter 
of fact way, and does not appear to be bothered by it.  This in turn 
may be due to the fact that this symptom did diminish, unlike his 
fatigue which was ever present. 
 
Thomas:... I was just about sick, I wasnae sick! [Someone 
enters the room] Oh, come in, errr…. I wasnae sick, but oh, I 
wasnae far away fae it and I thought I‟d not be able to stop, 
but no, it cleared up and that was it ... (Thomas, interview 1, 
page 15). 
 
Suzie also singled out the symptom of fatigue from all of the other 
symptoms that she was experiencing at that time, due to the 
significant restrictions it placed on her life since being diagnosed with 
lung cancer.  In the following excerpt we see how her sense of self 
has dramatically changed due to the impact of fatigue on her life. 
 
Suzie: Just lifeless really, you know ... falling asleep all the 
time, just wanting to go to your bed and I wouldn‟t give into it 
to begin with then I thought this is silly, it‟s actually your body 
telling you to rest and I used to go down for a wee nap in the 
afternoon, slept all night [slight laugh] ... but I was, I felt guilty 
going to bed, because I was never one for going to my bed in 
the afternoons or during the day, but I had to do it. 
Roma: And what, what ... and why do you think you felt, 
you felt guilty about going to bed? 
Suzie: Because I had never ever done it before, I don't, I 
don't know, just felt I shouldn‟t be in bed during the day, it‟s 
hard to ... 
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Roma: Can you, if you don't mind can you tell me a bit 
more about why you felt you shouldn‟t be in bed during the 
day, is there anything that‟s made you think that way? 
Suzie: No, I just feel bed‟s for night time and you‟re lazy if 
you go to bed [laughs] ... I was never one for, you know I was 
always on the go, probably felt guilt because I was always on 
the go and then couldn‟t do it, it might sound daft, but ...   
Roma: No, no ... and, and you were saying there as well, 
you didn‟t want to give into it at first ... 
Suzie:   Mm hmm.  I thought, if I don't give into this, it‟ll be 
fine, I‟ll get over it, but you can't, you‟ve got to give in, cause 
your so tired … (Suzie, interview 1, page 5).  
 
Suzie‟s narrative has demonstrated how her fatigue was all-
consuming with her sleeping most of the day and night and doing 
little else.  Her use of the term „lifeless‟ indicates the profound loss of 
sense of self that she experienced at this time and was opposite to 
the active persona that she described herself as being in the past.  As 
was common with Suzie throughout both of her interviews, the 
perceived stigma that she associated with her lung cancer diagnosis 
appeared to influence her symptom experiences.  The main reason 
that she tried to resist the impact of fatigue upon her appeared to be 
due to a fear of potential discrediting by others who may have viewed 
her as being „lazy‟.  When she did eventually give in to her fatigue, of 
interest is the way that Suzie appeared to blame her „body‟ by stating 
„it‟s actually your body telling you to rest‟.  By doing this it may be 
inferred that Suzie intentionally made this statement to displace any 
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blame from her „self‟ for sleeping all day and therefore reduce the 
risk of potential culpability.   
 
As with Thomas, we can see in the quote below that the evident 
distress and loss of sense of self that Suzie associates with her 
fatigue, does not appear to be apparent in her experiences of other 
concurrent symptoms such as hair loss.  In the quote below, in 
comparison to the way that Suzie talks about her fatigue and the way 
that this symptom impacts on her life and her sense of self, we see 
that in her dialogue below concerning her experiences of hair loss 
does not afford the same level of detail.  Furthermore, what is 
evident is the way that she appears to minimise this symptom and 
does not appear to be unduly upset by its occurrence.   
 
Roma: Is it OK if we go back and have a wee, just to ask 
you a few things about them, just when, you know, you were 
saying that, that your hair came out, can you tell me a wee, 
wee bit about that, about how you felt when that was 
happening, or .. ? 
Suzie: Well, it wasn‟t too bad, it was only coming out 
when I was combing it, I've heard people saying that, you 
know, when they get up in the morning it‟s been lying on the 
pillow, but I didn‟t have anything like that, it was just patches 
all over but I wasn‟t completely bald ... but eh, my, my hair 
was always a bit fine anyway, I always had very, very fine hair, 
but as I say it wasn‟t too bad, it was coming out when I used to 
comb my hair ... 
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Roma: ... and how did you find losing your hair?  How did 
you feel when that was happening? 
Suzie: Well, I just hoped that I wouldn‟t go completely 
bald and I didn‟t ... mmm mmm ... 
Roma: Mmm, were you thinking anything else, or ... ? 
Suzie: No, no ... (Suzie, interview 1, pages 21-22). 
 
The contrast in the two quotes detailed above provide further 
evidence to demonstrate how within the experience of symptom 
clusters, the participants did not view all their symptoms as being of 
equal weighting but paid particular attention to those which had a 
significant impact on their sense of self.   
 
Such findings were also reflected in Dan‟s narratives.  For Dan, 
despite experiencing several concurrent symptoms such as cough, 
breathlessness, lack of appetite, weight loss and fatigue, it was the 
symptom of breathlessness which was the focus of much of his 
narratives surrounding his loss of sense of self.  Dan‟s breathlessness 
was central to his experience of lung cancer, and he afforded much 
time and detail in both of his interviews to talk about the impact and 
significance of this symptom in his life.  In the following excerpt we 
see how simple, previously taken for granted, everyday activities 
were compromised due to his breathlessness:   
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Dan:  Well, I was always, I was always … I, I could walk in that 
back door, walk to the shed, cut the grass, go to the caravan, 
get the water, wash the caravan and wash three motors and 
the caravan in an hoor, now it would take me an hoor to walk 
to the shed and fill the pails noo, never mind washing them 
because you just don‟t have the breath, your intake of breath.  
OK your lung‟s full oh cancer, we know that, but your intake oh 
breath isn‟t enough, it‟s like the day, what you want tae dae so 
you‟re within yourself a percentage angry wi' yoursel if you like 
because no being able tae dae what you did before that, you 
know your, your mind disnae go back and say, „Christ I cannae 
dae that noo,‟ your mind goes forward and says „I‟ll still dae it,‟ 
… you know, it does, well mine does anyway… (Dan, interview 
2, page 13).  
 
At the start of the quote, Dan appears to be bragging at how much 
he could do in the past, and this may have been a way for him to try 
and reclaim a sense of the person he was before he was diagnosed 
with lung cancer.  There is a sense of underlying sadness when he 
talked about how he could no longer carry out these activities and 
this may have been because he knew that there was all likelihood 
that he would never regain this level of functioning again.  Of 
significance is the evident disharmony between Dan‟s body and mind 
at this time.  His mind appeared to want to do things, but his failing 
body couldn‟t, which resulted in heightened feelings of anger and 
frustration.  This occasion was not the only time that Dan appeared 
to make this distinction from his body and his mind, often at times 
when his symptoms were severe.  It may be inferred that Dan used 
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this body and mind disassociation as a way of coping with his 
symptoms in order to try and regain a sense of control.  He may have 
felt that if he can‟t control his body, he could at least control his 
mind.  
 
The contrast in the way that Dan talked about his breathlessness 
compared to the other symptoms that he experienced at this time (as 
with the other two participants detailed above) is also apparent.   In 
the following quote he talks about his gastritis.  Compared to his 
breathlessness, which he describes in vivid detail as significantly 
impacting on his level of functioning and sense of self, we see how he 
does not associate the same level of significance to this symptom, 
with no mention of its impact on his sense of self.  This in turn may 
be due to the fact that his gastritis was being successfully managed 
whereas his breathlessness, which he describes throughout both 
interviews as being hard to control, was instead unpredictable and 
resulted in an innate fear of death:   
 
Dan:  My stomach‟s no really been right since December, no in 
pain, you know but it goes like a furnace if you like, at times.  
The bottom oh your gullet and your stomach it‟s, it‟s no 
indigestion, as you know, it‟s, it‟s really burny eh, so they‟ve 
gave me tablets for that which has actually cured the, the 
symptoms, if you like ... (Dan, interview 1, page 13).   
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The above findings have highlighted the loss of sense of self 
experienced by the participants due to the symptoms that they were 
experiencing.  Of significance to the study of symptom clusters in 
patients with advanced lung cancer is that despite experiencing 
several concurrent symptoms at this time, the participants‟ narratives 
surrounding their loss of sense of self appeared to focus on only one 
symptom.  This symptom appeared to be of particular significance to 
the participants due to its impact on their level of physical 
functioning, leading to significant restrictions being placed on the 
activities that they could undertake, ultimately impacting on their 
sense of self. 
 
Relative to the experience of symptom clusters and loss of sense of 
self was also the way that some of the participants spoke of times 
when they experienced several concurrent symptoms of high severity 
which resulted in them no longer recognising themselves.  Such 
findings can be referenced to the work of Corbin (2003) on „The Body 
in Health and Illness‟ where she writes about „knowing one‟s body‟ 
and refers to Merleau Ponty‟s work on the „Phenomenology of 
Perception‟ (Merleau Ponty 1962) when stating that the body is „the 
embodiment of who we are.  The self becomes what it is through the 
 232 
 
body.  The body is the self‟s representative of the world‟ (Corbin, 
2003: 258).   
 
This point is exemplified in the following quote by Richard who 
experienced several concurrent symptoms of high severity due to his 
radiotherapy treatment and recalled how „awful‟ he felt at this time 
(see section 8.1).  Of salience to Richard is another point in his 
interview when he recalled how „bad thoughts‟ came into his mind 
when receiving this treatment.  When asked to explain this term, he 
described how such thoughts stemmed from a fear that his 
radiotherapy would not work and he would die of his lung cancer.  
This fear was based on his experiences of his father dying of lung 
cancer, who, like Richard, received radiotherapy treatment but died 
soon after from his disease. Therefore, at the back of Richard‟s mind 
during this time was a fear that he would follow in his father‟s 
footsteps.   
 
Roma: I mean, you were telling me how you were feeling 
there at the end of your radiotherapy and you said, you said ... 
and when you finished you felt awful ... 
Richard: Awful, really ... 
Roma: ...and you were telling me how you felt ... 
Richard: Aye. 
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Roma: ... at that time.  Is there anything going through 
your mind at that time, when you were feeling that way? 
Richard: No, no ... eh, the only way I can describe it as ... 
my body was blank, so was my mind, I just ... I went up the 
stair to my bedroom and stayed there, just didnae come oot 
and then I said the last week oh the radiotherapy, when I went 
up to my, the bedroom and stayed there, I didnae get oot till I 
was going back for more radiotherapy and then after I was 
finished, I must have been up the stair a week, at least a week 
before I came back doon – awful, no reading the paper, no 
watching television – nothing, I just couldnae be bothered 
doing anything ... I would really say that, that was a really 
horrendous period, terrible, absolutely terrible ... (Richard, 
interview 2, page 13).  
 
The profound distress experienced by Richard after his radiotherapy 
treatment is evident.  His narrative suggests that the concurrent 
symptoms that he was experiencing at this time were so severe that 
he experienced a total loss of sense of self and this is intimated by 
the way that he stated „my body was blank, so was my mind‟.  There 
is an underlying sense that this experience traumatised Richard as he 
no longer recognised himself and feared what would happen to him 
as a consequence.  In response to such events, Richard hid himself 
away in his room doing very little, and there is a sense that he 
stayed in there, waiting for his sense of self to return.   
 
Emily had similar recollections to Richard and in her interview 
described how her sense of self was severely compromised when she 
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underwent radiotherapy treatment.  During this time, she 
experienced concurrent symptoms which caused significant 
debilitation, resulting in her barely managing to perform the most 
basic activities of daily living.  The profound tiredness that she 
experienced due to her treatment is apparent, and this appears to be 
exacerbated by the other concurrent symptoms that she is 
experiencing, such as sickness and feeling depressed.  Of pertinence 
to this thesis is the way that she states that she felt as „if my body 
wisnae my own‟ which implies that her body was unfamiliar to her 
due to the impact of her symptoms upon her self.  There is an 
underlying sense that Emily felt that if such episodes were transient, 
and not constant, then she would have been less distressed by these 
events in her life.   
 
Roma: What was the tiredness, how would you describe it 
when you were … ? 
Emily: Well, I just felt, as if my body wisnae my own and 
night was coming into day … if I could come to myself for a wee 
while in between, but it was more like, I had a, I mean I wis 
sick … I just wanted to sleep all the time and I think that was 
depressing me, because I was hoping that when I got the, the 
chemotherapy, the rad., the radiotherapy, sorry … that eh, I 
would got there and get it and come back and that'd be it till 
the next time … (Emily, interview 1, page 73). 
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Such findings are further elaborated in the following quote by Emily, 
when she explained why she felt her „body wisnae my own‟ during 
such times: 
 
Roma: Em, and you described, described, when you were 
talking about that, you said it‟s as if your body‟s not your own,  
Emily: Uh huh, uh huh   
Roma: Can you just explain a wee bit more about …    
Emily: [slight pause] Eh, well I think it‟s because you, 
you‟re find, you‟re finding it quite difficult to do a lot of the 
things, or most things, because all you want to do is try and 
sleep and even if you‟re not sleeping you just feel drained, you 
don‟t, you don‟t want to, or you don‟t feel that you‟ve got to 
get up, it‟s an effort to go to the toilet.  I don‟t know what 
makes you feel like that.  Apart from your getting the 
radiotherapy, I don‟t know, I don‟t know what part oh it makes 
you feel like that, luckily again, it disnae last forever. 
Carer: It wis every day for a month, a month though, 
wis'nt it? 
Emily: Mm hmm. 
Carer: So it takes a lot out you, going away into the [place 
name] all the time and coming back and, every day ...   
Roma: Yeah. 
Emily: Oh, I suppose all these things, they just, that‟s 
what I mean, you don‟t feel like yourself.  Sometimes I often 
wonder if I ever will feel myself years ago, I really don‟t know 
whether [laughs], eh, I would know how I felt for years to go 
for me, if it came and hit me in the eye … (Emily, interview 2, 
page 56). 
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In the first instance, the unfamiliarity of her body at such times 
appears to be due to the incapacitation that Emily‟s multiple 
symptoms create, which make even the most basic of physical 
functions such as going to the toilet an effort.  Within the quote, it is 
also apparent that Emily tries to find some comfort in what is 
happening to her by reassuring herself that such episodes do not last 
forever and that they are to be expected due to the frequency and 
duration of her radiotherapy treatment.  However, the remorse and 
sadness which accompanies such experiences is evident, and this 
appears to be primarily due to her fear that she may never regain her 
sense of self again.  Such feelings were of particular pertinence to 
Emily, as throughout her interviews she talked about looking forward 
to „the good bits‟ - the short periods in her life when she could live 
without the burden of illness and feel more like herself „from within‟:    
 
Roma: And, and what do you mean by that when you say, 
you know, „start getting more like yourself‟, can you explain a 
wee bit about what that means? 
Emily: Well, I'm more like myself from within … that‟s, 
that‟s part oh it over.  Eh, and now I can get into the good bits, 
the wee times, the short times I've got in between something 
else cropping up and you‟re no looking for around the corner 
'cause you not ... you just think you‟re grateful to feel better 
and you just want to try and do a wee bit more things that you 
couldn‟t do when you were unw., when you felt unwell.  
Sometimes that disnae last for very long and then something 
else comes along… (Emily, interview 2, page 3).  
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This quote illustrates the pattern of illness in Emily‟s life – the bad 
times followed by the good.  The liberation offered by the „good bits‟ 
is evident and appears to have resulted in Emily living a less 
restricted life and being able to do things that she couldn‟t in the 
past.  Linked to this is her perceptions of her sense of self at this 
time; feeling „more like myself from within‟ suggests that her sense 
of self was regained in absence of symptoms of high severity, when 
she was able to recognise her body once again.  The quote also 
suggests a link between the body and wellbeing; the more that Emily 
recognised her body, the better she felt.   
 
The previous section presenting the sub-theme of „The impact of 
symptom clusters on the self‟ has demonstrated the core role that 
the experience of symptom clusters played in the loss of sense of self 
experienced by the participants.  Of particular interest to this thesis, 
is the way that despite the participants experiencing several 
concurrent symptoms at this time, most of their dialogues 
surrounding their loss of sense of self, focused only on one symptom.  
This symptom in particular appeared to be sentinel to their 
experiences of loss of sense of self, due to its significant impact on 
the individual‟s level of functioning which in turn limited any activities 
that they could undertake.  It also illustrated the role of the body in 
relation to the concept of the self, how at times when the participants 
 238 
 
experienced concurrent symptoms of high severity, their body, which 
they had become accustomed to, became unfamiliar, which in turn 
severely compromised their sense of self at this time.    
 
Related to the loss of sense of self experienced within the context of 
the experience of symptom clusters was also the way that many of 
the participants talked about how they felt they were a burden due to 
the dependency that their multiple symptoms created on others.  
This link is presented in the following section which details the theme 
of „Being a burden‟.   
 
9.3  Being a burden 
According to Charmaz (1983), being a burden „essentially involves 
becoming more dependent and immobilized‟ and „follows closely upon 
loss of hope and loss of recapturing positive self images of the past‟ 
(Charmaz 1983:118). 
 
Apparent in many of the participants‟ interviews were feelings of 
being a burden due to the symptom clusters that they were 
experiencing, as they now relied on their carers to undertake many of 
the functions and roles that they themselves occupied in the past.  
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Inbuilt in many of their dialogues were feelings of frustration, as they 
wanted to maintain these roles but couldn‟t.   
 
Feelings of being a burden were of particular importance to some of 
the female participants.  Their inability to maintain traditional roles 
such as cooking and cleaning due to the multiple symptoms that they 
were experiencing often resulted in their male partner taking on 
these duties.  This in turn manifested itself in feelings of guilt and 
being a burden as they felt that it was their duty in their marriage to 
carry out these roles.   
 
This finding is demonstrated in the following quote by Jessie who was 
significantly debilitated by the multiple symptoms that she 
experienced such as breathlessness, lack of appetite, hair loss, 
fatigue, nocturia, headache, pain, constipation, and insomnia.  In the 
following quote, she talks about how her husband now does all the 
housework and the guilt that she feels as a consequence of this: 
 
Roma: I mean, you‟ve mentioned feeling guilty, just, you 
know a couple of times there ... 
Jessie: Uh huh, aye. 
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Roma: ... em, if you don't mind can you tell me why, why 
you think you feel guilty?  Can you explain that a wee bit more 
to me? 
Jessie: I think it‟s just in my nature to be like that, em ... I 
would think, wouldn‟t it?   
Carer: Aye, you just feel that you should be dain these ...   
Jessie: I just feel I should be ... aye, I should be ... aye, I 
should be, it was like ... it, I mean even before I was ill in any 
way eh, I wouldnae lie in bed long – no because I had to get up 
for anything, I would have felt guilty if I had lain and I mean – 
that‟s daft, that‟s, that‟s crazy, but I would say oh no, I better 
get up, that‟s no good lying in your bed ... aw, aw naw you 
cannae dae that, but I think it‟s ... as I say it‟s just in my 
nature, I just ... I see [name of husband] doing this housework 
and I know I should be doing it; if I was able I would it, but eh 
... that kind of thing it makes me ... I feel guilty, I really do.  
That‟s awright for a couple oh weeks but when it goes on and 
on it‟s ... it‟s quite, you know, quite a bit, but as I say I think 
it‟s just, a lot oh my make-up [personality] is like that em, I 
would feel guilty anyway [laughs] ... eh ... I don't know ... I 
don't know why else I should feel guilty aboot it, but I do and 
that‟s just daft, 'cause [name of husband] does ... I know 
[name of husband] disnae mind doing it fur me, he's no doing 
it wi' a grudge ... 
Carer: No, I ... 
Jessie: ... he's doing, he does it quite willingly but if it was 
somebody that was doing the thing and was really ... you know 
didnae want to do the ... you know and let you know they 
didnae want to do it ... well that would be ... that would be 
terrible, I couldnae live like that no ... I couldnae ... [laughs] ... 
I couldnae live like that, but ... you wonder how folk get on 
that are on their own ... (Jessie, interview 2, pages 27-28).   
 
In the above quote, Jessie appears to be upset at her dependency on 
her husband because it is not in her „nature‟ to act in her way.  There 
is an underlying sense that she feels that her incapacitation has been 
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forced upon her, and she is angry at this, as she can no longer fulfil 
her role as a wife.  She appears to try and salvage a sense of the 
person she was in the past, by reflecting on the active person she 
was before her illness, and she appears to find comfort in this, 
reassuring herself that she in not acting in this way based on her own 
volition.  There is also a sense that the guilt she feels as a result of 
her husband now undertaking many of her roles is worsened as it is 
now a constant occurrence with her progressing condition.  However, 
her feelings of guilt at the same time appear to be diminished as she 
feels that her husband does not grudge helping her but does it 
willingly.  Her use of social comparison also helps Jessie reflect on 
her circumstances and come to the conclusion she is better off than 
others in a similar condition.   
 
Linked to such findings is also the way that some of the male 
participants tried to minimise the burden of their cancer on others by 
concealing the multiple symptoms that they were experiencing.  Of 
relevance to these male participants was the way that they often 
talked about their family in their interviews and described how, as a 
father, they felt that their main role was to provide for them and 
protect them from any harm.  The quote from Richard below best 
exemplifies this finding:   
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Richard:  … I‟ve just been positive the whole way through, 
obviously for my family as well, don‟t let them see, don‟t get 
me wrong there‟s been days when I‟ve been really down 
wakening up in the morning and coughing and spluttering and 
getting up and being breathless, I didnae let them see me like 
that I let them see the jolly side and they‟ve seen that the 
whole way and it‟s helped them, it‟s helped my family … 
(Richard, interview 1, page 5).  
 
Throughout his interviews, Richard talked a lot about how he had 
adopted a positive attitude and how this had helped him cope with 
his illness.  To him, being positive had some therapeutic benefit 
which he felt helped in his fight against cancer.  However, from the 
quote above, it is evident that the adoption of a positive attitude had 
another meaning for Richard.  To him, being positive was also a way 
of concealing the myriad symptoms that he was experiencing from 
his family, often to the detriment of himself.   
 
The above findings have described the profound loss of sense of self 
experienced by the participants due to the symptom clusters that 
they were experiencing.  It has also described how this loss of sense 
of self experienced by the participants was closely followed by 
feelings of being a burden to others.  In an attempt to try and adapt 
to this loss, the following section details the third sub-theme „Trying 
to maintain a coherent and valued self‟.  This sub-theme describes 
the strategies that the participants employed to try and recapture 
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some element of their past lives and build their self esteem in light of 
their sense of self being compromised due to the symptom clusters 
that they were experiencing.   
 
9.4  Trying to maintain a coherent and valued self 
As stated above, this section of this thesis describes the strategies 
used by the participants to cope and adapt to the loss of sense of self 
that they experienced as a result of the symptom clusters that they 
were experiencing.  It details how many of the participants used the 
process of downward social comparison to reassure themselves that 
there were people who were worse off than them in the world.  The 
section also illustrates how many of the participants strived for 
normality, to capture elements of their life that were at threat or had 
been lost. 
 
9.4.1  Comparing themselves to other people with cancer 
Within the experience of symptom clusters and loss of sense of self, 
many of the participants used a strategy of downward social 
comparison in order reassure themselves that there were others who 
were worse off than them.  This strategy appeared to help them build 
self esteem and create positive perceptions of themselves.   
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The types of social comparisons made by the participants appeared 
to be influenced by their gender.  For the female participants, the 
comparisons that they made were often between themselves and 
people who were younger than them.  This may in part have 
originated from the natural female instinct to protect their young.  
This is best illustrated in the following quote by Jessie who talked 
about how she felt sorry for „these young folk‟: 
 
Jessie:… you never ever sort of imagined you'd get to that 
stage and yet I mean, at the same time I say to myself you‟re 
s…, I'm only 71, so I thought well, you‟re lucky, I mean there's 
some young folk don't get to 21, by God, and they have cancer, 
that‟s the ones I really feel sorry for.  I mean I feel, I've had a 
life ... you know, and we‟ve, we‟ve done lots oh things haven‟t 
we, been lots oh holidays and had good times and I don't 
regret anything at all.  Em, but these young folk ... oh, I think 
that‟s awful sad, really terrible that they, they‟ve no had any 
life at all and they're going through aw this, you know ... 
(Jessie, interview 1, page 7).  
 
In the first instance, it is evident that being in such an incapacitated 
state was never in Jessie‟s anticipated life biography.  There is an 
underlying sense of sadness and at the same time shock that she had 
come to a stage in her life when she could no longer undertake many 
of the roles and activities which she had become accustomed to in 
the past.  Although she was 71, there was a sense that Jessie felt 
that she was too young to be in this incapacitated state and had lots 
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of things in life that she still wanted to do.  In order to cope with 
such thoughts, she used the process of downward social comparison 
and compared herself to younger people who had died of cancer, 
stating that she had at least „had a life‟.  This, in turn, appeared to 
make Jessie reflect on her life and find comfort in her conclusion that 
she had had a good life.   
 
In contrast to Jessie and some of the other female participants, the 
male participants in this study appeared to use social comparison in a 
different way in a bid to recapture their sense of self that had been 
fractured due to the symptom clusters that they were experiencing.  
The male participants would often compare themselves to other 
people with chronic illnesses, and focus on their physical attributes, 
commonly coming to the conclusion that they were fitter and better 
than them.  This is exemplified in the following quote by Dan when 
he described a time when he was in hospital and compared himself to 
other people with cancer who were in his ward: 
 
Dan:  I've had my eyes opened in the last year, when you‟re 
looking aboot you, I mean I was lying in, I ended up in a ward 
after the biopsy eh, six oh us and I can assure you I was the 
healthiest oh the six and I'd just come oot an operation so 
when you‟re looking aboot yae, yae keep saying to yoursel – 
I'm no bad and I always say that tae, cause there's always 
somebody worse just next tae yae, and I mean you get into 
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they, you get the em, clinics in [name of hospital].  Pre-ch…, 
pre-chemo clinics if you like and you‟re looking roond aboot you 
and you‟re saying to yourself – my God like, you know and I'm 
complaining … (Dan, interview 1, page 17).  
 
The above quote highlights how this was a new experience to Dan 
and one that he had not encountered in his life before.  This, in turn, 
may explain why there is a sense that Dan was scared at what he 
saw around him and why he felt the need to convince himself that he 
was different from the rest.  It is evident that he came to the 
conclusion that he was „the healthiest‟ patient in the ward, based only 
on the outward physical appearance of the others.  He may have 
done this because it was the only information that was available to 
him with which to make such comparisons.   When claiming that he 
was the fittest, he tried to convey to the researcher that there was no 
doubt in his mind that this claim was true.  However, there is an 
underlying sense that he actually did this to convince himself that his 
claims were true as well. 
 
Paul appeared to adopt a similar strategy in trying to maintain a 
coherent and valued sense of self.  Like Dan, he based his social 
comparison on the visibility of the outward physical attributes of 
others: 
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Paul:…you say to yoursel, “God‟s sake,” you know, and you see 
other people and they're infirm and they cannae walk and 
they‟ve got amputees up there on that ward as well and, I'm 
like that, there is a bit oh hope for me, well there's hope for 
them as well, but some oh them cannae handle it, you know 
and you hear a wee wuman she's greeting during the night and 
I says “Who‟s that, is that a wuman‟s voice?”  „Cause this other 
guy was, “Aye she, she's doon in another ward there, she 
cannae accept that she's loast her leg, right” … (Paul, interview 
1, page 11). 
 
In the process of downward social comparison, of interest is the way 
that Paul viewed people with obvious physical impairments as being 
worse off than himself, despite being diagnosed with a terminal 
illness.  When related to the feelings of stigma expressed by the 
participants in the previous chapter on „The lived experience of 
symptom clusters and the role of context and meaning‟, it may be 
inferred that Paul viewed these conditions as being worse as they 
were overtly visible and his cancer was not – it was hidden.  Such 
findings may also be related to the following section on the role of 
„normality‟, where Paul talked about how he commonly bracketed off 
thoughts of cancer in order to cope with his illness.  It may be 
proposed that if he had outwardly visible manifestations of his 
disease then it would have made this process of achieving normality 
much harder.   
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As well as using the process of downward comparison in an attempt 
to regain their sense of self which had been compromised due to the 
symptom clusters that they were experiencing, many of the 
participants also spoke about how they strived to achieve a sense of 
„normality‟ in their lives.  To most, normality described the state of 
their lives before they were diagnosed with cancer.  Accessing parts 
of „normality‟ appeared to assist the participants in their attempt to 
try and regain a valued and coherent sense of self.  This is detailed in 
the following section. 
 
9.4.2  Normality   
Many of the participants talked about „normality‟ in their interviews.  
For most this was a term that they used to describe the states of 
their lives prior to being diagnosed with lung cancer.  The main 
reason that the participants appeared to strive to access normality 
was to regain a sense of the person they were before their illness.  
For many, normality was reached when they could undertake roles 
and/or activities that they were accustomed to in the past – many of 
which had been fully or temporarily compromised due to the 
symptom clusters that they were experiencing.  What was also 
apparent was the evidence of feelings of positivity and wellbeing 
which accompanied such times when they could access elements of 
their „normality‟.   
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Some of the participants accessed normality, by „bracketing‟ the 
impact of their illness on their lives.  According to Bury (1982), 
people do this in order to cope with their illness so that its effects on 
the person‟s sense of self remain relatively slight.  For two of the 
participants, Paul and Flora, their striving for normality had much in 
common with the above.  Paul, in the following quote, talked about 
how he tried to not to think about cancer: 
 
Paul:  I don't really think aboot cancer noo, I just put it tae the 
side, it‟s something that I've got and I don't think aboot it till I 
need tae get medication or something like that, that‟s the only 
time I think aboot the cancer, other than that I just have a 
normal day, because I believe if I had to go the other way and 
out on a negative thing, well … you‟re only going tae depress 
yoursel, you'd sit in the house and wouldnae go out … (Paul, 
interview 1, page 2). 
 
Paul appeared to try and live a „normal‟ day by bracketing off 
unpleasant and unwanted thoughts regarding his lung cancer.  His 
dialogue suggests that he did achieve this state of normality most of 
the time.  However, this appeared to only become problematic when 
he had to take medication, implying that when he experienced 
symptoms he found it hard to erase the reality of having cancer from 
his conscious thought.   
 
 250 
 
As previously stated, for many of the participants, a return to 
normality was signified by being able to do things they were 
accustomed to in the past.  What were also evident were the feelings 
of wellbeing and positivity that accompanied this return to this state.  
This is best exemplified in the quote below by Suzie who expressed 
overt joy at feeling well again.  Such heightened feelings may, in 
part, have stemmed from the extreme fatigue that Suzie experienced 
when receiving treatment, which prevented her from performing even 
the most basic of tasks.  In light of such experiences, Suzie appeared 
to re-evaluate her life, resulting in an appreciation of the simple thing 
in life that she once took for granted: 
 
Roma: And when you, you know you were saying there it‟s 
good to feel well again ...   
Suzie: Mm hmm ...  
Roma: ... can you describe ...   
Suzie: Just I can do things now, do things about the house 
and go for a walk, go round shops, go out in the fresh air, just 
... trying to get back to normal. 
Roma: Oh, and ... but when you say normal ... what do 
you, what, what do you mean by that?  What, what's normal to 
you? 
Suzie: Just feeling well and being able to do things, you 
know ... the simple things in life! – like going for a walk, mmm 
mmm ... 
Roma: And how do you feel being able to do these things 
now?   
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Suzie:  I think it‟s great, I think it‟s wonderful, I really do think 
it‟s wonderful (Suzie, interview 1, page 4). 
 
Similar feelings of joy were also expressed by Emily who talked about 
how she could cope better on the days that she didn‟t have to go to 
the hospital.  The days when she could, at least for a short period of 
time, live a normal life and do normal things.  Of interest was the 
way that Emily described how she dipped in and out of normality, and 
used the metaphor of „being put on a roundabout‟ to describe this 
feeling.  The „roundabout‟ was used to describe how periods of feeling 
good and accessing normality were often cut short by planned 
hospital appointments and procedures, which brought the reality of 
her illness back to the fore.  She also spoke of the anger that she felt 
towards the dizzy turns that she was experiencing, which from all of 
the concurrent symptoms that she was experiencing at that time, she 
directly attributed as preventing her from accessing the little 
normality that she had left in her life: 
 
Roma: ... last time you spoke about your dizzy turns and 
you were saying that you felt angry about it ... 
Emily: Mm hmm... 
Roma: If you don‟t mind could you just explain, why you 
described it in that way? 
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Emily: It was because that affects my life again.  Because 
again, I've to try and find another way to get a way around it, 
from day to day, because the dizziness is keeping me back 
from the wee bit normality I've got.  I've got tae, this is 
something else that‟s eh, coming into my life that I don‟t want 
it to be there.  I just want it away out my life for good, no just 
for a couple of weeks, and so far I cannae get it to find out 
what‟s causing it, so I think that‟s why I'm angry, again, it‟s 
nobody‟s fault, just me I get browned off, maybe that‟s the 
word, and that‟s what makes me angry … [pause] … It‟s funny 
'cause I'm, you just, I mean, I don‟t know, again, these things 
are only human I think, people that have, that have, live a 
normal life they get browned off as well if something goes 
wrong that‟s keeping them off their daily routine, you know 
what I mean, so, that‟s just something again that goes along 
wi' different things, only I think at time, I just get too many oh 
them, to get browned off with and that‟s why I get angry.  
That‟s all (Emily, interview 2, page 14).   
 
The heightened anger that Emily felt towards her dizzy turns is 
evident, and this appeared to be due to this symptom in particular 
from all the rest she was experiencing preventing her from accessing 
the little periods of normality that she had left in her life.  There is an 
underlying sense that she felt that if she could get rid of this 
disruptive symptom for good, then her periods of normality would 
last longer.  However, she appeared to feel frustrated as she couldn‟t 
find out what was causing her symptom and therefore could not 
source ways in which to manage it.  Throughout the excerpt is a 
sense that Emily felt that she was a victim of her illness and this may 
have been due to the feelings of low self esteem and worthlessness 
that she expressed at other times in her interviews.  Linked to such 
negative perceptions of herself was the way that Emily tried to 
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salvage some positive images by implying that her reaction was to be 
expected and that anyone else in the same position would have acted 
in a similar way.   
 
9.5 Conclusion 
This chapter has demonstrated the core role that the experience of 
symptom clusters played in the loss of sense of self experienced by 
the participants as they prevented them from undertaking many of 
the roles/activities that they had been accustomed to in the past and 
in which they had built positive self images upon.  For many of the 
participants, despite experiencing multiple symptoms at this time, 
symptoms such as fatigue and breathlessness appeared to be of 
significant salience to them due to their direct impact on their level of 
physical functioning.  For some, their loss of sense of self was most 
profound at times when they experienced concurrent symptoms of 
high severity, which resulted in the participants no longer recognising 
themselves and viewing their body as something that was „alien‟ and 
unfamiliar to them. 
 
The findings have also demonstrated how being a burden closely 
followed on from the loss of sense of self experienced by the 
participants due to the symptom clusters that they were experiencing 
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and the heightened feelings of anger, guilt, frustration and distress 
which often accompanied this.  The chapter has also illustrated the 
strategies employed by some of the participants to try and 
intentionally hide the multiple symptoms that they were experiencing 
from their loved ones, in an attempt to try and protect them from the 
burden of their illness.   
 
The results presented in this chapter have also highlighted how the 
participants, when faced with a threat to the self, due to the 
symptom clusters that they were experiencing, mobilised resources 
to try and maintain a coherent and valued sense of self.  This 
included using strategies such a downward comparison and striving 
for normality, the state of their life before being diagnosed with lung 
cancer. 
 
With reference to this thesis and the study of symptom clusters in 
patients with advanced lung cancer, the results of this chapter have 
demonstrated that the experience of symptom clusters in patients 
with advanced lung cancer is not simply reflective of the physical 
manifestation of the symptom experience, but has far reaching 
consequences on an individual‟s life and sense self.  The results of 
this chapter have demonstrated how complex the experience of 
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symptom clusters in patients with advanced lung cancer is, impacting 
on the individual within the context of their life in a number of ways.   
 
Such findings highlight the need for studies exploring the concept of 
symptom clusters in patients with cancer, not to ignore, but to 
recognise and address this complexity.  Having presented the 
findings pertaining to the super-ordinate theme of „Symptom clusters 
and loss of sense of self‟, the following chapter will follow on from 
this and discuss the findings of this study relative to the research 
questions asked and with reference to the wider literature and, in 
doing so, will make recommendations for future research and 
practice.   
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Chapter 10 Discussion 
 
10.1 Introduction 
This chapter discusses the findings of this study in relation to the 
research questions posed in this thesis and the wider literature.  Based 
on the new information generated by this study, it will be postulated 
that the study of symptom clusters in patients with cancer, with its 
reductionist approach to measurement, needs to widen this approach, 
to one that encompasses the central elements of the patient experience 
of this phenomenon, and therefore recognises the influential roles that 
context and meaning play.  
 
This discussion of the results presented in this thesis pertaining to the 
study of symptom clusters in patients with cancer, will be followed with 
recommendations being made for future research and clinical practice, 
before a conclusion to this thesis is made.  However, prior to these 
findings being considered, it is important to discuss the strengths and 
limitations of this study.  In line with the selected methodology (IPA), 
and akin to Chapter 1 (Introduction) and Chapter 4 (Methodology), the 
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strengths and limitations of this study will be discussed using the first 
person.   
 
10.2 Strengths and limitations of this study 
I feel that the main strength of this study is the homage that it pays to 
the role of the experiential expert – the patient, an integral element of 
the study of patients with cancer, who has largely been neglected in 
symptom cluster research to date.   
 
I demonstrated this patient focus with the qualitative approach I 
employed in this study, which, in comparison to quantitative 
approaches, did not attempt to reduce the patient experience to 
objective data explained using statistical associations, but aimed instead 
to capture the patient experience of this phenomenon in all its reality 
and complexity.  This patient focus was further strengthened by my 
selected methodology, IPA, with its idiographic focus and commitment 
to understanding the lived experience of the individual within the 
particular context of their life world (Smith et al. 2009a:29).  My choice 
to use unstructured interviews as a method of data collection further 
added to this patient focus.  As discussed in chapter 7, my choice to use 
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unstructured interviews was based on my review of the literature (see 
chapter 3) and my observation that the concept of symptom clusters 
within the discipline of cancer nursing and the associated definitions 
currently used had not been developed inductively and therefore, it may 
be argued, might represent the viewpoint of the researcher and not the 
patient.  I therefore wanted to inductively elicit what the lived 
experience of symptom clusters in patients with advanced lung cancer 
was, and I felt that they only way to do this was to ensure that I did not 
introduce any predefined concepts, but to allow people who were 
experiencing symptom clusters to openly talk about issues that they felt 
were of salience to them within their lives.  This unstructured approach 
in the exploration of cancer related symptoms that have been argued to 
be poorly defined, such as fatigue, for example, has been previously 
reported in the literature (Magnusson et al. 1999; Glaus et al. 1996). 
 
In order to ensure that I explored the phenomena of symptom clusters 
using this unstructured approach, if at any time the patient mentioned 
any symptoms within their experiences, I always probed, asking them 
to elaborate in greater detail about their experiences, particularly at 
times when they experienced multiple symptoms, noting whether or not 
they perceived any of the characteristics of symptom clustering evident 
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within current definitions and the literature.  Furthermore, in line with 
my selected methodology (IPA) with its focus on cognitions, when the 
participants talked about their symptoms, I asked them to tell me what 
they were thinking at that time, what was going through their minds, 
and how they felt, in order for me to comprehend how people with 
advanced lung cancer experiencing multiple, concurrent symptoms 
perceived their symptom experiences, and whether any commonalities 
existed between their perceptions of their multiple symptoms and what 
the current evidence base pertaining to the concept of symptom clusters 
in patients with cancer suggests. 
 
It could be argued that using a more structured approach, directly 
asking the participants their perceptions of symptom clusters, may have 
provided more focused data relative to the experience of symptom 
clusters in patients with advanced lung cancer.  However, I felt that 
asking patients to talk about their experiences of symptom clusters 
would have been problematic, as this term is not recognised within lay 
accounts, and asking people to directly talk about phenomena that they 
are not familiar with appeared to be inappropriate.  Furthermore, if a 
more focused approach had been used, I felt that I ran the risk of losing 
the essence of the inductive approach that I intended to use with IPA by 
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introducing characteristics of a concept that had been predefined by 
researchers, and one that may have influenced the way that the 
respondents replied to the questions posed.   
 
In line with this unstructured approach was also my choice to ask the 
question at the start of the first interview, „what does cancer mean to 
you?‟  The decision to ask this question was made for a number of 
reasons.  As discussed above, I could have asked the respondents a 
direct question about symptom clusters, but based on the inductive 
nature of my study, the lack of recognition within lay accounts as to 
what a symptom cluster is and the risk of influencing the respondents‟ 
responses, I chose not to take this line of questioning.  In cognisance of 
the factors previously cited, and taking into consideration my 
epistemological stance and the methodology selected (IPA) (see chapter 
4), I felt that it was appropriate to open the interview with a question 
which focused on meaning.  This type of questioning, focusing on 
meaning, is common in studies employing IPA, based on its appreciation 
of the central role that cognitions play in the lived experience (Smith et 
al. 2009a) and has previously been used in studies exploring the 
symptom experience of patients with cancer (Magnusson et al. 1999).  
Furthermore, there is an abundance of literature that demonstrates the 
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core role that meaning plays in the illness experience (Thorne 1999; 
Johnson Taylor 1995; O'Connor et al. 1990; Kleinman 1988a; Good and 
Good 1980; Mishler 1979; Frankl 1959), and it‟s relevance to the 
symptom experience (Krishnasamy 2000; Ferrell and Dean 1995; 
Kleinman 1988a; Good and Good 1980).  Moreover, I also felt that this 
approach took into consideration the viewpoints of seminal authors 
within the area cancer symptom research, who view symptoms as not 
being simply a „reflection of the disease‟, but as representing the 
meaning that the illness holds for the individual (Kirkmayer et al. 1994; 
Tishelman et al. 1991).  This point is characterised in the following 
quote by Dan: 
 
Dan:  See if I could breathe, I'd be perfect within myself – 
perfect (Dan, interview 2, page 52).   
 
Relative to the study sample, limitations include the high rate of 
attrition, with three patients dying before the second interview could be 
conducted.  It therefore may be questioned whether having reduced the 
time between interviews may have prevented such levels of attrition. 
However, as previously stated, I felt that this issue was common in 
conducting research in people with advanced cancer (Harris et al. 2008) 
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and therefore, changing the timing of interviews would not prevent this 
level of attrition and may, in fact, have resulted in the overburdening of 
the frail patient population selected.  Furthermore, it has to be 
acknowledged that all the participants in this study did have advanced 
lung cancer, and therefore it may be argued that patients with less 
advanced disease may have provided a different perspective of the 
experience of symptom clusters within their lives.   
 
With regard to the study sample, the number of patients recruited to 
this study, whilst being the upper limit advocated for studies employing 
IPA (Smith et al. 2009a), is small, and therefore limits any 
generalisation of the findings to a wider patient population.  
Furthermore, the participants in this study were only recruited from one 
clinical site in Scotland, and this may further limit any generalisations 
made.  Whilst it is openly acknowledged within the literature and in this 
thesis that the results of an IPA study „represent a perspective rather 
than a population‟ (Smith et al. 2009a:49) and that the findings are 
therefore held to be local to the patient population recruited, it may be 
argued that the high level of consensus between the participants in this 
study and transferability of the study findings to the wider theoretical 
and empirical literature (see section 10.3 that follows), provides 
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evidence to substantiate these tentative findings, and warrant their 
further exploration in a wider patient population.   
 
A further consideration is that a more comprehensive understanding of 
the experience of symptom clusters in patients with advanced lung 
cancer may have been achieved if a mixed methods approach had been 
used (Burke, Johnston and Onwuegbuzie 2004).  It is contended that 
this combination of both qualitative and quantitative approaches within 
a study allows the strengths and weaknesses of each component to be 
„offset‟ to draw on the overall strength of the study (Bryman 2006).  
Furthermore, the different approaches used can be argued to have the 
ability to answer different research questions providing a more 
comprehensive understanding of the phenomena under investigation 
and provide the means of recruiting a wider sample of patients in which 
to draw conclusions from (Bryman 2006).   
 
However, it has been highlighted within the literature that using mixed 
methods within a study is not merely a case of joining quantitative and 
qualitative approaches, and a number of researchers have highlighted 
the challenges in the adoption of this approach (Pope and Mays 1995).  
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Furthermore, there remains debate in the literature as to whether both 
methodologies can be successfully integrated.  A recent literature review 
of mixed methods papers found that the majority of those papers 
reported qualitative and quantitative results independently of one 
another (O'Cathain et al. 2008).  Moreover, a number of researchers 
have noted the challenges of combining qualitative and quantitative 
approaches due to the differing epistemological and ontological 
perspectives inherent to each (Bryman 2007; Wendler 2001).   
 
However, whilst acknowledging the potential utility of using a mixed 
methods approach in this study, I contend that taking into account my 
aim, to inductively explore and understand the  experience of symptom 
clusters in patients with advanced lung cancer, using qualitative and 
quantitative methods in an investigation such as this, might have 
limited the depth of data collected (Driscoll et al. 2007).  Furthermore, 
it has been postulated by Krishnasamay (2000) that „Without securing 
meaning before measurement, it is unlikely that an instrument will 
provide data which can contribute to an understanding of how the 
phenomena under investigation impact on the lives of the participants 
and what factors exacerbate or relieve it‟ (Krishnasamy 2000:411).  
Therefore, taking into account that lived experience of symptom clusters 
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has not previously been explored, and therefore the meanings that such 
experiences hold for the person experiencing this phenomena have not 
previously been elucidated, I felt that it was inappropriate to use an 
approach that would attempt to measure a phenomenon that is poorly 
defined and one that has not previously been explored from a patient 
experience perspective.  Therefore, taking these factors into account, I 
felt that a qualitative methodology was the most appropriate approach 
to capture in depth the lived experience of symptom clusters in patients 
with advanced lung cancer and thus address the aims and research 
questions posed for this study.   
 
It may also be contended that other qualitative approaches, instead of 
IPA, may have been more appropriate to explore the lived experience of 
symptom clusters in patients with advanced lung cancer.  As discussed 
in chapter 4, based on my epistemological beliefs (contextual 
constructionist), a number of methodological approaches were 
considered in light of the aim of my study and the research question 
posed.  These included Social Constructionist version of Grounded 
Theory, Discourse Analysis and IPA (Willig, 2001).   
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Whilst the Social constructionist version of Grounded Theory was an 
„attractive‟ methodology to explore the lived experience of symptom 
clusters in patients with advanced lung cancer, it was not selected as 
this methodology was primarily developed to theorize social processes 
and to answer sociologically derived questions (Charmaz 2000).  
Furthermore, its suitability to answer research questions regarding the 
meaning and nature of the lived experience has been questioned (Willig, 
2001) with some advocating the use of phenomenological types of 
inquiry for this.  Discourse analysis was another methodology which 
may have been appropriate for use in this study.  Whilst this approach 
offers a sophisticated understanding of the use of language, I felt that 
its sole focus on language and its dismissal of the role of cognitions, 
limited its ability to address the aim and research questions posed in 
this study.   In order to explore and understand the lived experience of 
symptom clusters in patients with advanced lung cancer, I felt that it 
was important not only to focus how people talk about a phenomenon, 
but also to understand what they think about it and why.  Therefore, I 
felt that it was important that the role of cognitions had to be central to 
any methodology that I adopted for use in my study and I felt that 
Discourse Analysis did not encompass this. 
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IPA, as opposed to the other methodologies which are consistent with a 
contextual constructionist approach, was selected for this study based 
on its phenomenological origins and focus on the lived experience of the 
person in the context of their own life   Furthermore, IPA highlights and 
pays homage to the role of cognitions within the lived experience, 
deeming this to be central to understanding how people understand and 
make sense of their experiences.  Based on these two central 
components of IPA, I felt that this methodology was the most 
appropriate to address the aim of this study which was to explore and 
understand the experience of symptom clusters in patients with 
advanced lung cancer.  Furthermore, this methodology had not 
previously been used in studies of symptom clusters in patients with 
lung cancer, and therefore had the potential to elicit new insights into 
the phenomena being explored. 
 
Relative to the method of data collection selected and the sensitivity of 
the research topic as described in chapter 6, some of the participants 
did become tearful during their interviews.  This commonly occurred 
when they talked about the losses that they had experienced since 
being diagnosed with lung cancer.  At such times, the participants were 
given the opportunity to end the interview, but all declined.  However, 
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after such events, in order to prevent any further upset, I did feel wary 
of probing any sensitive issues that were raised in fear of causing the 
participant any further upset, and this may in turn have limited the data 
collected and therefore the research findings to some extent. 
 
Another potential limitation of this study was that although most of the 
participants were interviewed alone, two of the participants asked if 
their partners could sit in on the interview, which I felt that I had to 
allow on ethical grounds.  This led to me having to address the impact 
that this might have on the data collected and its subsequent analysis.  
From the related literature, issues such as intrusion, inclusion, power 
and differences in opinion had been reported in joint interviews (Morris 
2001; Askey 1996).  However, Morris (2001), reporting on her 
experiences of using joint interviews in the cancer context, found that it 
did not appear to inhibit participants when discussing sensitive topics, at 
times provided a fuller account of their experiences, and was acceptable 
to them.  A similar experience was found in this study during the 
interviews, that the presence of the partner did not appear to inhibit the 
interview process and, in line with Morris (2001), appeared to enhance 
the interview process.   
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Relative to the interviews conducted with the participants in this study, 
the temporal nature of the interviews needs to be considered in light of 
the phenomena under investigation and the advanced nature of the 
participants‟ disease.  Whilst interviews are regarded by most as being 
the „staple means of data collection within most kinds of qualitative 
research‟ (Flowers 2008), the timeframe of the recall period is difficult 
to determine, and, as stated by Flowers (2008: 24-25), „our “recall 
period” is often a complex sense of the past as seen through the lens of 
the present (the interview itself) and often tied to particular, salient 
experiences‟.  Therefore, it may be argued that whilst the participants in 
this study were experiencing symptom clusters on recruitment to this 
study and did talk about their experiences of multiple concurrent 
symptoms during their interviews, some of their experiences elicited 
during their interviews, may pertain to their past experiences of lung 
cancer and therefore not at times when they were experiencing 
symptom clusters.  Therefore, it must be acknowledged that some of 
the symptom experiences reported in this thesis may pertain to the 
symptom experience per se, and not directly to the concept of a 
symptom cluster.  However, it may be contended that this limitation 
may also apply to previous qualitative studies of symptom clusters in 
patients with cancer reported in the literature (Lopez et al. 2011; 
Molassiotis et al. 2010; Molassiotis et al. 2008) and, to a certain extent, 
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studies that have employed quantitative methods of measurement, 
which, whilst often stipulating the period of recall, e.g last week or 
month, provide no means to glean as to whether the people filling in the 
questionnaires were experiencing these symptoms all at the same time 
or separately.   
 
Furthermore, the approach adopted in this study raises the question as 
to what extent the data reflects the experience of symptom clusters or 
the symptom experience per se.  Given the results, I feel that this thesis 
does reflect the lived experience of symptom clusters in patients with 
advanced lung cancer for the following reasons.  Firstly, all the patients 
in this study were experiencing multiple, concurrent symptoms, and 
were therefore exhibiting the phenomenon which was the focus on this 
study.  Secondly, I feel that the use of IPA and an unstructured 
approach to data collection, did allow me to explore the concept of 
symptom clusters in patients with advanced lung cancer, but in novel 
way.  IPA facilitated an inductive bottom-up generation of data, allowing 
the participants to talk about issues of importance to them in their lives 
in the first instance, prior to me probing and exploring their experiences 
of symptom clusters.  It may be argued that this approach facilitated an 
appreciation and understanding of the context in which the experience 
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of symptom clusters occurs, which, to date, has not previously been 
reported in the literature.  Thirdly, in line with my IPA stance and my 
unstructured approach to data collection, is also cognisance of the fact 
that at times when the participants in this study (who were experiencing 
multiple, concurrent symptoms), talked about their symptom 
experiences, I did actively probe, trying to find out what they thought 
about their symptoms and why they thought that way.  I feel that my 
observation that the participants in this study, not only chose to talk 
about their experiences of multiple symptoms, but also chose to focus 
their narratives on individual symptoms, does not imply that their 
narratives were not related to symptom clusters, but rather provide 
data, whilst tentative, to illustrate that people with advanced lung 
cancer, within the lived experience of symptom clusters, do not only 
focus only groups of symptoms, but also appear to pick out salient 
symptoms from the rest that they are experiencing at that time.  
Therefore, such findings do provide novel avenues of inquiry for future 
research in the area of symptom cluster to either support or refute the 
findings presented in this thesis.   
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Lastly, it must be acknowledged that the transcripts and the quotes that 
are written in this thesis are written in local dialect, and therefore this 
may make it more difficult for some readers to understand. 
 
Having discussed the strengths and limitations of this study, the 
following section will focus on the study findings with reference to the 
research questions posed and the wider literature. 
 
10.3 Discussion of study findings with wider reference to the 
wider literature 
The previous section has discussed the strengths and limitations of this 
study, where it has been argued that the main strength of this study is 
the homage that it pays to the experiential expert – the patient.  This 
final section follows on from this patient-centred focus, where it is 
discussed how the findings of this study have replied to the two 
research questions posed, which are:  
 
 What is the „lived experience‟ of symptom clusters in patients with 
advanced lung cancer? 
 How do people with advanced lung cancer understand and make 
sense of the symptom clusters that they are experiencing? 
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Based on the findings presented in this thesis, it will be argued that the 
study of symptom clusters in patients with cancer, with its affinity to the 
biomedical model, is significantly limited as it does not encompass the 
core roles that context and meaning play in the lived experience of this 
phenomenon.  It will therefore be contended that it is imperative that 
the study of symptom clusters in patients with cancer widens its 
approach and starts to acknowledge these important elements of the 
lived experience.  Only by doing this can we ensure that future research 
fully reflects the real life manifestations of the experience of symptom 
cluster in patients with cancer, which, it can be argued, is the only basis 
from which effective, patient-centred, symptom cluster interventions 
can be developed.   
 
This section will start by providing a summary of the key findings of this 
study, detailing for the first time in the literature, the lived experience 
of symptom clusters from the perspective of patients with advanced 
lung cancer.  This will then be followed with a discussion of the results 
of this study with reference to the research questions and wider 
literature, particularly their importance and relevance to existing 
research that has been conducted in the area of symptom clusters in 
patients with cancer to date.  This summary will then be followed by 
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recommendations for future research and practice, before conclusions 
from this thesis are drawn.   
 
10.3.1 Summary of key findings  
In reply to the first research question asked in this thesis, it is clear 
from the findings of this study that the lived experience of symptom 
clusters in patients with advanced lung cancer manifests itself in a fear 
of death, „felt stigma‟, loss of sense of self and feelings of being a 
burden, which cause significant distress and suffering within the 
individual in the context of their lives.   
 
From the results of this study, what is also apparent is that within the 
lived experience of symptom clusters in patients with advanced lung 
cancer, four core symptoms (fatigue, cough, pain and breathlessness) 
commonly comprise the symptom clusters experienced and that the 
occurrence of symptom clusters are most prevalent during periods of 
cancer related treatment.  Furthermore, within the lived experience of 
symptom clusters in patients with cancer, most of the clusters 
experienced, particularly during periods of treatment which are transient 
in nature, with others remaining throughout the patient journey.   
 275 
 
Based on the findings of this study and of particular significance to this 
thesis, is the notion of the sentinel symptom within the lived experience 
of symptom clusters in patients with advanced lung cancer, with 
patients not perceiving all the concurrent symptoms that they 
experience as being of equal weighting, but instead giving some 
symptoms priority over others based on the meanings that they ascribe 
to them. 
 
In reply to the second research question posed in this thesis, it is 
evident that people with advanced lung cancer understand and make 
sense of the symptom clusters that they are experiencing in a number 
of ways.  For some of the participants in this study, they tried to 
understand and make sense of the symptom clusters that they were 
experiencing by using the concurrence as a means of attempting to 
deduce the cause of one symptom based on the occurrence of others. 
 
Another way that the participants in this study understood and made 
sense of their symptom clusters was by using the meanings that they 
ascribed to their experiences of this phenomenon.  In this study, the 
participants commonly associated their experiences of symptom clusters 
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with a fear of death, feelings of felt stigma and a loss of sense of self.  
Furthermore, what was apparent was that these meanings that the 
participants ascribed to their experiences of symptom clusters were in 
turn, derived from the wider context of their lung cancer diagnosis, and 
the way that they associated their illness with impending death and 
feelings of stigma.  These meanings also influenced the participants‟ 
interpretation of symptom clusters, in the way that they appeared to 
pick out salient symptoms from all the rest that they were experiencing 
at that time based on the symbolic connotations that specific symptoms 
held for them.   
 
10.3.2 Study findings with reference to the wider literature 
The previous summary and the results chapters in this thesis have 
provided for the first time, an insight into the lived experience of 
symptom clusters in patients with advanced lung cancer, illuminating its 
complexity, and the core role that context and meaning play in such 
experience.  However, on comparing the findings of this study with the 
evidence base pertaining to the study of symptom clusters in patients 
with cancer, what is apparent at the most basic level is the evident 
disparity observed between what the patients‟ actual experiences of 
symptom clusters and the experience that the data in the current body 
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of evidence depicts.  This contrasting observation, relative to the results 
of this study, applies to both the current definitions offered in the 
literature and empirical evidence to date and will be discussed in 
relation to the literature in the section that follows.   
 
10.3.3 The patient experience and current definitions 
When we look at current definitions of symptom clusters detailed below, 
it is clear from the results of this study, that the core elements of the 
patient experience of this phenomenon are not recognised.   
 
When three or more concurrent symptoms are related to each 
other they are called a symptom cluster.  The symptoms within a 
cluster are not required to share the same etiology (Dodd et al.,  
2001b). 
Later added to the definition -  
Symptom clusters may have an adverse effect on patient 
outcomes and may have a synergistic effect as a predictor of 
patient morbidity (Dodd et al, 2004). 
 
When two or more symptoms that are related to each other and 
that occur together.  Symptoms clusters as composed of stable 
groups of symptoms, are relatively independent of other clusters, 
and may reveal specific underlying dimensions of symptoms.  
Relationships among symptoms within a cluster should be 
stronger than the relationship among symptoms across different 
clusters.  Symptoms in a cluster may or may not share the same 
etiology (Kim et al. 2005). 
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For example, Dodd‟s (2001b; 2004) definitions focus on the number of 
symptoms within a cluster, the relationship between cluster symptoms, 
their aetiology and impact on patient outcomes.  Kim‟s (2005) definition 
covers the same biomedical domains except she extends details on the 
relationships between different clusters of symptoms.   
 
However, when referred back to the findings of this study in chapters 8 
and 9 detailing the patient experience of symptom clusters, the inherent 
limitations of these current definitions become apparent.  Whilst there 
are some similarities between the lived experience of this phenomenon 
and current definitions, such as the way that the participants in this 
study did appear to associate the occurrence of certain symptoms with 
others, the findings of this study, nevertheless do demonstrate how 
limited current definitions are.  This is particularly evident in the way 
that the current definitions lack any detail of the subjectivity of the 
experience of symptom clusters, the distress associated with such 
experiences and more importantly do not address the central role that 
context and meaning play.  This point is exemplified in the following 
quotes by Flora when she talks about the multiple concurrent symptoms 
she experienced during her radiotherapy treatment: 
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Flora:  Weak, I could hardly do anything, it took me all my time, it 
gave you a very tired feeling, it took you all your time to get out 
of bed and put your clothes on, sometimes I just put my dressing 
gown on, and come down, I still had my nightie on, you know 
that‟s how weak it felt, you know.   But after a week I started to 
get better again, mm hmm.  But I really felt ill for a week, I did 
…Tired, tired, as if I'd been ill, you know, say you had a bad 
illness, say like a chest infection or anything like that and you feel 
weak, I had one not so long ago didn‟t I?  I had a chest infection 
and pleurisy, mm hmm … I was just dragging my feet behind me, 
I was … that‟s when I let [daughter] make my dinner and that, 
you know make my food and I was kinda off my food as well, 
mmm mmm, … Flora, interview 1, page 24). 
 
Such experiences are further elaborated in the quote that follows, when 
Flora talks about her thoughts during this time:  
 
Flora:  All I could think was my gosh, I hope I get better, uh 
huh, this is a terrible feeling, uh huh.  Why did I feel it was like 
that?  Well I'd never ever felt like that before, you know I'd never 
felt like that before because I was always fairly healthy and got 
around, but it was horrible, mmm mmm.  But I used to say to 
myself “I must get better, I will get better”, and I did get better … 
Roma: Could, if, you know, if you want, can you tell me a 
wee bit more about that, about why you were thinking that at the 
time – I must get better, I will … ? 
Flora: Well, I had lots of things I wanted to do, you know … 
yes, that‟s how I felt, there was lots of things I wanted to do, mm 
hmm.  I can't go just now [meaning to die], there's tons of things 
I want to do, mm hmm … [slight pause] … (Flora, interview 1, 
pages 25-26). 
 
 280 
 
The findings of this study therefore raise questions as to why current 
definitions have chosen to neglect these crucial elements of the lived 
experience of symptom clusters in patients with cancer. 
 
It may be argued that the neglect of these core elements of the lived 
experience of symptom clusters in patients with cancer has occurred 
because current definitions have not been developed inductively, using 
patient experience to guide them.  It may therefore be contended that 
current definitions represent the viewpoint of the researcher and not the 
patient.  Thus it may be argued that these definitions are hegemonic 
and that their neglect of the patient perspective and predominant 
biomedical focus has significantly contributed to the development of a 
body of empirical evidence which portrays a narrow view point of the 
reality of the lived experience of symptom clusters within a person‟s life.  
 
The neglect of these important, subjective characteristics of the 
experience of symptom clusters revealed by this study, is, to an extent, 
surprising, considering they are recognised by the theories (Lenz and 
Pugh 2008; Humphreys et al. 2008) and model (Armstrong 2003) which 
claim to underpin this body of research.  Whilst the results of this study 
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are novel in that they have not previously been reported relative to the 
experience of symptom clusters in patients with advanced lung cancer, 
of interest and significance to this thesis is that all of these conceptual 
frameworks claiming to underpin the study of symptom clusters in 
patients with cancer are reflected to some degree in the findings of this 
study.   
 
For example, the Theory of Unpleasant Symptoms (Lenz et al. 1997) 
focuses on the antecedents (context) of the symptom experience and 
does not only focus on the intensity and timing of symptoms but also 
acknowledges the distress associated with the symptom experience and 
the quality, that is to say what it feels like to have a symptom.  Within 
the Theory of Symptom Management (Humphreys et al. 2008) 
commonalties with the findings of this study include the way that it 
focuses not only on the experience of the symptom but also its  
perception, and the way that it pays homage to the importance of the 
role of context in the symptom experience.  The Model of Symptoms 
Experience developed by Armstrong (2003) which also claims to 
accommodate the concept of symptom clusters, has much in common 
with the participants‟ experiences of symptom clusters in this study, 
particularly the role that it affords to meaning in the symptom cluster 
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experience.  Within this model there are two types of meaning: 
„situational‟ meaning, which is defined as being the person‟s „perception 
of a new event and their capacity to handle it‟, and existential meaning 
which is their „global representations of their places in the world‟ 
(Armstrong 2003:603).  Of relevance to the findings of this study is the 
way that this framework portrays „existential meaning‟ as encompassing 
the „situational meaning‟ of the symptom, which, in turn, surrounds the 
experience of symptoms.  This conceptualisation fits well with what was 
observed in this study relative to the experience of symptom clusters, 
as it was the meanings that the participants ascribed to their lung 
cancer diagnosis, which in turn, influenced the meanings that the 
participants ascribed to their experience of symptom clusters, which in 
turn manifests itself in the actual way that symptom clusters were 
understood and made sense of by the participants.  
 
Therefore, it may be argued that the similarities observed between the 
findings of this study and the conceptual frameworks that claim to 
underpin this body of research (Lenz and Pugh 2008; Humphreys et al. 
2008; Armstrong 2003) suggest that researchers developing current 
definitions of symptom clusters have either neglected to consult the 
theoretical base which informs it or have instead used a biomedical 
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framework, choosing to pick objective parameters that are easily 
measured and quantified.  In either case, it may be contended that it 
has been the researcher who has defined what the core characteristics 
of symptom clustering are, such as the number of symptoms in a cluster 
and the relationships between symptoms, which, when compared to the 
results of this study, can be argued to represent little of the patient 
interpretation of this phenomenon.   
 
Therefore, such observations call for current definitions of symptom 
clusters in patients with cancer, to widen their focus, acknowledging the 
subjectivity of the experience of symptom clusters, the distress that 
such experiences can causes, and crucially, the core role that context 
and meaning plays in such experiences.   
 
This argument for current definitions of symptom clusters to broaden 
their focus, is supported not only from the new insights of the lived 
experience of symptom clusters gleaned in this study, but is also 
substantiated by the wider literature exploring the patient experience of 
symptoms in the area of chronic illness (Thorne 1999; Devins 1994; 
Charmaz 1991; Bury 1991; Corbin and Strauss 1987; Charmaz 1983; 
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Bury 1982) and cancer (Bender et al. 2008b; Desnoo and Faithfull 
2006; Ekfors and Petersson 2004; Booth et al. 2003; Murray et al. 
2002).  These studies, akin to the results detailed in this thesis, have 
reported how patients with such conditions do not focus on objectifying 
their symptoms, but have a greater concern for the subjective 
manifestations of their symptoms.  For example, the seminal works of 
scholars such as Kleinman (1988a; 1988b; 1980), Cassell (1982; 1978), 
Charmaz (1991; 1983) and Bury (2001; 1997; 1982) have all illustrated 
in some way the negative impact of the symptom experience on the self 
and how this impacts on those around them.  Similar findings have also 
been recently reported in patients with cancer (Cayless et al. 2010; 
Hubbard et al. 2010; McCann et al. 2010) where it has been argued that 
many commonalties exist between the cancer experience and the 
experience of chronic illness.   
 
Many studies have also reported the central role that meaning plays in 
the symptom experience.  For example, the fear of death experienced 
by the participants in this study has also been reported previously in the 
literature, relative to the experience of pain, breathlessness, weight loss 
and fatigue (Lindqvist et al. 2006; Hopkinson et al. 2006; Lindqvist et 
al. 2004; Alderbratt and Stang 2000; O'Driscoll et al. 1999; Ferrell and 
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Dean 1995).  Of particular relevance and reflective of the findings of this 
thesis is a study by Aldelbratt and Strang (2000) in patients with brain 
tumours, who reported that „worrying‟ symptoms, such headaches, 
acted as „trigger phenomenon‟ that were regarded by patients as being 
„memento mori‟ of their impending mortality, causing significant anxiety 
and distress.  As with fear of death, perceived stigma has also been 
reported relative to the symptom experience in patients with cancer 
(Wilson and Luker 2006; Chapple et al. 2004; Rosman 2004; MacDonald 
and Anderson 1983) and, as was found in the patients in this study, 
such experiences often centralised around a fear of potential discrediting 
and the overt visibility of symptoms that were symbolic of cancer, such 
as breathlessness.   
 
Therefore, the importance of these wider subjective experiences of 
symptom clusters, particularly the role of context and meaning, cannot 
be ignored based on the findings of this study, and the studies detailed 
above.  Furthermore, this argument for current definitions of symptom 
clusters in patients with cancer to address the context and wider, 
subjective manifestations of the symptom experience, is also supported 
in alternative models of care (Crossley 2000; Good and Good 1980; 
Engel 1977).  These models of care appreciate and include these wider 
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subjective domains (see chapter 2), and, as argued earlier in this thesis, 
appear to be more fitting to accommodate and appreciate the 
complexity and subjectivity of the illness experience from the 
perspective of the patient. 
 
10.3.4  The patient experience and current empirical base 
The lack of semblance with the body of evidence on symptom clusters in 
patients with cancer and the findings of this study also extends to the 
results of empirical studies, which, it can be argued, do not recognise 
these crucial elements of the patient experience of this phenomenon, as 
depicted by the participants in this study.   
 
Whilst there is consensus between the results of this study and current 
empirical base, regarding the existence of core symptoms (fatigue, 
breathlessness, cough and pain) that commonly constitute symptom 
clusters identified in patients with cancer (Molassiotis et al. 2010; 
Reyes-Gibby et al. 2006; Beck et al. 2005; Fleishman 2004; Niven 
2003), the high prevalence of symptom clusters during periods of 
cancer related treatment (Lopez et al. 2011; Kim et al. 2009; Kim et al. 
2008; Maliski et al. 2008; Honea et al. 2007) and the nature of 
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symptom clusters with some being transient and others chronic in 
nature (Molassiotis et al. 2010; Gift et al. 2003).  A significant limitation 
of this body of evidence is that it does not acknowledge the core roles 
that context and meaning play in the experience of this phenomenon.  It 
may be argued that the neglect of these important domains of the lived 
experience of symptom clusters in patients with cancer has occurred 
due to the predominant use of reductionist methods of measurement, 
which, due to their narrow view point, have simplified a phenomenon 
which is by its nature complex, and deeply embedded in context and 
meaning.  
 
Therefore, the critique of the biomedical model offered in chapter three 
of this thesis also extends to the study of symptom clusters in patients 
with cancer, where it can be argued that the dominance of reductionist 
methods has excluded many of the human aspects of the experience of 
symptom clusters (Thorne 1999; Cassell 1982; Cassell 1978; Engel 
1977), have not comprehended the whole person (Cassell 1982), have 
not captured the full reality of the experience of symptom clusters, and 
have not acknowledged the social, historical and cultural factors that 
influence such experiences (Willig 2001).  These finding also support the 
critique offered by Krishnasamy (2000) that the use of reductionist 
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methods of measurement have little relevance to the lives of the 
individual and that they often hide the distressing facets of the 
symptom experience.  This notion is supported by Benner who states 
that the limitations of reductionist methods of measurement are most 
apparent relative to the symptom experience (Benner and Wrubel 
1989). 
 
The critique of the limitations of the predominant use of reductionist 
methods of measurement in the study of symptom clusters in patients 
with cancer to date can also be contended on the grounds that such 
methods should not be used to measure phenomena that are poorly 
understood and defined (Krishnasamy 2000).  The results of this study 
have significantly contributed to this argument, highlighting the 
limitations of current definitions of symptom clusters in patients with 
cancer and how they have limited semblance with the lived patient 
experience of this phenomenon within a person‟s life.   
 
Of relevance to and supporting this discussion is that such limitations in 
current definitions have also been previously identified in the literature, 
where repeated calls for the clarification of the concept of symptom 
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clusters in patients with cancer have been made (Hadi et al. 2008b; 
Miaskowski and Aouizerat 2007; Barsevick 2007b; Kim et al. 2005; 
Dodd et al. 2004).  This is articulated by Dodd (2004), who states that 
the study of symptom clusters in patients with cancer is in the phases of 
concept exploration and clarification, where the concept  has been 
introduced in the literature but „it is too early to articulate its definite 
properties and potential explanatory power‟ and where the refining of 
symptom clusters as a concept is required in order to „resolve the 
conflicts about meaning and definitions‟ (Dodd et al. 2004:77).  Findings 
of this study further support this observation, highlighting how current 
definitions do not address the core elements of the lived experience of 
this phenomenon and therefore raise the question why researchers are 
trying to measure a concept which is not clearly articulated and where 
core characteristics have not been meaningfully defined.   
 
This viewpoint is shared by Krishnasamy (2000), who states that by 
trying to measure poorly defined phenomena using reductionist 
methods, without clarification of the meanings that the phenomena 
holds for patients in the context of their lives, we are unlikely to 
„contribute to an understanding of how the phenomena under 
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investigation impacts on the lives of patients and what factors 
exacerbate or relieve it‟ (Krishnasamy 2000:411).   
 
Once again, this observation, relative to the findings of this study, 
highlights a discrepancy in the framework of this body of research and 
calls for more studies of the patient experience of symptom clusters in 
order to determine what the core characteristics of symptom clusters in 
patients with cancer are, to further clarify the concept, to thereafter 
dictate what domains of this experience are meaningful to the patient, 
and, ultimately, which characteristics are amenable to measurement.   
 
Linked to this discussion is how this study has demonstrated the 
importance of addressing the experience of symptom clusters at the 
level of the individual within the context of their life.  It can be argued 
that reductionist methods of measurement aim to make generalisations 
at a group level.  However, within this study, whilst commonalities did 
exist between the participants‟ experiences of symptom clusters, what 
was also apparent was the idiographic nature of their experiences of this 
phenomenon, with particular relevance to the way that they would 
choose to pick out „salient symptoms‟ from the clusters of symptoms 
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that they were experiencing.  This highlighting of individual symptoms 
within the experience of symptom clusters, varied from individual to 
individual, based on the meanings that they ascribed to these specific 
symptoms.  For example, sentinel symptoms which were singled out by 
the participants based on their symbolic connotations with perceived 
stigma, all differed from each other, and included rash, breathlessness, 
cough and hair loss.  Therefore, such observations, whilst highlighting 
the limitations of reductionist approaches, and the need to further 
explore the experience of symptom clusters at the level of the 
individual, may also open up novel avenues of thought for the 
development of patient-centred symptom cluster interventions.  It may 
be postulated that if we target the symptoms that patients prioritise and 
highlight as being meaningful in their lives, then it is possible that 
effective treatment of these „sentinel‟ symptoms will have a beneficial 
crossover effect on the other cluster symptoms being experienced.   
 
Of note is that this prioritisation of symptoms has been previously 
reported in patients with cancer with symptoms such as fatigue, pain 
and dyspnoea being commonly indentified (Butt et al. 2008; Stromgren 
et al. 2006; Tishelman et al. 2000).  However, such studies have also 
demonstrated that the symptoms of greatest intensity are not 
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necessarily the ones that are prioritised by patients (Butt et al. 2008; 
Tishelman et al. 2000).   
 
This singling out of „sentinel‟ symptoms within the experience of 
symptom clusters in patients with cancer, therefore, emphasises the 
importance of targeting and prioritising the treatment of symptom 
clusters, not only based on objective measures such as intensity, but 
also on the importance of capturing the meaning of symptoms in order 
to understand the impact and nature of these symptoms in the person‟s 
life.  This hierarchical positioning of the importance and meaning of 
symptoms by patients with cancer experiencing symptom clusters can 
therefore inform how the research framework for this phenomenon may 
be modelled and further developed. 
 
Of relevance to this discussion is also the suggestion previously made in 
the literature (Lopez et al. 2011; Molassiotis et al. 2008) that the 
patient narrative may be a better tool than the use of reductionist 
methods of measurement and statistical tests in order to determine 
evidence of symptom clustering in patients with cancer.  The findings of 
this study support such calls because an appreciation of lay accounts 
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allows understanding to develop, not only regarding what symptoms are 
of greatest salience to the person, but also of what potential 
interventions may be of use.  The notion of a „sentinel‟ symptom as a 
potential symptom cluster intervention as discussed above, provides 
insights into the value of lay accounts (Bury 2001) and how they may 
be used to inform the development of future interventions.    
 
This study and the novel insights which it provides on the lived 
experience of symptom clusters in patients with advanced lung cancer 
and, as substantiated by findings in the wider literature, therefore 
provides evidence to suggest that current definitions offered in the 
literature and the empirical base representing the study of symptom 
clusters in patients with cancer are limited as they do not encompass 
core elements of the lived experience of this phenomenon as depicted in 
this study, such as the role of context and meaning.  It may be argued 
that such significant limitations have transpired due to the biomedical 
framework adopted in the study of symptom clusters in patients with 
cancer to date, with its focus on the objective domains of the symptom 
experience and use of reductionist methods of measurement.  Findings 
from this study suggest that such an approach does not encompass the 
full perspectives of the patient.  Therefore it may be postulated that by 
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continuing to conduct research on the concept of symptom clusters in 
patients with cancer using a predominantly reductionist approach, risks 
future studies being conducted which are of limited relevance to the 
patient and to the people caring for them and therefore are of limited 
value in developing future interventions.   
 
Therefore, the findings of this study and the new contributions made to 
this body of research by exploring the lived experience of this 
phenomenon, may allow researchers to address current limitations and 
offer new directions for the study of symptom clusters in patients with 
cancer, taking cognisance of the patient perspective.  Such an approach 
would ensure that those with the experiential knowledge can contribute 
to the determination of what the core characteristics of symptom 
clusters in patients with cancer are and therefore strengthen the 
scientific base which underpins this important and emerging body of 
research.   
 
Therefore, having discussed the novel contributions and implications of 
the findings of this study to the existing body of research on symptom 
clusters in patients with advanced lung cancer, the following section will 
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conclude this thesis and make recommendations based on findings of 
this study for future research and practice.   
 
10.4 Conclusions and Recommendations 
In conclusion, this study used a qualitative approach, (informed by a 
contextual constructionist epistemological stance), utilising IPA to 
explore the lived experience of symptom clusters in patients with 
advanced lung cancer and identified how patients understood and made 
sense of the experience of this phenomenon.  This IPA approach was 
original to the exploration of the lived experience of symptom clusters in 
patients with advanced lung cancer and has not been reported 
previously in the literature.  The benefits of the use of IPA and 
unstructured interviews demonstrated the strengths of this patient-
centred approach by the richness and depth of the data collected, and, 
in particular, its ability capture the context and the meaning embedded 
in the experience of symptom clusters in patients with advanced lung 
cancer.   
 
The findings of this study provide new insights into the lived experience 
of symptom clusters in patients with advanced lung cancer by exploring 
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the experience of this phenomenon from the perspective of the patient.  
The results of this study demonstrated that the lived experience of 
symptom clusters in patients with advanced lung cancer does not 
manifests itself within the confines of the biomedical model as the 
current body of evidence would lead us to believe, but has far reaching 
consequences for the individual in the context of their life.  For the 
participants in this study, that is, patients with advanced lung cancer, 
the experience of symptom clusters manifests itself in a fear of death, 
„felt‟ stigma, loss of sense of self and feelings of being a burden.   
 
The findings also provide new insights into how patients with advanced 
lung cancer understand and make sense of their experiences of 
symptom clusters.  For some, the concurrence of symptoms within a 
cluster acted as a means of them trying to deduce the cause of the 
symptoms that they were experiencing, with them often attributing the 
occurrence of one or two symptoms on the formation of another.   
 
Another way that the participants in this study understood and made 
sense of the symptom clusters that they were experiencing was by 
using the meanings that they ascribed to concurrent symptoms that 
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they were experiencing.  In this study, the participants frequently 
associated their experiences of symptom clusters with a fear of death, 
feelings of stigma, and a loss of sense of self.  Furthermore, what was 
apparent from the findings of this study was that the meanings that the 
participants ascribed to their experiences of symptom clusters were 
derived from the wider context of their lung cancer diagnosis, and the 
way that they associated their illness with impending death, feelings of 
stigma and a loss of sense of self.    
 
These meanings that the participants ascribed to their experiences of 
symptom clusters also appeared to result in them choosing to pick out 
salient symptoms from all the rest that they were experiencing at that 
time, due to the strong symbolic connotations that these individual 
symptoms held for the participants.  These results therefore indicate 
that patients with advanced lung cancer do not view all of their 
symptoms as being of equal weighting but instead give certain 
symptoms greater priority than others based on their meaning within 
their lives; these might be defined as „sentinel symptoms‟.  Such 
findings therefore provide unique insights into the study of symptom 
clusters in patients with advanced lung cancer.  
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The findings have also contributed to the evidence base by providing 
evidence to substantiate the need to broaden the quantitative approach 
which has dominated the study of symptom clusters to date, with its 
focus on objective parameters that can be only be quantified and 
assessed using statistical associations.  The lack of semblance with the 
current definitions and empirical evidence and the findings of this study, 
suggest that current definitions are limited and that reductionist 
methods of measurement are oversimplifying a phenomenon which, by 
its very nature, is complex.  By placing these definitions and methods of 
measurement as boundaries within the research framework, it may be 
argued that it is preventing the generation of data which can open up 
new avenues of inquiry and the subsequent development of patient-
centred symptom cluster interventions. 
 
Based on the results of this study, it is argued that in order to 
strengthen the scientific and empirical base underpinning the study of 
symptom clusters in patients with cancer, there is a need to widen its 
scope, to encompass the perspective of the patient.  This has the 
potential to facilitate the identification of what the core elements of the 
experience of symptom clusters in patients with cancer are.  This, in 
turn, can then be used to redefine definitions to reflect the real life 
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experiences and perspectives of the patient, and not the researcher.  By 
doing this we are also more likely to be measuring what is meaningful 
to the patient.  It is upon this basis that effective symptom 
management interventions can be developed, that will make a 
significant impact on the lives of the individual and within clinical 
practice.  Therefore, based on this discussion of the results of this 
study, the following recommendations for future research and clinical 
practice are made. 
 
10.5 Recommendations for research 
The new insights offered by this research have many implications for 
the study of symptom clusters in patients with advanced lung cancer.  
First, they provide evidence to substantiate the limitations of 
reductionist methods of measurement, which have significantly 
influenced the study of symptom clusters to date.  Such limitations are 
demonstrated by the way that current definitions and the existing 
empirical base do not acknowledge the core role that context and 
meaning play in the lived experience of symptom clusters in patients 
with advanced lung cancer.  Therefore, this thesis advocates that 
research exploring the experience of symptom clusters in patients with 
cancer widens its scope and moves away from its reliance on 
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reductionist methods of measurement, encompassing an appreciation of 
the contributions that the patient experience of phenomenon can make 
to this emerging body of research, and one that instead of trying to 
simplify such experiences, addresses them in all their complexity.   
 
Secondly, linked to this recommendation is a call for the re-
conceptualisation of current definitions of symptom clusters in patients 
with cancer, which, it can be argued, based on the findings of this 
study, represent a narrow viewpoint of the reality of the experience of 
this phenomenon within a person‟s life.  In order to ensure that current 
definitions are grounded in „reality‟, it is imperative that more 
qualitative studies like this one are conducted, exploring the lived 
experience of this phenomenon in all its complexity.  Generating further 
such data will allow the research community to gain consensus of the 
core characteristics of symptom clusters in patients with cancer in order 
to direct future research which is more meaningful and, ultimately, will 
strengthen the current evidence base.  
 
Thirdly, the findings also highlight the need for further research to 
explore the role of context and meaning in the experience of symptom 
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clusters in patients with cancer and its future place in revised 
conceptualisations.  Based on the findings of this study, the depth of 
data collected and the novel insights provided, it may be argued that 
qualitative methodologies, informed by a contextual constructionist 
stance such as IPA, are well placed for such exploration, allowing the 
experience of symptom clusters in patients with advanced lung cancer 
to be fully elucidated.  Furthermore, the notion of a „sentinel symptom‟ 
as discussed previously, warrants further consideration, as this may 
open up new and innovative avenues for the development of meaning-
based symptom cluster interventions in the future.   
 
10.6 Recommendations for clinical practice 
The results of this study have implications for practitioners involved in 
the assessment and management of symptom clusters in patients with 
cancer. The findings have highlighted the importance of recognising the 
complexity of the experience of symptom clusters in patients with 
advanced lung cancer, and the core roles that context and meaning play 
in such experiences.  Therefore, such findings call for clinicians involved 
in the assessment and management of symptom clusters in patients 
with cancer, not to rely on reductionist methods of measurement which 
aim to simplify phenomenon to measurable units, but to complement 
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such quantitative methods with narrative approaches.  This focus on the 
patient narrative will provide clinicians with an insight into the patient‟s 
interpretation of the experience of symptom clusters, which is crucial to 
the development and delivery of effective symptom management 
interventions.  This call for a focus on narrative symptom clusters is 
reflected in the literature, where it has been postulated that such 
approaches allow the development of „patient-centred‟ rather than 
statistically driven interventions (Lopez et al. 2011).    
 
Following on from this is the call for health professionals involved in the 
assessment and management of symptom clusters in patients with 
cancer to further explore the role of meaning in such experiences.  
Based on the findings of this study, meaning was central to the 
participants‟ experiences of symptom clusters and also the way that 
they understood and made sense of this phenomenon, with them often 
picking out symptoms that were of personal significance to them in the 
context of their lives.  Therefore, the role of the „sentinel‟ symptom as 
previously discussed in chapters 8 and 9 of this thesis warrants further 
investigation.   Table 15 below provides a framework for clinical practice 
where the role of the sentinel symptom may be further explored in the 
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management of symptom clusters in patients with advanced lung 
cancer.  As detailed below, a three step approach is advocated. 
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Table 15:  Framework for clinical practice for the management of symptom clusters in patients with advanced lung 
cancer –  
Management of the „sentinel‟ symptom 
Pre-
intervention: 
Patient 
assessment:   
 Assessment of current symptoms experienced (incidence, severity, distress, 
associated meaning, associations between symptoms) 
 Patient asked what symptom/s is/are of greatest concern to them and why? 
 Patient hierarchy of symptoms determined in partnership with the patient using 
responses gleaned above to identify sentinel symptoms.   
 
Intervention 
 Sentinel symptoms identified by patients as being of greatest concern prioritized 
and targeted using existing interventions 
 
Post-
intervention: 
Evaluation 
 Assessment of current symptoms experienced (incidence, severity, distress, 
associated meaning, associations between symptoms).  
 Patient asked what symptom/s is/are of greatest concern to them and why? 
 Patient hierarchy of symptoms determined in partnership with the patient using 
responses gleaned above to identify sentinel symptoms 
 Observation of differences between pre and post intervention stages to evaluate 
effectiveness of intervention 
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Utilising this framework would provide clinicians with a tool to ensure 
that patient experience is central to the assessment and 
management of symptom clusters in clinical practice.  As argued 
throughout this thesis, it is time for the study of study of symptom 
clusters in patients with cancer to widen its approach, away from the 
dominance of the biomedical model and reductionist methods of 
measurement, to one that also appreciates and acknowledges the 
importance of lay perspectives of illness.  It is time for the study of 
symptom clusters in patients with cancer to bring the „person‟ in. 
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Appendices 
Appendix 1:  Patient Information Sheet 
Part 1 
Study title:  The Experience of Symptom Clusters in Patients with Lung Cancer 
Introduction 
I am a PhD student undertaking a study which is looking at the experience of 
symptoms in patients with lung cancer and would like to invite you to take part in 
this study.  Before you decide, it is important for you to understand why the 
research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.  Take time 
to decide whether or not you wish to take part. 
What is the purpose of the study? 
The study aims to understand what it is like for people who have lung cancer to 
experience a number of symptoms at the same time. We are interested to know 
more about people‟s symptoms and what effect this has on people‟s lives. The 
study may help health professionals to improve ways in which they manage 
symptoms for people when they have a diagnosis of lung cancer. 
Why have I been chosen? 
You have been chosen because you have been diagnosed with lung cancer. We aim 
to have 10 patients taking part in the study. 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent 
form. If you decide to take part you are still free to withdraw at any time and 
without giving a reason.  If you decide to withdraw at any time, or not to take part 
at all, it will not affect your care or treatment in any way.  
What will happen to me if I take part? 
If you agree to take part, you will meet the researcher who is conducting this 
study, who will ask to interview you 2 times over a period of 3 to 5 weeks. The 
interviews will normally take place in your home if that is convenient for you. If 
you would prefer they can also be held in a private room in the hospital. 
Expenses and Payments 
It is anticipated that the interviews will take place in your home or at the hospital.  
If your interview is being conducted at the hospital, the researcher will try to 
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arrange this at a time that you will be attending the hospital for another 
appointment.  You will not be reimbursed for any expenses in relation to this study. 
What do I have to do? 
If you are interested in taking part in the study, you will be asked by your doctor 
or nurse at your hospital to sign a form saying that you agree for your contact 
details to be passed onto the researcher conducting the study.  The researcher will 
then contact you to explain more about the study. If you agree to take part, she 
will ask you to sign a consent form and will arrange to meet you.  
The researcher will first ask you to talk about in detail what cancer means to you.  
She will then ask you talk about your life and your experiences since being 
diagnosed with lung cancer, with a particular focus on the symptoms that you have 
experienced at this time. It is expected that it will take around an hour to take part 
in the interview. If you agree, the researcher will record the interview, to make 
sure there is an accurate record of the interview. Disks will be stored securely at 
the University of Stirling and no-one outside the research team will have access to 
them.  At the end of the first interview, the researcher will ask you if you would 
agree to be interviewed three to five weeks later to discuss in more depth some 
issues that you may have raised during the first interview and any new matters 
that may arise.  If you do not want to take part in a further interview, you will be 
thanked for your time and your treatment or care will not be affected in anyway.  
You are free to withdraw at any time if you decide you no longer wish to take part.  
If you do agree, the researcher will begin the next interview by feeding back their 
thoughts on the last interview; this is to allow you to check that they have an 
accurate account of what you have said.  This table shows how many times you will 
be contacted during the study: 
 
Week 1 1st interview  
Week 3-5 2nd interview 
 
What are the possible disadvantages or risks of taking part? 
As you will be talking about what cancer means to you, your life and experiences of 
symptoms since being diagnosed with lung cancer, you may find this upsetting.  If 
you did feel that taking part in the study was upsetting you, then you can withdraw 
from the study without having any effect on your future treatment and care. If you 
wish, you can discuss these feelings or concerns with your doctor or nurse. (Details 
to be inserted).  
What are the possible benefits of taking part? 
Although there are no direct benefits to you, taking part in this study will give you 
the chance to say what you think about your illness and the symptoms that you 
have experienced as a result of it.   The study may help other people affected by 
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lung cancer in the future by helping us to understand people‟s symptoms and 
develop ways in which we can manage them better. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed.  The detailed information on this 
is given in part 2.  
Will my taking part in this study be kept confidential? 
Yes.  All the information about your participation in this study will be kept 
confidential.  The details are included in Part 2. 
Contact for Further Information 
If you would like to talk to someone else before deciding to take part, or at any 
time during the study, you can contact Mrs Roma Maguire, Research Fellow,  
Cancer Care Research Centre, by phoning 01786 460063 or emailing 
roma.maguire@stir.ac.uk. If you would like advice from someone not involved in 
the study, you can contact (details to be inserted) 
This completes part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering 
participation, please continue to read the additional information in Part 2 before 
making any decision. 
 
Part 2 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak with 
the researcher who will do their best to answer your questions (Roma Maguire – 
01786-46-0063).  If you remain unhappy or wish to complain formally, you can do 
this through the NHS complaints procedure.  Details can be obtained from the 
hospital.  In the event that something goes wrong and you are harmed during the 
research study, there are no special compensation arrangements.  If you are 
harmed and this is due to someone‟s negligence then you may have some grounds 
for legal action for compensation against the University of Stirling but you may 
have to pay legal costs. The normal National Health Service complaints 
mechanisms will still be available to you (if appropriate).   
Will my taking part in the study be kept confidential? 
If you join the study, some parts of your medical records and the data collected for 
the study will be looked at by authorised persons from the University of Stirling.  
All will have a duty of confidentiality to you as a research participant and nothing 
that could reveal your identity will be disclosed outside the research site. 
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All information which is collected about you during the course of research will be 
kept strictly confidential.  
No-one will be able to recognise you from any report about the study – your name 
and anything which could lead to anyone being able to identify you will be 
removed. 
Involvement of the General Practitioner/Family Doctor (GP) 
The researcher is required to tell your GP that you are taking part in the study, but 
this will only be done if you agree.  
What will happen to the results of the research study? 
The findings of this study will be presented in a thesis which will be submitted by 
the researcher for the award of a PhD qualification.  The findings will also be 
published in academic journals. You will not be able to be identified in any report or 
publication.  You can receive a short summary of the findings if you wish.  
Who is organising and funding the research? 
The researchers is being organised and supported by the Cancer Care Research 
Centre at the University of Stirling. 
Who has reviewed the study? 
The Local Research Ethics Committee and the local Research and Development 
Office at [name of hospital] have reviewed the study and approved it. 
Thank you very much for taking the time to read this information. 
 
 346 
 
Appendix 2:  Consent to pass on personal details 
Title of Project: The Experience of Symptom Clusters in Patients with Lung Cancer 
 
 
Name of Researcher:  
        
I confirm that I give authorisation for (name of PI to be inserted) ……………………. to 
provide (name of researcher to be inserted) ………………from the Cancer Care 
Research Centre at the University of Stirling my contact details to contact me to 
discuss the above study.   
 
_________________ ________________ ______________ 
Name of Patient   Signature   Date  
________________   _________________ ______________ 
  
Name of Person taking consent Signature   Date 
(if different from researcher) 
 
When completed, 1 for patient; 1 for researcher site file; 1 (original) to be kept in 
medical notes 
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Appendix 3:  Patient consent form 
Centre Number: 
Study Number: 
Patient Identification Number for the trial:   
Title of Project: The Experience of Symptom Clusters in Patients with Lung Cancer 
Name of Researcher:  
Please initial box 
I confirm that I have read and understand the information sheet dated September 
2006(version 1) for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights being 
affected. 
 
I understand that interviews may be tape recorded. It has been explained to me 
that tapes and questionnaires will be stored securely and that I will not be 
identified by anyone outside the research team. 
 
I agree to my G.P. being informed of my participation in the study 
 
I understand that relevant sections of my medical notes and data collected during 
the study may be may be looked at by responsible individuals from the University 
of Stirling, from regulatory bodies or from the NHS Trust, where it is relevant to 
my taking part in this research.  I give permission for these individuals to have 
access to my records. 
 
I agree to take part in the above study 
 
 
________________________ ________________ ______________ 
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Name of Patient    Signature  Date  
_________________________ _________________ ______________
   
Name of Person taking consent  Signature  Date 
(if different from researcher) 
_________________________ ________________ ______________  
Researcher     Signature  Date   
When completed, 1 for patient; 1 for researcher site file; 1 (original) to be kept in 
medical notes 
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Appendix 4:  Interview summary/reflexive notes 
Patient ID: 
Date: 
Number of interview: 
Completed by: 
 What were the main issues or themes that struck you in this contact? 
 Summarize the information you collected 
 Anything else that struck you as salient, interesting, illuminating or 
important in this contact? 
 What questions do you have in considering the next interview?  
 How did you feel when doing the interview? 
 Any other thoughts/comments regarding this interview? 
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Appendix 5:  Examples of empirical studies of symptom clusters in patients with cancer 
(2001-2011)  
 
 
Qualitative studies 
Author Theoretical 
Framework 
 
Study Aim/s Design Sample Measures Analysis 
(to 
determine 
symptom 
clusters) 
Cluster findings 
(Lopez et 
al. 2011) 
Leventhal and 
Johnsons Self 
Regulation 
Theory 
(Leventhal 
and Johnson 
1983) 
To explore the 
explanations 
about the 
development 
and co-existence 
of symptoms 
and how 
patients 
attempted to 
self-manage 
them 
Qualitative, 
longitudinal 
study design 
Homogenous 
n=10 
Semi-structured 
interviews, over 
four time points 
(beginning of 
treatment, three, 
six and twelve 
months later) 
Content 
analysis 
Four major narrative 
clusters indentified 
from the data: 
Tiredness, 
sleeplessness, pain, 
depression and 
weakness 
 
Hair loss, ocular 
changes, body image, 
identity experience 
and anxiety 
 
Nausea, loss of 
appetite, taste 
changes, bowel 
function, weight 
changes and distress 
 
Numbness and tingling 
sensations in the 
hands and feet, 
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restlessness, 
sleeplessness and 
depression 
(Molassiot
is et al. 
2010) 
Not detailed To explore the 
symptom 
experience of 
patients with 
cancer over a 1-
year period from 
both the patient 
and  informal 
caregiver 
perspective 
Qualitative, 
longitudinal 
study design 
Homogeneous 
n=17 
Semi-structured 
interviews 
IPA (Smith 
et al. 
2009a) 
Findings indicate that 
a cluster of interacting 
respiratory symptoms 
play a central role in 
patients‟ symptom 
experiences within the 
lung cancer 
population. The 
interviews also 
suggest that 
symptoms such as 
cough which are 
under-represented in 
research within this 
population may play 
an important role in 
patients‟ symptom 
experiences 
(Molassiot
is et al. 
2008) 
Not detailed To explore the 
experience of 
chemotherapy 
related nausea 
in patients with 
cancer. 
Qualitative, 
descriptive 
study 
Heterogeneous 
sample 
n=17 
 
 
Single, semi-
structured 
interviews 
Content 
analysis 
(Strauss 
and Corbin 
1990) 
Range of symptoms 
linked with nausea 
were described by 
patients, these were 
categorised as 
concurrent (those that 
were not consistently 
present with nausea) 
and associated 
symptoms (those 
symptoms that 
participants clearly 
described as 
temporally occurring 
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in conjunction with 
nausea). 
 
Concurrent symptoms 
(number of 
quotations):  sleep 
disturbance (n=4), 
fatigue (n=7), bloating 
(n=2), sore throat 
(n=2), sweating (n-2), 
weakness (n=4), 
dizziness (n=1) and 
headache (n=2), flu 
like symptoms (n=3) 
and feeling hot and 
cold (n=2).  
Combinations of these 
symptoms were also 
present when nausea 
developed. 
 
Associated symptoms 
i.e. those clearly 
occurring in 
conjunction with 
nausea – burping 
(n=1) associated with 
a hot sensation (n=1), 
a „feeling [of needing] 
to swallow, push 
things down‟ n=1) and 
regurgitation (n=1); 
intolerance of smells 
(n=1), taste 
disturbance (n=7), 
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loss of appetite 
(n=15), vomiting 
(n=11) dry heaves 
(n=4).  Frequently 
associated symptoms 
emerged including loss 
of appetite, vomiting 
and taste changes and 
they often occurred 
simultaneously 
suggesting a possible 
symptom cluster‟ 
 
Quantitative Studies 
(Dodd et 
al. 2010) 
Symptom 
Management 
Theory 
(Humphreys 
et al. 2008) 
To determine 
whether: 
*subgroups of 
oncology 
outpatients can 
be identified 
based on a 
specific 
symptom cluster 
(pain, fatigue, 
sleep 
disturbances, 
depression) 
*these 
subgroups differ 
on outcomes 
(i.e., functional 
status, quality of 
life) 
*subgroup 
membership 
Secondary 
analysis of 
data 
(T1 start of 
chemo-
therapy 
T2 end of 
chemo-
therapy 
T3 end of 
study) 
Homogeneous 
Breast cancer 
n=112 
 
 
 
*Worst pain scale 
(Miaskowski et al. 
2006) 
*Piper Fatigue Scale 
(Piper 1987) 
*General Sleep 
Disturbance Scale 
(Lee 1992) 
*CES-D (Sheehan 
et al. 1995) 
*Karnofsky 
Performance Status 
(Karnofsky et al. 
1948) 
*Multidimensional 
Quality of Life Scale 
(Ferrell et al. 1989) 
Cluster 
analysis 
At T1 and T2, four 
patient subgroups 
were identified: 
*ALL LOW (one or no 
symptom greater than 
the cut score) 
*MILD (two 
symptoms), 
*MODERATE (three or 
four symptoms), 
*ALL HIGH (four 
symptoms). 
 
At T3, three 
subgroups were 
identified: 
*MILD 
*MODERATE 
*ALL HIGH. 
 
Subgroups with high 
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changes 
over time. 
severity levels of all 
four symptoms had 
poorer functional 
status and QOL at 
each time point than 
other subgroups 
(p<0.001). 
 
 
(Lui et al. 
2010) 
 
 
Not detailed To explore the 
associations 
between a pre-
treatment 
cluster (sleep 
disturbance, 
fatigue and 
depression) and 
longitudinal 
profiles of the 
same symptoms 
during 
chemotherapy 
Quantitative
, 
prospective, 
longitudinal 
study design 
Homogeneous 
Breast cancer 
n=76 
 
 
*Pittsburg Sleep 
Quality Index 
(Buysse et al. 
1989) 
*Multidimensional 
Fatigue Symptom 
Inventory- Short 
Form (Stein et al. 
1998) 
*Center of 
Epidemiological 
Studies – 
Depression 
(Sheehan et al. 
1995) 
ANOVA 
Pearson 
Correlation 
Analysis 
*All women reported 
more sleep, fatigue 
and more depressive 
symptoms compared 
to baseline 
*Women with more 
pre-treatment 
symptoms continued 
to experience worse 
symptoms during 
treatment than those 
who began with fewer 
(Cheung 
et al. 
2009) 
Not detailed To characterize 
the patterns of 
symptom 
clusters among 
advanced cancer 
outpatients and 
to explore the 
impact of 
different cancer 
sites on these 
Prospective, 
quantitative 
study design 
Heterogeneous 
n =  1366 
 
 
*Edmonton 
Symptom 
Assessment Scale 
(Bruera et al. 1991) 
Principal 
component 
analysis 
 
 
Cronbach‟s 
alpha 
coefficient 
 
 
*Cluster 1 – fatigue, 
drowsiness, nausea, 
decreased appetite 
and dyspnoea 
*Cluster 2- anxiety 
and depression 
 
Two clusters identified 
for each cancer site: 
*CNS:Cluster A – 
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clusters anxiety, depression 
and wellbeing 
Cluster B – pain, 
drowsy, fatigue and 
dyspnoea 
*Head and Neck:  
Cluster A: anxiety, 
depression, fatigue, 
dyspnoea and 
wellbeing 
Cluster B: pain, 
drowsy, appetite, 
nausea 
*Breast: 
Cluster A: anxiety, 
depression, drowsy, 
nausea 
Cluster B: appetite, 
wellbeing, dyspnoea 
*Lung cancer: 
Cluster A: Anxiety and 
depression 
Cluster B: Appetite, 
wellbeing, pain 
*GI: 
Cluster A: Anxiety, 
depression, nausea, 
pain, drowsy 
Cluster B: Appetite, 
wellbeing, fatigue and 
dyspnoea 
*GU: 
Cluster A: Anxiety, 
depression, nausea 
Cluster B: Appetite, 
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wellbeing, fatigue and 
pain 
*Gynaecological: 
Cluster A: Anxiety and 
depression 
Cluster B: Appetite, 
wellbeing and fatigue 
*Haematological: 
Cluster A: Anxiety, 
drowsy, fatigue, 
dyspnoea 
Cluster B:  Appetite, 
nausea 
*Anxiety and 
depression 
consistently clustered 
together in solid 
tumours regardless of 
disease type 
*Pain and drowsiness 
clustered together for 
cancers of the CNS 
and head/neck 
*Decreased appetite 
and poor general 
wellbeing clustered 
together for breast, 
lung, GI, GU and GYN 
malignancies 
*Cluster of anxiety, 
drowsiness, fatigue 
and dyspnoea was 
unique to 
haematological 
malignancies 
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(Finnegan 
et al. 
2009) 
Not detailed To identify: 
*sub-groups of 
adult cancer 
survivors using 
self reports of 
frequency, 
severity and 
distress rating 
for 8 symptoms 
(lack of energy, 
worry, pain, 
difficulty 
sleeping, feeling 
irritable, feeling 
nervous, 
difficulty 
concentrating 
and feeling sad) 
Prospective, 
quantitative 
study design 
Heterogeneous 
n=100 
 
 
*MSAS (Portenoy et 
al. 1994) 
*Health promoting 
lifestyle profile 
(Walker et al. 1987) 
*The Ferrans and 
Powers Quality of 
Life Index:  Cancer 
III version (Ferrans 
1990) 
Latent 
variable 
mixture 
modules 
Cluster of 8 symptoms 
identified: 
lack of energy, worry, 
pain, difficulty 
sleeping, feeling 
irritable, feeling 
nervous, difficulty 
concentrating, and 
feeling sad 
 
(Kim et 
al. 2009) 
Not detailed To determine 
the occurrence 
rates for 
symptoms and 
the severity of 
symptoms at the 
middle, end and 
1 month after 
the completion 
of radiotherapy 
treatment, to 
determine the 
number and 
types of 
symptom 
clusters at these 
time points to 
Prospective, 
longitudinal 
study design 
Heterogeneous  
n=160 
 
 
*MSAS (Portenoy et 
al. 1994) 
Exploratory 
factor 
analysis 
Although not identical 
for all three time 
points, 3 relatively 
similar symptom 
clusters were 
identified in the study 
sample over time: 
*mood-cognitive 
cluster 
*sickness-behaviour 
cluster 
*treatment-related 
or pain symptom 
cluster 
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evaluate for 
changes over 
time in these 
symptom 
clusters 
(Wilmoth 
et al. 
2009) 
 
 
Theory of 
Unpleasant 
Symptoms 
(Lenz and 
Pugh 2008) 
To provide initial 
validation of a 
proposed 
symptom cluster 
of fatigue, 
weight gain, 
psychological 
distress, and 
altered sexuality 
in breast cancer 
survivors 
Descriptive, 
cross 
sectional 
study 
Homogeneous 
Breast cancer 
n=15 
*Piper Fatigue Scale 
(Piper 1987) 
*Profile of Mood 
States (McNair et 
al. 1992) 
*Wilmoth sexual 
behaviours 
questionnaire 
(Wilmoth and Tingle 
2001) 
*Demographic data 
form 
Linear 
regression 
Clustering of all 
symptoms observed in 
7 patients 
Clusters of three 
symptoms occurred in 
3 patients 
One patient only 
experienced one of the 
four symptoms 
(Yamagis
hi et al. 
2009) 
Not detailed To clarify the 
prevalence of 
physical and 
psychological 
symptoms and 
concerns among 
a representative 
sample of cancer 
patients 
receiving 
chemotherapy in 
the outpatient 
setting and to 
evaluate 
symptom 
clusters in this 
study population 
Quantitative 
prospective, 
longitudinal 
study design 
Heterogeneous  
n=462 
 
 
 
 
*Brief screening 
interview for 
adjustment 
disorders(Akizuki et 
al. 2003) 
*Japanese version 
of the 
M.D.Anderson 
Symptom Inventory 
(Okuyama et al. 
2003) 
*The EORTC QLQ-
C15-PAL (Groenvold 
et al. 2006) 
*Impact 
thermometer for 
use in combination 
with the Distress 
Cluster 
analysis 
Three symptom 
clusters identified: 
*Fatigue and 
somnolence 
andPain, dyspnoea, 
and numbness 
*Nausea, appetite loss 
and constipation 
*Psychological distress 
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Thermometer as a 
brief screening tool 
for adjustment 
disorders and/or 
major depression 
(Akizuki et al. 
2005) 
*Cancer Needs 
Questionnaire 
(Cossich et al. 
2004) 
(Bender 
et al. 
2008a) 
Not detailed To identify and 
compare 
symptom 
clusters in 
individuals with 
chronic health 
problems with 
cancer versus 
individuals with 
chronic health 
problems who 
do not have 
cancer. 
Exploratory, 
secondary 
analysis of 
data 
 
 
Heterogeneous  
n=746 
 
 
*Comorbidity 
Questionnaire 
(Charlson et al. 
1987) 
*CRCD 
Sociodemographic 
Scale 
Exploratory 
factor 
analysis 
Clusters for total 
sample: 
*cluster 1:  shortness 
of breath, chest 
palpitations, chest 
pain, abdominal pain, 
back pain 
*Cluster 2: night 
sweats, fatigue, 
nausea and vomiting 
*Cluster 3:  leg or arm 
weakness, generalised 
pain, joint pain, 
walking problems, 
balance problems 
*Cluster 4:  weight 
loss, weight gain, loss 
of appetite, over-
eating 
 
Cancer History: 
*Cluster 1:  skin rash, 
itching, night sweats, 
constipation, dizziness 
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standing, abdominal 
pain, back pain 
*Cluster 2:  fatigue, 
nausea, diarrhoea, 
generalised pain, 
sleeping problems 
*Cluster 3:  leaking 
urine, frequent 
urination, walking 
problems, balance 
problems 
*Cluster 4:  weight 
gain, over eating, 
shortness of breath, 
chest palpitations, 
joint pain 
 
No cancer history: 
*Cluster 1:  shortness 
of breath, chest 
palpitations, chest 
pain, back pain 
*Cluster 2:  night 
sweats, fatigue, 
nausea, diarrhoea, 
abdominal pain, sleep 
problems 
(Chow et 
al. 2008) 
Not detailed To explore the 
presence of 
symptom 
clusters in 
patients with 
brain 
metastases and 
if they change 
Prospective, 
longitudinal 
study design 
Heterogeneous  
n=170 
 
 
*Edmonton 
Symptom 
Assessment Scale 
(Bruera et al. 1991) 
Principal 
component 
analysis 
with 
varimax 
rotation 
 
Cronbach‟s 
Three symptom 
clusters found at 
baseline: 
*Cluster 1: fatigue, 
drowsiness, shortness 
of breath and pain 
*Cluster 2:  anxiety 
and depression 
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with whole brain 
irradiation 
 
alpha *Cluster 3:  poor 
appetite, nausea, and 
poor sense of well 
being 
(Hadi et 
al. 
2008a) 
Not detailed To validate the 
symptom cluster 
identified in a   
previous study 
(Hadi et al. 
2008b) 
Quantitative 
prospective, 
longitudinal 
study design 
Heterogeneous  
n=57 
 
 
*Brief Pain 
Inventory 
 
 
Principal 
component 
analysis 
with 
varimax 
rotation 
Two symptom clusters 
identified: 
 
*Cluster 1: worst pain 
and interference with 
general activity, 
normal work and 
walking ability 
*Cluster 2:  
interference with 
mood, sleep, 
enjoyment with life, 
and relations with 
others 
 
 
 
(Maliski 
et al. 
2008) 
Not detailed To identify 
symptom 
clusters that 
include urinary 
and erectile 
dysfunction 
among men 
treated with 
prostate cancer 
Secondary 
analysis of 
data 
Homogeneous 
Prostate cancer 
n=402 
 
 
PCI-SF – quality of 
life questionnaire 
for men with 
prostate cancer 
(Litwin et al. 2004) 
 
Medical Outcomes 
Study Short Form, 
version 2 (SF-36) 
(Ware and 
Sherbourne 1992) 
Four 
analytic 
approaches 
used: 
*Frequency 
and co-
occurrence 
(symptom-
based) 
*Correlatio
ns 
(symptom-
based) 
Composition of the 
clusters was not 
consistent 
 
Emotional distress and 
fatigue figured 
prominently in all 
analytic methods 
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*Factor 
analysis 
(symptom 
based) 
*Cluster 
analysis 
(patient –
based) 
 
(Olson et 
al. 2008) 
Not detailed To develop a 
causal model of 
the relationships 
between 
symptoms in 
cancer palliative 
care patients as 
they approach 
death and 
investigate the 
changing 
associations 
among the 
symptoms and 
between those 
symptoms and 
wellbeing 
Secondary 
analysis of 
data 
Heterogeneous 
n=82 
 
 
 
 
Edmonton 
Symptom 
Assessment Scale 
(Bruera et al. 1991) 
 
 
Structural 
equation 
modelling 
 
 
*Model fit was 
acceptable and 
explained between 
26% and 83% of the 
variation in appetite, 
tiredness, depression 
and wellbeing. 
*Drowsiness displayed 
consistent effects on 
appetite, tiredness 
and wellbeing. 
*Anxiety‟s effect on 
wellbeing shifted 
importantly, with a 
direct effect and 
indirect effect through 
tiredness at one 
month being replaced 
by an effect working 
exclusively through 
depression at one 
week. 
Yeh et al, 
2008 
Not detailed To derive 
symptom 
clustering in a 
large group of 
Descriptive 
correlation 
study 
 
Heterogeneous  
n = 144 
 
 
*M-SAS Children 
(Collins et al. 2002) 
*Play Performance 
Scale for Children 
Cluster 
analysis 
Five clusters of 
symptoms identified: 
*Cluster 1:  
Symptoms related to 
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older paediatric 
patients with 
cancer in Taiwan 
and to examine 
whether each 
cluster differed 
based on 
gender, type of 
cancer and 
disease, pain 
and functional 
status 
 (Lansky et al. 1987) 
*Hospital records 
used to collect data 
on patient 
characteristics, 
disease information, 
demographic data 
collected from 
parents 
sensory discomfort 
and body image 
(internal concerns) – 
dry mouth, itching, 
diarrhoea or loose 
bowel movement, 
numbness or tingling 
or pins and needles 
feelings in the hands 
or feet, changes in 
skin, feeling of being 
nervous, I do not look 
like myself 
*Cluster 2:  
Symptoms related to 
circulatory and 
respiratory system 
malfunction:  
shortness of breath, 
dizziness, swelling of 
arms or legs, cough, 
problems with 
urination 
*Cluster 3:  Fatigue, 
sleep disturbance and 
depression:  difficulty 
concentrating or 
paying attention, 
difficulty sleeping, lack 
of energy, feeling of 
being drowsy, feelings 
of sadness, worrying, 
feeling of being 
irritable, sweating 
*Cluster 4:  Body 
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image (external 
concern) and eating 
difficulties:  weight 
loss, hair loss, mouth 
sores, constipation or 
feeling uncomfortable 
because bowel 
movements are less 
frequent, difficulty 
swallowing 
*Cluster 5:  
Symptoms related to 
gastrointestinal 
irritation and pain:  
nausea, vomiting, lack 
of appetite, pain, 
changes in the way 
food tastes 
*Cluster 5:  boys 
reported higher 
distress than girls 
(p<0.05); patients 
with leukaemia 
experienced more 
distress in cluster 3 
than patients with 
other tumours. 
Patients with pain 
reported statistically 
higher distress in all 
five clusters 
(Chen 
and Lin 
2007) 
Not detailed *To validate the 
three clusters of 
symptoms 
identified in 
Secondary 
analysis 
Heterogeneous  
n=321 
 
 
MDASI –T (Lin et al. 
2007) 
Confirmator
y factor 
analysis 
*3 symptom clusters 
(sickness, 
gastrointestinal, 
emotional) were 
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previous study 
(sickness, 
gastrointestinal, 
emotional) in a 
larger sample of 
patients. 
*To examine 
how four 
disease/ 
treatment 
variables 
(diagnosis, 
disease stage, 
cancer 
treatment and 
hospitalisation) 
were associated 
with the three 
symptom 
factors. 
 replicated in different 
sample 
*Higher scores for 
each cluster 
associated with poorer 
functional status 
*Metastatic disease, 
receiving concurrent 
chemotherapy and 
radiotherapy 
associated with poorer 
functional status 
 
 
 
 
 
 
 
(Chow et 
al. 2007) 
Not detailed To explore 
whether bone 
pain „clusters‟ 
with other 
symptoms in 
patients with 
bone metastases 
Quantitative
,prospective
,longitudinal 
study design 
Heterogeneous  
n=518 
 
 
Edmonton 
Symptom 
Assessment Scale 
(Bruera et al. 1991) 
 
 
Principal 
component 
analysis 
with 
varimax 
rotation 
Three symptom 
clusters were 
identified: 
 
Cluster 1: fatigue, 
pain, drowsiness, and 
poor sense of well 
being 
Cluster 2: anxiety and 
depression 
Cluster 3:  shortness 
of breath, nausea and 
poor appetite 
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(Fox et 
al. 2007) 
Theory of 
Unpleasant 
Symptoms 
(Lenz et al. 
1997) 
To describe the 
co-occurring 
symptoms 
(depression, 
fatigue pain, 
sleep 
disturbance and 
cognitive  
impairment),  
quality of life 
and functional 
status in 
patients with 
high grade 
glioma 
Descriptive, 
correlational 
study 
Homogeneous 
high grade 
glioma 
n=73 
 
 
*Cognitive 
Functioning Sub-
scale of the Medical 
Outcomes Scale 
(Hays and Stewart 
1992) 
*Depression 
Subscale of the 
Hospital Anxiety 
and Depression 
Scale (Zigmond and 
Snaith 1983) 
*The Brief Pain 
Inventory (Serlin et 
al. 1995) 
*The Brief Fatigue 
Inventory (Mendoza 
et al. 1999) 
*Sleep Disturbance 
Scale (Lee 1992) 
*Physical, 
Functional and 
Brain Subscales of 
the Functional 
Assessment of 
Cancer Therapy 
Scale (Weitzner et 
al. 1995) 
*The Fox Simple 
Quality of Life Scale 
(Fox 2004) 
 
 
Correlation 
 
Hierarchical 
multiple 
regression 
analysis 
 
 
Significant inter-
correlations 
demonstrated between 
the co-occurring 
symptoms 
(depression, fatigue, 
sleep disturbance, 
cognitive impairment).  
(Depression and pain 
not inter-correlated). 
 
*Cluster 1:  
Depression, fatigue, 
sleep disturbance and 
cognitive impairment  
significantly correlated 
with quality of life 
*Cluster 2:  
Depression, fatigue, 
sleep disturbance, 
cognitive impairment  
and pain significantly 
correlated with 
functional status 
 
Depression accounted 
for 26% of the 
variance in quality of 
life, other cluster 
symptoms displayed 
minimal contributions 
 
Depression explained 
56% of the variance in 
functional status and 
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pain explained an 
additional 5%.  Other 
cluster symptoms 
explained only 1% in 
variance of functional 
status 
(Molassiot
is et al. 
2008) 
Not detailed To explore the 
experience of 
chemotherapy 
related nausea 
in patients with 
cancer. 
Qualitative, 
descriptive 
study 
Heterogeneous 
sample 
n=17 
 
 
Single, semi-
structured 
interviews 
Content 
analysis 
(Strauss 
and Corbin 
1990) 
Range of symptoms 
linked with nausea 
were described by 
patients, these were 
categorised as 
concurrent (those that 
were not consistently 
present with nausea) 
and associated 
symptoms (those 
symptoms that 
participants clearly 
described as 
temporally occurring 
in conjunction with 
nausea). 
 
Concurrent symptoms 
(number of 
quotations):  sleep 
disturbance (n=4), 
fatigue (n=7), bloating 
(n=2), sore throat 
(n=2), sweating (n-2), 
weakness (n=4), 
dizziness (n=1) and 
headache (n=2), flu 
like symptoms (n=3) 
and feeling hot and 
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cold (n=2).  
Combinations of these 
symptoms were also 
present when nausea 
developed. 
 
Associated symptoms 
i.e. those clearly 
occurring in 
conjunction with 
nausea – burping 
(n=1) associated with 
a hot sensation (n=1), 
a „feeling [of needing] 
to swallow, push 
things down‟ n=1) and 
regurgitation (n=1); 
intolerance of smells 
(n=1), taste 
disturbance (n=7), 
loss of appetite 
(n=15), vomiting 
(n=11) dry heaves 
(n=4).  Frequently 
associated symptoms 
emerged including loss 
of appetite, vomiting 
and taste changes and 
they often occurred 
simultaneously 
suggesting a possible 
symptom cluster‟ 
(Barsevic
k et al. 
2006a) 
Not detailed To test, through 
secondary 
analysis , a 
Secondary 
analysis of 
data 
Heterogeneous 
n= 295 
 
*The General 
Fatigue Scale (Meek 
et al. 1997) 
Hierarchical 
multiple 
regression 
Mediation model failed 
in the intervention 
group 
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mediation 
hypothesis 
about the direct 
and indirect 
relationships 
between fatigue 
and depressive 
symptoms 
through a 
pathway 
including 
functional status 
 
Mediation 
hypothesis – 
proposed that 
functional status 
was a mediator 
between fatigue 
and depressive 
symptoms 
*The Functional 
Performance 
Inventory (Leidy 
1999) 
*The Short Form of 
Profile Mood States 
(McNair et al. 1992) 
 
 
analysis  
Control group – part 
mediation reported 
(43%) of the total 
mediated effect – 
state that the 
mediation hypothesis 
was supported 
 
 
 
 
(Fox and 
Lyon 
2006) 
Theory of 
Unpleasant 
Symptoms 
(Lenz et al. 
1997) 
To explore the 
prevalence and 
intensity of 
depression, 
fatigue and pain 
in survivors of 
lung cancer, to 
examine the 
relationship of 
symptoms in a 
cluster and to 
examine the 
relationship of 
the symptom 
Secondary 
analysis 
 
Homogeneous 
Lung cancer 
n=51 
 
 
*Questionnaires – 
Short Form 36 
Health Status 
Survey 
*Quality of life – 
Fox Simple Quality 
of Life Scale(Fox 
2004) 
Pearson‟s 
correlation 
and 
multiple 
regression 
analysis 
Two significant 
correlations were 
depression and 
fatigue.  The cluster 
explained 29% 
(p<0.01) of the 
variance in quality of 
life in lung cancer 
survivors 
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cluster to quality 
of life 
(Glaus et 
al. 2006) 
Not detailed To explore the 
occurrence and 
frequency of 
menopausal 
symptoms in 
women with 
breast cancer 
undergoing 
cancer 
treatment and to 
investigate their 
relationship with 
fatigue 
Prospective, 
cross 
sectional 
study 
Homogeneous 
Breast cancer 
n=373 
 
 
*Clinical Checklist 
for Patients with 
Endocrine 
Therapy(Hopwood 
1998) 
*International 
Breast Cancer 
Study Group Linear 
Analogue Scales 
addressing the side 
effects of hormonal 
treatment and 
coping with disease 
and treatment 
(Bernhard et al. 
1997) 
Cluster 
analysis 
Cluster of menopausal 
symptoms identified – 
hot flashes, weight 
gain, tiredness, 
decreased sexual 
interest and vaginal 
dryness 
(Hoffman 
et al. 
2006) 
The Theory of 
Unpleasant 
Symptoms 
(Lenz et al. 
1997) 
To examine the 
relationships 
among pain, 
fatigue, 
insomnia and 
gender while 
controlling for 
age, co-
morbidities and 
stage in patients 
newly diagnosed 
with lung cancer 
Secondary 
analysis 
Homogeneous 
Lung cancer  
n=80 
 
 
*Cancer Symptom 
Experience 
Inventory (Given 
and Given 2002) 
*Co-morbidity 
questionnaire (Katz 
et al. 1996) 
Multinomal 
log-linear 
modelling 
used 
A model containing all 
main effects (two-way 
interactions of pain 
and fatigue, pain and 
insomnia, and 
insomnia and gender , 
and the three-way 
interaction of pain, 
fatigue and insomnia 
along with the three 
covariates (age, 
comorbidites, and 
stage of cancer) was a 
good fit to the data.  
*Parameter estimates 
indicated that a 
statistically significant 
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effect from the model 
was the three- way 
interaction of pain, 
fatigue and insomnia – 
co-variates did not 
make a difference. 
*Symptom cluster 
exists consisting of 
pain, fatigue and 
insomnia 
(Miaskow
ski et al. 
2006) 
Not detailed To identify 
subgroups of 
outpatients with 
cancer based on 
their 
experiences with 
the symptoms of 
fatigue, sleep 
disturbance, 
depression and 
pain; to explore 
whether patients 
in the subgroups 
differed on 
selected 
demographic , 
disease and 
treatment 
characteristic 
and to 
determine 
whether patients 
in the subgroups 
differed on two 
important 
Descriptive, 
correlational 
study 
Heterogeneous 
sample 
n=191 
 
 
*Karnofsky 
Performance Status 
Scale (Karnofsky et 
al. 1948) 
*Lee Fatigue Scale 
(Gay et al. 2004) 
*General Sleep 
Disturbance Scale 
(Dorsey et al. 2004) 
*Center for 
Epidemiological 
Studies-Depression 
Scale (CES-D) 
(Carpenter et al. 
1998) 
*Multidimensional 
Quality of Life Scale 
Cancer (Ferrell et 
al. 1989) 
 
*Descriptive 
numeric rating scale 
for worst pain 
intensity (Jensen 
2003) 
Clusters 
analysis 
The cluster analysis 
procedure identified 4 
relatively distinct 
subgroups of patients.  
*Those who reported 
low levels of all four 
symptoms (35%), 
*Those who reported 
high levels of all four 
symptoms (15%) 
*Those who reported 
high levels of fatigue 
and low levels of pain 
(35%) 
*Those who reported 
low levels of fatigue 
and high levels of pain 
(15%). 
 
Patients categorised in 
the „all low‟ subgroup 
reported higher quality 
of life scores than 
those in the other 
three subgroups 
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patient 
outcomes; 
functional status 
and quality of 
life 
 
 
(p≤0.01).  No 
differences were found 
between patients in 
the high fatigue and 
low pain and low 
fatigue and high pain 
groups.  Patients in 
the „all high‟ subgroup 
reported lower quality 
of life scores that the 
other three subgroups 
(p≤0.001). 
(Reyes-
Gibby et 
al. 2006) 
Not detailed To evaluate 
whether 
respondents of a 
survey of a 
nationally 
representative 
sample of adults 
aged 50 or over 
with a history of 
cancer had 
excess risk of 
pain, depression 
and fatigue.  To 
compare the 
clustering/co-
occurrence of 
symptoms 
between those 
with a history of 
cancer and 
those without. 
Secondary 
data 
analysis 
Heterogeneous 
sample 
n=17,210 
 
 
*Single questions 
on pain and fatigue. 
*Center for 
Epidemiologic 
Studies on 
Depression (CES-
D).  (Carpenter et 
al. 1998) 
Chi-square 
tests. 
 
Multivariate 
analysis 
Statistically significant 
differences (p<0.001) 
were observed for the 
occurrence of pain and 
fatigue cluster, fatigue 
and depression cluster 
and pain-depression 
and fatigue cluster 
between those with 
and those without a 
history of cancer 
 
Those with a history of 
cancer higher risk of 
experiencing symptom 
clusters 
(Wang et 
al. 2006) 
Not detailed The aim of this 
study was to 
Quantitative 
longitudinal, 
Homogeneous 
Lung cancer 
M.D.Anderson 
Symptom Inventory 
Mixed 
effect 
Four clusters of 
symptoms with unique 
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establish a 
profile of the 
development of 
different 
symptoms over 
the time of 
therapy and to 
examine 
symptom related 
functional 
interference in 
patients with 
non-small cell 
lung cancer 
undergoing 
concurrent 
chemotherapy 
prospective 
study design 
n=64 
 
 
(Cleeland et al. 
2000) 
growth 
curve 
models 
temporal relationship 
to the course of CXRT 
were identified. 
*Cluster 1:  rates of 
change for both pain 
and sore throat 
steadily and 
significantly increased 
in severity over the 
course of therapy and 
then decreased in the 
post therapy phase 
*Cluster 2:  showed a 
rapid increase in 
therapy related GI 
toxicities, including 
nausea and vomiting, 
in the early and mid 
CXRT periods. 
*Cluster 3: non-
specific symptoms 
that included fatigue, 
lack of appetite, 
drowsiness, sleep 
disturbance, dry 
mouth and distress, 
reflected an increase 
in severity in both the 
early and late therapy 
periods. 
*Cluster 4: included 
affective symptoms 
such as sadness, 
cognitive issues 
(difficulty 
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remembering), and 
other disease or 
treatment related 
symptoms (shortness 
of breath, cough and 
numbness) – no major 
change in severity 
over the course of 
treatment 
*Cluster 3:  has the 
highest predictive 
value for total 
interference with daily 
activities followed by 
cluster 4, cluster 1 
and cluster 2. 
(Chan et 
al. 2005) 
Theory of 
Unpleasant 
Symptoms 
(Lenz et al. 
1997) 
To assess the 
existence of a 
symptom cluster 
involving 
breathlessness, 
fatigue and 
anxiety in 
patients with 
advanced lung 
cancer 
undergoing 
palliative 
radiation 
Quantitative 
prospective, 
longitudinal 
study design 
Homogeneous 
Lung cancer 
n=27 
 
Visual analogue 
scales measuring 
the intensity of 
breathless, anxiety 
and fatigue 
Pearsons 
product-
moment 
correlation 
 
Spearman 
coefficients 
The correlations 
between the three 
symptoms were 
moderately strong 
(r=0.49 – 0.75).  The 
proposed symptom 
cluster had high 
internal consistency 
across T0-T2.  These 
data support the 
notion that the 
symptoms may be 
viewed as a symptom 
cluster 
(Ridner 
2005) 
Not detailed To compare the 
quality of life 
and symptoms 
between breast 
cancer survivors 
Cross 
sectional, 
mixed 
methods 
study 
Homogeneous 
Breast cancer 
n=64 
 
 
Quantitative data:  
*sociodemographic 
information, 
medical data, BMI, 
arm extra cellular 
Logistic 
regression 
equations 
 
Qualitative 
A symptom cluster 
that included 
alteration in limb 
sensation, loss of 
confidence in body, 
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who have 
developed and 
undergone 
treatment for 
chronic 
lymphoedema 
with those who 
have not 
developed 
lymphoedema 
fluid volume. 
*Quality of life: 
FACT-B (Cella 
1997) and FACT-B 
Plus 4 Subscale 
(Coster et al. 2001) 
*Upper Limb 
Lymphoedema 
Scale(Launois and 
Alliot 2000) 
 
Symptoms:  
*Symptoms 
Checklist 
(developed by the 
PI) 
 
Depressive 
symptoms:  
*(Carpenter et al. 
1998) 
*Profile of Mood 
States (POMS-SF) 
(Curran et al. 1995) 
 
Qualitative data: 
Patients with 
lymphoedema 
responded in 
writing to the 
question:  during 
the past week what 
other difficulties 
have you 
experienced 
data:  
transcribed, 
content 
analysed, 
peer 
reviewed 
and 
categories 
identified. 
decreased physical 
activity, fatigue, and 
psychological distress 
was identified 
 
Symptom cluster 
findings were 
supported by 
responses to the 
question posed – 
„when responses were 
categorised, ten 
themes emerged – 
psychological distress, 
altered arm sensation, 
fear of injuring arm, 
fatigue, poorly 
educated health 
professional, sleep 
disturbance, infection, 
treatment 
limitations/benefits, 
secondary impact on 
the body, and change 
in wardrobe/jewellery 
use.  Interestingly, as 
in the quantitative 
instruments, pain and 
depression were 
absent from these 
narratives. 
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because of your 
lymphoedema? 
(Carpente
r et al. 
2004) 
Not detailed To compare 
sleep quality and 
disturbance, 
fatigue and 
depressive 
symptoms 
between breast 
cancer survivors 
and healthy 
women 
experiencing hot 
flashes and to 
examine 
relationships 
among sleep 
and remaining 
variables(fatigue
, depressive 
symptoms, and 
frequency of hot 
flashes) 
Cross 
sectional, 
descriptive, 
comparative 
study 
Heterogeneous 
n=30 
*Menopausal status 
– Massachusetts 
Women‟s Health 
Study (Brambilla et 
al. 1994) 
*Sleep:  Pittsburg 
Sleep Index 
(Buysse et al. 
1989) 
*Fatigue: POMS-SF 
(Curran et al. 1995) 
*Depressive 
Symptoms: 
(Sheehan et al. 
1995) 
Non-
parametric 
Spearmann
‟s statistics 
Global sleep scores 
were significantly 
positively correlated 
with fatigue and 
depression, but not 
with flash frequency 
(Gift et 
al, 2003) 
Theory of 
Unpleasant 
Symptoms 
(Lenz et al. 
1997) 
To determine 
whether 
symptom 
clusters 
identified at the 
time of diagnosis 
remained 3 and 
6 months after 
diagnosis 
Secondary 
data 
analysis 
Homogeneous 
 
Lung Cancer 
n=112 
Physical Symptom 
Experience Tool 
(Given et al. 1993) 
*Cronbach‟
s alpha 
*Pearsons r 
correlations 
*Pearsons 
product-
moment 
correlation 
*ANOVA 
*Logistic 
regression 
The cluster of 7 
symptoms (fatigue, 
weakness, weight loss, 
appetite loss, nausea, 
vomiting, altered 
taste) remained over 
the course of lung 
cancer and is an 
independent predictor 
of the patient‟s death. 
(Wilmoth (Barton- To identify the Literature    Analysis of the 
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et al. 
2004) 
Burke 1997) 
postulated a 
cyclical 
relationship 
between 
fatigue and 
sexuality  
symptom cluster 
of fatigue, 
weight gain and 
altered sexuality 
caused by the 
treatment of 
breast cancer 
review literature suggests a 
link among the 
symptoms of fatigue, 
weight gain and 
altered sexuality. 
(Dodd et 
al. 
2001b) 
Model for 
Symptom 
Management 
(Dodd et al. 
2001a) 
To determine 
the effect of the 
symptom cluster 
of pain, fatigue, 
and sleep 
insufficiency on 
functional status 
during three 
cycles of 
chemotherapy 
Secondary 
analysis 
Heterogeneous 
n=93 
 
 
 
*Disease and 
Treatment 
Questionnaire 
(developed and 
used by 
investigative team) 
*Karnofsky 
Performance Status 
(Karnofsky et al. 
1948) 
*The Quality of Life 
Cancer (QOL-CA) 
version (Padilla et 
al. 1990) 
*Demographic 
questionnaire 
(developed and 
used by 
investigative team 
 
Two-stage 
hierarchical 
multiple 
regression 
*KPS at time 1, age, 
pain and fatigue were 
significantly correlated 
with KPS at time 2 
*Inter-correlations 
between symptoms 
(pain, fatigue, and 
sleep insufficiency) 
were low (pain to 
fatigue r=0.22, pain to 
sleep insufficiency r=-
0.06) and fatigue to 
sleep insufficiency r=-
0.13). 
*The overall 
hierarchical multiple 
regression model 
explained 48.4% of 
the variance in 
functional status 
*KPS at time 1 
explained 30.8% of 
the variance in KPS at 
time 2 
*Second step, KPS at 
time 1 partialled out 
from KPS at time 2, 
the four independent 
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variables were all 
predictors in the 
change in functional 
status between time 
points 1 and 2.  Age 
explained 11.8% of 
the change, pain 
explained 10.7% of 
the change, fatigue 
explained 7.3% of the 
change.  Sleep 
insufficiency 
statistically was not 
significant only 
explaining 1% of the 
change. 
 
 
(Given et 
al. 2001) 
Not detailed After adjusting 
for age, and 
number of co-
morbid 
conditions, does 
site and stage of 
cancer predict 
functional 
limitations prior 
to diagnosis? 
 
When compared 
with age 
adjusted 
national norms 
on physical 
functioning, how 
Mixed 
methods, 
cross 
sectional 
Heterogeneous 
n=826 
 
 
*Co-morbid 
conditions identified 
through a patient 
interview 
*Demographic, 
disease treatment 
related 
characteristic from 
case notes  
*Medical Outcomes 
Study 36-item 
Short Form (Ware 
and Sherbourne 
1992). 
*At intake interview 
patients asked to 
recall physical 
Polychromo
us logistic 
regression 
Pain, fatigue and 
insomnia has a 
consistent and 
negative effect on 
losses in functioning 
unrelated to the 
patients treatments or 
their co-morbid 
conditions 
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well does age, 
stage of cancer, 
number of co-
morbid 
conditions, 
treatments and 
clusters of 
symptoms 
explain changes 
in physical 
function 
between 3 
months prior to 
and 6 to 8 
weeks following 
diagnosis? 
functioning level 3 
months prior to 
diagnosis of cancer 
and at current time 
(6-8 weeks 
following diagnosis) 
*Symptom 
assessment, patient 
asked to report if 
within two weeks 
prior they had 
experienced pain, 
insomnia or fatigue 
plus other 
symptoms 
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Appendix 6:  Example of analysed transcript 
 
Exploratory codes Example of data analysis:  Original Transcript 
 
Dan Interview 2 
Emergent 
themes 
 
General Inquiry  
 
 
 
 
 
 
 
 
 
Wanting to make sure that 
interview is for a good cause – 
altruistic reasons? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[tape starts with patient talking] 
 
DAN: So what are you going for with this? 
 
DAN: It‟s a PhD, that I'm … 
 
DAN: PhD? 
 
ROMA Yeah, I'm trying to … hopefully 
 
DAN: And what do you get when you get the … is that you home and 
dry? 
 
ROMA Eh, well, I don‟t know if it‟s home and dry but … 
 
DAN: But you know what I mean, aye 
 
ROMA It‟s, it‟s, it‟ll help things along hopefully, it‟ll help … 
 
DAN: You? 
 
ROMA Primarily it‟ll help … 
 
DAN: You?  Us? 
 
ROMA … people like you 
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Wanting to make sure that it 
will help other people like him? 
 
 
 
 
Wants to makes sure that the 
results of the study are used 
to help others like him?   
 
Making sure his data will be 
used – not sure why he is 
saying this – some distrust 
from past experiences? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAN: Oh right, aye 
 
ROMA … you know to understand about your experiences … 
 
DAN: Uh huh, aye, aye 
 
ROMA … the symptoms that your experiencing to try and … 
 
DAN: And will you move about when you get this PhD or will you be 
studying at, staying permanent in a permanent position, in, in a unit 
somewhere? 
 
ROMA It‟s, it‟s the Cancer Care Research Centre, so we do a lot 
… 
 
DAN: Oh right 
 
ROMA … a lot of research around this area, so … 
 
DAN: Aye, aye, aye, aye 
 
ROMA I‟d like to stay there 
 
DAN: Aye so it‟s, it‟s … 
 
ROMA all tied in 
 
DAN: It‟s all tied in, aye, aye, aye.  You‟re no drifting away fae 
something … 
 
ROMA No 
 
DAN: No, no 
 
ROMA No, if I do I‟ll make sure I use it, I would never …  
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Does he really not care or is 
he just saying this? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Praising health professionals- 
putting them on a pedestal – 
why? – reliance on them to 
live in light of being diagnosed 
with a life limiting illness 
 
Does he really think this – 
they way he is describing the 
system is like a conveyor belt 
– has to think this way to cope 
with what is happening to him 
 
DAN: Aye, aye 
 
ROMA … you‟ve given me your time 
 
DAN: Aye, no, no, I wondered what you were … I'm only asking the 
question like, at the end oh the day I'm no caring what you dae wi' it, 
it‟s been a pleasure geing you my advice but I just wondered what you 
were going to do wi' that 
 
 
 
ROMA Mmm mmm, well it‟s hopefully to understand what's 
going on and then try and manage symptoms better, understand 
from your perspective  … 
 
DAN: Aye, being the patient 
 
ROMA … which to me is really, really important 
 
DAN: Aye, aye, aye being the patient is important I suppose 
 
ROMA Oh it is 
 
DAN: I mean you go tae, you, you got to various consultants and folk 
eh, they're very nice but they meet you and a quarter of an hour later 
they're meeting somebody else, I mean I don‟t know how eh, they 
remember you at times, because you‟re sitting talking away to them, 
they're no reading their notes and all of a sudden they‟ll come and say 
to you, oh you had this, that and the next thing on such and such a 
date, and your saying, how the hell does he remember, the amount of 
peoples he's meeting in a week, he can pin point you to a certain article 
or a certain thing, it amazes me how a, any consultant of any … can go 
back and say, Ok, he has‟nae had time obviously tae read your notes 
that day because it‟s boom, boom … you know it just, basically well I‟ll 
 
 
 
 
 
 
 
 
 
 
 
 
Reliance on 
health 
professional to 
live 
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Comfort in feeling that health 
professionals are dedicated to 
him – does he feel that his life 
is in their hands?  Coping 
mechanism? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes tone and direction of 
the interview – does this a lot 
when talks about things that 
he finds upsetting –does not 
like to display any 
weakness.... 
 
 
 
 
 
More important things on his 
mind than the last interview?  
say quarter of an hoor, every quarter of a hoor, it‟s no, no really that 
but you know what I mean, they're maybe, you‟ve got so many 
patients in the morning, so many patients in the afternoon, well he 
has‟nae got time tae read aw your minutes and then the next day he's 
away somewhere else, so he's reading someone else‟s notes and it 
amazes me just exactly 
 
ROMA How they just pick it up 
 
DAN: How they pick it up.  Photographic memory is, is a one way of 
putting it, I don‟t think it‟s photographic memory, I think it‟s dedication 
 
ROMA Yeah, yeah.  I think to do the job … 
 
DAN: Dedicated 
 
ROMA … you‟ve got to be dedicated to it 
 
DAN: Dedication ( sounds emotional) 
 
ROMA It‟s good to know that and know that isn‟t it … 
 
DAN: Right, where are we going 
 
ROMA OK, so it‟s just to say thanks for agreeing to take part … 
 
DAN: No problem 
 
ROMA … in this next interview em, and first of all I'm just going 
to ask you em, can you tell me about any thoughts that you‟ve 
had concerning the things that we talked about last time, 
anything that‟s … 
 
DAN: Do you want the honest truth?  Never gave it a thought 
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Wanting to please – be a good 
patient – scared of getting 
things wrong? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Uses humour a lot – coping 
ROMA OK 
 
DAN: I'm being perfectly honest wi' yae, you walked oot that door and 
I says a very nice lady, I enjoyed the talk wi' her and I never gave it 
another thought 
 
ROMA OK 
 
DAN: So you might be disappointed in that 
 
ROMA No, no, it‟s just to see if there's anything … 
 
DAN: No 
 
ROMA … like you know when I, when I went away 
 
DAN: If I've gave you the wrong answer … 
 
ROMA No, there's no right or wrong answers 
 
DAN: … I‟ll apologise, but I never gave it one more thought 
 
ROMA Oh that‟s … 
 
DAN: And I had to say to J today, you were coming tonight, I says and 
eh, we‟ll have another wee chat, and it wasn‟t till you phoned last week 
that you even entered my mind 
 
ROMA That‟s good 
 
DAN: Hmm … so … 
 
ROMA That‟s, that‟s fine.  Em … 
 
DAN: You can go hame any time you like [laughs].  No, no, naw … 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Humour – 
coping 
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mechanism 
 
 
 
 
 
 
 
 
Cancer never goes away – 
suggests significant events 
have happened over the past 
few days. 
Realistic about his prognosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Will try and help – want to 
help – altruism 
 
 
 
Giving researcher place of 
being the professional – 
modest in what he can offer  
naw it‟s just … 
 
ROMA It‟s just to say you know if I went away if there's 
anything you thought of … 
 
DAN: Naw 
 
ROMA      “maybe I should have mentioned that or did I tell the 
girl that, or …“ 
 
DAN: No, no.  It‟s just what you said earlier, it‟s the way of life.  You 
came, we had a talk, I've still got it when you went away, I never gave 
it another thought.  I gave a lot of other things a lot of thought like you 
know but, I never gave that a thought, there‟s a lot of things, other 
things had happened like you know …through this day [4.08] but eh, 
again before the end oh the night ………………. [4.12], no … 
 
ROMA OK 
 
DAN: … so fire away … 
 
ROMA So, so as I said really what I'm going to do is just really 
have a wee chat with you and mention some things that you 
mentioned in the last interview and ask you to talk about them a 
bit more or to explain them to me or things likes that 
 
DAN: If I can 
 
ROMA Yes 
 
DAN: [laughs], I maybe no 
 
ROMA Yeah, just see how it goes 
 
DAN: I‟ll maybe no…you can pit your ain words in if I tell you, I‟ll tell 
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Worst disease of all because it 
kills you?   
 
Childhood experiences of 
cancer framed negative 
perception of disease now? 
 
Associates death and 
breathlessness as being inter-
linked - ?reason why symptom 
is of such significance to him? 
Talks about it a lot in 
interviews 
 
Childhood experiences of 
cancer – STIGMA -  – avoiding 
people with the disease/ 
associated with a bad death- 
sticks in his mind – affects the 
way he views the disease 
currently? 
 
Tries to distance self from way 
he treated people with cancer 
as a child – embarrassed at 
this past actions? 
you, you can pit yer ain words in [laughs] 
 
ROMA But they‟ll all be yours - honestly  
 
DAN: Oh right, oh well 
 
ROMA Em, so you right, you‟ll remember last time we, we had a 
chat and the first I said em, you know what does cancer mean 
to you, that was the first question, that‟s … 
 
DAN: It‟s a hell oh a disease, I‟ve told you, I'm still saying that 
(laughs).  What, well when you were younger it wis‟ the hell oh aw 
diseases and in actual fact as far as I'm concerned, it‟s the hell oh aw 
diseases because it either kills you, makes you breathless, well it 
inevitably kills you, but so does a million and one other things, but 
really it‟s the last thing you want.  I mean at one time if you mentioned 
you had cancer – Jesus Christ it was like a red rag to a bull, I mean 
everybody gies you a wide berth, you know that yoursel I mean, let‟s 
be honest about it like, I mean, eh, you walk doon the street and 
somebody‟ll say – oh he's got cancer, Christ you were nearly across the 
road at one time and I'm talking in older day, I'm not talking, I'm 
talking when I was a wee boy like, so I'm going really back.  I mean 
this is before cancer, they did'nae have cures in these days but it wis, 
as far as I'm lead to believe and brought up it wis the hell oh aw 
diseases so that‟s, that‟s the only explanation, it‟s always stuck in my 
mind, you know when you were a wee boy at the school – oh Joe, Joe, 
Joe so and so‟s got cancer or, it could be cancer of the leg…it could be 
cancer anywhere, I mean there's a million and one cancers as you 
know, I mean we‟ve no aw got the same, if we hud aw the same, we‟d 
aw be the same, we‟re aw Jock Thompson‟s bairns, but we‟re no aw the 
same eh, so, eh, that‟s the only explanation and me saying that, that I 
can give you, if you can take anything oot oh that … 
 
 
 
 
 
 
 
Fear of death 
 
Childhood 
experiences of 
cancer - 
stigma 
Salient 
symptom – 
breathlessness 
– fear of death 
Childhood 
experiences of 
cancer - 
stigma 
Fear of death 
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Points out that everyone is an 
individual – is this because he 
wants to distance himself from 
the stereotypical persona of a 
person with lung cancer – still 
associates an element of 
stigma with the disease? 
 
 
 
Suggests these view points 
were very strong as a child – 
hard to shift such thoughts 
now?  Reason why they 
permeate his experiences 
now? 
 
Avoiding people with cancer 
when he was a child – uses 
humour – is he embarrassed 
about this?  Tries to point out 
that he was a child at the time 
– not fully responsible for his 
actions? 
 
Does he feel an element of 
stigma – he has something 
that no one else wants? 
 
Using social comparison to 
cope – everyone has to get 
something – he is not different 
– does this make him feel 
 
 
 
 
 
 
 
 
 
 
ROMA Mmm mmm 
 
DAN: … you know it‟s just what's kinda more drummed into you but, 
what your lead to believe, is that a better word? 
 
ROMA Mmm mmm.  From when you were a wee boy? 
 
DAN: Aye, aye, it‟s just.  You‟re at the school and you‟re going to 
school and Joe "so and so's" got this….and your saying, you know you, 
you did'nae know any better, you know … it was, just what I've said 
[laughs] … don‟t go near him, [laughs], you know, he's goat something 
naebody wants … well you have goat something naebody wants really 
at the end oh the day, but if you don‟t get this you get something else I 
suppose….in this present day and age because there's a million and one 
things in the world that‟s every bit as bad  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Childhood 
experiences of 
cancer - 
stigma 
 
 
 
 
 
Stigma and 
lung cancer 
 
 
Social 
comparison - 
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more accepted? 
 
Social comparison – there are 
other diseases that are just as 
bad 
 
Changes tone to cancer 
charities – is this because he 
wants to feel like something is 
being done to help him – 
people are looking for cures – 
HOPE?  Feels comfort in 
thinking this? 
 
 
 
Now values life – precious to 
him, in light of fear of death? 
 
Praising people who are 
involved in care of people with 
cancer – his lifeline? 
 
 
 
 
Value of life – angry that 
people making decisions re 
drugs put a price on a life – 
shows how much he values 
being alive 
 
 
 
 
 
 
 
 
 
 
....and they are trying very hard, I mean give Cancer Research due … 
eh, credit where it‟s due, they are trying hard….and in saying that, I'm 
talking about ca., and I may be talking oot..this may no be known…I 
reckon Cancer Research are doing a marvellous job but there's some oh 
the organisations bleeding it because that money that‟s going in, is'nae 
aw going tae it as far as I'm led to believe, which I think is wrong.  I 
would gie to Cancer Research numerous times but I'm led to believe on 
certain circumstances all your donations are not going to where it‟s 
supposed to be.  I may be wrong, I‟ll retract my statement if I am 
wrong, but that‟s my feelings.  You‟ll know better than me and I'm no 
asking you to say yes or no…you know, but there is certain 
organisations collecting for Cancer Research and it‟s no going but they 
are doing a marvellous job and there is more and more people 
dedicated like yoursel and em, oncologists and eh, pharmacists fighting 
to get em, pills, treatment, various types of treatment for various 
cancers and they are winning.  I mean you, you read I the paper there 
– oh there's a new, this new things out eh, but it‟s costing too much, 
what's - don‟t get me started – what is a, what's a life worth?  I mean 
hell when I got the Tarceva I could understand that it‟s a lot of money, 
so therefore they‟ve goat to apply tae the health board, irrespective of 
what health board it is, you‟ve got to apply.  Can we give this patient 
the tablet because it‟s costing X amount oh pounds per month?  My 
argument to that is, it should‟nae matter a damn what it costs a month.  
What's that man‟s life or that ladies life or that kids life worth?  You 
cannae pit a price oan life.  So why do we need to go doon that road, 
this is maybe … am I, am I going away oaf track here 
 
coping 
 
 
 
 
 
 
 
 
Value of life – 
fear of death 
 
Reliance on 
health 
professionals 
to live 
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Identified as a cancer patient 
due to his rash – did not have 
to tell her, she knew.... 
 
 
Angry at the way that the man 
was treated – value of life and 
you can‟t put a figure on it? 
 
 
 
 
Links cancer prognosis with his 
breathlessness – marginal 
increase and breathlessness 
worsens - talks about this 
symptom a lot – salient 
symptom from all the others 
he is experiencing? 
 
Use of „we‟ a lot of the time – 
feels health professionals are 
in a team with him – he is not 
alone? 
 
Does not want the answer 
because he does not really 
ROMA No but, can you tell me why you feel like that – why? 
 
DAN: Well if you, if you need something why do you no get it?  
Instead of saying and apply, I mean in England there just em, no that 
awfy long ago, there was a thing in the news there that eh, it was 
costing too much eh, for the tablets, I mean I, and in actual fact I went 
to [name of hospital] for one CT scan and there was an old chap sitting 
next to me, he‟d came up fae Man., he stayed in [town hospital is 
situated in] but he was on his own, and he was getting his treatment in 
[name of hospital] and he came up tae [town hospital is situated in] for 
his CT scan and he was sitting right next to me and his daughter said to 
me – are you on Tarceva?  I says yes, she says aye I thought that wi' 
the kinda, ken I had a light rash, and the old boy says aye, I'm oan it 
tae, he says eh, it cost me £3,000 he says, I had to buy my first lot, I 
says – you what?  He says I had to buy it, he says I'm, I'm down in 
Manchester he says, they‟ll no give me it.  So that old guy, noo he, 
Christ …he must have been late 70‟s, early 80‟s I would reckon and 
he‟d tae pit oot 3 grand to buy this Tarceva.  Noo tae me, possibly the 
guys worked aw his days like you know, this is me getting on my high 
horse by the way [laughs].  That gentleman should have deserved a bit 
of quality of life as he put it and he's, he's needing tae fork oot 3 grand 
hoping, hoping that it‟s going to cure him, we don‟t know.  When I was 
on the Tarceva, my cancer marginally increased and that‟s, well it was 
just today that I learned that they reckon this is where part of this 
breathlessness is now coming in, cause at Christmas my cancer was 
stable, it is now stable again like the last, at mid-term eh, chemo it was 
stable.  They don‟t know what it is the day like you know but em, and I 
said to J about it, she says well we don‟t really know but she says that 
marginal increase could cause enough, you know tae, tae offset your 
breathing slightly – we‟re only guessing, because see at the end of the 
day you‟ll never actually get the answer to say it was that or it wis'nae 
that, but we‟re no really wanting the answer was it that or was it that... 
 
 
 
 
 
 
 
 
 
Value of life – 
fear of death 
 
 
Breathlessness 
– salient 
symptom  
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want to know all the detail – 
some denial? 
 
 
All he cares about if his 
breathlessness can improve – 
scared of what will happen if it 
doesn‟t?  Only cares about this 
symptom? Not the others? 
 
Trying at the same time to 
blame other causes apart from 
his cancer?  Coping? 
 
Protecting health professionals 
– needs them to live? 
 
Trying to reassure himself that 
if this treatment does not work 
for his breathlessness 
something else will? 
 
 
 
 
 
Shocked at how quick his 
treatment was stopped?   
 
 
 
 
 
 
 
 
 
 
 
 
 aw we‟re wanting the answer is can the breathing come back to what it 
was prior to that, it could have [hiccups] been possibly [sorry about the 
hiccups], it could possibly have been nothing tae dae wi' it anything, it 
could have been something, it could have been a bug fae somewhere 
else, because I wis oan em, I went tae my ain doctor and I was on 
antibiotics oh Christ for about 12 weeks and they ch., they gave us eh, 
started oaf wi' obviously Amoxycillin and then they upped it to 
something else, did'nae much improve it, upped it to something else … 
it‟s trial and error but the doctors and various staff, they, they cannae 
eh, it‟s no like a motor car that‟s broken doon eh, we‟ll pit a new bit in 
it and it‟ll go, you‟ve goat tae just work through the, the various 
systems oh pills like you know and if you get one, fair enough, you‟re 
lucky, you may need two, you know but you haven‟t time ..you get 
there in the end… I think, you know, so you give them due, but again 
back to the pills eh, I think you should get them if you need them, 
that‟s my philosophy 
 
 
 
 
ROMA I think that‟s fair enough 
 
DAN: [laughs]  and on that note, when the minute they knew that my 
Tarceva wis'nae working they stopped, Dr R was on holiday at the time 
and the consultant at the time, I just forget the name he says, stop 
them as of now – now.  At that particular time I had a box oh 150 mil 
Tarceva‟s with two out it, I had a box wi' 100 mil no opened and I had a 
box half, 16 tablets oot oh a box, all in this house.  Now the box that 
wis'nae opened, was never touched, the seal was still oan it, they aw 
came individually wrapped in foil, every tablet, in a box, every wan oh 
 
 
Breathlessness 
– salient 
symptom – 
only concern is 
this symptom 
 
Minimising 
symptoms - 
coping 
Reliance on 
health 
professionals 
to live 
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Linked to previous comment – 
angry that peoples‟ lives are 
determined by money and cost  
 
 
 
 
 
 
 
Feels so strong about it would 
have broken the law.... 
 
 
 
 
 
 
 
 
 
Thinks he is talking about 
things that are not of interest 
to the researcher – always 
wants to get things right – 
scared of what happens if he 
gets things wrong. 
 
 
 
 
 
 
 
 
they tablets went back and was destroyed – noo tae me, that is where 
the National Health Board, irrespective oh where it is you live, it‟ll be 
Scotland, England, Ireland or blood Wales is losing their money.  Why 
did that pack, why did that box eh, that was never even opened, the 
carton was never even opened, it was sealed, why did that need to go 
and get destroyed?  There's naebody can gie me that answer, that‟s 
where the money‟s wasted.  Instead of saying can we afford tae gie this 
guy the tablet, the tablets that‟s not being used, genuinely not being 
used and not being opened should go back oan the shelf, because 
naebody‟s touched the damn things, it‟s a farce.  And I've, and I've said 
to the wife often, see that old guy that was doon there, see if I had 
have been sitting, I know it would have been against the law tae gie me 
them, but id have laid them doon and says – oh I‟ve accidentally left 
them there …. there a box oh Tarceva‟s – I never gave you them.  
Three grand! 
 
ROMA It‟s a lot of money 
 
DAN: ………… [15.11] you would‟nae have walked away and left three 
grand there if you were‟nae going to be buying them.  Again it wis'nae, 
I didn‟t break the law but somebody professionally could have took that 
box from me put them tae him and says – there you are, professional 
I'm saying, not willy nilly, like a consultant.  Because I mean, you‟ve 
even got X-ray machines noo that can X-ray, pin point things, the just 
stick that box through the X-ray, they can tell you whether that box has 
been tampered wi' already … you know there is ways, there is various 
ways and means oh saving money on the health … again I'm away, I'm 
maybe away miles fae you now 
 
 
 
ROMA No, no it's good to hear your, your views on what you 
think of things that are related to what you‟ve had to go through 
 
DAN: That‟s my thing oan the tablets 
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Not blaming the health 
professionals caring for him – 
they are his life line? 
 
 
 
 
 
 
 
 
 
 
 
 
Patients would not interfere 
with tablets as they are their 
life line? 
 
Why would he think that 
health professionals would not 
trust their patient – has he 
himself thought about this? 
 
 
Wants to be a good patient 
 
 
 
 
 
ROMA Mmm mmm, mmm mmm 
 
DAN: OK, it‟s different if you open a bottle, a bottles away like ken but 
… on, that, that … in my family, eh we were just talking about that on 
Sunday, my son and my daughter were just talking about the money 
that was wasted within this whole household, now this is only one 
household – how many more households?  And it‟s nothing tae dae wi' 
the consultant that‟s, that‟s prescribing the pills, it‟s just he's 
prescribing the pills tae his, the best of him knowledge, they are not 
doing with you, so therefore he's got to cancel them, so … give him a 
fighting chance 
 
ROMA Mmm mmm, mmm mmm 
 
DAN: … by giving them to someone else, stick them through a scan … 
 
ROMA Something like that 
 
DAN: There‟s naebody that going to give you a wee bloody pill, stick 
something in it, to go to aw the both eh, I mean we‟re, we being 
patients wi' cancer, the last thing on your mind is to interfere wi' 
tablets, it‟s the last thing oan your mind is to start interfering, oh I've 
to stoap taking them, you shove them in the drawer, you don‟t start 
saying, oh I‟ll dicky there up or something like, you know because 
that‟s basically what's … they're saying that we cannae use them 
because you‟ve had them … [laughs] 
 
ROMA I know it‟s … 
 
DAN: … but carry away, I‟ll no interrupt you any longer 
 
ROMA No, no as I say it‟s good to hear what you think about 
things, that‟s important, so no that was good to hear 
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Angry at drug companies and 
system for preventing people 
from accessing drugs that may 
help them – feels that they do 
not value life? 
 
 
 
 
 
 
 
 
DAN: Aye, aye, I think the expense oh the National Health is really 
needing to be … 
 
ROMA Looked at 
 
DAN: … looked at, from that perspective, where there's a tablet or a 
box oh tablets, whether it be any kind oh tablet, if it‟s never been 
opened – don‟t waste it 
 
ROMA Put it back in the system 
 
DAN: Aye 
 
ROMA aye 
 
DAN: Aye.  I mean there, there a firm there I think it was last week, 
they were geing yae, they were giving yae stuff for, is it breast cancer 
.. he, and if it did'nae work eh, you were to get it for nothing 
 
ROMA Aye, id heard that on the news 
 
DAN: … I mean that‟s something, that‟s something phenomenal isn‟t 
it? … tae, tae say that if this disnae work, you can have it for nothing, 
that‟s a drug company, so I mean, they cannae dae that … there's got 
to be a, it‟s no a con but there's got to be something somewhere along 
the lines, I mean a drug company cannae make drug, drugs are very, 
very expensive  - as we know and I don‟t know bloody much, but I 
know this much – they are expensive to develop, it‟s the developing 
stages I think that the drug…so therefore em … how can they dae it?  
But it‟s some … 
 
ROMA It is … no, no, it‟s a good point 
 
DAN: Oh aye, aye, aye 
 
 
 
 
 
 
 
 
 
 
 
 
Value of life – 
fear of death 
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Scared of causing upset – 
wants to do things right? 
 
 
Apologetic – does not want to 
cause any upset 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Realistic about prognosis  
 
 
 
 
Taking treatment to live – but 
also wants some quality to his 
ROMA Em … 
 
DAN: But as I said … they're so far advanced now 
 
ROMA mmmmm….ok 
 
DAN: Sorry about that wee burst, out-burst 
 
ROMA No 
 
DAN: [laughs] 
 
ROMA It's good to hear what you think about different things, it 
all shapes your experience that you are, so that‟s, that‟s great.  
Em, just go harping back to what we were talking at the start 
you know when I was saying what, what does cancer mean to 
you … em, when we were talking last time you said you know if 
you'd got it, you‟ll always have it … 
 
DAN: Mmm mmm … well I will anyway 
 
ROMA Minimise it as much as possible… 
 
DAN: Uh huh, aye minimise it as much as possible 
 
ROMA can you, can you explain a wee bit more about why, why 
you said that? 
 
DAN: Well you don‟t want to, you don‟t want tae have it, but when 
you‟ve goat it, I'm going for chemo at the moment and the reason I'm 
going for chemo is to minimise the cancer, so that…long-term, I‟ll live 
longer, I might be a bloody pest, but I‟ll live longer and that is why you 
want to minimise the cancer, your hear, you‟re trying to …well you get 
to my kind of age you, you‟ve maybe had your quality of life but your 
still looking for a bit of quality of life, even in retirement you‟re looking 
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life as well?  Does he have 
this? 
 
Social comparison – others like 
him – comfort in this  
Going through chemo just to 
live – sounds like he has no 
quality of life at this time – 
despite him saying earlier that 
he would like to have this – 
primacy of just being alive?  
Living another day takes over 
everything else 
 
Body tells him how he is – 
when body not „normal‟ 
indicates to him that things 
are not good- suggests that he 
feels that his body is „alien‟ to 
him – concurrent symptoms in 
determining the self –gastritis, 
heartburn 
 
 
 
Conscious of changes in his 
body due to treatment – 
symptoms not normal – not 
familiar with what is 
happening to his body – body 
is a gauge for him determining 
how he is?  Linking up 
symptoms – stomach burns, 
then „thrapple‟ – gullet burns? 
 
for a bit of quality of life, but I mean there's … again, how many folk 
sees retirement, some folks only a fortnight in retirement, so I mean 
eh, naw you don‟t want it, you cannae get rid oh it, if you cannae get 
rid oh it, the next best thing tae dae is minimise the problem.  And 
mini., and as far as I'm concerned I'm going to take chemo, I'm going 
through aw this, I definitely do not have quality of life, that is one thing 
I do not have but, I'm prepared tae pit up wi' the life I've goat to 
minimise it.  I mean there's some days em, Christ you could eh, you 
could run a mile because you don‟t just feel like, there's 9 or 10 days 
oot oh 20, you could say, oh Christ I don‟t just feel right today, like 
your stomach could be kinda a burning sensa., you know there's things 
in your body that you cannae, I could‟nae really explain to you but, you 
know it‟s, your tastes no right, your feels no right, you know there's 
just something no there, or something that should'nae be there eh, it‟s, 
but they say eh … normal, it‟s no normal … does that maybe help you?  
So therefore … 
ROMA Can you explain a wee bit more about that, about “not 
normal” 
DAN: … well I've seen me lying in bed and my stomach rumbles and 
eh, your, your all of a sudden, your stomach begins to burn and your, 
your thrapple [gullet] begins to burn but your, you‟ve no got heart-
burn, you know it, it drifts away, so whether it‟s the chemo, the drugs 
your on, or what it is, you don‟t know but your, your body must change 
wi', wi' what your taking…you know, I mean your getting chemo there 
eh, what does, what, what chemo does to me, will probably no dae the 
same to you, you know although we could be on the chemo….each body 
has a different function or each body functions differently, can I put it 
that way, so therefore what affects you, may no affect me, and what 
affects me, may no affect you, so therefore as I say em, up to well, up 
to lately I've never been put off my food and I go into hospital there 
and I see folk that are like beanpoles, cannae eat, cannae dae this …  
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Pointing out his is different 
again – trying to show that he 
is better/healthier than other 
people with a similar illness? 
 
Views weight loss as a 
discrediting characteristic – 
wants to distance himself from 
people with cancer who have 
this symptom – does he 
stigmatise them?  See‟s weight 
loss as preventing people from 
doing things – he still works, 
it‟s important to him – scared 
if he loses too much weight it 
will stop him from working? 
Linking weight loss with 
breathlessness  
Using concurrence/clusters as 
a means of finding cause of his 
symptom 
Views weight loss as being due 
to his breathing – once again 
breathlessness comes to the 
fore in his narrative- 
demonstrates how meaningful 
this symptom is to him.  
Blames much of the impact of 
his disease on this symptom 
 
Scared as he views weight loss 
with loss of functioning and 
nearing death?  
 
 
 
 
 
 
 
 
I've lost a wee bit oh weight in the last month, I‟ll be perfectly honest 
wi' yae, I have lost, maybe about 6 pund, the last month, but that‟s 
through the breathing and God knows what like, you know, cause your 
were‟nae feeling like eating.  I mean my wife makes a dinner there and 
she pits it doon in front oh me, she says a sparrow would eat mare 
some days, because she‟ll phone up and say what are you wanting, oh 
id like this for my dinner, id like that for my dinner, you drive hame and 
you drive in, then you pit your bag doon, you pit your bag and take you 
shoes oaf, wash your hands, wash your face, which I have'nae done, by 
the way em … and she pits the dinner oot in front oh yae and by the 
time you‟ve goat it in front oh yae, you don‟t want it, you take a look at 
it and you kinda peck at it like a blood hen, you know … you eat a wee 
bit but your only eating quarter because, I don‟t know whether it was 
something in the mind, or in the body or that, but you just don‟t feel 
like eating that.  And you‟ve been looking forward to this aw day like, 
you know.  I mean you have a plate oh soup, maybe tatties and steak 
or something like you know, and, and you‟ll be eating … well I've seen 
me actually eating a steak and all of a sudden, you‟re eating the steak 
and then all of a sudden the meat begins to roll as if you cannae 
swallow it and that puts you right oaf, so there when you start that, 
instead of cutting it wee and eating it again, you throw it to the side, so 
there's aw they wee kinda, I mean I suppose it‟s perseverance wi' 
yourself but eh, you say to yourself, Christ I'm no hungry now you 
know … 
 
 
 
 
 
Symptoms and 
stigma – 
weight loss – 
salient 
symptom  
 
 
Linking 
symptoms – 
weight loss 
and 
breathlessness 
–concurrence 
for finding 
cause of 
symptom 
 
Breathlessness 
– salient 
symptom 
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Tries to please wife by asking 
for he to cook things?  Does 
not want to be a burden to 
her? 
 
Does he disassociate his body 
from his mind – why? – can 
control his mind but not his 
body? 
 
 
 
Does not like his family seeing 
this – if he does not eat it is 
overtly visible to others – can‟t 
hide the impact of his disease 
from them? (see other quote 
where he says he tries to hide 
his symptoms to protect his 
family).  Is this why it makes 
it worse for him as everyone 
can see? 
Does not like people to nag 
him – see above- visibility to 
others of his disease and 
prognosis – weight loss so 
significant as like breathing 
you need to eat to live – linked 
with fear of death? 
Weight loss also significant to 
Dan – is this because this 
symptom too is like 
 
 
 
 
 
 
ROMA And how do you feel when your, you feel that, you know 
the dinners put in front of you and you don‟t feel hungry any 
more … what, what, what are you thinking? 
 
DAN: No well, you‟ve got much of a chance in this house because they 
all moan at you, “     why are you no eating? … “ like, you know, and I‟ll 
say for God‟s sake gie us peace I'm no wanting any mare, because my 
sons there, my daughters sometimes there, the wife‟s there and she 
will say, Christ is that aw your eating like you know, so you don‟t get, 
you don‟t get forgetting that you haven‟t ate it, because everybody 
roond aboot you is reminding you and that makes me even worse 
[laughs] 
 
ROMA But why, why? 
 
DAN: I don‟t know why, it‟s just a case of … I don‟t want it, you know 
and they‟ll no take no for an answer, you know … (laughs)…so .. 
 
 
 
 
 
 
 
 
 
 
ROMA Could you, you know in the last interview you mentioned 
weight loss a few times … 
 
 
 
Being a 
burden- not 
wanting family 
to see 
symptoms  
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breathlessness – you need to 
eat to live?  No mention of 
other symptoms really –do 
they not concern him? 
 
Knows things are not getting 
better – not denying how he is 
on this occasion 
 
Trying to blame weight loss on 
not eating due to chemo – 
linking up symptoms-weight 
loss and anorexia - contrasts 
to earlier where he blames it 
on his breathlessness – some 
denial here? 
Linking weight loss and 
breathlessness 
 
Concerned re weight loss  – 
links it to prognosis  
 
 
 
Trying to provide reasons for 
him to believe that it is not his 
cancer which is causing the 
weight loss – it‟s due to him 
not eating foods he did before? 
 
DAN: Aye, aye, aye … I'm bad this time 
 
ROMA Can you tell me a wee bit more about why you talked 
about ???? 
 
DAN: Well, I wis'nae eating, that‟s why I … that‟s the only reason I've 
lost weight, because I wis'nae eating, you know eh., loss oh appetite if 
you like through – possibility chemo.  I think it must do.  But I, I've 
kept average weight right through up till,    [25.09] average weight 
right for a year and a half, it‟s aw aboot the 75 kilo mark, I'm doon tae 
aboot 72 and a half the now so I've lost two and a half kilos in about 
the time I've seen you, this is about 5, 6 weeks, because I know for a 
fact up until the weekend there, I wis'nae eating and I've taken a, an 
awfy and I can't answer the question so don‟t even, ask me why … but 
all of a sudden I've taken a sudden hate to chips, I don‟t know why but 
I just hate … and I could eats chips ?????? [25.45] then all of a sudden, 
I was oot oan Friday night for a meal, there were 24 oh us there and I 
had a steak and E had a steak and I ate half the chips and normally my 
plate would have been clear [26.01] you'd have thought the locusts had 
have went through it and all of a sudden,…..[26.06] even on the 
Saturday night we go oot for a fish supper, or, I'm saying a fish supper, 
a chippie – nae chips, single fish, you know … or if I had chips just get 
us, just get us em, just you buy it … whatever your buying we‟ll just 
half the chips, they just .. I don‟t know why, I can answer the question, 
I don‟t know, I've just suddenly taken a steele to chips, potatoes – aye, 
nae problem, any shape or form – potato…no problem 
 
ROMA No chips 
 
DAN: … but chips – nope and I can't answer your question 
 
ROMA Well..that‟s fine… 
 
DAN: I'm being perfectly honest wi' yae, I haven‟t got an answer to it, 
 
Weight loss- 
salient 
symptom 
 
 
Linking up – 
weight loss 
and lack of 
appetite 
 
Linking up 
symptoms – 
weight loss 
and 
breathlessness 
 
 
 
Minimising 
symptoms - 
coping 
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Interesting in the way that he 
does not talk about symptoms 
all together – experiencing lots 
of symptoms but dialogue 
commonly focuses on 
symptoms which are of 
significant meaning to him – 
seems to be their association 
with impending death – 
picking out salient symptoms 
form the rest? 
Does not want to go there to 
find an answer – in denial –a 
„fad‟?  Does not like not 
knowing the cause of his 
symptoms – can‟t control it? 
Feels comfort that his is 
improving – fact that others 
have commented on this 
reinforces to him that this 
must be true – trying to 
convince himself and the 
researcher of this? 
 
Breathing again – blames this 
solely on his condition 
worsening – scared that he 
was going to die – once again 
link with breathlessness and 
death.  Very important as he 
spontaneously talks about this 
again bearing in mind… for all I know [laughs], no, you know.  No I'm 
joking em, no, they're just they kind oh fads, it‟s a fad for want of a 
better word, it‟s a fad, I suppose if somebody pit them doon and says 
right, eat that…you would dae it, it‟s a fad [laughs].  But naw, naw I 
wis, I'm, I'm … definitely up to the weekend there I wis'nae eating but 
I'm, I'm, it is improved, I can assure you, but it‟s been commented on 
[laughs], so whether the wee change on Friday night made a different 
or no, change of company … you don‟t know … 
 
ROMA Mmm, I'm pleased 
 
 
 
 
 
 
 
 
 
 
 
 
DAN: …  you get into it, y., y., y., as I said I was going doon, the 
breathing was getting to me and I was gradually sliding the wrong way, 
I'm usually sliding – “uphill” but wi' the breathing getting tae me I was 
sliding doon hill, but I was feart I was going to slide too far doonhill, 
you know what I mean 
 
 
 
 
 
ROMA Can you tell me a wee bit more …about… 
 
DAN: Well eh, during the xx [name of nurse] and…… and aw that says 
 
Minimising 
symptoms - 
coping 
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symptom  
Positive thinking – feels that 
this has some therapeutic 
benefit – see previous quote in 
interview 
Breathing affecting him – 
scared that it will come to a 
point when they can no longer 
treat his breathlessness – feels 
at this point death will be very 
near – afraid of this 
Comes to this point – jokes he 
would commit suicide – but 
then states that he is jesting – 
shows how significant this 
symptom is to him 
Uses humour a lot when 
talking about issues which he 
finds upsetting 
Changes subject – talks about 
how he needs humour to cope 
with what his happening to 
him 
Social comparison – coping – 
others who are worse than him  
 
All that matters to him is that 
he is still breathing – still alive 
– is this at whatever cost?  
Breathing and life...why 
sentinel to him 
it was your attitude, your approach that‟s kept you up you know eh, 
and with this breathing getting to me and so…[makes gasping sound] it 
does get you down, you say to yoursel, and what and, and they‟ll say to 
you, we‟ll maybe no can dae much fur yae em, it‟s just through the 
illness and your saying to yourself, Jesus Christ if that‟s the case I‟ll 
jump oaf … I know that I'm telling it to you, but I don‟t really mean it, 
I‟ll jump oaf a brig and dae away wi' masel then you know, rather than 
this hinging our yae and, and I said the other day…and I got for my last 
chemo this week, next week, I says to her what happens efter that wi' 
the breathing, I says do I get a Calor Gas can tied tae my back, ken 
[cracks joke], I'm still joking about it like, you know but, seriously deep 
down it is very serious like you know em, but you‟ve goat tae keep your 
pecker up by joking aboot things like, you know because if everybody 
was dull in doldrum, the world would be a hellish place, you‟ve goat to 
have a bit of laughter in life and your actually make, your basically 
keeping your ain perk up by making a joke by saying, well I don‟t want 
a hose stuck up my nose, kind of thing like you know … [laughs], you 
know he was like that [demonstrates], …………………… [29.09] because 
actually your making a joke regarding yourself, I've, I've seen other 
folk oh my god… you feel very sorry for people….it‟s a way oh life … em, 
if you have to get it, you‟ve to get it … it‟s the only way to walk one fit 
in front oh the other then you dae it … and folk‟s say to me, how are 
you this morning, I‟ll say fine .. eh, aye no bad I says, how are you, ah 
nae use oh complaining, naebody listens like you know or eh, och I 
walk along the road and I'm still breathing, so I take it I'm still here 
like, you know, just … you know somebody said to me, I says well I 
walk some other ??????? how are you this morning?  I says I woke up 
this morning and I'm still here, so … another day … and that‟s the way 
I've looked at it, throughout.  It‟s no until I wake up in the morning and 
I'm still breathing, I'm still here, the mans daing his joab, he's keeping 
me alive [laughs] and hopefully he‟ll keep me alive a long while.  
Because as I said to you the last time, I asked him one day outright, I 
says how long has I got to go?, he says how long have I got, he says 
eh, I could jump in front of a bus the morn and be deed, I says well 
that is very true, but the ????????????????????? I could jump in front 
attitude 
Breathlessness 
– salient – fear 
of death 
 
Humour - 
coping 
 
 
 
 
 
Social 
comparison - 
coping 
 
Breathlessness 
– salient – 
need to 
breathe to live 
 
Social 
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Value of life – just being alive 
is good enough for him 
Comfort that the consultant 
told him that his is like 
everyone else – no one really 
knows what the future 
holds….social comparison 
Body – he will know when he 
is at that stage- his body will 
tell him – once again uses the 
body as a gauge in 
determining how he is- his 
sense of self 
Praising health professionals – 
his lifeline? 
 
 
 
 
 
 
 
Breathlessness – loss of sense 
of self – cant do these things 
anymore due to his symptoms 
– appears to blame his 
breathlessness on this- 
sentinel again...no mention of 
his other symptoms 
oh a bus the morn tae mate, the man cannae answer the question.  OK 
when you, possibly when you get further doon the line and your really 
in a state they can say well you‟ve got X amount of months, years, 
days, weeks, but you‟re really doon, by that time you know yoursel, 
cause it‟s you should know yerself [laughs] eh, and naw they don‟t, 
they're doing their job, like everybody else… to the best of their ability, 
you know I admire them for it 
 
 
 
 
 
 
 
 
 
 
ROMA Em, can I pick up on em, you know when you were talking 
about your breathlessness and from what you were saying, you 
were saying you were going down the slope … 
 
DAN: Aye, aye 
 
ROMA … can, can you explain, can you tell me …  
 
DAN: Well I was always, I was always … I, I could walk in that back 
door, walk to the shed, cut the grass, go to the caravan, get the water, 
wash the caravan and wash 3 motors and the caravan in an hoor, it 
would take me an hoor to walk to the shed and fill the pales noo, never 
mind washing them because you just don‟t have the breath, your intake 
of breath.  Ok your lungs fool oh cancer, we know that, but your intake 
oh breath isn‟t enough, it‟s like the day, what you want tae dae so your 
within yourself a percentage angry wi' yoursel of you like because no 
being able tae dae what you did before that, you know your, your mind 
disnae go back and say, Christ I cannae dae that noo, your mind goes 
comparison - 
coping 
 
 
Reliance on 
health 
professionals 
to live 
 
 
 
 
Loss of sense 
of self and 
symptoms – 
breathlessness 
– salient 
symptom  
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Makes him angry – he wants 
to do this but his body won‟t 
let him – sense of loss at the 
person he was and the person 
he is now 
 
 
 
Previously talks about having 
cancer and minimizing it and 
now talks about there being a 
cure – in denial to an extent?   
Talks about breathlessness 
being out of control  - using 
his instincts to try and help 
himself – shows how primitive 
function is to him 
Trying to convince himself that 
he is better as his breathing is 
better 
Loss of sense of self – 
breathlessness preventing him 
from even undertaking the 
most basic of tasks 
Putting people with medical 
knowledge on a pedestal – 
needs them to live – reliance 
on them? 
 
 
forward and says I‟ll still dae it … you know, it does, well mine does 
anyway … 
 
ROMA And when you get angry what are you, what are you 
thinking 
 
DAN: Naw, no you don‟t get angry … well ?????????? says Christ 
almighty here we go again like, you know … what, there‟ll need to be a 
cure for this … but there probably, well there might be a cure I reckon 
my breathing‟s better this week than it was last week, because last 
week, oh Christ it was really I mean, I was standing for 5 minutes, I 
walked fae here to that gate I've to stand at the gate for 5 minutes to 
get … and I mean really stand and dae nothing and if I was lying in my 
bed and I got breathless, I could‟nae lie, I had to sit up, feet out the 
edge of the bed, it probably did'nae … well I'm no medically minded but 
as far as my mind was concerned it telt me get my legs our the side oh 
that bed and sit on the edge of the bed and breath, I might no, I might 
no get as much breath lying, but as far as I was concerned, in my mind 
when I was lying I wis'nae getting an intake of breath the same as you 
were sitting up, I might be right and I might be wrong, you‟ll ken better 
than mmm mmm, being medically minded, I think you get more breath 
intake sitting up than you dae lying doon 
 
 
 
 
 
 
ROMA What were you thinking when you were feeling this 
breathlessness? 
 
DAN: Oh Christ, you were thinking, is it your last minute?  Naw, no 
really like you know but, your saying to yoursel Christ I hope this 
disnae last too bloody long or if this gets worse they‟ll need tae dae 
something real, you know.  Oh aye it‟s, it‟s just, that‟s the kind of stage 
 
 
 
 
 
 
Breathlessness 
– salient 
symptom  - 
loss of sense 
of self – basic 
activities 
affected 
 
 
 
Fear of death 
breathlessness 
– salient 
symptom 
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Breathlessness – scared he 
was going to die – longer it 
lasts appears the threat of 
death becomes greater. 
Something real suggests that 
if it lasts he can‟t deny what is 
happening anymore that he 
may really die this time-reason 
why so salient to him 
Breathlessness – you need to 
breathe to live – reason why 
this symptom is so meaningful 
to him 
Scared of not doing things 
right – scared of the 
consequences? 
 
 
Last week was the worst 
experience of all – scared him? 
Constant presence of this 
symptom – others he has 
talked about have been 
transient in nature- chronicity 
of his breathlessness linked to 
the meaning that it holds for 
him? 
 
Glad he does not have pain - 
points out that morphine is not 
for pain - ? associates pain 
your at like, you know, what do we do next like, you know … but what 
dae you dae next if you cannae get a … if you cannae get a breath, 
Christ you might as well no be here…you‟ll no be hear, cause it‟s the 
breathing that keeps you going, and if you get to the stage that you 
have to crawl, it‟s nae life, it might come to that, you know don‟t know 
like you know, we‟ll cross the bridge day by day and as far as I'm 
concerned I'm going back up the hill – the day.  Am I geing you the 
wrang answers the day? 
 
 
 
 
 
 
ROMA You don‟t give me any wrong answers, I told you … it‟s 
your, your story, honestly…that‟s what I am interested in… 
 
DAN: aye, naw well that‟s em, naw the breathing, the breathing was 
really eh, I've been short oh breath for a, a, a number oh month, but 
really last week was the daddy, when I had to say to him, eh, look 
you‟ll need tae, and that‟s when that lady doctor said I would‟nae know 
what to give you and in actual fact it was Dr R that prescribed the 
tranquil., the tranquilisers and the em, oral … Christ … 
 
ROMA Morphine 
 
DAN: … morphine 
ROMA Morphine 
 
DAN: Now the oral morphine he says is not for pain, I says no, I've no 
got any, I've nae pain, I have nothing – see if I could breath, id be 
perfect within myself – perfect 
 
 
 
Fear of death  
 
 
 
 
 
 
 
 
 
Breathlessness 
– salient - 
chronicity 
 
 
 
 
Breathlessness  
- sentinel 
symptom – 
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with death? 
Very strong quote – „…see if I 
could breathe, I'd be perfect 
within myself – perfect…‟ – 
demonstrates how sentinel 
breathlessness is to his 
experiences – does not talk 
about any of his other 
symptoms in the same way – 
hierarchy of symptoms? 
 
 
 
This quote demonstrates how 
he views his breathlessness as 
being significantly different 
from all his other symptoms – 
he does not appear to be as 
concerned about other 
symptoms – is this because 
they are more amenable to 
treatment – transient, don‟t 
last long - he does not link 
them to death?  
 
 
 
Takes two tablets and this 
symptom is sorted – not the 
same case with his 
breathlessness – does not 
 
 
 
 
 
 
 
 
 
 
ROMA Why…why do you think that?  
 
DAN: Because I know, my body‟s fine.  OK I've got these wee burning 
sensations but I have'nae had them since I had the steroids and 
morphine and, and I'm taking pills to augment, you know you take your 
em, it‟s a tablet in the morning, a tablet at night, I've to take two a day 
because oh the, oh the em, the tablets I'm taking during the day, the 
steroids, you‟ve goat to take one for your stomach, so that‟s possibly 
settled my stomach oot … the [tries to think of name of tablet] 
 
DAN: Omeprazoles? 
 
 
ROMA Omeprazole? 
 
 
ROMA Yeah, yeah 
 
DAN: I take one in the morning and one at night, so possibly that‟s 
ironed oot, possibly when I had the heartburn or, or that, possibly 
would‟nae hae the burning sensation if I was getting Omeprazoles I 
would‟nae have had it, I'm just saying – possibly, not, I wouldn‟t have 
had it – possibly, so therefore that may have eliminated that factor but 
since I've been oan them em, and the steroids eh, he reckons this will 
open the airways, my own doctor doon there, she was a German 
picks out from 
all the rest 
Breathlessness 
salient 
symptom – 
body is fine if 
he does not 
have this 
symptom – 
suggest does 
not view other 
symptoms in 
the same way 
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have the same impact on him 
 
 
 
 
Had a lot of medical 
knowledge for a lay person – 
uses lots of medical terms 
when describing his condition 
Exercises are not what he 
wants?  Wants something 
more definitive to treat his 
breathlessness? 
Giving health professionals 
their place – not criticising 
them – needs them to live? 
Is he trying to convince 
himself that his breathing is 
better – once again 
disassociating mind from body 
– his mind may say his 
breathing is better but is his 
body saying this as well?  Is 
he trying to convince himself? 
Marginal difference – sounds 
like he is trying to convince 
himself that this is the case 
Gauges how he is base on his 
physical functioning 
Trying to cope with what is 
doctor, she I went to her because of the breathing… because of the 
reasons, she says I don‟t think it‟s antibiotics your needing, she says I 
think your needing to go and see your oncologist, she says he‟ll give 
you something for your breathing … she said and she mentioned 
something, she says there's em, exercises you do … it could be your 
lung lying against a, an air vent … an air … an air … an air vent … 
[corrects himself], an air tube, you know she said it could be pressing 
slightly and curtailing the flow of air, she says and there is em, 
exercises you get and I says – “exercises?”, but I didn‟t argue because 
I mean, she's a professional and she says go to your … I says well I just 
… it so happens to chance that I'm going tomorrow, she says well ask 
him tomorrow and she says if you‟ve got any problems come back to 
me, she says and I‟ll write a letter, bit I, I don‟t have any problems at 
[name of hospital], I cannae praise them enough, I can't … id pit [name 
of hospital] on a pedestal, really – I can't praise them enough.  So I 
had nae problems there and that‟s when I got this, aw this stuff and 
that was only last Tuesday, Tuesday … a week since I started taking 
them and I find if not true reflection but in my mind…my breathing is 
partial better than it was and that‟s me taking them for a week, so they 
may only be kicking in by now so, I don‟t know, we‟ll keep taking them, 
I've got 10 days, she says she would see me next week when I got for 
my second lot of chemo, if I require mare I‟ll get them, so if it‟s 
improving, I‟ll gladly take them.  But in my mind there is a marginal 
difference in my breathing.  I can walk that 10, 15 yards further than I 
wis at this time last week and no get breathless, so to me that is a 
difference, so they may be working, they will be working no doubt.  I've 
no, I've no, I've nae, nae qualms aboot it not working, but you‟ve goat 
tae gie the thing time … 
 
ROMA Mmm mmm, yeah 
 
 
DAN: … like a flower, a flowers got to grow, so, you‟ve goat tae gie it 
 
 
 
Reliance on 
health 
professionals 
and treatment 
to live 
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happening to him – is he 
talking about medicines taking 
time to work because he is 
scared of the consequences if 
they don‟t  
 
Reason why breathlessness is 
so significant to Dan – this is 
what the future holds for him 
and he is scared of it?  Once 
again talks about suicidal 
ideation if his breathlessness 
were to get so bad – 
demonstrates how the 
meanings that he associates 
with his symptom significantly 
impacts on him and his life 
Jests that he is only kidding? 
Scared of his illness impacting 
on his family and hurting them 
– talks previously of wanting 
to protect them- ? Does not 
want to be a burden? 
 
Panics when he can‟t breathe 
as he is scared he is going to 
die – feels helpless when he 
experiences this symptom – 
has little control over it? 
Links breathlessness with 
a chance, I mean yae cannae take pills the night and hope your awright 
the morn, you‟ve goat, you hae …………….  I was at the doctors 3 days 
ago, he gave me thur pills, they're no daing any bloody good – he's 
only taking for 3 days, so … you give them a chance, there's my … no, 
no … so … 
 
ROMA OK.  So, you know we, we were talking about 
breathlessness before as well and you says it could be a sign of 
the future, when you were talking about your breathlessness 
 
DAN: Well that‟s what I was getting to last week…it was a sign oh the 
future, because they were telling me that eh, and there might no be 
nothing you can dae aboot it, well I says I would‟nae like to go a bit 
breathless like that.  What I would dae, I don‟t think I would dae away 
wi' masel … don‟t … I'm no that bloody stupid but you may start to get 
????????????????????????????????????? [39.36] eh, you might start to 
get em, narky wi' people around you who are trying to help you, I'm 
only like saying you might start tae, tae go doon that avenue 
 
 
 
 
 
 
 
ROMA Right 
 
DAN: .. you know because if you cannae get a breath there's nothing 
worse because breathlessness tends to stem panic, cause if you can't 
get a breath – you panic.  So therefore it‟s just…through the board – 
breathlessness – panic, panic sets in and what you dae in a panic you 
cannae answer, there nobody can answer a panic attack, you know … 
you dae think, you had somebody in a … I mean if somebody was 
coming to help you, your no interested in this person helping you, all 
you want tae dae is get air, so I mean – you can have a panic, you 
 
 
 
 
 
Breathlessness 
– salient 
symptom – 
fear of death – 
sign of the 
future 
 
 
Humour 
Being a burden 
– protecting 
family 
Linking up 
symptoms – 
breathlessness 
and anxiety 
Symptom 
clusters –
threat of death 
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anxiety  
Scared of hurting family when 
he is breathlessness- uses 
third person – has this 
happened in the past? 
Distress associated with this 
symptom 
Unintentionally –once again 
loss of control with 
breathlessness – genuine – 
wants to convey that he is not 
putting this on 
 
Scared of being a burden 
Gets to stage when his 
breathlessness is so bad that it 
impacts on others appears to 
be intolerable to him 
Scared of reaching that point 
in his illness – however sense 
that he knows that this day is 
likely to come... 
States once again how he 
hopes he never reaches this 
stage- demonstrates how 
much this thought distresses 
him/ how scared he is 
Use of „we‟ again – he is not 
alone 
 
could hurt somebody unintentionally through a panic attack, trying to 
get air, a genuine simple thing, so I mean that‟s, you know I would‟nae 
like that scenario if you like to have a, a, a, ah need air…. and your, 
your, your automatic instinct is to go ootside – for what reason?, 
nobody  knows, but everybody‟s instinct is – ootside.  There's air 
ootside, there's nae air in the hoose, there's air ootside, it‟s the same 
bloody air I the hoose if you open the windae, maybe no as much but 
you know, so that‟s the concern if you were, if you were getting to the 
stage that you had no breath, you'd really get angry wi' the folk roond 
aboot yae and get narky, you know.  I don‟t know, I don‟t know it, it‟s 
another, it would be another adventure if you want for a better word 
and one I hope never to cross … [slight pause] … that‟s as ??????? as I 
can pit it 
 
 
 
 
 
 
 
 
ROMA OK 
 
 
DAN: … I hope I never cross it … 
 
ROMA Mmm mmm 
 
DAN: Mmm mmm?  Does that                      
 
ROMA Yes 
 
DAN: hmm, hmm 
 
ROMA em, when we were talking about breathlessness last time 
nearing…? 
Being a burden 
– symptoms – 
wants to 
protect family 
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If he can find out the cause of 
his breathlessness then he can 
control it – make him feel 
better?  Uses concurrence as 
means of trying to find out the 
cause of a symptom – how 
people make sense of the 
clusters they are experiencing? 
Links breathlessness to 
gastritis 
If it‟s his stomach then the 
threat posed by his 
breathlessness lessens? 
Blames it on a one off event – 
helps him cope with what is 
happening to him  
Lots of medical knowledge 
again – using terms health 
professionals would use 
as well you were saying that when you were breathless, you 
were saying is it my stomach that‟s causing the breathlessness 
or is it the cancer? 
 
DAN: Aye well we don‟t know that, there naebody can answer that 
 
ROMA Can you tell me a wee bit more about why, why … 
 
DAN: Well that‟s why I was saying about this burning sensation … 
 
ROMA Mmm mmm 
 
DAN: … you know did I have an infection in … when, when I went … I 
still maintain I've never been right eh, since, your just getting the very 
same story as you got the last time by the way, since I got the CT scan 
on the Monday and the, and the chemo the next day way back at the 
new year, I reckon that was my downfall [banging sound], and I don‟t 
give a monkey who says it, I reckon that was my … to get the one thing 
one day and the one thing the next day.  Noo they may be two 
completely different things, one might not contract the…. you know it 
might just be a … it's happened, but I reckon that is the time that my 
stomach changed.  Whether it was wi putting the dye through, which 
disnae go through your stomach, well maybe it does go through your 
stomach … your … well everything goes through your stomach at the 
end of the day I suppose, and I think wi' the dye going through it and 
the chemo the next day my innards, for what oh a better word – no ma 
stomach, ma innards never got a chance, they got blasted wi' too much 
stuff aw within 24 hoors and my, well I might have gent., I might have 
a gentle stomach, I don‟t know what I've goat, you know what I mean?  
So possibly my stomach or my innards, if you like, could‟nae cope wi' 
the in., influx oh the two things within the 24 hours, you know, so I've 
never actually been able tae throw that oaf, but I can't prove that and 
I‟ll no even be trying to prove it…because they're daing their best tae 
help you, so why put an obstacle in somebody‟s road and say, I 
should‟nae have had that…it‟s, it‟s, done, dusted, water under the 
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Blaming health professionals 
on his stomach symptoms but 
then at the same time pointing 
out that he is not criticising 
them – protecting health 
professionals -lifeline 
Does not want anyone else to 
hear him questioning his 
treatment/care – fear of what 
would happen – needs health 
professionals to live 
Good patient – wants to 
protect health professionals 
 
 
 
 
Using clustering to determine 
concurrence of symptom -  
Using logic – cancer is static – 
so breathlessness must be due 
to something else (his 
gastritis?) – does he really 
believe that his cancer is static 
– is his body telling him 
otherwise? 
Modesty – giving health 
professionals their place 
bridge – end oh story.  But in my, back oh my mind and it‟ll always be 
in the back oh my mind, but I will never ever question it outside this 
house and I'm talking to you and it‟s oan that [points to recorder] 
 
ROMA Yeah, but it‟s all, you know it‟s all anonymous sort of 
thing 
 
DAN: I know that, but I'm just saying to you, that other people would 
chase it, I will never chase it – never 
 
ROMA Just, you know when you, when you were talking about 
your, your breathlessness and the cause of it, I'm just 
interested to know why … 
 
DAN: ???????????????????????? 
 
ROMA … why, why you‟re questioning is it your stomach and … 
 
DAN: Aye well … 
 
 
 
ROMA … or your ca., ????????????????????????????????? 
 
DAN: Well I questioned this further back than last week tae eh, why 
and I questioned it the day, why is it if my cancer is static ..am I 
suddenly breathless?  You know, in my joab if something‟s static, it lies 
there in a bloody corner and does nothing, you know so if it‟s why has 
my body all of a sudden became breathlessness come fae, because that 
cancers static, but I know I'm maybe, I'm maybe too “thick”, for want 
oh better words that I'm no picking this up because, when it‟s static I 
maintain that it‟s no daing anything but it‟s, it‟s dead wood so why is it 
altering the breath?  It must be coming fae somewhere else … 
 
ROMA Right 
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professionals 
and treatment 
to live 
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Body is telling him that things 
are not good – breathlessness 
is still bad – trying to find out 
where it is coming from so 
that he can have more control 
over it? Using clustering as a 
means of doing this... 
 
 
 
Now trying to attribute 
breathlessness to old age – 
coping/denial?  Tries to 
convince himself but he cant 
Uses humour when talking 
about emotive topics 
 
Pounding – suggests treatment 
significantly impacts on him 
but then states the reverse by 
demonstrating how he does 
not need to be hospitalised, 
treatment quick – suggests 
impact is minimal 
Comparing self to others to 
cope? 
Trying to build positive 
perceptions of himself – how 
he can still drive, pointing out 
that he is still okay 
 
DAN: … and that‟s where the tire., that‟s where, that‟s where I'm 
getting the tie up, if people, you know … does that maybe, you know 
this word static to me is – nothing‟s happening; but something‟s 
happening to me, so where is this that‟s happening tae me, coming fae.  
There's half saying aye – your static, this half‟s saying yer no static so 
is there something in this half that I don‟t know about like you know?   
So that‟s where the … 
 
ROMA mmmm…. 
 
DAN: I'm, I'm throwing balls in the air, pitting three up and probably 
getting 5 doon, or pitting 3 up and getting four doon, you know this is 
where my thoughts are coming fae, is it coming fae somewhere else, 
that‟s the only thing I can say tae yae, it‟s possibly no coming fae 
anywhere else, it‟s just, as time goes by, we do get breathless in old 
age … [starts to laugh] … would be a simple answer…but naw there's 
this, everybody‟s got their own thoughts on various things and that‟s 
just basically what I can tell you, so that‟s where I'm getting the, the 
left oh the right if you like of the two scenarios, likes is it coming fae 
my stomach, is it coming fae my … cannae be coming fae my cancer, 
my cancer‟s static so it‟s goat tae be somewhere else.  But your body 
does take a bit oh pounding during em, treatment and I've been very 
fortunate that I've had treatment, but I've never ever needed to stay in 
a hospital overnight and get aw this 24 hour jabs and Christ knows aw 
what like you know, I'm, I'm in and oot in an hoor, an hoor and a half 
max…if it‟s busy, and I'm very, very, I've been very, very fortunate, I 
mean very, very fortunate to have what I've goat, be in the position I'm 
in, talk aboot it, walk in, see the consultant, I walk in the morn and get 
my Tarceva and at half past 3 I‟ll drop back oot and I‟ll jump in the 
motor and come hame.  It has never ever stopped me from driving 
home from treatment, the chemo has never … the wife did it the first 
twice and I says there‟s a waste oh time, I'm as well driving masel she 
would stay in the motor anyway, she was driving the motor but I was 
sitting in the passenger seat driving the motor, cause that‟s my style, I 
 
 
 
 
 
Minimising 
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coping 
 
Humour 
 
 
 
Social 
comparison - 
coping 
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Feels good that he can still 
drive – positive perceptions – 
makes him feel that things are 
not so bad – trying to bring 
back his sense of self  
 
Goes back to work – reinforces 
to him that things are okay 
Bragging how he has coped 
with the impact of his 
treatment – makes him build 
self esteem and feel good 
about himself  - trying to 
capture elements of his past 
life to  build positive 
perceptions 
 
 
Gold chemo – feels comfort in 
the thought that he has been 
given the best of treatment? 
Suggests he did have side 
effects from treatment but 
blaming on the way in which 
his treatment was 
administered rather than the 
impact of the treatment on 
himself –denial  
 
 
cannae sit if somebody driving the motor … irrespective of who it is…I 
dae it, I, I mean if I was going wi' you, id quite happily go doon the 
road but I would‟nae show you that I wis'nae comfortable, you know, I 
like driving masel, I love driving, drive, driven aw my days.  Driving 
was my career and my hobby, thousands oh miles a year and I just 
love driving, so therefore for somebody else to drive me it aint a bloody 
holiday and every time I've been in the year and a half tae my, I've, 
I've driven home, I've walked oot that oncology day unit, walked doon 
the lift, out the front door, stuck the key in the ignition and driven 
hame, neither up nor down.  I've seen me going to my work, I've seen 
me going for chemo at 11 o‟clock and I'm back in my work having a cup 
oh tea and a biscuit and carrying oan, so that‟s how much the chemo 
affected me, it didn‟t affect me that way and I'm grateful, whether it 
was the type I was given and they said at the time I was getting it, it 
was very strong stuff I was getting, you know, because it was gold I 
was getting … 
 
 
 
ROMA Mmm mmm 
 
DAN: … I was getting gold chemo at the time and it was, I think it was 
£500, was it £500 – no?, £300 – no?, it was … you know it was, it was 
away up in the hundreds like, it wis'nae just a wee, it was a bag … it 
was either £500 or … it took an hour, an hour and 20 minutes to 
??????? the bag, the bag so that gies you an idea, about an hour and 
20 minutes, you‟re in aboot two hoors the time you get your drip and 
your, your drip and your God knows … your flush, your drip and then 
your flush at the end, your flush at the end, your flush at the ends 
about 10 minutes like, but em, naw, and I think also em, I think it aw 
depends who‟s giving you our chemo, in my mind, because I've had it 
fae various people and there's always one particular person crops up 
and the minute I get that particular person [bangs hand on table] … I 
have a wee problem … 
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work 
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Blaming administration of 
treatment but then at the 
same time acknowledging that 
it could be due the impact of 
treatment on himself?  Trying 
to convince himself but it‟s not 
working 
Blaming health professionals 
but then protecting them again  
 
Humour 
Believes in the power of the 
mind – does he really think 
that his treatment is working? 
 
 
 
 
 
 
 
Recognising that there is a 
ROMA Right 
 
DAN: … I've had it twice – a small problem and I'm saying no more … 
 
ROMA OK 
 
DAN: … a small problem … but it was mentioned ???????? in a diplomatic way and it‟s been rectified … so it maybe just have been an unfortunate situation, what the plumber ????????????? and the pipe 
burst, it wis'nae the boys fault it burst but the unfortunate thing was he 
joined it and they might go to another hoose and do the very same, or 
he's did it twice, it could be a bad, it could just be the way your body 
was on the day, you could be slightly low, you could have been, you 
know, so I mean why complain about something, it could be … the fact 
there could be 90% yourself and, and the reaction to whatever‟s been 
administered to you, it might have … not a thing to do with the person 
that‟s administering it but the only person you can blame is the guy 
that says look … or the guy or the lady … the doctors …  
 
 
 
....you‟ve goat tae blame somebody, your no going tae blame yoursel 
[laughs], so … that‟s another, it‟s psychological at the end of the bloody 
day, perceived it as psychological … I don‟t care… and, and people wi' 
cancer I think it‟s … they're approach.  I mean some folk say, you tell 
somebody and it just goes [demonstrates facial expression of 
somebody that‟s just been told that someone has cancer], I don‟t know 
why, I can't answer the question, but it just goes eh, and that‟s you, 
you‟re in a psy., a psychological mode eh, it‟s up to yoursel to get back 
oot it then … 
 
ROMA Can you tell me a bit more about why you think it‟s 
psychological? 
 
DAN: Well it must be.  As I said to you earlier, your body might be low 
on that particular day that your getting your, your treatment, 
irrespective of what treatment I mean eh, as I said to you about that 
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limit to what health 
professionals can do for him 
Humour 
Praising health professionals – 
protecting them  
Feels comfort that they are 
doing their best for him 
Realises their limitations – 
does this scare him...then 
talks about the future...does 
not want to dwell on the 
present 
Knows that his outlook is bad 
but does not want to think 
about illness –just look to the 
future 
Wanting to go out in caravan 
but cant – too ill – lost 
elements of his past life he 
enjoyed – loss of sense of self  
 
Humour when talking about 
emotive subject 
 
 
Trying to please – scared he is 
not saying the right thing 
 
earlier, this guy goes to the doctor three days afore it and gets pills and 
three days later he‟s still the same, I mean is this guy looking for 
miracles?  I mean they don‟t all walk on water [laughs], do you know 
what I mean?  So I mean … and I'm no religious by the way [laughs], 
but you know, you know where I'm coming fae em, we don‟t, were no 
aw God and them that‟s administering it are no God either, they're 
there tae dae a joab, they're daing their best, as I've said for an hoor, 
or well near enough an hoor, they're daing their best, they're no God, 
but they‟ll dae their damndest for you, so I mean it‟s up to you to help 
as much as you can to assist them, because if you can psychologically 
and I'm going somewhere where I've never been before, if you can 
keep your mind oan life and look to well … the future if you like, you 
want to be here … Christ we all want to be here ten years fae now, so I 
mean why sit on a chair, doom and gloom and say, I've goat this and 
I've goat that, let‟s get bloody up and get oan wi' it and that‟s my, I 
mean I've goat a new caravan there, I'm wanting, it‟s sat there for 
three weeks, I'm champing at the bit, ………….a bloody monument, it‟s 
life, you don‟t, you‟re no, you cannae turn the clock back, I've said to 
you earlier, we‟ve goat it, get oan wi' it … [laughs] 
 
 
 
 
 
 
 
 
ROMA Are you OK to go on talking, I've got another few things 
to ask you, is that alright 
 
DAN: Mmm, aye, am I no very good wi' yae the night hen? 
 
ROMA No you‟re great, you‟re telling me a lot, honestly, you‟re 
telling me lots of, it‟s all your experiences it‟s … it‟s lovely to 
hear them 
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Neutropenia – lots of 
symptoms – sense that he was 
scared as he had not 
experienced this level of 
symptoms before – not in 
 
DAN: ?????????????????????????????????????? 
 
ROMA No, not at all.  It‟s your story I said, that‟s what's 
important.  You know we were talking there about, we talked 
about a lot of things but one of the things you were saying, you 
know you drive the car, you go in for treatment, you come home 
… 
 
DAN: Aye, aye 
 
ROMA … and last time we were talking you were saying you 
know that, that Christmas … 
 
DAN: Aye, aye, aye … 
 
ROMA … when you, you, you said you were sitting by the 
radiator and you were shivering and you said … 
 
DAN: Oh that was afore I went in for the week 
 
ROMA Aye, or when you were in and you said that that was the 
only time I ever had a real experience 
 
DAN: And that was ooooh … really, that was … 
 
ROMA … and it was just when you said that was a real 
experience, can you … 
 
DAN: It was an experience sitting there like a, a budgie in a spor I was 
sitting there shaking like a budgie on a leaf in a tree because my back 
was against that radiator, that radiator was fill oan, my back, I was, the 
wife was sitting here sweating, sitting there and I'm sitting there 
shaking eh, couldn‟t get a, couldn‟t get a heat, just could‟nae and, and 
that was on the Fri., the Friday? And they put it oaf on the Friday and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptom 
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control of his body – scared  
Clusters of symptoms during 
treatment – rigors, sweating, 
feeling cold 
 
Praising health professionals – 
comfort in that they are caring 
for him 
 
 
 
 
 
 
 
Bad experience for him – talks 
about eating – significance to 
him of not losing weight (see 
previous quote re „bean poles‟ 
– associates stigma with this 
symptom?  Also weight loss – 
underlying fear of death – so 
prominent to him 
 
Praising health professionals 
Lots of detail about food – 
important to him that he does 
not lose weight – symbolic of 
we did'nae got tae … the wife did'nae take us tae em, [name of 
hospital] to the Saturday and whenever they saw us – you need a bed 
and I lay in a bed in a ward for a full week fae the Saturday to the 
Friday and for 24 hours a day, aw that time, I had one needle or two 
needles in that airm and a bag hinging for a week and you were getting 
yoan eh, salt tablets, they wee geing me tablets, there were one sister, 
I admired her, she stood right in front of me and the wife and threw 
them, threw them oan the flare at the doctor and says – “these do no 
agree with Mr S”.  I was getting, it was a drink, ken the salt drink, I 
was taking the drink and as quick as I was taking the drink I was sick 
and the doctor says – “it can't be”, she says “it is” 
 
ROMA ?????? 
 
DAN: … so she said to him give him the coated tablets and she gave 
me, she goat me the coated tablets and I had nae problem with them, 
but they wee geing me this drink and as quick as I was taking it and 
I'm no joking, as quick as I was drinking it, it was back in the sick bowl.  
I asked, I had taken it and she says, she just flung it doon oan the 
trolley, she did'nae throw it on the floor like … she flung it … and 
shoved the trolley – that‟s no use; cause it … that‟s making the patient 
worse.  But for full week oh it was murder and as for hospital food, oh it 
was like the Ritz, that was the ………………. you could‟nae get anything 
bloody decent to eat.  You had a cup oh tea in the morning and a roll 
and Christ you looked, you lay  in your bed and looked forward to this 
roll in the morning and said Christ that‟ll keep me going an hour now … 
I remember it and talked about it on Friday night, talked about it a lot 
… this, they were all very, the staff‟s all very good they just gie oot 
dinners.. this lassie, she was on the ward, she says eh, got Shepherds 
Pie the day, so I says I‟ll have some oh that hen, so she laid it doon 
and it looked awright, and had a bite at it, …………… I saws I think 
you‟ve left the Shepherd in it hen, take it away I don‟t even like it, it 
was minging, it was rotten but again this is the health board, they're 
haulin‟, as I've, well at that particular time they were haulin‟ meals fae 
[name of place in England] to [name of hospital] ………………what's 
clusters – 
threat of death 
nearing  
 
 
 
 
 
 
Reliance on 
health 
professionals 
to live 
 
 
 
Weight loss – 
salient 
symptom - 
threat of 
death/ 
previous 
statement re 
stigma? 
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disease progression? 
Blaming weight loss on food - 
if he can find a cause, does he 
feel more in control of this 
symptom? 
Humour 
Angry that he was given food 
of this standard – prevented 
him from eating – fear of 
losing weight?  Blaming weight 
loss on food and not on his 
illness?   
Bad experience 
Lots of medical knowledge 
 
 
Felt violated – not in control of 
what was happening to him – 
scared him? 
 
 
 
Not happy with this …health 
professionals having that level 
of control over him 
 
 
wrong wi' the old fashioned kitchen? 
 
ROMA I know 
 
DAN: … a square meal a day, suppose it‟s only bloody tatties and 
mince .. I don‟t … it‟s all frozen, pre-packed Christ, stuffed, stick it on a 
shelf for three month and say och we‟ll get it when we need it and 
that‟s what's wrang wi' our food the day.  Dieticians would be Christ, 
going mental and they don‟t know what's, there's stuff in packets 
through there and what … OK they tell you that it disnae go off – my 
arse.  You put stuff in a fridge freezer, it disnae go aff, naw it disnae go 
aff, no………………………  As long as it‟s frozen, it‟s fine – nah.  That is the 
only thing I would say regarding hospital‟s but as far as experience is 
concerned, naw I would‟nae like tae dae that again, because actually it 
was because oh the white cells and I, I had two units oh blood to boost 
my blood when I was in there tae like ken, oh they went to town like, 
you know they did'nae, there was no …………………… there were nane oh, 
that‟s a different scenario, no they really went to town wi' it, the service 
through aw the staff in any department and there was one sister she, 
she, she bred dogs,  and I don‟t know it must have been like, it must 
have been something … it was the needle you goat and eh, it was in 
your stomach, where I was getting aw this … and she just came up one 
day and she just goes like that … [demonstrates] ????????? [phone 
rings] and that was it 
 
Chat re phone ringing...... 
 
DAN: So eh, and that‟s how you get the jag, and I came oot black and 
blue for a couple, I says that was you that did that – aye, I ken .. it was 
just … ………… she just … 
 
ROMA and when she did that, what did you, what were you 
thinking? 
 
DAN: I wasn‟t thinking nothing, it was too quick 
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Protecting health professionals 
 
 
 
 
Uses humour – needs it to 
cope with what is happening to 
him 
 
 
 
 
Aim to please nurses – keep 
them happy/ on his side?  
Uses humour to do this – a 
good patient? 
 
 
 
Social comparison to cope – 
feels better knowing that 
people are worse off than him  
 
 
ROMA Right 
 
DAN: It happened, if she‟d come over and said to me I'm giving you 
an injection in your stomach …… she just come up [demonstrates] – 
done.  I says – “thank you very much” I says .. and when the last lot 
oh chemo and the last CT scan I got…the young lassie she tried this 
airm and she just did'nae, y., well your either lucky or your unlucky aint 
you, wi' a needle, so she goes tae this airm and eh, she was talking, we 
were talking and her wee assistant was wi' her and I says how are you 
liking it in here, she says …….. I thought………joke, she says – “yes”, I 
says well you‟ll no learn much aff oh this lassie I says she was a 
butcher in Morrison‟s before she came her, she just … you know but 
just away kinda, well if you want break the ice.  I mean she, she was 
unlucky, she had to go here like ken, so I'm saying to her and you 
learning much and she was a, she was a butcher before she came in 
here in Morrison‟s, because she did'nae get it right the first time like, 
you know but that‟s just, that‟s my style, I like to have a wee bit oh 
crack, cause nine times out of ten, you get folk going in there and it‟s – 
hello, hello … cheerio [says this in a door tone] you know – life‟s too 
short.  Let‟s have a bit oh hilarity if you can deal wi', if, and in actual 
fact when I went in for my biopsy there was an old chap fae Ayr in ward 
lying wi' me and we kept, we kept that ward going just wi' the banter 
and the nurses loved it because it was a different, to what they were … 
the norm, you know 
 
ROMA Cause you, you were saying when you were in there you 
were thinking there was people worse off than you 
 
DAN:  And they were worse off, they were .. you're lying … I, I was in a 
room em, and there was 6 beds and I had an old guy in that corner 
there, ????????????????????????????? and he's saying to me din'nae 
worry aboot it son, he says, I've had it and have beat it, and that old 
guy used to sit, he used to keep me awake, cause he wis, he was aye 
spittin‟ you know, he had it really bad but his philosophy was he had 
 
 
 
 
 
 
Reliance on 
health 
professionals 
to live 
 
Humour  
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Scared at what he saw – did 
this heighten his fear of death 
– reality of illness before his 
eyes  
 
Back to praising health 
professionals again  
Body – marvellous – using this 
to cope and convince him that 
the body can come over many 
things 
 
 
 
 
 
 
 
 
 
 
 
beat it, I says very good, if you‟ve beat it, I‟ll beat it and I agreed wi' 
the guy… he was in a helluva state and there was another guy up, 
another guy up in the far away corner, the wife was in visiting me, we 
were asked to go oot and the guy had just conked oot and died in the 
bed and 10 minutes later he did it again, so they whipped him oot, he 
died and they brought him roond twice when we were there, but as I 
said, the first time we were asked to go oot and then we come, we goat 
back in … Christ we were‟nae in ten minutes till – away again.  He died 
………. the guy was sitting up and I'm saying tae masel Christ almighty 
this is wonder … I mean, you really get your eyes opened, it‟s a thing, 
you never, you go through life up to you know, I went through life and 
a hospital was the last thing that was ever oan my mind to think about 
who was in it and what was happening, oh OK, if you need a hospital, 
you went tae a hospital but em, the things they dae in there, I mean 
there's two instances in one day that this guy had passed away, they 
brought him roond and then by the end oh the week he's sitting up 
quite jovial.  They found oot what the problem is like, you know 
something … so I mean that to me is a marvel, it‟s a wonder.  Life‟s a 
wonder.  The body‟s a … the body‟s a marvellous thing, you know … I 
mean if you, if you take poison, as long as you don‟t take too much 
poison it‟ll, it‟ll fight it.  Some oh your, some oh your, some your em 
tablets, as you know, are poisonous and they're feeding them tae yae, 
like Mickey Mouse sweeties [laughs], you know but it‟s, it‟s timed if you 
like, it‟s aw set so therefore it‟s doing the job it‟s supposed tae dae and 
your bodies coping with the poison.  If you get an infection, what's an 
infection – a bit of poison, if you get the cold it‟s maybe no poison, but 
it‟s an infection, it comes to the surface doesn‟t it.  The body‟s … 
generating it‟s ain reaction if you like, you know to keep you … so 
therefore that‟s what was driving me to that radiator,  my body was 
reacting, but the thermostat in my brain wis‟nae acting tae the rest oh 
my body, it was going the other way 
 
ROMA I'm interested to know why you described it as that was 
your, what was it… it was the only time I ever experienced a 
“real” experience  
 
 
Social 
comparison - 
coping 
 
 
 
 
Fear of death 
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Real experience, clusters of 
symptoms, not experienced it 
before, scared of what would 
happen – body alien to him - 
scared he was going to die 
Shaking, shivering, sweating  
 
Could not make sense of what 
was happening to him at this 
time 
 
Sense that he does not like his 
wife seeing him this way – 
tries to protect his family – not 
be a burden?  States in 
previous interview – wants to 
hide burden of illness from 
family 
 
Scared – lots of symptoms – 
never had an experience like 
this before - scared he was 
going to die?  Could not make 
sense of what was happening 
to him at this time –could not 
find a cause – clusters severe 
–feels death nearing  
 
 
DAN: aye 
 
ROMA … ???????????????????????? 
 
DAN: … that wis, well I did'nae know what wis wrong wi' me, I wis'nae 
in control there, I'm sitting there shaking, and really shaking so 
therefore I don‟t know, I'm, I'm cold … I'm cold and the beds bloody 
soaking.  So that‟s, this is a thing, you know – how am I sweating and 
I'm sitting here shaking wi' my back against the radiator.  Aw my clays 
were … in fact ???????????? was sitting oan my feet … my legs to stoap 
me fae shaking, that‟s how bad I was shaking and your saying to 
yourself, what a worrying experience this is like, you know, what's 
causing this?  So that‟s where the experience‟s coming fae, the wife‟s 
sitting here, she's sitting wi' his hands on my legs tae stoap my legs fae 
going [demonstrates shaking legs], they were rattling aff their ???????? 
 
ROMA right 
 
DAN: That‟s the experience 
 
ROMA How did that make you feel when all that was going on, 
what … ? 
 
DAN: Christ I did'nae know what I was feeling, you know, it did'nae, it 
wis'nae … you did'nae tend to say, how is this making me feel, it was a 
case oh what the bloody hell‟s causing this?  And at that time, we 
did'nae know it was the white cells or the red cells, my white cells were 
like 1.8 or something.  I had no resistance to infection as the report it 
was put to me; my resistance was zilch and I think it wis, I think my 
red cells was about 8, my white cells wis about 2 or something so it 
gies you an idea, that‟s disnae mean anything to me, but I've a lot of 
knowledge is dangerous they say.. but I'm learning as I go.  I'm, I'm 
getting more knowledge in as much as I now know the, the level your 
white cells should be at and the level your red cells should be at, 
 
 
 
Symptom 
clusters – 
threat of death 
nearing – real 
experience 
 
 
 
 
 
Being a burden 
 
 
Symptom 
clusters – loss 
of sense of self 
– body alien to 
him – not 
recognizing 
what was 
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Use of „we‟ 
Lots of knowledge of the 
condition now – does he feel 
more in control of things if he 
understands their cause? 
 
Building self-esteem – trying 
to demonstrate positive 
reflections of self – he has 
achieved this – feels good that 
he can help people 
 
 
 
 
Learning first aid so that had 
can help himself more – 
understand what is happening 
to him? 
 
 
 
 
 
 
Had attended first aid course 
for himself as well as others – 
to reduce any fear he is 
possibly that‟s because I've just oaf oh a, a First Aid Course through the 
work there to get my First Aiders Certificate, you go through aw this 
procedure over a period oh maybe three and half month, you know oor, 
oor training‟s quite, we go, we go out to get our training ken, but that 
is where you, you get they medical books and see when, see when I, 
Ok I'm getting ??????????? I was getting this em, I was going for this 
test, there were 10 oh us, you know I'm no bloody interested in First 
Aid, and for the first couple oh lessons it was boring to a certain extent 
because it wis away fae the norm, you know, but see as the time 
passed you goat your heed into the book … 
 
ROMA mmmm…. 
 
DAN: … and it does grip yae.  And they‟ll say “what do you do here” – 
oh you put them in the recovery position, you‟ll do this and you‟ll do 
that and do the next thing and now…I'm no saying I'm a professional, 
by no means but I'm a damn sight more knowledgeable - … 
 
ROMA You‟ve got a lot of knowledge 
 
DAN: … now, that I did'nae have three month prior, I mean three 
month prior, if somebody had dropped in the street, id have said, come 
oan – keep going, you‟ll no dae it noo, you‟ll no dae it noo, your, your 
will would‟nae let yae 
 
ROMA Mmm, cause you know….  
 
DAN: You know and as the, as the, as the guy that was taking it says, 
they will never believe you for no being able to help somebody, so don‟t 
be frightened – a lot oh peoples frightened to go up and say “can I 
help?” – never be frightened and that was one oh the things he pumped 
in, if anybody collapses roond aboot yae, never be frightened to go 
because you‟ll not be charged wi' anything, you know, you‟ve not 
administered anything, you‟ve only either sat them up, made them 
comfortable, put them I the recovery position, sent somebody for an 
happening to 
him 
 
 
Loss of sense 
of self – build 
self esteem 
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experiencing 
 
 
 
Lots of medical knowledge – 
understands why that episode 
happened now – makes him 
feel more in control? 
 
 
 
 
 
Building positive perceptions of 
self – feels good that he can 
do this – has achieved 
something 
 
 
 
 
 
 
 
Trying to do the right thing – 
not wanting to disappoint 
ambulance, or sent somebody for the medical profession.   You know 
and it‟s when you get into this kind of thing, you say to yourself, this is 
bloody marvellous and it does grip you.  So I now … that‟s where, I now 
know, well a little knowledge is dangerous but I now know how low 
your blood should be, how many pints oh bloods in your body, what 
your temperature, well I know my temperature anyway, but there's aw 
they kind oh things and when you put them aw the gither, body 
temperature 36, 36 .. you know, things, things, things … Christ things 
normally I would‟nae giving a monkey because they were just, I don‟t 
know, but ask now, and you‟ll rhyme them aff, and you will remember 
them for the rest of your life – I don‟t know why, in fact we had an 
incident, we had a guy, the boy that was ??????????????? the two oh 
them were on the same site and just – oooh, it‟s since you were here 
last … we had a guy he bought a house, he came in at … came in at 4 
o‟clock, he took a panic attack – asthma, panic attack and the big fella 
and I went doon, Ok we‟ll send out and ambulance eh, but the big fella, 
big B and I went doon and we comforted the guy and we actually 
talked, we put him in the recovery position and we talked to him oan 
his doorstep again…. so we sat and we put a towel doon and eh we sat 
and put him in the recovery position at the door and we talked to him, 
by the time the ambulance that guy had … he wis'nae right … they took 
him away in the ambulance – but, he was calm through talking.  The 
two oh us did'nae talk like, we just, I was feeding B and B was feeding 
me, but between, we did'nae confuse him, you know and we reckon we 
helped that guy, maybe we did'nae help the guy, we don‟t know ??..we 
took the credit of helping the guy… 
 
ROMA I'm sure you did, that‟s, that‟s … 
 
DAN: ?.........so that‟s, that‟s the kinda, that‟s where the little 
knowledge is dangerous [laughs] 
 
ROMA Oh good, sometimes it can, it can work for you and work 
against you 
 
Loss of sense 
of self – 
(building self 
esteem) 
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Loss of sense of self – life he 
had in the past is lost-realistic 
that he will never reach this 
again – sad – no quality to his 
life any longer – living is 
enough? 
Why point out that it was 
mentioned by his doctor – is it 
enough for him just to be 
alive- does the quality of his 
really matter to him?  Does 
not want to ask for too much? 
 
 
 
Emphasises this again – 
DAN: Aye, aye … that‟s me getting away fae the cancer again by the 
way 
 
ROMA No, no, it‟s all important, as I say it‟s all important, I 
mean I've very conscious that we‟ve gone on here … just that 
there's something, if you don‟t mind can we have a wee chat 
about this before we sort of finish off ... 
 
DAN: aye 
 
ROMA … but when we first started talking, we were just talking 
about normality and you said to me you says, you know I don‟t 
have, you know you said your quality of life that … 
 
DAN: Mmm mmm 
 
ROMA … oh, what was it again … 
 
DAN: Well as Dr R said to me, I would like to give you quality of life, 
you‟ve got the cancer, but he says we‟ll do what we can to give you 
quality of life.  Well quality of life to me is what I had before I had the 
cancer, which I‟ll never get noo, but you‟re looking for a s close to that 
or as damn near it as possible.  So the quality of life was never 
mentioned by me, it was brought up by the consultant who says to me 
we‟ll try and give you quality of life, that was after I had the shakes and 
Christ knows aw what wi' the first lot of chemo cause it was just, and I 
got the 3rd dose and it was the gold, it must have been too strong for 
my delicate stomach [laughs].  So eh, he's not, we‟ll try and give you 
quality … I‟d like to return quality of life to you if I can, I says thank 
you very much, so that‟s where the word “quality of life” came fae, that 
was not my wording, but that‟s where it‟s came fae, so tae me quality 
oh life is being going oan with your daily business to the best oh your 
ability with as little pain or suffering as possible is my interpretation of 
quality of life.  That I walk oot there, I walk doon that road there and if 
I could keep walking I‟ll keep walking and I‟ll walk back and I‟ll no have 
 
 
 
 
 
 
 
 
 
 
 
Fear of death 
– value of life 
 
 
 
Loss of sense 
of self 
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quality of life came from his 
doctor? Living is enough for 
him? 
 
 
 
Contrast to what he said above 
– work gives him some quality 
Work a significant coping 
mechanism for him 
 
Building self esteem – almost 
bragging that he still works – 
symbolic of him fighting 
disease and demonstrates to 
him that things are okay? 
Feels valued 
Feel fortunate that he has such 
a good employer 
 
 
Work gives him some quality 
of life 
 
 
 
 
any ups or downs, I've had a perfect day.  That is what I term quality, 
but the eh, initial eh, word – quality of life, did not come from me, it 
came from the consultant who wanted to return quality of life to my 
way of life 
 
ROMA If you don‟t mind…can you tell me why you feel you don‟t, 
you don‟t have a quality of life, is it from what you‟ve just told 
me there about?  
 
DAN: We have quality of life, we‟ve aw goat quality of life, I mean 
what you day every day is your life, what I day ever days is my life, I 
like my work, OK I may be bloody stupid but … Dr R maintains that my 
work has kept me going and there's no many firms like the firm that I  
work wi' that lets yae dae what I'm daing.  I mean I'm fortunate to 
have a company that does that…….I got to my work, if I don‟t feel it, I 
was told at the start – if you want to come to your work, come to your 
work – if you don‟t feel well in the middle of the day, jump in that 
motor and go hame 
 
ROMA That‟s great isn‟t it, that‟s good 
 
DAN: That‟s a lot … 
 
ROMA Mmm mmm 
 
DAN: … off your mind 
 
ROMA Yeah 
 
DAN: So that then gives you quality of life, because you are free to 
suit yourself and I've been told numerous times – you should‟nae be 
here, if you want to be here, we‟re no sending yae hame, if you don‟t 
feel right, you get in that motor and go hame … 
 
ROMA That‟s good 
 
 
 
 
Work – coping  
 
 
 
 
Loss of sense 
of self – build 
self esteem? 
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Sounds sad that he has no 
longer any quality of life 
 
 
 
 
 
 
 
 
 
 
Hiding the burden of his illness 
from others 
 
 
Found interview a positive 
experience – „it‟s been good‟ – 
not opened up to anyone 
before? 
 
 
DAN: … and don‟t tell anybody, just go … [slight pause] 
 
ROMA They must think very highly of you eh, to … ? 
 
DAN: They did say that 
ROMA Yes, yes 
 
DAN: Quality of life [slight pause] 
 
ROMA Mmm mmm.  Are you OK? 
 
DAN: Mmm mmm [sounds quite emotional] 
 
ROMA … do you want us to stop here then, yeah … that, that 
was really the only thing just cause you were talking about that 
I thought it would be good to hear what you thought about it, 
you know how, cause you raised it, so it was just to try and get 
a wee bit more understanding about it 
 
DAN: Was it … [sniffs] 
 
ROMA … what you thought about it and … 
 
DAN: Mmm 
 
ROMA … that‟s fair enough 
 
DAN: That‟s the first time I've been like that … [meaning being upset] 
 
ROMA mmmm… 
 
DAN: Mmm [still sounds emotional].  It‟s been good, mmm.  Anything 
else? 
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ROMA No, that was, you‟ve told me a lot and you‟ve explained a 
lot that was missing  
 
DAN: Sorry about that 
 
ROMA There's nothing to be sorry about … at all … do you want 
me, do you want me to switch that off … 
 
DAN: No, carry on 
 
ROMA I mean you‟ve, you‟ve told me lots, lots of … 
 
DAN: I don‟t think so 
 
ROMA Oh you have, honestly.  I wouldn‟t say that … 
 
DAN: I don‟t think you‟ve gained a lot fae me 
 
ROMA Oh I have.  Your experience is very special and it‟s really 
good to hear about it ..... 
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